data_2kp1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kp1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.47 ' CB ' ' HA ' ' A' ' 52' ' ' ALA . 13.9 Cg_endo . . . . . 0 C--O 1.24 0.591 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.558 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.7 p -67.42 130.1 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.806 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 m -73.52 106.45 5.31 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.377 0.608 . . . . 0.0 111.015 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.58 111.02 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 47.4 t -106.45 129.21 60.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 15' ' ' LYS . 15.5 m -79.94 172.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.63 -24.55 67.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.166 0.508 . . . . 0.0 110.419 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HG3' ' OD1' ' A' ' 16' ' ' ASN . 16.5 tptp -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.808 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 30.8 m-20 -99.96 -14.21 18.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.9 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HA ' HG11 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -51.02 -40.43 58.19 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -176.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.9 -11.09 59.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.269 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.5 pt-20 -106.45 -41.5 5.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.33 1.062 . . . . 0.0 111.198 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.412 HG12 ' HG3' ' A' ' 19' ' ' GLU . 31.7 mm -84.41 -57.33 4.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 CA-C-N 113.045 -1.888 . . . . 0.0 112.229 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.472 ' HA ' HG13 ' A' ' 28' ' ' VAL . 65.8 t -82.21 -32.77 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.442 0 CA-C-O 122.006 0.907 . . . . 0.0 111.578 -172.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 27.4 2.71 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.415 ' OD1' HG23 ' A' ' 25' ' ' THR . 52.1 t0 -94.32 139.6 30.87 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.775 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -105.79 15.2 27.1 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.127 0.571 . . . . 0.0 111.483 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.415 HG23 ' OD1' ' A' ' 23' ' ' ASP . 69.6 p -81.19 -13.07 58.96 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.42 0.629 . . . . 0.0 109.439 174.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -160.55 161.85 32.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.936 0.894 . . . . 0.0 108.61 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.631 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.1 m-20 -82.43 128.8 34.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' A' ' 21' ' ' VAL . 21.5 t -119.38 123.06 70.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.692 0.758 . . . . 0.0 111.612 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.461 HD12 ' OH ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -94.36 114.08 26.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 10.8 tt -108.53 144.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.284 -1.366 . . . . 0.0 112.739 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 38.4 tt0 -120.66 121.28 37.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.786 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 97.5 m-85 -91.43 121.85 33.5 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -141.26 -173.47 3.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.786 0.803 . . . . 0.0 112.314 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -142.92 148.49 45.86 Favored Pre-proline 0 N--CA 1.429 -1.509 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -83.93 -12.62 8.34 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.004 1.802 . . . . 0.0 110.463 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -95.56 0.95 53.56 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.605 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 53.8 t -83.37 117.24 22.89 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.562 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.47 -29.54 74.9 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.533 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 65.1 m80 -67.33 -39.92 85.88 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.43 -32.92 74.8 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.201 0.524 . . . . 0.0 110.489 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 64.4 mmtt -65.83 -18.68 65.5 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.612 0.72 . . . . 0.0 111.396 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.85 -11.76 21.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.895 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.734 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 97.0 mt -97.02 -26.74 14.9 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.267 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.63 97.33 Favored Pre-proline 0 C--N 1.284 -2.271 0 C-N-CA 124.665 1.186 . . . . 0.0 113.641 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.33 0.96 8.42 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.574 1.516 . . . . 0.0 112.781 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 13.2 pttm -109.4 -32.3 7.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.584 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.47 -43.9 20.1 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.293 -171.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.405 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 1.6 mp0 -79.56 -12.59 59.85 Favored 'General case' 0 N--CA 1.409 -2.515 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.564 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.97 -52.01 5.18 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.92 -34.5 64.39 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.37 93.89 Favored Glycine 0 CA--C 1.479 -2.209 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.771 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -58.39 -53.31 59.73 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -54.53 -42.59 71.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.61 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -76.77 -45.99 26.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.99 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.74 17.7 3.84 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 9.1 tppt? -128.93 -36.11 1.81 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.654 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 21.8 t -100.76 -155.53 0.52 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -57.21 -0.22 0.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -114.19 3.12 15.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 57' ' ' SER . 57.8 pttt -74.96 -6.33 48.69 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.892 0.853 . . . . 0.0 111.096 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.76 -2.34 17.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.371 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -117.78 -130.1 0.3 Allowed 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.441 ' CG2' HG22 ' A' ' 112' ' ' ILE . 2.1 p -53.88 130.62 15.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.697 0.761 . . . . 0.0 112.071 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -114.78 128.47 71.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.001 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 9' ' ' VAL . 40.9 mm -85.21 123.32 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -131.29 163.48 27.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 48.9 pttt -157.15 143.66 18.14 Favored 'General case' 0 CA--C 1.48 -1.73 0 O-C-N 121.87 -0.519 . . . . 0.0 112.303 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 10.9 p -121.69 144.3 31.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -84.67 113.55 21.37 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.72 -0.11 46.02 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.143 -171.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.7 t -127.3 -7.12 5.87 Favored 'General case' 0 N--CA 1.424 -1.757 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.767 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.74 -33.73 9.73 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -119.15 132.78 56.01 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.455 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.34 106.33 12.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -87.17 141.97 33.29 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.507 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.81 2.38 7.11 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 123.282 2.655 . . . . 0.0 110.598 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -79.33 -175.86 4.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.471 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -105.51 131.6 52.71 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 125.653 1.581 . . . . 0.0 109.012 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.3 mm -109.28 124.28 65.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.34 28.24 6.58 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.395 1.093 . . . . 0.0 112.441 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.6 -120.33 0.67 Allowed Glycine 0 C--N 1.296 -1.641 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.52 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 36.7 t80 -115.36 -52.55 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 165.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 6.3 Cg_exo -91.37 170.82 3.08 Favored 'Trans proline' 0 N--CA 1.423 -2.641 0 N-CA-C 109.42 -1.031 . . . . 0.0 109.42 165.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 83' ' ' PRO . 97.6 m -163.04 152.17 14.89 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.0 mt -121.91 137.3 55.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.467 ' O ' HG22 ' A' ' 30' ' ' ILE . 94.1 mttt -140.63 128.15 21.4 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.193 0.521 . . . . 0.0 110.73 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.4 tm? -98.53 117.02 32.01 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 20.7 m-85 -100.55 96.31 5.21 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.436 ' HA ' ' OD1' ' A' ' 27' ' ' ASP . 11.8 Cg_endo -66.52 160.39 46.08 Favored 'Trans proline' 0 CA--C 1.465 -2.936 0 C-N-CA 122.024 1.816 . . . . 0.0 111.67 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.31 77.12 8.22 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.0 -20.35 0.67 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.185 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.22 55.27 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.926 0.87 . . . . 0.0 111.462 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.45 -1.99 29.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.201 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.3 -16.2 35.68 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -138.47 63.88 35.88 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.508 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 84.0 Cg_exo -49.33 160.36 0.94 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.749 3.633 . . . . 0.0 113.196 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.3 t -96.51 97.93 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.3 t -74.52 132.91 42.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.46 168.53 19.56 Favored 'General case' 0 C--N 1.278 -2.51 0 C-N-CA 125.999 1.72 . . . . 0.0 108.975 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.3 m -115.56 -18.89 10.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.107 0.479 . . . . 0.0 110.567 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.77 115.13 1.82 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.915 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -83.67 -10.96 57.82 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 111.435 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 65.68 18.18 11.11 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.203 1.001 . . . . 0.0 113.011 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.0 t -138.3 150.94 47.11 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.292 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.48 -33.76 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 125.507 1.523 . . . . 0.0 109.632 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -58.25 -45.88 86.98 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 122.825 1.298 . . . . 0.0 109.957 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 25.9 t70 -73.7 -27.84 61.42 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 112.115 -2.312 . . . . 0.0 109.696 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.568 ' O ' HD13 ' A' ' 112' ' ' ILE . 17.5 mt -69.67 -43.36 72.7 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.26 -53.45 39.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 110' ' ' LYS . 2.7 tmmm? -60.64 -32.78 71.94 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.908 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.747 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -59.97 -71.17 0.14 Allowed 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.713 -176.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 108' ' ' LEU . 4.0 mp -70.9 -8.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.612 1.196 . . . . 0.0 109.34 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.83 -23.68 25.23 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.555 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 -37.7 4.51 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 122.122 0.963 . . . . 0.0 108.941 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.747 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 58.1 m-80 -87.22 -27.65 22.85 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 113.2 -1.818 . . . . 0.0 109.648 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.79 158.31 42.72 Favored Glycine 0 N--CA 1.408 -3.216 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -87.76 -26.01 23.12 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.631 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.9 m-85 -80.59 -16.19 54.75 Favored 'General case' 0 N--CA 1.388 -3.544 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.92 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 58.2 57.85 3.78 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.44 86.15 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.769 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.407 ' CG ' ' HA ' ' A' ' 48' ' ' GLU . 47.4 Cg_endo . . . . . 0 CA--C 1.516 -0.383 0 CA-C-O 121.792 0.663 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 p -81.11 124.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.926 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 48.1 m -63.11 108.96 1.36 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.746 0.784 . . . . 0.0 111.39 -173.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.5 t -79.15 107.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.71 129.01 56.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 15' ' ' LYS . 17.1 m -78.77 170.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.308 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -26.29 66.66 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 13' ' ' VAL . 32.0 tttm -55.72 -51.42 67.39 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.611 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.555 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -100.46 -3.89 29.98 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.355 -172.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -54.28 -38.69 66.17 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 26.1 p-10 -81.07 -5.2 57.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.592 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 12.3 pt-20 -106.26 -44.68 4.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.574 1.178 . . . . 0.0 110.841 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.437 HG12 ' HG3' ' A' ' 19' ' ' GLU . 23.2 mm -81.43 -54.74 9.39 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.367 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG23 HD11 ' A' ' 30' ' ' ILE . 83.9 t -81.34 -30.99 11.31 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 CA-C-O 121.28 0.562 . . . . 0.0 111.643 -174.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -95.16 32.17 1.77 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -96.75 151.65 19.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.09 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' HB3' ' HD3' ' A' ' 93' ' ' LYS . 7.7 p-10 -115.45 17.88 16.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.712 0.291 . . . . 0.0 111.512 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 p -71.36 -37.27 71.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HA ' ' CE1' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -146.66 176.23 10.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.559 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.9 m-20 -82.02 141.35 33.3 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 21' ' ' VAL . 38.2 t -126.01 119.53 54.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.732 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.457 ' HG ' HD22 ' A' ' 87' ' ' LEU . 9.2 mt -86.57 121.08 28.6 Favored 'General case' 0 CA--C 1.468 -2.211 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 21' ' ' VAL . 9.6 tt -114.0 144.87 20.69 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 117.518 -1.673 . . . . 0.0 110.289 173.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -129.83 113.61 14.89 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.356 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' ' 84' ' ' THR . 28.5 m-85 -78.91 134.2 36.9 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -145.02 -171.71 3.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.296 0.997 . . . . 0.0 110.435 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -141.98 155.94 65.42 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.403 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 22.3 Cg_endo -84.4 -16.35 5.9 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.641 1.56 . . . . 0.0 110.261 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.403 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 57.8 p-90 -96.18 2.86 53.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.039 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.677 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.5 t -84.43 119.05 24.68 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.489 -173.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.17 -23.94 76.08 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.433 ' O ' HD12 ' A' ' 43' ' ' LEU . 35.8 m80 -76.0 -42.69 47.3 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 122.722 -0.281 . . . . 0.0 111.472 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.677 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 20.5 p -68.5 -25.14 64.81 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.587 0.708 . . . . 0.0 109.911 -178.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 53.5 mtmt -75.3 -5.24 43.66 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.504 0.668 . . . . 0.0 110.863 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.7 -16.04 23.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 11.2 mp -93.27 -10.96 33.72 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.228 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.29 -45.27 54.64 Favored Pre-proline 0 C--N 1.287 -2.131 0 C-N-CA 125.005 1.322 . . . . 0.0 113.219 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -67.82 -30.92 32.92 Favored 'Trans proline' 0 C--N 1.378 2.107 0 CA-C-N 120.136 1.084 . . . . 0.0 110.92 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 2.2 ptmm? -75.38 -33.18 61.01 Favored 'General case' 0 C--O 1.201 -1.494 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 13.9 m-85 -68.75 -50.97 46.16 Favored 'General case' 0 CA--C 1.465 -2.323 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.031 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HA ' ' CG ' ' A' ' 8' ' ' PRO . 41.4 mt-10 -69.73 -36.47 75.89 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.219 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 17.1 mm-40 -85.28 -46.61 10.85 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.086 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.441 HD23 HG11 ' A' ' 105' ' ' VAL . 2.4 tm? -76.16 -39.52 54.74 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.71 -30.66 59.47 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 118.781 -1.676 . . . . 0.0 112.754 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -68.4 -47.12 68.15 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.363 173.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 89.5 mt -62.62 -41.11 98.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.253 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.458 ' HH ' HG12 ' A' ' 109' ' ' ILE . 3.7 m-85 -80.47 -46.88 15.16 Favored 'General case' 0 N--CA 1.414 -2.236 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.926 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.76 12.71 12.2 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 45.6 mtmt -134.47 -19.37 1.89 Allowed 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 123.235 0.614 . . . . 0.0 112.556 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 50.6 m -100.53 -170.84 1.92 Allowed 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.24 9.87 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.75 -5.26 29.01 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.4 pttp -76.91 -11.1 59.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.236 1.017 . . . . 0.0 109.221 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.67 -16.91 26.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.51 -133.9 0.34 Allowed 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 3.1 p -58.6 133.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.74 0.781 . . . . 0.0 112.752 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.97 133.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.1 mm -95.18 113.2 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 10' ' ' THR . . . -118.47 156.97 28.12 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 123.529 0.518 . . . . 0.0 110.567 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -147.63 140.51 24.9 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 p -126.2 141.0 47.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -88.11 115.81 25.85 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.42 -12.62 59.98 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.93 0.892 . . . . 0.0 112.288 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 t -112.85 -18.73 12.2 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.281 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.04 -26.23 18.43 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -133.0 95.62 3.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.331 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.08 133.61 49.25 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.795 0.807 . . . . 0.0 111.657 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.69 152.05 42.64 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.251 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.07 -1.63 9.4 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 123.506 2.804 . . . . 0.0 112.11 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' CG ' ' HZ2' ' A' ' 86' ' ' LYS . 38.8 t70 -83.42 144.13 29.81 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.432 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.75 133.6 35.14 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.408 0.623 . . . . 0.0 109.47 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.606 HG23 ' OG1' ' A' ' 84' ' ' THR . 31.2 mt -111.03 128.13 67.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.706 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.488 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 1.7 mp0 -68.24 -36.36 79.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.22 -126.35 3.76 Favored Glycine 0 C--N 1.295 -1.704 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 79' ' ' ILE . 11.8 t80 -112.91 -49.04 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 6.1 Cg_exo -88.62 168.19 5.95 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.436 1.424 . . . . 0.0 110.226 168.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.606 ' OG1' HG23 ' A' ' 79' ' ' ILE . 22.9 m -161.6 138.04 8.21 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 19.8 mt -106.75 139.74 27.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 50.6 mtmt -143.5 121.87 12.35 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 121.061 0.458 . . . . 0.0 110.136 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.457 HD22 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tm? -98.25 112.87 24.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.545 ' CE2' ' HG3' ' A' ' 96' ' ' PRO . 27.5 m-85 -97.22 97.76 4.1 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 27' ' ' ASP . 19.3 Cg_endo -70.0 161.94 44.07 Favored 'Trans proline' 0 CA--C 1.468 -2.791 0 C-N-CA 121.557 1.505 . . . . 0.0 111.719 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.84 77.64 7.7 Favored 'General case' 0 N--CA 1.399 -2.975 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.01 -19.92 0.75 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.237 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.404 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -135.06 39.61 2.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.897 0.856 . . . . 0.0 110.529 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.447 ' HD3' ' HB3' ' A' ' 24' ' ' ASP . 42.1 pttt -67.45 -5.67 15.92 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.638 1.175 . . . . 0.0 110.872 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.96 -20.58 49.53 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.05 67.68 27.22 Favored Pre-proline 0 N--CA 1.433 -1.288 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.545 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 22.9 Cg_exo -49.26 164.71 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 124.298 3.332 . . . . 0.0 113.056 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 18.6 t -92.78 89.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -73.14 126.11 29.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.176 -1.375 . . . . 0.0 111.782 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.67 176.0 9.25 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.658 -174.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -108.82 -53.23 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.59 136.87 2.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.728 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.6 p -108.37 -7.95 15.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 20.5 ttp85 65.81 8.37 5.24 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.911 0.885 . . . . 0.0 112.234 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.402 HG21 ' HB3' ' A' ' 107' ' ' ASP . 4.7 t -123.56 146.88 47.79 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.653 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.441 HG11 HD23 ' A' ' 50' ' ' LEU . 78.2 t -77.78 -35.35 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 125.687 1.595 . . . . 0.0 110.078 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -62.92 -43.83 97.73 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.198 0.999 . . . . 0.0 110.45 -173.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.7 t70 -69.25 -28.76 66.61 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 113.261 -1.79 . . . . 0.0 109.988 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.474 HD13 ' NZ ' ' A' ' 46' ' ' LYS . 32.3 mt -68.98 -46.12 68.88 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.458 HG12 ' HH ' ' A' ' 54' ' ' TYR . 64.0 mt -55.15 -53.86 30.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.559 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 22.2 tptp -62.64 -25.16 67.97 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.74 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.3 t80 -69.11 -62.35 1.42 Allowed 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.441 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.4 mt -71.63 -9.82 13.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.554 1.169 . . . . 0.0 108.544 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.92 -19.71 23.01 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.534 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 42.8 mt-10 -110.42 -43.27 3.92 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 122.461 1.124 . . . . 0.0 108.361 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.737 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 60.8 m-80 -85.27 -29.74 24.36 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.017 -1.902 . . . . 0.0 109.909 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.9 149.29 28.09 Favored Glycine 0 N--CA 1.397 -3.965 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.617 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -89.78 -20.24 23.76 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.186 0.993 . . . . 0.0 108.774 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.559 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 21.3 m-85 -85.24 -5.46 59.32 Favored 'General case' 0 N--CA 1.393 -3.295 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.602 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 48.76 52.43 14.06 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.545 1.153 . . . . 0.0 110.871 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.03 93.15 3.24 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.269 2.089 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.459 -0.549 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 65' ' ' ILE . 2.3 p -69.64 129.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.554 -1.203 . . . . 0.0 107.922 175.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -76.18 110.65 10.85 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.872 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.5 105.83 6.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 16' ' ' ASN . 47.6 t -108.59 114.15 45.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 15' ' ' LYS . 31.3 m -68.91 168.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -23.18 65.49 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.258 0.552 . . . . 0.0 110.918 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HB3' HG21 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -60.95 -46.01 92.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.189 174.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 13.8 m-20 -99.96 -13.51 19.08 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.936 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.425 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.02 -33.44 25.15 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -74.47 -13.2 60.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.045 0.45 . . . . 0.0 111.624 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.6 pt-20 -105.96 -52.47 2.8 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.642 0.734 . . . . 0.0 110.92 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.456 HG12 ' HG3' ' A' ' 19' ' ' GLU . 20.6 mm -74.35 -57.83 5.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.889 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 28' ' ' VAL . 91.6 t -74.93 -33.27 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.23 1.014 . . . . 0.0 110.777 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.0 tp -96.06 23.72 6.22 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.548 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD1' HG22 ' A' ' 25' ' ' THR . 7.6 t70 -75.02 167.69 21.43 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.522 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -115.94 -3.71 12.12 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.202 -0.936 . . . . 0.0 112.679 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.454 HG22 ' OD1' ' A' ' 23' ' ' ASP . 14.8 t -111.74 3.16 17.58 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.204 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 25' ' ' THR . 66.1 mmtt -135.64 138.75 43.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 71.0 m-20 -76.47 116.9 17.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 171.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 21' ' ' VAL . 39.9 t -112.92 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.714 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.408 ' HG ' HD22 ' A' ' 87' ' ' LEU . 8.0 mt -84.12 124.63 31.34 Favored 'General case' 0 CA--C 1.464 -2.361 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 13.3 tt -116.1 143.76 25.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.229 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HB3' ' CB ' ' A' ' 67' ' ' LYS . 29.2 tt0 -115.78 117.18 29.5 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 95.1 m-85 -84.44 121.11 27.11 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -141.47 -171.53 3.33 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.865 0.841 . . . . 0.0 112.705 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.79 154.17 32.64 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.415 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 11.2 Cg_endo -80.7 -20.51 7.84 Favored 'Trans proline' 0 CA--C 1.505 -0.932 0 C-N-CA 121.675 1.583 . . . . 0.0 109.947 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.415 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 64.7 p-90 -91.82 4.69 52.28 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.125 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.78 117.19 22.5 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.829 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.3 -35.75 92.07 Favored Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.537 ' O ' HD12 ' A' ' 43' ' ' LEU . 79.6 t60 -65.32 -45.36 84.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.806 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.89 -41.52 91.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -70.94 -2.93 16.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.477 ' O ' ' HE2' ' A' ' 46' ' ' LYS . . . -102.23 -22.17 14.22 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.658 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 10.8 mp -92.44 -16.26 26.11 Favored 'General case' 0 C--O 1.195 -1.805 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.005 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.59 92.6 Favored Pre-proline 0 C--N 1.275 -2.639 0 C-N-CA 124.702 1.201 . . . . 0.0 112.967 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.8 Cg_exo -63.75 -35.21 58.64 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.14 1.226 . . . . 0.0 111.632 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -81.75 -30.97 32.19 Favored 'General case' 0 C--O 1.177 -2.754 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.905 -175.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.658 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -77.53 -29.6 52.41 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.065 -174.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -83.43 -29.55 27.99 Favored 'General case' 0 C--O 1.191 -1.982 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.964 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.566 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 52.6 mt-10 -79.95 -45.06 19.18 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.909 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.99 -39.1 63.9 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.39 -37.06 90.09 Favored Glycine 0 CA--C 1.479 -2.169 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.027 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -64.88 -50.79 65.17 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 96.0 mt -57.49 -40.11 77.91 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -76.99 -46.75 22.83 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.655 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.63 19.44 2.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -137.15 -27.49 0.97 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.885 -0.509 . . . . 0.0 110.358 176.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.695 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 27.5 t -94.38 -157.07 0.53 Allowed 'General case' 0 C--O 1.208 -1.127 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.79 1.56 0.86 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.15 2.61 21.15 Favored 'General case' 0 CA--C 1.481 -1.709 0 O-C-N 121.336 -0.853 . . . . 0.0 109.118 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.0 pttp -75.21 -9.34 58.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 122.204 1.002 . . . . 0.0 109.546 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -104.53 -0.58 27.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.041 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.75 -132.33 0.24 Allowed 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.42 HG21 HG23 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -43.3 128.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.49 1.516 . . . . 0.0 112.798 176.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -107.61 131.54 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.438 ' O ' HG21 ' A' ' 9' ' ' VAL . 40.7 mm -95.3 118.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 172.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -133.13 161.26 34.89 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.029 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.458 ' CB ' ' HB3' ' A' ' 31' ' ' GLU 0.256 61.4 pttt -156.41 146.95 21.64 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.17 140.37 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.893 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.11 115.65 22.49 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.27 -4.97 55.4 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.986 0.914 . . . . 0.0 112.26 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -118.34 -15.43 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.288 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.91 -33.03 12.34 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -118.57 118.02 30.55 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.27 114.6 12.82 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.955 0.884 . . . . 0.0 109.43 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.11 143.06 25.47 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.48 -3.15 6.71 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 123.016 2.477 . . . . 0.0 110.417 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.24 174.67 4.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.739 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -103.87 118.87 37.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.528 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.04 139.87 19.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.95 0.9 . . . . 0.0 109.083 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.34 -16.35 24.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.33 -94.39 0.17 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.515 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 51.9 t80 -128.15 -51.42 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.7 Cg_endo -94.5 168.82 1.76 Allowed 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 120.93 1.087 . . . . 0.0 109.661 166.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.3 m -163.35 143.32 8.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 31.6 mt -107.38 134.93 47.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -136.38 132.5 35.62 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 3.3 tm? -101.88 115.07 29.74 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -99.58 96.18 4.32 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HG2' ' C ' ' A' ' 92' ' ' ALA . 11.8 Cg_endo -64.69 160.07 42.12 Favored 'Trans proline' 0 CA--C 1.46 -3.183 0 C-N-CA 122.066 1.844 . . . . 0.0 112.157 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -79.16 78.23 5.63 Favored 'General case' 0 N--CA 1.397 -3.08 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.263 173.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.71 -33.06 0.82 Allowed Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.697 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 94' ' ' GLY . . . -121.78 37.16 4.43 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.625 0.726 . . . . 0.0 111.349 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -69.0 16.69 0.05 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.27 1.028 . . . . 0.0 112.708 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -117.1 -2.46 18.37 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.457 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 13.6 pt20 -135.1 45.32 1.39 Allowed Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 115.215 -0.493 . . . . 0.0 109.987 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 69.6 Cg_exo -44.56 155.95 0.25 Allowed 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 124.549 3.5 . . . . 0.0 115.577 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.56 97.52 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 t -75.6 127.58 33.39 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.282 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 149.11 45.13 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.287 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.5 m -84.2 -30.35 25.85 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.33 0.586 . . . . 0.0 109.55 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.11 104.74 2.75 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.7 m -70.45 -5.78 31.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.718 0.807 . . . . 0.0 113.17 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 27.3 ttp180 64.22 29.2 13.93 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.233 1.016 . . . . 0.0 110.509 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 107' ' ' ASP . 7.3 p -123.68 159.33 29.59 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.689 -0.632 . . . . 0.0 111.881 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.73 -40.48 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.569 0.748 . . . . 0.0 109.137 174.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.461 ' HA ' HD13 ' A' ' 109' ' ' ILE . 23.7 mt-10 -65.44 -38.56 90.25 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 122.657 1.218 . . . . 0.0 110.03 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.9 t70 -76.5 -22.35 54.6 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.317 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.34 -44.98 64.02 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.096 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 106' ' ' GLU . 70.8 mt -53.47 -53.46 24.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 48.4 mmtt -70.02 -13.98 62.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.791 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -71.3 -63.77 1.05 Allowed 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.476 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 2.5 mt -69.52 -12.82 16.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 122.615 1.198 . . . . 0.0 108.503 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -88.26 -27.93 21.43 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.331 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -113.76 -27.61 7.73 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.712 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.791 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.4 m-80 -92.57 -27.69 17.2 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.583 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.25 160.21 47.67 Favored Glycine 0 N--CA 1.406 -3.327 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.824 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 90' ' ' ALA . 48.7 mtpt -93.68 -23.71 18.14 Favored 'General case' 0 CA--C 1.474 -1.957 0 CA-C-N 118.392 1.096 . . . . 0.0 109.537 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.607 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 4.7 m-85 -77.99 -15.84 58.61 Favored 'General case' 0 N--CA 1.405 -2.682 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.989 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 56.52 59.26 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.78 78.69 0.45 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -173.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.688 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.6 Cg_endo . . . . . 0 CA--C 1.507 -0.828 0 CA-C-O 121.753 0.647 . . . . 0.0 111.79 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.432 HG23 ' C ' ' A' ' 65' ' ' ILE . 1.8 p -83.25 129.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.99 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.734 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 m -69.15 105.93 2.65 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.995 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -78.21 109.88 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 16' ' ' ASN . 43.2 t -113.63 115.36 49.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 15' ' ' LYS . 18.4 m -72.34 170.17 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.42 -3.12 13.06 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.528 0.68 . . . . 0.0 111.546 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.442 ' HB3' HG21 ' A' ' 13' ' ' VAL . 3.2 tppp? -78.27 -35.65 47.79 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.125 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.444 ' HB2' HG11 ' A' ' 12' ' ' VAL . 11.6 m-20 -112.02 -8.87 14.03 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.817 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.45 -27.84 27.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 9.9 p30 -83.71 -9.92 58.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 108.834 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -46.5 4.1 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.574 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.14 -49.87 13.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.317 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 30' ' ' ILE . 88.5 t -79.59 -26.91 12.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-O 121.53 0.681 . . . . 0.0 111.447 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -99.49 26.79 5.77 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-O 122.514 1.15 . . . . 0.0 108.552 -175.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.21 149.41 44.63 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.689 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.19 9.63 14.69 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.524 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -115.38 6.55 14.86 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.861 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -160.1 158.73 30.84 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.564 0.746 . . . . 0.0 108.994 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.8 m-20 -86.9 123.4 31.99 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 47.4 t -114.65 117.11 54.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.626 -0.671 . . . . 0.0 112.506 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HG ' HD21 ' A' ' 87' ' ' LEU . 6.6 mt -89.12 111.02 21.69 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 10.6 tt -103.6 143.6 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.33 -1.348 . . . . 0.0 112.208 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' CD ' ' HZ3' ' A' ' 67' ' ' LYS . 28.3 tt0 -117.66 113.16 21.49 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.148 175.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.434 ' CD1' HD12 ' A' ' 79' ' ' ILE . 96.6 m-85 -77.69 124.08 27.49 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 169.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.537 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 17.6 p90 -139.7 -176.96 4.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.304 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -147.31 148.07 30.49 Favored Pre-proline 0 N--CA 1.418 -2.071 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.403 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 9.7 Cg_endo -79.68 -20.78 9.02 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 121.365 1.377 . . . . 0.0 110.361 -173.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.403 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 1.9 p90 -97.53 8.01 45.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.247 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 27.7 t -81.76 124.04 29.29 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.971 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.85 99.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.347 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -68.28 -35.91 78.58 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.014 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 47.2 t -65.91 -37.1 85.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.34 0.59 . . . . 0.0 110.163 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.9 mtmt -71.38 -10.0 59.06 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.405 0.621 . . . . 0.0 111.116 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.77 -21.76 17.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.215 1.007 . . . . 0.0 109.061 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.671 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 95.7 mt -87.56 -23.42 24.35 Favored 'General case' 0 C--O 1.177 -2.761 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.51 -52.67 57.74 Favored Pre-proline 0 C--N 1.267 -3.021 0 C-N-CA 125.13 1.372 . . . . 0.0 114.151 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.51 -27.12 23.27 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 121.31 1.34 . . . . 0.0 112.353 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 3.8 ptpp? -85.67 -32.46 21.96 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.671 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -76.44 -33.48 58.76 Favored 'General case' 0 N--CA 1.402 -2.858 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.314 -171.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 46.4 mt-10 -83.11 -20.88 34.0 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.65 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.2 tt0 -86.14 -49.24 7.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.86 -36.79 64.88 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.86 -36.42 81.88 Favored Glycine 0 CA--C 1.476 -2.352 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.044 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -61.3 -55.05 36.22 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 88.4 mt -61.94 -39.66 92.86 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.617 -176.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 3.3 m-85 -84.16 -20.18 32.89 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.13 22.23 13.09 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.9 tppt? -142.5 -42.05 0.33 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.39 0.614 . . . . 0.0 110.036 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 44.7 m -88.53 -156.25 0.37 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.18 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.35 17.04 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -126.31 -1.97 6.93 Favored 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 121.477 -0.765 . . . . 0.0 109.874 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 23.2 pttm -70.45 -7.65 44.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.311 1.053 . . . . 0.0 110.059 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.55 -6.43 20.58 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.682 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -115.13 -48.14 2.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.147 0.975 . . . . 0.0 110.854 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.52 155.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.036 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 53.3 t -135.96 127.83 44.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 172.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.432 ' C ' HG23 ' A' ' 9' ' ' VAL . 32.1 mm -93.82 126.67 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.2 165.66 20.89 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.565 0.346 . . . . 0.0 111.556 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.442 ' HZ3' ' CD ' ' A' ' 31' ' ' GLU . 23.4 mtpp -144.39 148.74 35.07 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.68 135.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -82.63 106.85 14.82 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 -11.97 59.92 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 123.845 0.858 . . . . 0.0 112.023 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -105.43 -15.03 15.13 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.495 0.664 . . . . 0.0 111.01 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.16 -28.78 11.26 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -126.57 111.97 14.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.915 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.94 127.73 33.24 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.58 148.55 37.95 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.347 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -84.84 -6.78 9.59 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.859 2.373 . . . . 0.0 111.189 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.51 137.69 38.05 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.294 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -82.76 140.37 33.06 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.309 0.576 . . . . 0.0 110.306 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.516 HG22 ' OG1' ' A' ' 84' ' ' THR . 55.4 mt -126.9 132.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 124.225 1.01 . . . . 0.0 108.803 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -73.94 -29.32 61.96 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.54 0.685 . . . . 0.0 110.647 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.62 -114.37 1.9 Allowed Glycine 0 C--N 1.299 -1.503 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.5 t80 -123.84 -53.4 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.826 171.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -89.99 155.47 4.88 Favored 'Trans proline' 0 N--CA 1.419 -2.855 0 CA-C-N 120.154 1.091 . . . . 0.0 109.936 169.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.516 ' OG1' HG22 ' A' ' 79' ' ' ILE . 6.9 m -163.85 140.44 6.78 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.538 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 30.2 mt -107.89 134.65 49.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 86.8 mttt -135.86 129.46 32.39 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.461 HD21 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -100.46 115.97 31.32 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -99.27 97.84 5.87 Favored Pre-proline 0 C--N 1.292 -1.894 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HA ' ' OD1' ' A' ' 27' ' ' ASP . 11.3 Cg_endo -70.04 161.83 44.49 Favored 'Trans proline' 0 CA--C 1.465 -2.962 0 C-N-CA 121.986 1.791 . . . . 0.0 111.076 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.05 77.22 6.76 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-O 123.004 1.383 . . . . 0.0 109.107 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.15 -34.84 0.72 Allowed Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.779 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 89' ' ' PRO . . . -112.8 33.19 5.15 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.912 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 0.92 1.5 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.286 1.434 . . . . 0.0 112.787 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.76 -12.15 28.83 Favored Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.423 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 4.0 pt20 -134.63 51.07 5.58 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 122.87 0.468 . . . . 0.0 110.982 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 17.2 Cg_exo -45.28 157.08 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 124.512 3.475 . . . . 0.0 114.818 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 22.0 t -90.27 97.08 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.906 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -75.9 128.55 35.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.086 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.27 166.13 25.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.692 -172.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.5 t -98.85 -33.91 10.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 143.24 172.52 14.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.517 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.503 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.9 m -128.55 150.17 50.3 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -98.88 34.28 2.13 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.83 0.824 . . . . 0.0 109.692 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -146.11 149.13 33.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.209 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.4 -29.63 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.291 0.567 . . . . 0.0 109.513 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.14 -45.38 93.24 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 122.236 1.017 . . . . 0.0 110.126 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 26.3 t70 -71.97 -24.27 61.56 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.63 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.5 mt -71.92 -44.56 63.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.857 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.22 -51.49 62.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -68.06 -20.32 64.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.798 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.746 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.7 OUTLIER -69.06 -64.48 0.86 Allowed 'General case' 0 C--O 1.183 -2.416 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.416 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.0 mt -67.3 -15.28 19.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 122.758 1.266 . . . . 0.0 108.286 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.81 -21.22 29.98 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.816 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -117.87 -40.1 3.04 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 122.051 0.929 . . . . 0.0 109.818 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.746 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.5 m-80 -80.28 -26.08 39.1 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.916 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.41 164.58 45.68 Favored Glycine 0 N--CA 1.404 -3.448 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.238 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -94.23 -26.26 16.72 Favored 'General case' 0 CA--C 1.458 -2.572 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.445 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.8 m-85 -83.63 -11.64 57.02 Favored 'General case' 0 N--CA 1.379 -3.992 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.39 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 53.86 60.46 3.63 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.458 1.099 . . . . 0.0 108.772 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -47.82 24.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.274 -2.683 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 CA--C 1.516 -0.418 0 N-CA-C 107.191 -1.888 . . . . 0.0 107.191 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.509 HG22 ' C ' ' A' ' 65' ' ' ILE . 1.5 p -68.2 133.58 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.725 171.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 m -66.05 102.75 0.84 Allowed 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 121.448 0.642 . . . . 0.0 110.153 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.55 102.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 55.2 t -98.72 126.52 51.86 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.884 0 C-N-CA 125.915 1.686 . . . . 0.0 107.443 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 15' ' ' LYS . 27.7 m -79.03 173.87 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.21 -17.53 64.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.885 0.374 . . . . 0.0 110.916 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 13' ' ' VAL . 33.5 tttm -65.67 -45.14 84.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.401 0.62 . . . . 0.0 110.546 171.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 61.2 m-20 -93.79 -10.14 35.16 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.775 -165.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -58.9 -37.28 76.27 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.477 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 8.6 p30 -79.83 -7.22 58.56 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.867 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.9 pt-20 -105.75 -51.39 3.0 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 122.019 0.914 . . . . 0.0 110.882 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.464 HG12 ' HG3' ' A' ' 19' ' ' GLU . 35.4 mm -80.02 -52.96 13.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.409 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 28' ' ' VAL . 60.7 t -82.95 -21.24 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 CA-C-O 122.025 0.917 . . . . 0.0 111.002 -173.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -100.72 29.0 4.75 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.64 133.11 34.84 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -105.5 21.18 17.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -105.3 -8.25 18.37 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.291 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.406 ' HD2' HG21 ' A' ' 64' ' ' VAL . 20.3 pttm -154.81 159.55 40.66 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.835 0.854 . . . . 0.0 108.78 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 79.0 m-20 -80.93 120.31 24.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 21' ' ' VAL . 22.3 t -111.65 119.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.045 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.406 ' HG ' HD22 ' A' ' 87' ' ' LEU . 10.5 mt -88.07 123.21 32.53 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 9.3 tt -113.66 149.25 16.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 117.806 -1.557 . . . . 0.0 110.447 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.466 ' OE1' ' HB3' ' A' ' 43' ' ' LEU . 35.2 tt0 -130.66 113.17 13.85 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.371 0.605 . . . . 0.0 109.844 175.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.492 ' HD1' ' O ' ' A' ' 84' ' ' THR . 95.7 m-85 -75.33 131.68 40.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 173.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.498 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.8 p90 -147.67 -173.25 4.23 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.709 0.766 . . . . 0.0 111.652 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -150.52 148.1 23.06 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.91 -16.87 8.56 Favored 'Trans proline' 0 CA--C 1.499 -1.269 0 C-N-CA 122.13 1.887 . . . . 0.0 110.299 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -91.19 -1.12 57.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.705 -1.588 . . . . 0.0 111.267 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 45.2 t -86.31 117.85 25.38 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.127 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.74 -28.82 73.47 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.623 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 20.1 t60 -63.14 -46.25 88.1 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 30.9 t -60.93 -33.06 72.57 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.252 0.548 . . . . 0.0 111.368 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 41.8 mmtt -63.68 -12.12 31.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.42 16.83 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.928 1.347 . . . . 0.0 108.862 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 39' ' ' HIS . 10.2 mp -99.0 -22.86 15.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.604 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -68.79 -44.28 30.49 Favored Pre-proline 0 C--N 1.283 -2.312 0 C-N-CA 124.637 1.175 . . . . 0.0 113.296 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 51.2 Cg_endo -64.5 -16.56 55.83 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.569 1.513 . . . . 0.0 113.116 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.08 -28.47 12.69 Favored 'General case' 0 CA--C 1.473 -2.015 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.647 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -73.87 -39.41 63.96 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.12 -174.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.17 -20.85 43.86 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 119.703 -0.799 . . . . 0.0 113.112 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.3 tt0 -85.44 -46.45 10.89 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -73.2 -40.89 64.38 Favored 'General case' 0 CA--C 1.467 -2.231 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.21 94.6 Favored Glycine 0 CA--C 1.461 -3.296 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.133 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.49 -56.09 25.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.4 mt -59.75 -43.01 94.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.194 -175.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.64 -42.72 33.81 Favored 'General case' 0 C--O 1.188 -2.153 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.55 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.1 16.54 8.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.0 tppt? -130.87 -33.01 1.61 Allowed 'General case' 0 C--N 1.316 -0.848 0 O-C-N 122.049 -0.407 . . . . 0.0 110.538 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.571 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 14.3 t -96.08 -160.82 0.82 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.222 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.16 15.19 0.07 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.541 1.136 . . . . 0.0 113.434 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.42 ' H ' ' C ' ' A' ' 57' ' ' SER . 13.4 m-85 -118.05 -3.16 11.14 Favored 'General case' 0 C--O 1.194 -1.868 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 57' ' ' SER . 60.8 pttt -71.75 -4.18 26.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.835 0.826 . . . . 0.0 112.848 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -110.35 -9.59 14.63 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -98.0 -49.96 4.57 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.239 1.019 . . . . 0.0 109.352 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.2 t -137.26 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.058 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.406 HG21 ' HD2' ' A' ' 26' ' ' LYS . 53.7 t -124.75 130.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.509 ' C ' HG22 ' A' ' 9' ' ' VAL . 34.9 mm -94.68 122.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -132.51 158.61 41.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 122.578 0.351 . . . . 0.0 110.703 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -151.93 139.36 19.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.654 -0.654 . . . . 0.0 109.955 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 11.1 p -116.44 139.87 41.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -85.58 110.28 19.13 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.84 -9.73 59.56 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 124.077 0.861 . . . . 0.0 112.331 -172.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -109.93 -18.17 13.45 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.436 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.28 -32.91 11.66 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -123.28 101.62 7.47 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.82 116.11 4.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.301 0.572 . . . . 0.0 110.6 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -91.96 144.97 30.05 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.502 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -90.24 0.11 5.41 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.168 2.579 . . . . 0.0 112.246 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -78.53 -179.02 6.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.071 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.66 106.37 14.43 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.017 0.913 . . . . 0.0 109.974 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.527 HG22 ' OG1' ' A' ' 84' ' ' THR . 43.9 mt -96.56 136.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.103 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -9.17 53.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.16 -116.46 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.502 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 78.3 t80 -118.16 -58.84 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.77 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.5 Cg_exo -87.85 156.67 7.38 Favored 'Trans proline' 0 N--CA 1.425 -2.519 0 CA-C-N 120.385 1.173 . . . . 0.0 109.414 167.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.527 ' OG1' HG22 ' A' ' 79' ' ' ILE . 17.6 m -159.25 136.93 10.1 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.843 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 42.8 mt -101.64 137.43 29.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.53 121.96 19.43 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.0 tm? -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 16.6 m-85 -96.57 100.43 7.1 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HA ' ' OD1' ' A' ' 27' ' ' ASP . 12.7 Cg_endo -65.97 159.36 49.53 Favored 'Trans proline' 0 CA--C 1.463 -3.045 0 C-N-CA 121.812 1.674 . . . . 0.0 109.92 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.6 77.23 8.47 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.892 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.18 -39.24 0.45 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 113.0 -1.909 . . . . 0.0 110.269 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -109.46 58.18 0.61 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.242 1.02 . . . . 0.0 110.493 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 8.13 3.36 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.167 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.53 -1.85 9.05 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.598 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 47.8 mt-30 -133.12 46.74 2.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.42 0.688 . . . . 0.0 110.803 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 85.6 Cg_exo -54.1 156.25 13.46 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 123.561 2.841 . . . . 0.0 113.245 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 t -95.37 95.68 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.133 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -72.19 128.45 35.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.434 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.44 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -141.31 170.85 14.95 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 125.289 1.436 . . . . 0.0 109.502 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.5 t -108.13 -31.13 8.05 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.162 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.65 110.79 0.61 Allowed Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.591 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.1 m -62.69 -26.43 68.66 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 123.751 0.821 . . . . 0.0 111.838 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 64.61 17.72 11.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.987 0.915 . . . . 0.0 112.254 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -152.04 153.41 33.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.258 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.2 -39.19 28.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 124.676 1.19 . . . . 0.0 109.739 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -55.75 -47.69 76.55 Favored 'General case' 0 C--O 1.251 1.184 0 C-N-CA 124.926 1.29 . . . . 0.0 110.936 -172.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.5 t70 -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.758 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 23.0 mt -70.7 -39.97 73.13 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.571 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.42 -52.62 54.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -70.07 -15.77 63.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.742 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.3 t80 -71.51 -62.74 1.3 Allowed 'General case' 0 C--O 1.191 -1.983 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.497 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.2 mt -65.94 -13.72 16.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.871 1.319 . . . . 0.0 108.015 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 111' ' ' PHE . . . -82.81 -33.5 27.2 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.681 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -109.06 -35.21 6.38 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.929 0.871 . . . . 0.0 109.39 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.742 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.7 m-80 -86.07 -30.0 22.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.267 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.91 163.92 51.3 Favored Glycine 0 N--CA 1.406 -3.331 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.873 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.433 ' HZ1' ' HB3' ' A' ' 117' ' ' LYS . 10.2 mtpm? -98.9 -23.33 15.38 Favored 'General case' 0 CA--C 1.452 -2.799 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.629 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.475 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.9 m-85 -80.04 -14.09 58.81 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.516 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 55.78 56.1 6.43 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 124.184 0.927 . . . . 0.0 110.011 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.37 38.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.43 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.482 0.828 0 CA-C-O 121.663 0.61 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.556 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.3 p -73.0 133.12 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.927 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 18.9 m -74.9 107.96 7.32 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 121.735 0.778 . . . . 0.0 111.129 -173.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.73 108.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.8 t -109.82 110.49 32.33 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.643 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 16.3 m -69.81 166.97 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.66 -23.53 63.14 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.152 0.501 . . . . 0.0 110.698 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB3' ' CG2' ' A' ' 13' ' ' VAL . 44.2 tttp -59.97 -42.4 94.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.396 173.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HB2' HG13 ' A' ' 12' ' ' VAL . 20.0 m-20 -105.75 -9.88 17.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.491 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -54.07 -27.52 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -86.46 -8.15 57.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.303 1.049 . . . . 0.0 108.939 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -105.86 -43.19 4.94 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.693 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mm -94.06 -54.7 6.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.466 HG22 HD11 ' A' ' 30' ' ' ILE . 78.3 t -72.98 -25.51 22.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 CA-C-O 121.885 0.85 . . . . 0.0 112.077 -174.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 22' ' ' LEU . 1.7 tm? -99.8 16.32 24.04 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 122.502 1.144 . . . . 0.0 108.974 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.47 150.7 23.59 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.122 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.519 ' HB3' ' CE ' ' A' ' 93' ' ' LYS . 6.3 p-10 -115.29 17.09 16.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -90.85 -14.23 32.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.677 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HG3' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.06 161.15 42.92 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.156 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 m-20 -78.47 126.21 30.44 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 21' ' ' VAL . 33.5 t -115.37 115.29 48.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.412 ' HG ' HD22 ' A' ' 87' ' ' LEU . 8.8 mt -85.72 128.51 34.81 Favored 'General case' 0 CA--C 1.467 -2.243 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 12.7 tt -115.9 144.76 22.8 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 C-N-CA 118.026 -1.469 . . . . 0.0 110.564 171.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -125.41 112.25 16.07 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -78.14 126.91 31.5 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.564 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.7 p90 -144.03 -175.79 4.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.111 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.1 144.23 21.18 Favored Pre-proline 0 N--CA 1.42 -1.954 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -80.1 -17.81 10.37 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 121.627 1.551 . . . . 0.0 110.249 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -89.65 1.16 56.39 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.638 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 42.0 t -83.68 118.89 24.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.346 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.11 -38.29 94.14 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.552 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.8 m80 -68.11 -36.99 80.65 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.857 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 34.8 t -64.91 -34.83 79.34 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.797 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 56.5 mtmt -69.07 -15.27 63.41 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.542 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.54 -10.31 32.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.075 0.94 . . . . 0.0 109.438 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 78.7 mt -97.77 -13.51 21.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.858 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.77 90.81 Favored Pre-proline 0 C--N 1.255 -3.543 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.531 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.44 -12.58 20.68 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.355 1.37 . . . . 0.0 113.059 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 9.8 ptmm? -92.27 -32.24 15.1 Favored 'General case' 0 CA--C 1.466 -2.268 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.556 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -82.95 -41.48 18.77 Favored 'General case' 1 N--CA 1.378 -4.075 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.078 -171.876 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -73.69 -42.39 61.32 Favored 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.682 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.632 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 tt0 -74.79 -38.4 62.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.791 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 108' ' ' LEU . 24.3 tp -72.79 -40.18 66.1 Favored 'General case' 0 CA--C 1.472 -2.027 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.66 96.69 Favored Glycine 0 CA--C 1.473 -2.573 0 CA-C-N 113.559 -1.655 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.78 -53.53 49.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.0 mt -52.35 -39.1 60.29 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 124.169 0.918 . . . . 0.0 110.968 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.281 4.1 m-30 -77.79 -49.86 13.49 Favored 'General case' 0 C--O 1.187 -2.213 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.071 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.513 ' C ' ' HE2' ' A' ' 56' ' ' LYS . . . -76.1 6.91 4.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -120.39 -43.97 2.49 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 124.369 1.068 . . . . 0.0 109.304 -177.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -91.68 -169.59 2.34 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -76.86 28.93 0.13 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -122.51 4.18 9.62 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -65.42 -16.65 63.84 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -119.35 5.09 11.18 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.735 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -95.33 -45.57 7.08 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.532 1.158 . . . . 0.0 109.245 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -135.0 142.99 38.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.866 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.391 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' A' ' 26' ' ' LYS . 51.4 t -119.21 119.54 61.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 9' ' ' VAL . 40.7 mm -86.6 116.14 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.737 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -127.24 160.71 30.45 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.174 0.511 . . . . 0.0 111.32 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -153.78 145.18 23.09 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 122.015 -0.428 . . . . 0.0 110.24 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.38 140.79 47.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.63 109.18 17.79 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.33 60.43 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.292 1.037 . . . . 0.0 112.681 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 t -111.36 -18.1 12.98 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.571 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.58 -30.37 13.33 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -131.53 83.29 2.09 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 131.52 46.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.849 0.833 . . . . 0.0 110.102 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.13 156.86 36.58 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.531 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.43 -7.69 11.72 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.768 2.312 . . . . 0.0 110.469 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -67.42 153.25 44.12 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.114 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.89 126.88 39.35 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -124.51 128.8 73.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.794 0.331 . . . . 0.0 110.479 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -81.03 -27.71 35.68 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.121 0.568 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.13 -120.22 3.83 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.527 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.3 t80 -133.22 -58.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.1 Cg_endo -87.67 149.33 7.37 Favored 'Trans proline' 0 N--CA 1.424 -2.613 0 CA-C-N 120.252 1.126 . . . . 0.0 109.188 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -162.45 149.99 13.9 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.6 mt -110.37 138.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 91.3 mttt -137.21 128.42 27.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.511 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 3.4 tm? -101.34 115.07 29.67 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.427 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 7.6 m-85 -98.67 97.51 4.93 Favored Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 88' ' ' TYR . 19.5 Cg_endo -66.65 158.1 57.62 Favored 'Trans proline' 0 CA--C 1.464 -3.01 0 C-N-CA 121.993 1.796 . . . . 0.0 111.14 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.94 77.91 8.71 Favored 'General case' 0 N--CA 1.394 -3.258 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.69 -23.17 0.34 Allowed Glycine 0 N--CA 1.422 -2.246 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.231 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.34 61.11 1.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.539 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.519 ' CE ' ' HB3' ' A' ' 24' ' ' ASP . 19.7 ptpt -77.81 5.28 9.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.283 0.633 . . . . 0.0 110.536 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.65 -11.83 25.94 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.419 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.0 pt20 -130.71 48.23 3.55 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 122.789 0.436 . . . . 0.0 110.831 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 28.8 Cg_exo -46.51 150.4 2.34 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.285 2.656 . . . . 0.0 113.365 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 18.7 t -93.82 98.92 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.542 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.1 t -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.447 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.48 160.0 40.65 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.938 -169.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 p -87.37 -58.71 2.48 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.531 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.16 121.77 4.77 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -80.54 22.3 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 59.41 22.12 10.55 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 t -137.73 159.13 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 122.282 -0.261 . . . . 0.0 110.343 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.0 t -77.18 -29.42 17.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 124.045 0.938 . . . . 0.0 110.257 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.24 -45.71 90.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 123.331 1.538 . . . . 0.0 108.869 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -62.1 -35.97 80.32 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 111.302 -2.681 . . . . 0.0 109.305 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.423 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.2 mt -75.16 -43.53 51.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.49 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.6 mt -55.14 -52.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -66.01 -22.87 66.47 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.382 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.738 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.5 OUTLIER -67.34 -63.73 1.0 Allowed 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.523 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.5 mt -71.81 -8.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.494 1.14 . . . . 0.0 108.953 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.8 -28.98 15.59 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.313 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.17 -43.92 6.46 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.738 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 61.4 m-80 -85.84 -29.93 23.35 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.166 -1.833 . . . . 0.0 109.833 -174.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -74.15 155.77 49.47 Favored Glycine 1 N--CA 1.392 -4.243 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.915 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -94.82 -23.11 17.63 Favored 'General case' 0 CA--C 1.468 -2.175 0 CA-C-O 121.753 0.787 . . . . 0.0 109.195 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.526 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 17.2 m-85 -82.21 -9.73 59.4 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 51.81 51.88 15.68 Favored 'General case' 0 C--N 1.365 1.242 0 C-N-CA 124.325 1.05 . . . . 0.0 110.376 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -75.1 90.42 2.51 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.185 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 C--O 1.245 0.839 0 N-CA-C 109.536 -0.986 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 65' ' ' ILE . 1.5 p -69.91 125.56 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 12' ' ' VAL . 20.2 m -72.96 106.72 4.97 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.0 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.6 114.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 16' ' ' ASN . 83.5 t -116.62 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.409 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 16.2 m -71.88 173.51 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.638 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.02 -26.95 66.5 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.471 0.708 . . . . 0.0 110.852 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB3' HG21 ' A' ' 13' ' ' VAL . 30.4 tttm -62.08 -50.99 69.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 54.0 m-20 -86.85 -14.49 41.92 Favored 'General case' 0 CA--C 1.464 -2.356 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.196 -168.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.404 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 6.7 t80 -57.79 -32.14 67.25 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -78.87 -17.93 54.78 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.9 pt-20 -104.49 -45.16 4.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.415 1.102 . . . . 0.0 111.213 -173.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.465 HG12 ' HG3' ' A' ' 19' ' ' GLU . 33.7 mm -83.91 -54.35 9.17 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.486 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.466 ' HA ' HG11 ' A' ' 28' ' ' VAL . 61.1 t -81.62 -37.15 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 121.474 0.654 . . . . 0.0 111.278 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.8 35.07 1.16 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.51 ' OD2' ' HD3' ' A' ' 26' ' ' LYS . 17.6 t70 -86.87 151.79 23.02 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.143 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.74 14.35 16.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 p -101.67 -23.12 14.29 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.319 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.51 ' HD3' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -142.33 164.85 29.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.527 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 74.4 m-20 -81.63 120.02 24.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.9 t -115.1 121.02 66.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.728 0.775 . . . . 0.0 111.227 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 tp -93.33 124.94 37.67 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 12.4 tt -115.1 147.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 C-N-CA 117.596 -1.642 . . . . 0.0 112.953 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 27.3 tt0 -117.15 114.37 23.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.419 ' HD2' ' O ' ' A' ' 84' ' ' THR . 97.4 m-85 -83.84 124.15 30.65 Favored 'General case' 0 CA--C 1.464 -2.344 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 170.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -142.41 -172.5 3.63 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.311 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.99 150.7 39.55 Favored Pre-proline 0 N--CA 1.419 -2.006 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -78.65 -20.12 10.87 Favored 'Trans proline' 0 CA--C 1.5 -1.223 0 C-N-CA 121.391 1.394 . . . . 0.0 110.152 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -89.28 -2.78 58.6 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.489 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 47.0 t -77.11 118.52 19.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.467 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.73 -37.23 93.92 Favored Glycine 0 C--O 1.236 0.225 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -64.84 -42.13 95.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.918 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.7 t -62.55 -43.14 99.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.079 0.466 . . . . 0.0 110.704 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 49.5 mtmt -66.65 -18.44 65.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.601 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 -18.96 25.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.596 0.712 . . . . 0.0 109.424 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.602 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 72.6 mt -88.47 -26.86 21.86 Favored 'General case' 0 C--O 1.196 -1.752 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.372 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.11 -51.57 61.08 Favored Pre-proline 0 C--N 1.286 -2.171 0 C-N-CA 125.813 1.645 . . . . 0.0 114.299 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -66.01 -30.81 47.47 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.066 1.178 . . . . 0.0 111.319 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' CB ' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -87.45 -28.9 21.81 Favored 'General case' 0 CA--C 1.43 -3.65 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.243 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.602 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -73.83 -36.33 64.91 Favored 'General case' 0 N--CA 1.386 -3.651 0 O-C-N 123.78 0.675 . . . . 0.0 109.61 -174.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.93 -49.48 61.55 Favored 'General case' 0 C--O 1.193 -1.912 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.595 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.622 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 40.8 mt-10 -75.15 -33.26 61.5 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -173.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 108' ' ' LEU . 13.0 tp -73.15 -41.69 63.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.81 -43.07 99.65 Favored Glycine 0 CA--C 1.475 -2.437 0 CA-C-N 112.922 -1.945 . . . . 0.0 112.271 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -62.8 -52.05 64.71 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 84.2 mt -60.35 -36.68 78.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.746 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.251 2.0 m-85 -76.42 -50.95 12.82 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 116.932 -1.907 . . . . 0.0 110.873 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -83.6 22.76 1.03 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -151.07 -31.26 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 176.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 m -87.06 -85.78 0.16 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.36 -5.33 9.87 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -126.41 23.48 6.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 19.3 pttp -69.89 -15.42 63.07 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.351 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -116.26 15.9 15.86 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -131.97 -110.46 0.24 Allowed 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 119.909 -0.717 . . . . 0.0 110.984 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.9 t -55.51 129.45 16.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 123.499 0.72 . . . . 0.0 111.853 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -114.48 123.99 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.022 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.5 mm -89.33 118.55 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -126.14 165.9 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -155.83 144.72 20.49 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 122.077 -0.389 . . . . 0.0 110.744 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.7 p -127.05 145.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.78 111.89 22.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.11 -14.7 61.02 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 t -107.98 -6.27 16.68 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.258 0.551 . . . . 0.0 111.492 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.05 -48.26 2.99 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -100.56 101.1 11.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.09 117.12 8.68 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.091 0.472 . . . . 0.0 110.886 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.24 150.0 36.32 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.626 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -89.94 -4.41 5.32 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.029 2.486 . . . . 0.0 112.273 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' CG ' ' HZ1' ' A' ' 86' ' ' LYS . 36.6 t70 -69.43 144.87 53.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.856 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.48 113.29 22.3 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.641 0.734 . . . . 0.0 109.455 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.51 HG23 ' OG1' ' A' ' 84' ' ' THR . 55.3 mt -106.32 144.93 14.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.373 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -80.78 -17.24 51.56 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.885 0.85 . . . . 0.0 111.318 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -144.38 -112.19 0.81 Allowed Glycine 0 C--N 1.278 -2.673 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.489 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 48.2 t80 -123.21 -54.68 0.03 OUTLIER Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.28 171.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.9 Cg_endo -89.36 155.06 5.48 Favored 'Trans proline' 0 N--CA 1.429 -2.284 0 CA-C-N 120.307 1.145 . . . . 0.0 110.324 170.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.51 ' OG1' HG23 ' A' ' 79' ' ' ILE . 15.9 m -165.84 143.3 5.56 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.7 mt -105.86 133.57 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.504 ' HZ1' ' CG ' ' A' ' 77' ' ' ASP . 94.4 mttt -135.95 124.02 22.92 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.193 0.52 . . . . 0.0 110.392 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.421 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 3.4 tm? -98.47 115.33 28.3 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -95.92 98.16 3.67 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.427 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -68.54 158.32 58.16 Favored 'Trans proline' 0 CA--C 1.461 -3.145 0 C-N-CA 121.586 1.524 . . . . 0.0 110.302 178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.91 77.47 8.73 Favored 'General case' 0 N--CA 1.402 -2.834 0 C-N-CA 118.632 -1.227 . . . . 0.0 107.974 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.95 -34.1 0.44 Allowed Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.915 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.65 35.98 4.71 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.109 0.957 . . . . 0.0 109.963 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 2.73 1.4 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 125.523 1.529 . . . . 0.0 112.126 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.15 25.94 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.4 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 4.0 pt20 -137.34 54.52 8.34 Favored Pre-proline 0 CA--C 1.578 2.034 0 C-N-CA 123.724 0.809 . . . . 0.0 110.808 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 12.9 Cg_exo -45.06 160.61 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 125.014 3.809 . . . . 0.0 115.137 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.4 98.6 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.329 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 14.2 t -73.52 132.49 42.93 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.651 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.71 164.41 30.29 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.184 -174.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -87.35 -68.55 0.74 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.74 129.17 1.26 Allowed Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -71.63 -37.19 70.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 117.195 0.498 . . . . 0.0 110.821 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 65.96 17.43 10.8 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.284 1.033 . . . . 0.0 111.375 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -150.18 161.7 41.89 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' A' ' 46' ' ' LYS . 61.8 t -86.2 -43.23 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.04 0.447 . . . . 0.0 109.955 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -54.4 -39.36 67.18 Favored 'General case' 0 N--CA 1.396 -3.165 0 C-N-CA 126.188 1.795 . . . . 0.0 112.665 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.6 t70 -80.75 -23.38 39.45 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.511 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 112' ' ' ILE . 17.3 mt -74.7 -41.6 59.91 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.713 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.62 -51.52 70.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -65.8 -21.34 66.48 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.029 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.754 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -68.22 -65.51 0.69 Allowed 'General case' 0 C--O 1.186 -2.27 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 108' ' ' LEU . 3.1 mt -67.72 -12.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.517 1.151 . . . . 0.0 108.806 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.77 -22.2 24.69 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.05 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -114.78 -35.39 4.84 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 122.261 1.029 . . . . 0.0 109.166 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.754 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 57.6 m-80 -88.97 -21.93 23.29 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.478 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.16 163.9 41.79 Favored Glycine 0 N--CA 1.404 -3.452 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.749 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.427 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 12.0 mmmm -93.68 -24.71 17.76 Favored 'General case' 0 CA--C 1.457 -2.61 0 CA-C-N 118.228 1.014 . . . . 0.0 108.406 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.527 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 20.6 m-85 -81.41 -14.0 57.64 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.549 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 54.68 55.91 7.37 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 123.989 0.806 . . . . 0.0 109.101 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.65 82.18 0.43 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.265 1.892 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.626 176.698 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 17.8 Cg_endo . . . . . 0 CA--C 1.509 -0.771 0 CA-C-O 121.673 0.614 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG23 ' CD2' ' A' ' 47' ' ' TYR . 1.6 p -70.44 118.61 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.904 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.926 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 m -63.23 107.11 0.99 Allowed 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.571 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.7 t -79.99 109.82 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.23 128.77 64.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 15' ' ' LYS . 18.9 m -75.27 166.94 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -60.99 -21.72 63.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 110.587 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HB3' HG23 ' A' ' 13' ' ' VAL . 46.0 tptt -62.44 -52.87 61.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.34 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -95.56 -3.33 46.69 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.524 -174.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -56.46 -24.05 43.05 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -87.96 -8.89 55.04 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 10.8 mt-10 -104.53 -51.74 3.03 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.363 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.63 -51.12 14.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.361 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' HG11 ' A' ' 28' ' ' VAL . 60.3 t -83.31 -28.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.88 0.848 . . . . 0.0 110.709 -172.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.56 26.35 6.22 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.212 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.72 141.32 28.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.574 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -109.0 21.64 16.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.4 p -93.07 -17.41 23.86 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.679 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -150.09 166.05 30.94 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 73.8 m-20 -80.52 130.42 35.13 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 21' ' ' VAL . 24.8 t -119.69 118.4 57.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.334 -0.854 . . . . 0.0 112.005 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.418 ' HG ' HD23 ' A' ' 87' ' ' LEU . 9.4 mt -87.8 116.34 25.88 Favored 'General case' 0 CA--C 1.473 -1.983 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.475 HG21 ' O ' ' A' ' 86' ' ' LYS . 12.6 tt -106.07 145.23 14.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 118.089 -1.445 . . . . 0.0 110.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HB3' ' HG2' ' A' ' 67' ' ' LYS . 37.1 tt0 -127.94 109.59 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.447 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 95.9 m-85 -73.01 128.38 35.29 Favored 'General case' 0 CA--C 1.465 -2.305 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.515 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 27.3 p90 -142.76 -170.95 3.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 124.014 0.821 . . . . 0.0 111.242 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -148.34 144.61 18.88 Favored Pre-proline 0 C--N 1.289 -2.06 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.56 -22.52 12.1 Favored 'Trans proline' 0 CA--C 1.503 -1.041 0 C-N-CA 121.629 1.553 . . . . 0.0 110.419 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -97.36 3.58 51.02 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 113.129 -1.85 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 36.7 t -77.76 129.31 35.33 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.62 99.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.549 ' O ' HD11 ' A' ' 43' ' ' LEU . 8.5 m-70 -65.42 -44.34 87.69 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.092 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 35.4 t -56.48 -41.15 76.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.201 0.524 . . . . 0.0 110.519 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.8 mtmt -73.17 -2.75 22.88 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.013 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -107.37 -18.65 13.81 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.857 1.313 . . . . 0.0 108.411 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.549 HD11 ' O ' ' A' ' 39' ' ' HIS . 10.6 mp -96.93 -11.02 25.18 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.504 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -46.89 47.55 Favored Pre-proline 0 C--N 1.278 -2.518 0 C-N-CA 125.754 1.621 . . . . 0.0 113.935 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -60.51 -29.54 88.83 Favored 'Trans proline' 0 C--N 1.381 2.253 0 CA-C-N 120.983 1.387 . . . . 0.0 111.926 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 2.6 pttm -84.56 -31.48 24.35 Favored 'General case' 0 C--O 1.188 -2.167 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.742 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.519 ' CD2' HG23 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -79.3 -33.37 43.33 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.003 -174.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.491 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 35.3 mm-40 -70.04 -48.19 58.94 Favored 'General case' 0 C--O 1.185 -2.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.7 tt0 -71.41 -47.41 56.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.211 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.58 -39.3 73.97 Favored 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.55 95.27 Favored Glycine 0 CA--C 1.467 -2.945 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.86 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.24 -55.73 22.47 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 95.9 mt -56.7 -43.62 80.71 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.665 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -78.89 -41.88 28.63 Favored 'General case' 0 C--O 1.194 -1.825 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.6 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.67 16.58 6.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 6.3 tppt? -128.46 -36.87 1.85 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.127 -0.358 . . . . 0.0 110.523 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.541 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 10.5 m -87.42 -168.4 2.22 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -174.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -74.78 22.97 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.404 0.621 . . . . 0.0 112.567 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 57' ' ' SER . 19.5 m-85 -120.96 2.1 10.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 57' ' ' SER . 58.8 pttt -74.75 -0.27 17.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.017 0.913 . . . . 0.0 112.242 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -120.21 4.53 10.81 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.672 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.452 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 76.6 ttt180 -99.15 -48.89 4.68 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.757 1.265 . . . . 0.0 107.734 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 2.5 p -147.57 138.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.175 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.404 HG23 ' HG3' ' A' ' 26' ' ' LYS . 78.2 t -117.07 131.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.425 ' C ' HG21 ' A' ' 9' ' ' VAL . 37.9 mm -93.41 119.11 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -126.94 165.76 18.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.358 0.599 . . . . 0.0 111.907 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.421 ' HG2' ' HB3' ' A' ' 31' ' ' GLU . 56.1 mtmt -143.96 160.61 40.53 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.68 144.62 21.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 172.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -88.18 118.41 27.75 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.18 54.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.025 0.53 . . . . 0.0 111.907 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -119.63 -23.63 6.49 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.602 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.49 -24.3 14.82 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.77 97.49 5.74 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.73 111.88 1.14 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.151 0.501 . . . . 0.0 111.258 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.32 143.22 26.01 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.932 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -94.09 2.18 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.326 2.684 . . . . 0.0 109.981 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -80.14 165.58 22.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.32 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -88.65 123.38 33.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.422 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.8 mm -105.43 140.43 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.627 1.171 . . . . 0.0 108.125 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.9 -29.21 16.03 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.36 0.6 . . . . 0.0 110.479 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.01 -108.5 1.15 Allowed Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.52 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 t80 -117.82 -53.16 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 166.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 3.2 Cg_exo -90.45 162.2 4.45 Favored 'Trans proline' 0 N--CA 1.43 -2.245 0 C-N-CA 121.151 1.234 . . . . 0.0 109.244 164.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 97.8 m -161.32 141.13 10.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 33.9 mt -106.36 128.97 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.475 ' O ' HG21 ' A' ' 30' ' ' ILE . 41.2 mtmt -135.34 129.18 33.02 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 121.292 0.568 . . . . 0.0 109.645 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.4 tm? -100.38 117.7 35.11 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -98.98 97.55 5.21 Favored Pre-proline 0 C--N 1.291 -1.978 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.457 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 14.3 Cg_endo -68.03 160.68 47.56 Favored 'Trans proline' 0 CA--C 1.464 -2.989 0 C-N-CA 121.973 1.782 . . . . 0.0 111.746 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.54 77.43 8.4 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 122.638 1.208 . . . . 0.0 108.564 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.02 -39.25 0.56 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.915 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 94' ' ' GLY . . . -113.66 31.23 6.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.492 0.663 . . . . 0.0 110.864 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 13.61 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.658 1.183 . . . . 0.0 113.677 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -108.03 -13.08 20.72 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -140.03 70.27 35.24 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 123.981 0.912 . . . . 0.0 108.558 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.4 Cg_exo -49.31 160.24 0.96 Allowed 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 123.926 3.084 . . . . 0.0 113.428 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 54.1 t -100.53 104.16 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.43 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 t -75.23 132.19 40.91 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.632 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 146.53 39.66 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.714 -175.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -73.69 -59.31 2.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.491 0.662 . . . . 0.0 110.49 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.55 125.69 0.85 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.2 m -71.06 -41.54 70.6 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 60.99 26.09 16.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.371 1.081 . . . . 0.0 108.93 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.7 t -161.51 157.37 24.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.908 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.9 -37.12 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 124.18 0.992 . . . . 0.0 110.005 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -57.78 -45.16 86.37 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.277 1.036 . . . . 0.0 110.918 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -68.32 -31.0 70.11 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.794 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 27.8 mt -72.16 -42.75 65.58 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.311 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.61 -51.05 70.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -21.5 66.32 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.88 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.725 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -69.98 -61.33 1.82 Allowed 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.428 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 2.5 mt -69.48 -9.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.579 1.181 . . . . 0.0 108.281 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 111' ' ' PHE . . . -91.04 -24.4 20.06 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.869 -177.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -104.4 -39.7 6.35 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-O 123.225 1.488 . . . . 0.0 108.71 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.725 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 59.3 m-80 -95.6 -26.14 15.88 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.432 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.36 157.63 40.75 Favored Glycine 0 N--CA 1.403 -3.525 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.922 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.471 ' HB3' ' HZ3' ' A' ' 117' ' ' LYS . 4.3 mmmp? -88.39 -27.28 21.7 Favored 'General case' 0 CA--C 1.466 -2.251 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.503 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 26.0 m-85 -79.98 -11.2 59.81 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.242 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 55.32 45.9 24.6 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 124.244 0.965 . . . . 0.0 109.396 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . . . -67.05 86.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.005 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.11 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 43.5 Cg_endo . . . . . 0 CA--C 1.503 -1.048 0 CA-C-O 121.777 0.657 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.4 p -83.65 137.66 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.1 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.929 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 m -75.01 93.92 2.79 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 122.248 1.023 . . . . 0.0 110.378 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.23 104.52 3.59 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.386 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 13' ' ' VAL . 23.4 t -102.21 141.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.448 ' O ' HG11 ' A' ' 12' ' ' VAL . 20.6 m -85.24 170.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -59.93 -31.22 69.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.073 0.463 . . . . 0.0 110.294 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HB3' HG21 ' A' ' 13' ' ' VAL . 29.4 tttm -53.93 -39.79 66.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.152 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.483 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -110.45 -2.54 16.51 Favored 'General case' 0 C--O 1.208 -1.109 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.744 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 2.7 t80 -58.6 -30.93 67.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 8.5 p30 -77.93 -13.19 59.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 12.3 pt-20 -106.57 -44.75 4.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.404 1.097 . . . . 0.0 111.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' HG3' ' A' ' 19' ' ' GLU . 19.0 mm -79.16 -54.88 10.81 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.677 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.487 ' HA ' HG11 ' A' ' 28' ' ' VAL . 60.1 t -84.72 -29.66 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 121.62 0.724 . . . . 0.0 111.304 -173.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -97.94 32.37 2.41 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.698 ' OD2' HG21 ' A' ' 25' ' ' THR . 30.6 t70 -96.57 150.01 21.13 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.162 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -116.86 20.33 13.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.698 HG21 ' OD2' ' A' ' 23' ' ' ASP . 13.9 t -98.64 -3.67 35.58 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.475 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HA ' ' CE2' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -150.9 161.99 41.64 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.1 m-20 -81.46 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.2 t -118.04 121.62 67.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.148 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.431 ' HG ' HD21 ' A' ' 87' ' ' LEU . 9.9 mt -90.31 116.79 28.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.633 HG13 ' N ' ' A' ' 31' ' ' GLU . 1.5 tp -104.45 145.28 13.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.633 ' N ' HG13 ' A' ' 30' ' ' ILE . 41.2 tt0 -126.39 104.34 8.12 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 124.151 0.907 . . . . 0.0 108.589 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 84' ' ' THR . 98.3 m-85 -76.34 128.03 34.04 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -142.47 -175.39 4.44 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.949 0.881 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 37' ' ' CYS . . . -138.36 153.25 72.68 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 174.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 59.8 Cg_endo -84.16 -14.78 7.0 Favored 'Trans proline' 0 C--N 1.326 -0.607 0 CA-C-N 121.8 1.678 . . . . 0.0 110.665 -173.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.425 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 56.3 p-90 -96.64 4.58 51.83 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.624 -1.626 . . . . 0.0 111.772 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 46.4 t -80.63 121.57 26.0 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.628 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.83 92.85 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 46.5 m80 -60.72 -45.26 94.95 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 15.0 p -70.74 -25.7 63.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.952 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 56.3 mtmt -74.48 -20.59 59.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.6 0.714 . . . . 0.0 110.228 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.36 -9.83 37.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.672 1.225 . . . . 0.0 108.248 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 39' ' ' HIS . 81.0 mt -97.83 -11.92 22.75 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.036 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.45 -50.5 73.15 Favored Pre-proline 0 C--N 1.255 -3.509 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.546 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.13 -16.5 31.9 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 121.453 1.435 . . . . 0.0 113.052 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HD3' ' HA ' ' A' ' 43' ' ' LEU . 8.8 ptmm? -86.58 -38.49 17.09 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -82.11 -26.51 33.51 Favored 'General case' 0 N--CA 1.396 -3.13 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.117 -171.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.58 -33.08 54.01 Favored 'General case' 0 C--O 1.18 -2.583 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.241 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -83.45 -47.86 10.94 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 tp -64.64 -46.25 83.33 Favored 'General case' 0 CA--C 1.469 -2.147 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.75 -20.54 73.63 Favored Glycine 0 CA--C 1.474 -2.505 0 CA-C-N 114.172 -1.376 . . . . 0.0 114.987 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.592 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -71.7 -50.41 30.62 Favored 'General case' 0 CA--C 1.477 -1.856 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.59 -45.13 69.33 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.165 -173.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 42.2 m-85 -74.91 -27.67 60.31 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.88 16.1 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -136.86 -33.05 0.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.441 -0.162 . . . . 0.0 111.163 176.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 22.2 m -84.62 -164.31 0.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.81 28.06 0.17 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.9 3.52 5.97 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 22.6 pttp -72.56 -12.56 61.11 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.805 0.812 . . . . 0.0 111.048 -174.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -109.85 5.65 22.73 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -106.22 -49.77 3.29 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.372 1.082 . . . . 0.0 109.1 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 2.5 p -138.82 135.58 43.0 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.172 -1.831 . . . . 0.0 109.309 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.58 127.28 69.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 9' ' ' VAL . 31.8 mm -90.56 121.19 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.656 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -130.06 161.37 31.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.282 0.563 . . . . 0.0 111.701 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -152.03 145.29 24.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.83 139.69 50.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 109.71 -176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -82.18 101.48 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.39 -9.08 58.38 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.389 1.075 . . . . 0.0 112.412 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 t -105.84 -19.72 13.66 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.726 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.36 -42.76 9.12 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -113.11 102.77 10.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.012 -1.449 . . . . 0.0 107.529 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -67.71 135.1 52.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.91 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 32' ' ' PHE . 29.7 m -113.53 143.23 28.99 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.26 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.05 -8.57 16.59 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 123.303 2.669 . . . . 0.0 113.759 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.45 174.2 10.84 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.91 139.91 35.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.399 0.619 . . . . 0.0 109.626 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.583 HG23 ' OG1' ' A' ' 84' ' ' THR . 59.5 mt -123.39 117.06 50.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -74.85 -9.41 58.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.56 -140.11 4.9 Favored Glycine 0 C--N 1.3 -1.433 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.508 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 4.9 t80 -100.54 -50.44 0.19 Allowed Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -92.58 171.12 2.41 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 121.097 1.198 . . . . 0.0 110.291 167.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.583 ' OG1' HG23 ' A' ' 79' ' ' ILE . 3.1 m -169.17 146.8 3.67 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 49.7 mt -110.63 140.5 29.48 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.324 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 30' ' ' ILE . 65.7 mttm -140.26 127.6 21.26 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.431 HD21 ' HG ' ' A' ' 29' ' ' LEU . 3.1 tm? -102.07 111.95 24.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 15.2 m-85 -94.75 101.9 7.89 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HA ' ' OD1' ' A' ' 27' ' ' ASP . 11.8 Cg_endo -65.65 161.03 40.5 Favored 'Trans proline' 0 CA--C 1.464 -2.986 0 C-N-CA 121.658 1.572 . . . . 0.0 110.051 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.401 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -81.5 77.5 8.36 Favored 'General case' 0 N--CA 1.395 -3.207 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.887 173.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.38 -45.31 0.41 Allowed Glycine 0 N--CA 1.415 -2.711 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.909 171.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -104.62 58.47 0.7 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.856 0.836 . . . . 0.0 111.166 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -2.89 13.29 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.878 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.85 1.5 19.79 Favored Glycine 0 CA--C 1.497 -1.093 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.642 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 14.8 mt-30 -135.58 45.79 1.49 Allowed Pre-proline 0 CA--C 1.552 1.019 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.642 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 72.7 Cg_exo -60.11 159.28 26.66 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.773 2.315 . . . . 0.0 112.296 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.5 t -97.15 91.14 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -72.89 130.3 40.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.03 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.36 171.9 13.5 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 125.192 1.397 . . . . 0.0 108.798 -170.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -107.28 -62.28 1.44 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.207 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.45 127.77 1.35 Allowed Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.901 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -98.22 -27.62 14.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.756 0.313 . . . . 0.0 111.21 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 61.93 12.63 4.98 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.841 1.256 . . . . 0.0 112.095 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -138.15 158.13 44.93 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 121.776 -0.578 . . . . 0.0 110.971 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.97 -34.38 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 124.277 1.031 . . . . 0.0 109.597 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -57.19 -47.9 80.11 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.105 1.362 . . . . 0.0 110.136 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 22.6 t70 -70.15 -29.11 65.93 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.642 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.43 HD13 ' NZ ' ' A' ' 46' ' ' LYS . 22.2 mt -74.41 -39.66 62.49 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.3 mt -56.31 -54.11 31.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.5 tptp -64.61 -21.91 66.83 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.546 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.733 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.2 t80 -69.62 -64.83 0.8 Allowed 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 mt -65.58 -16.68 20.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.758 1.266 . . . . 0.0 108.272 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.43 -19.16 31.74 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.459 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 31.7 mt-10 -115.3 -44.86 2.96 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.963 0.887 . . . . 0.0 109.694 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.733 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.0 m-80 -79.33 -26.81 42.12 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.563 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.64 162.48 41.46 Favored Glycine 0 N--CA 1.404 -3.439 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.412 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 43.1 mtpt -96.99 -21.79 17.21 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.184 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.7 m-85 -77.56 -17.45 57.87 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.309 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 57.76 47.33 15.71 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 124.001 0.813 . . . . 0.0 109.504 175.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.23 96.28 1.38 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.11 -173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.21 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo . . . . . 0 N--CA 1.483 0.855 0 CA-C-O 122.033 0.764 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.508 HG23 ' CD2' ' A' ' 47' ' ' TYR . 2.6 p -71.37 131.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.339 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 13.7 m -69.58 102.89 1.94 Allowed 'General case' 0 N--CA 1.415 -2.225 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.958 -175.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.55 113.79 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.474 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.7 t -113.28 119.13 59.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 15' ' ' LYS . 28.7 m -71.45 170.45 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -26.19 67.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 110.79 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB3' HG23 ' A' ' 13' ' ' VAL . 2.8 tppp? -60.74 -53.04 62.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.759 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 39.7 m-20 -86.43 -15.52 40.02 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.257 -169.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.55 -32.23 49.85 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 4.2 p30 -75.05 -18.46 60.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 13.0 pt-20 -105.81 -45.64 4.33 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.161 0.981 . . . . 0.0 111.311 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.444 HG12 ' HG3' ' A' ' 19' ' ' GLU . 26.3 mm -78.25 -55.8 9.15 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.108 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.93 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' HG11 ' A' ' 28' ' ' VAL . 63.4 t -80.0 -35.91 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 111.495 -174.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -96.39 37.52 1.26 Allowed 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 26' ' ' LYS . 12.4 t70 -78.42 155.57 29.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.709 174.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -115.67 5.27 14.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -124.5 14.22 8.82 Favored 'General case' 0 C--O 1.249 1.078 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.875 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 23' ' ' ASP . 21.3 pttm -153.18 148.19 26.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 79.4 m-20 -80.63 119.32 23.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 21' ' ' VAL . 17.4 t -115.91 121.64 67.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.36 117.89 30.8 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 11.6 tt -112.26 145.79 17.89 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 C-N-CA 117.571 -1.652 . . . . 0.0 111.346 176.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.461 ' OE2' HD22 ' A' ' 43' ' ' LEU . 34.5 tt0 -127.55 108.21 10.6 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.505 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 91.5 m-85 -69.31 130.08 41.59 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.641 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 34.2 p90 -144.28 -172.57 3.81 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.608 0.718 . . . . 0.0 111.454 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 37' ' ' CYS . . . -153.33 150.43 23.63 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 3.4 Cg_endo -78.16 -24.85 7.75 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 121.607 1.538 . . . . 0.0 109.184 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.41 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 2.2 p90 -93.6 15.02 17.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 112.984 -1.916 . . . . 0.0 111.757 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 43.2 t -95.3 120.2 35.13 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.112 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.11 -35.01 82.63 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.635 ' O ' HD13 ' A' ' 43' ' ' LEU . 10.1 t60 -60.47 -53.21 60.24 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 11.8 t -54.65 -40.42 68.99 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -67.72 -12.27 60.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.93 -10.4 24.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.762 1.267 . . . . 0.0 108.708 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.8 mp -101.52 -17.62 16.32 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.722 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.95 -41.86 48.46 Favored Pre-proline 0 C--N 1.283 -2.316 0 C-N-CA 124.435 1.094 . . . . 0.0 113.225 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 35.7 Cg_endo -63.99 -20.26 67.59 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.739 1.3 . . . . 0.0 112.383 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 1.6 pttm -91.03 -32.73 15.79 Favored 'General case' 0 C--O 1.173 -2.963 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.51 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -73.32 -37.02 66.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.363 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.31 -17.34 46.15 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -87.84 -45.25 10.45 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 8.3 tp -69.59 -46.44 66.31 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.84 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.13 -31.01 71.77 Favored Glycine 0 CA--C 1.465 -3.034 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.996 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -62.56 -52.47 63.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 1.6 pp -64.21 -42.27 96.69 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.727 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.511 ' OH ' ' HA ' ' A' ' 109' ' ' ILE . 19.3 m-85 -66.97 -43.93 81.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.171 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.417 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . . . -93.55 16.12 14.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.3 tppt? -131.95 -26.07 1.99 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.681 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 29.1 t -85.53 -170.61 3.2 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.742 0.306 . . . . 0.0 110.181 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -72.42 12.21 0.5 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.872 1.269 . . . . 0.0 113.552 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.414 ' CE2' ' HA ' ' A' ' 54' ' ' TYR . 11.5 p90 -132.04 11.17 4.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 57' ' ' SER . 21.9 pttp -67.36 -13.31 61.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.016 0.912 . . . . 0.0 111.463 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.54 17.5 19.17 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.075 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HE ' ' HB3' ' A' ' 118' ' ' TYR . 16.4 ttp180 -125.7 -45.14 1.78 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 122.546 1.165 . . . . 0.0 108.963 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 112' ' ' ILE . 1.7 p -131.88 143.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 C-N-CA 126.556 1.942 . . . . 0.0 108.142 173.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.51 130.6 70.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 9' ' ' VAL . 46.2 mm -89.37 117.17 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -123.62 161.16 25.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.34 143.12 22.92 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.33 139.31 50.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -83.09 109.48 17.19 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.29 -11.73 59.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.193 0.933 . . . . 0.0 112.413 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 t -106.59 -27.09 11.07 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.656 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.29 -34.27 17.74 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -119.08 104.09 10.14 Favored 'General case' 0 N--CA 1.403 -2.784 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.74 118.8 13.06 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.302 0.572 . . . . 0.0 110.588 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.23 145.62 31.89 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.702 -174.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.1 -8.73 12.99 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.1 2.533 . . . . 0.0 111.282 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.82 -172.72 4.13 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.088 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.74 129.96 56.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.186 0.517 . . . . 0.0 110.67 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -84.14 129.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.71 -22.81 22.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.397 0.618 . . . . 0.0 110.837 -174.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.99 -105.42 0.62 Allowed Glycine 0 C--N 1.31 -0.899 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.539 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.6 t80 -117.82 -57.34 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.3 Cg_exo -91.5 164.41 3.53 Favored 'Trans proline' 0 N--CA 1.418 -2.963 0 N-CA-C 108.54 -1.369 . . . . 0.0 108.54 162.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.486 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 98.9 m -153.64 135.27 14.4 Favored 'General case' 0 C--N 1.27 -2.848 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.933 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 34.1 mt -98.9 136.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.502 ' O ' HG21 ' A' ' 30' ' ' ILE . 45.7 mtpt -139.19 117.38 11.86 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.3 tm? -96.89 114.41 26.03 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.409 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 31.7 m-85 -97.64 96.72 3.42 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 12.1 Cg_endo -68.78 158.98 55.64 Favored 'Trans proline' 0 CA--C 1.461 -3.173 0 C-N-CA 121.841 1.694 . . . . 0.0 111.143 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 77.34 8.23 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.79 -27.09 0.58 Allowed Glycine 0 C--N 1.298 -1.58 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.113 173.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 94' ' ' GLY . . . -124.64 31.72 5.63 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.833 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 13.24 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 124.815 1.246 . . . . 0.0 112.963 176.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -109.77 -12.54 18.43 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -147.7 71.72 11.56 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 34.9 Cg_exo -49.3 163.33 0.39 Allowed 'Trans proline' 0 C--O 1.25 1.104 0 C-N-CA 124.291 3.327 . . . . 0.0 113.824 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 28.8 t -97.5 102.23 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 t -81.1 128.74 34.07 Favored 'General case' 0 N--CA 1.427 -1.619 0 O-C-N 124.206 0.941 . . . . 0.0 109.981 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.432 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -137.04 158.01 45.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.47 -173.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -90.18 -3.25 57.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.432 0.634 . . . . 0.0 110.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.2 117.14 4.08 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -68.71 -33.05 73.28 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 65.73 13.61 9.06 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.509 1.147 . . . . 0.0 110.953 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 t -143.3 155.14 44.39 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.43 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.5 t -82.33 -39.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 124.958 1.303 . . . . 0.0 110.419 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -59.32 -44.75 92.56 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 121.937 0.875 . . . . 0.0 111.282 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 36.2 t70 -70.3 -25.76 63.47 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.956 -177.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 112' ' ' ILE . 18.4 mt -77.89 -38.98 44.63 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.511 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 69.8 mt -59.06 -50.07 81.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.599 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.8 tptp -63.49 -24.9 68.02 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.102 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.759 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.5 t80 -68.77 -65.49 0.7 Allowed 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.433 HG23 ' CG2' ' A' ' 63' ' ' VAL . 3.4 mt -66.7 -14.33 17.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.49 1.138 . . . . 0.0 108.743 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . . . -91.18 -11.93 36.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.485 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 46.8 mt-10 -120.42 -41.45 2.61 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.202 1.001 . . . . 0.0 109.384 174.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.759 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.9 m-80 -86.07 -24.6 26.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.652 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.17 168.18 51.67 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.424 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 13.4 mmmm -100.2 -24.64 14.51 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.883 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.468 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.5 m-85 -84.39 -12.76 53.88 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.899 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 35.0 mmtp 52.82 59.68 4.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.304 1.002 . . . . 0.0 110.016 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 81.52 0.78 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.779 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.757 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.16 -41.08 63.62 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.519 2.146 . . . . 0.0 111.419 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.1 mt -114.02 93.21 4.26 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.47 17.99 2.06 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 p -81.95 167.94 18.39 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.014 -0.593 . . . . 0.0 111.076 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.79 97.38 2.21 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 122.014 0.911 . . . . 0.0 111.08 -174.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.83 66.2 0.01 OUTLIER Glycine 0 C--N 1.281 -2.527 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.936 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' CB ' ' HA ' ' A' ' 52' ' ' ALA . 13.9 Cg_endo -62.73 -48.31 7.33 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.931 1.754 . . . . 0.0 108.648 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.558 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.7 p -67.42 130.1 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.806 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 m -73.52 106.45 5.31 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.377 0.608 . . . . 0.0 111.015 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.58 111.02 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 47.4 t -106.45 129.21 60.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 15' ' ' LYS . 15.5 m -79.94 172.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.63 -24.55 67.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.166 0.508 . . . . 0.0 110.419 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HG3' ' OD1' ' A' ' 16' ' ' ASN . 16.5 tptp -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.808 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 30.8 m-20 -99.96 -14.21 18.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.9 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HA ' HG11 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -51.02 -40.43 58.19 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -176.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.9 -11.09 59.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.269 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.5 pt-20 -106.45 -41.5 5.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.33 1.062 . . . . 0.0 111.198 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.412 HG12 ' HG3' ' A' ' 19' ' ' GLU . 31.7 mm -84.41 -57.33 4.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 CA-C-N 113.045 -1.888 . . . . 0.0 112.229 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.472 ' HA ' HG13 ' A' ' 28' ' ' VAL . 65.8 t -82.21 -32.77 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.442 0 CA-C-O 122.006 0.907 . . . . 0.0 111.578 -172.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 27.4 2.71 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' OD1' HG23 ' A' ' 25' ' ' THR . 52.1 t0 -94.32 139.6 30.87 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.775 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -105.79 15.2 27.1 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.127 0.571 . . . . 0.0 111.483 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.415 HG23 ' OD1' ' A' ' 23' ' ' ASP . 69.6 p -81.19 -13.07 58.96 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.42 0.629 . . . . 0.0 109.439 174.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -160.55 161.85 32.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.936 0.894 . . . . 0.0 108.61 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.631 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.1 m-20 -82.43 128.8 34.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' A' ' 21' ' ' VAL . 21.5 t -119.38 123.06 70.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.692 0.758 . . . . 0.0 111.612 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD12 ' OH ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -94.36 114.08 26.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 10.8 tt -108.53 144.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.284 -1.366 . . . . 0.0 112.739 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 38.4 tt0 -120.66 121.28 37.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.786 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 97.5 m-85 -91.43 121.85 33.5 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -141.26 -173.47 3.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.786 0.803 . . . . 0.0 112.314 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -142.92 148.49 45.86 Favored Pre-proline 0 N--CA 1.429 -1.509 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -83.93 -12.62 8.34 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.004 1.802 . . . . 0.0 110.463 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -95.56 0.95 53.56 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.605 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 53.8 t -83.37 117.24 22.89 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.562 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.47 -29.54 74.9 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.533 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 65.1 m80 -67.33 -39.92 85.88 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.43 -32.92 74.8 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.201 0.524 . . . . 0.0 110.489 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 64.4 mmtt -65.83 -18.68 65.5 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.612 0.72 . . . . 0.0 111.396 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.85 -11.76 21.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.895 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.734 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 97.0 mt -97.02 -26.74 14.9 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.267 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.63 97.33 Favored Pre-proline 0 C--N 1.284 -2.271 0 C-N-CA 124.665 1.186 . . . . 0.0 113.641 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.33 0.96 8.42 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.574 1.516 . . . . 0.0 112.781 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 13.2 pttm -109.4 -32.3 7.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.584 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.47 -43.9 20.1 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.293 -171.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 1.6 mp0 -79.56 -12.59 59.85 Favored 'General case' 0 N--CA 1.409 -2.515 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.564 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.97 -52.01 5.18 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.92 -34.5 64.39 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.37 93.89 Favored Glycine 0 CA--C 1.479 -2.209 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.771 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -58.39 -53.31 59.73 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -54.53 -42.59 71.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.61 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -76.77 -45.99 26.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.99 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.74 17.7 3.84 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 9.1 tppt? -128.93 -36.11 1.81 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.654 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 21.8 t -100.76 -155.53 0.52 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -57.21 -0.22 0.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -114.19 3.12 15.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 57' ' ' SER . 57.8 pttt -74.96 -6.33 48.69 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.892 0.853 . . . . 0.0 111.096 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.76 -2.34 17.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.371 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -117.78 -130.1 0.3 Allowed 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.441 ' CG2' HG22 ' A' ' 112' ' ' ILE . 2.1 p -53.88 130.62 15.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.697 0.761 . . . . 0.0 112.071 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -114.78 128.47 71.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.001 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 9' ' ' VAL . 40.9 mm -85.21 123.32 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -131.29 163.48 27.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 48.9 pttt -157.15 143.66 18.14 Favored 'General case' 0 CA--C 1.48 -1.73 0 O-C-N 121.87 -0.519 . . . . 0.0 112.303 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 10.9 p -121.69 144.3 31.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -84.67 113.55 21.37 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.72 -0.11 46.02 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.143 -171.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.7 t -127.3 -7.12 5.87 Favored 'General case' 0 N--CA 1.424 -1.757 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.767 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.74 -33.73 9.73 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -119.15 132.78 56.01 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.455 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.34 106.33 12.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -87.17 141.97 33.29 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.507 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.81 2.38 7.11 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 123.282 2.655 . . . . 0.0 110.598 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -79.33 -175.86 4.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.471 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -105.51 131.6 52.71 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 125.653 1.581 . . . . 0.0 109.012 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.3 mm -109.28 124.28 65.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.34 28.24 6.58 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.395 1.093 . . . . 0.0 112.441 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.6 -120.33 0.67 Allowed Glycine 0 C--N 1.296 -1.641 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.52 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 36.7 t80 -115.36 -52.55 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 165.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 6.3 Cg_exo -91.37 170.82 3.08 Favored 'Trans proline' 0 N--CA 1.423 -2.641 0 N-CA-C 109.42 -1.031 . . . . 0.0 109.42 165.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 83' ' ' PRO . 97.6 m -163.04 152.17 14.89 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.0 mt -121.91 137.3 55.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.467 ' O ' HG22 ' A' ' 30' ' ' ILE . 94.1 mttt -140.63 128.15 21.4 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.193 0.521 . . . . 0.0 110.73 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.4 tm? -98.53 117.02 32.01 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 20.7 m-85 -100.55 96.31 5.21 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.436 ' HA ' ' OD1' ' A' ' 27' ' ' ASP . 11.8 Cg_endo -66.52 160.39 46.08 Favored 'Trans proline' 0 CA--C 1.465 -2.936 0 C-N-CA 122.024 1.816 . . . . 0.0 111.67 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.31 77.12 8.22 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.0 -20.35 0.67 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.185 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.22 55.27 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.926 0.87 . . . . 0.0 111.462 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.45 -1.99 29.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.201 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.3 -16.2 35.68 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -138.47 63.88 35.88 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.508 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 84.0 Cg_exo -49.33 160.36 0.94 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.749 3.633 . . . . 0.0 113.196 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.3 t -96.51 97.93 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.3 t -74.52 132.91 42.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.46 168.53 19.56 Favored 'General case' 0 C--N 1.278 -2.51 0 C-N-CA 125.999 1.72 . . . . 0.0 108.975 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.3 m -115.56 -18.89 10.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.107 0.479 . . . . 0.0 110.567 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.77 115.13 1.82 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.915 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -83.67 -10.96 57.82 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 111.435 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 65.68 18.18 11.11 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.203 1.001 . . . . 0.0 113.011 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.0 t -138.3 150.94 47.11 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.292 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.48 -33.76 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 125.507 1.523 . . . . 0.0 109.632 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -58.25 -45.88 86.98 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 122.825 1.298 . . . . 0.0 109.957 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 25.9 t70 -73.7 -27.84 61.42 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 112.115 -2.312 . . . . 0.0 109.696 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.568 ' O ' HD13 ' A' ' 112' ' ' ILE . 17.5 mt -69.67 -43.36 72.7 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.26 -53.45 39.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 110' ' ' LYS . 2.7 tmmm? -60.64 -32.78 71.94 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.908 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.747 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -59.97 -71.17 0.14 Allowed 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.713 -176.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 108' ' ' LEU . 4.0 mp -70.9 -8.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.612 1.196 . . . . 0.0 109.34 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.83 -23.68 25.23 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.555 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 -37.7 4.51 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 122.122 0.963 . . . . 0.0 108.941 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.747 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 58.1 m-80 -87.22 -27.65 22.85 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 113.2 -1.818 . . . . 0.0 109.648 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.79 158.31 42.72 Favored Glycine 0 N--CA 1.408 -3.216 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -87.76 -26.01 23.12 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.631 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.9 m-85 -80.59 -16.19 54.75 Favored 'General case' 0 N--CA 1.388 -3.544 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.92 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 58.2 57.85 3.78 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.44 86.15 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.769 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.51 -53.24 3.58 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.528 2.152 . . . . 0.0 111.587 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.8 tp -117.3 115.44 25.27 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.12 149.9 7.94 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.2 m -83.63 93.44 7.89 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.358 0.599 . . . . 0.0 109.918 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -97.4 145.48 26.12 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.09 116.71 4.86 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.407 ' CG ' ' HA ' ' A' ' 48' ' ' GLU . 47.4 Cg_endo -72.26 -36.1 5.94 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 121.798 1.666 . . . . 0.0 110.88 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 p -81.11 124.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.926 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 48.1 m -63.11 108.96 1.36 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.746 0.784 . . . . 0.0 111.39 -173.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.5 t -79.15 107.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.71 129.01 56.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 15' ' ' LYS . 17.1 m -78.77 170.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.308 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -26.29 66.66 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 13' ' ' VAL . 32.0 tttm -55.72 -51.42 67.39 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.611 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.555 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -100.46 -3.89 29.98 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.355 -172.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -54.28 -38.69 66.17 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 26.1 p-10 -81.07 -5.2 57.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.592 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 12.3 pt-20 -106.26 -44.68 4.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.574 1.178 . . . . 0.0 110.841 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.437 HG12 ' HG3' ' A' ' 19' ' ' GLU . 23.2 mm -81.43 -54.74 9.39 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.367 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG23 HD11 ' A' ' 30' ' ' ILE . 83.9 t -81.34 -30.99 11.31 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 CA-C-O 121.28 0.562 . . . . 0.0 111.643 -174.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -95.16 32.17 1.77 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -96.75 151.65 19.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.09 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' HB3' ' HD3' ' A' ' 93' ' ' LYS . 7.7 p-10 -115.45 17.88 16.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.712 0.291 . . . . 0.0 111.512 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 p -71.36 -37.27 71.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HA ' ' CE1' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -146.66 176.23 10.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.559 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.9 m-20 -82.02 141.35 33.3 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 21' ' ' VAL . 38.2 t -126.01 119.53 54.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.732 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.457 ' HG ' HD22 ' A' ' 87' ' ' LEU . 9.2 mt -86.57 121.08 28.6 Favored 'General case' 0 CA--C 1.468 -2.211 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 21' ' ' VAL . 9.6 tt -114.0 144.87 20.69 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 117.518 -1.673 . . . . 0.0 110.289 173.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -129.83 113.61 14.89 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.356 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' HD1' ' O ' ' A' ' 84' ' ' THR . 28.5 m-85 -78.91 134.2 36.9 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -145.02 -171.71 3.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.296 0.997 . . . . 0.0 110.435 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -141.98 155.94 65.42 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.403 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 22.3 Cg_endo -84.4 -16.35 5.9 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.641 1.56 . . . . 0.0 110.261 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.403 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 57.8 p-90 -96.18 2.86 53.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.039 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.677 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.5 t -84.43 119.05 24.68 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.489 -173.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.17 -23.94 76.08 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.433 ' O ' HD12 ' A' ' 43' ' ' LEU . 35.8 m80 -76.0 -42.69 47.3 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 122.722 -0.281 . . . . 0.0 111.472 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.677 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 20.5 p -68.5 -25.14 64.81 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.587 0.708 . . . . 0.0 109.911 -178.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 53.5 mtmt -75.3 -5.24 43.66 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.504 0.668 . . . . 0.0 110.863 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.7 -16.04 23.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 11.2 mp -93.27 -10.96 33.72 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.228 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.29 -45.27 54.64 Favored Pre-proline 0 C--N 1.287 -2.131 0 C-N-CA 125.005 1.322 . . . . 0.0 113.219 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -67.82 -30.92 32.92 Favored 'Trans proline' 0 C--N 1.378 2.107 0 CA-C-N 120.136 1.084 . . . . 0.0 110.92 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 2.2 ptmm? -75.38 -33.18 61.01 Favored 'General case' 0 C--O 1.201 -1.494 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 13.9 m-85 -68.75 -50.97 46.16 Favored 'General case' 0 CA--C 1.465 -2.323 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.031 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HA ' ' CG ' ' A' ' 8' ' ' PRO . 41.4 mt-10 -69.73 -36.47 75.89 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.219 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 17.1 mm-40 -85.28 -46.61 10.85 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.086 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.441 HD23 HG11 ' A' ' 105' ' ' VAL . 2.4 tm? -76.16 -39.52 54.74 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.71 -30.66 59.47 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 118.781 -1.676 . . . . 0.0 112.754 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -68.4 -47.12 68.15 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.363 173.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 89.5 mt -62.62 -41.11 98.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.253 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.458 ' HH ' HG12 ' A' ' 109' ' ' ILE . 3.7 m-85 -80.47 -46.88 15.16 Favored 'General case' 0 N--CA 1.414 -2.236 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.926 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.76 12.71 12.2 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 45.6 mtmt -134.47 -19.37 1.89 Allowed 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 123.235 0.614 . . . . 0.0 112.556 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 50.6 m -100.53 -170.84 1.92 Allowed 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.24 9.87 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.75 -5.26 29.01 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.4 pttp -76.91 -11.1 59.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.236 1.017 . . . . 0.0 109.221 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.67 -16.91 26.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.51 -133.9 0.34 Allowed 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 3.1 p -58.6 133.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.74 0.781 . . . . 0.0 112.752 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.97 133.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.1 mm -95.18 113.2 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 10' ' ' THR . . . -118.47 156.97 28.12 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 123.529 0.518 . . . . 0.0 110.567 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -147.63 140.51 24.9 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 p -126.2 141.0 47.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -88.11 115.81 25.85 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.42 -12.62 59.98 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.93 0.892 . . . . 0.0 112.288 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 t -112.85 -18.73 12.2 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.281 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.04 -26.23 18.43 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -133.0 95.62 3.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.331 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.08 133.61 49.25 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.795 0.807 . . . . 0.0 111.657 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.69 152.05 42.64 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.251 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.07 -1.63 9.4 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 123.506 2.804 . . . . 0.0 112.11 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' CG ' ' HZ2' ' A' ' 86' ' ' LYS . 38.8 t70 -83.42 144.13 29.81 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.432 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.75 133.6 35.14 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.408 0.623 . . . . 0.0 109.47 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.606 HG23 ' OG1' ' A' ' 84' ' ' THR . 31.2 mt -111.03 128.13 67.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.706 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.488 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 1.7 mp0 -68.24 -36.36 79.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.22 -126.35 3.76 Favored Glycine 0 C--N 1.295 -1.704 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 79' ' ' ILE . 11.8 t80 -112.91 -49.04 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 6.1 Cg_exo -88.62 168.19 5.95 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.436 1.424 . . . . 0.0 110.226 168.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.606 ' OG1' HG23 ' A' ' 79' ' ' ILE . 22.9 m -161.6 138.04 8.21 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 19.8 mt -106.75 139.74 27.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 50.6 mtmt -143.5 121.87 12.35 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 121.061 0.458 . . . . 0.0 110.136 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.457 HD22 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tm? -98.25 112.87 24.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.545 ' CE2' ' HG3' ' A' ' 96' ' ' PRO . 27.5 m-85 -97.22 97.76 4.1 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 27' ' ' ASP . 19.3 Cg_endo -70.0 161.94 44.07 Favored 'Trans proline' 0 CA--C 1.468 -2.791 0 C-N-CA 121.557 1.505 . . . . 0.0 111.719 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.84 77.64 7.7 Favored 'General case' 0 N--CA 1.399 -2.975 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.01 -19.92 0.75 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.237 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.404 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -135.06 39.61 2.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.897 0.856 . . . . 0.0 110.529 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.447 ' HD3' ' HB3' ' A' ' 24' ' ' ASP . 42.1 pttt -67.45 -5.67 15.92 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.638 1.175 . . . . 0.0 110.872 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.96 -20.58 49.53 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.05 67.68 27.22 Favored Pre-proline 0 N--CA 1.433 -1.288 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.545 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 22.9 Cg_exo -49.26 164.71 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 124.298 3.332 . . . . 0.0 113.056 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 18.6 t -92.78 89.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -73.14 126.11 29.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.176 -1.375 . . . . 0.0 111.782 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.67 176.0 9.25 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.658 -174.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -108.82 -53.23 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.59 136.87 2.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.728 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.6 p -108.37 -7.95 15.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 20.5 ttp85 65.81 8.37 5.24 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.911 0.885 . . . . 0.0 112.234 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.402 HG21 ' HB3' ' A' ' 107' ' ' ASP . 4.7 t -123.56 146.88 47.79 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.653 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.441 HG11 HD23 ' A' ' 50' ' ' LEU . 78.2 t -77.78 -35.35 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 125.687 1.595 . . . . 0.0 110.078 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -62.92 -43.83 97.73 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.198 0.999 . . . . 0.0 110.45 -173.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.7 t70 -69.25 -28.76 66.61 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 113.261 -1.79 . . . . 0.0 109.988 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.474 HD13 ' NZ ' ' A' ' 46' ' ' LYS . 32.3 mt -68.98 -46.12 68.88 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.458 HG12 ' HH ' ' A' ' 54' ' ' TYR . 64.0 mt -55.15 -53.86 30.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.559 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 22.2 tptp -62.64 -25.16 67.97 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.74 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.3 t80 -69.11 -62.35 1.42 Allowed 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.441 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.4 mt -71.63 -9.82 13.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.554 1.169 . . . . 0.0 108.544 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.92 -19.71 23.01 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.534 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 42.8 mt-10 -110.42 -43.27 3.92 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 122.461 1.124 . . . . 0.0 108.361 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.737 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 60.8 m-80 -85.27 -29.74 24.36 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.017 -1.902 . . . . 0.0 109.909 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.9 149.29 28.09 Favored Glycine 0 N--CA 1.397 -3.965 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.617 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -89.78 -20.24 23.76 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.186 0.993 . . . . 0.0 108.774 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.559 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 21.3 m-85 -85.24 -5.46 59.32 Favored 'General case' 0 N--CA 1.393 -3.295 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.602 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 48.76 52.43 14.06 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.545 1.153 . . . . 0.0 110.871 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.03 93.15 3.24 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.269 2.089 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.828 0 CA-C-O 119.238 -0.757 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -73.53 43.25 0.75 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 124.45 3.433 . . . . 0.0 113.486 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.0 tp -85.06 1.76 46.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.523 1.154 . . . . 0.0 107.983 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.71 -144.68 4.68 Favored Glycine 0 N--CA 1.416 -2.693 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -91.61 12.31 21.45 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.823 0.82 . . . . 0.0 110.825 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.7 151.24 21.32 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.668 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.77 -178.25 30.01 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.17 -48.21 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.312 2.008 . . . . 0.0 110.515 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 65' ' ' ILE . 2.3 p -69.64 129.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.554 -1.203 . . . . 0.0 107.922 175.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -76.18 110.65 10.85 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.872 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.5 105.83 6.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 16' ' ' ASN . 47.6 t -108.59 114.15 45.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 15' ' ' LYS . 31.3 m -68.91 168.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -23.18 65.49 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.258 0.552 . . . . 0.0 110.918 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HB3' HG21 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -60.95 -46.01 92.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.189 174.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 13.8 m-20 -99.96 -13.51 19.08 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.936 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.425 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.02 -33.44 25.15 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -74.47 -13.2 60.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.045 0.45 . . . . 0.0 111.624 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.6 pt-20 -105.96 -52.47 2.8 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.642 0.734 . . . . 0.0 110.92 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG12 ' HG3' ' A' ' 19' ' ' GLU . 20.6 mm -74.35 -57.83 5.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.889 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 28' ' ' VAL . 91.6 t -74.93 -33.27 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.23 1.014 . . . . 0.0 110.777 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.0 tp -96.06 23.72 6.22 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.548 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD1' HG22 ' A' ' 25' ' ' THR . 7.6 t70 -75.02 167.69 21.43 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.522 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -115.94 -3.71 12.12 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.202 -0.936 . . . . 0.0 112.679 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.454 HG22 ' OD1' ' A' ' 23' ' ' ASP . 14.8 t -111.74 3.16 17.58 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.204 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 25' ' ' THR . 66.1 mmtt -135.64 138.75 43.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 71.0 m-20 -76.47 116.9 17.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 171.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 21' ' ' VAL . 39.9 t -112.92 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.714 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.408 ' HG ' HD22 ' A' ' 87' ' ' LEU . 8.0 mt -84.12 124.63 31.34 Favored 'General case' 0 CA--C 1.464 -2.361 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 13.3 tt -116.1 143.76 25.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.229 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HB3' ' CB ' ' A' ' 67' ' ' LYS . 29.2 tt0 -115.78 117.18 29.5 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 95.1 m-85 -84.44 121.11 27.11 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -141.47 -171.53 3.33 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.865 0.841 . . . . 0.0 112.705 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.79 154.17 32.64 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 11.2 Cg_endo -80.7 -20.51 7.84 Favored 'Trans proline' 0 CA--C 1.505 -0.932 0 C-N-CA 121.675 1.583 . . . . 0.0 109.947 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.415 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 64.7 p-90 -91.82 4.69 52.28 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.125 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.78 117.19 22.5 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.829 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.3 -35.75 92.07 Favored Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.537 ' O ' HD12 ' A' ' 43' ' ' LEU . 79.6 t60 -65.32 -45.36 84.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.806 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.89 -41.52 91.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -70.94 -2.93 16.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' O ' ' HE2' ' A' ' 46' ' ' LYS . . . -102.23 -22.17 14.22 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.658 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 10.8 mp -92.44 -16.26 26.11 Favored 'General case' 0 C--O 1.195 -1.805 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.005 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.59 92.6 Favored Pre-proline 0 C--N 1.275 -2.639 0 C-N-CA 124.702 1.201 . . . . 0.0 112.967 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.8 Cg_exo -63.75 -35.21 58.64 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.14 1.226 . . . . 0.0 111.632 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -81.75 -30.97 32.19 Favored 'General case' 0 C--O 1.177 -2.754 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.905 -175.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.658 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -77.53 -29.6 52.41 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.065 -174.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -83.43 -29.55 27.99 Favored 'General case' 0 C--O 1.191 -1.982 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.964 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.566 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 52.6 mt-10 -79.95 -45.06 19.18 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.909 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.99 -39.1 63.9 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.39 -37.06 90.09 Favored Glycine 0 CA--C 1.479 -2.169 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.027 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -64.88 -50.79 65.17 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 96.0 mt -57.49 -40.11 77.91 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -76.99 -46.75 22.83 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.655 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.63 19.44 2.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -137.15 -27.49 0.97 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.885 -0.509 . . . . 0.0 110.358 176.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.695 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 27.5 t -94.38 -157.07 0.53 Allowed 'General case' 0 C--O 1.208 -1.127 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.79 1.56 0.86 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.15 2.61 21.15 Favored 'General case' 0 CA--C 1.481 -1.709 0 O-C-N 121.336 -0.853 . . . . 0.0 109.118 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.0 pttp -75.21 -9.34 58.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 122.204 1.002 . . . . 0.0 109.546 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -104.53 -0.58 27.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.041 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.75 -132.33 0.24 Allowed 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.42 HG21 HG23 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -43.3 128.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.49 1.516 . . . . 0.0 112.798 176.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -107.61 131.54 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.438 ' O ' HG21 ' A' ' 9' ' ' VAL . 40.7 mm -95.3 118.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 172.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -133.13 161.26 34.89 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.029 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.458 ' CB ' ' HB3' ' A' ' 31' ' ' GLU 0.256 61.4 pttt -156.41 146.95 21.64 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.17 140.37 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.893 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.11 115.65 22.49 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.27 -4.97 55.4 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.986 0.914 . . . . 0.0 112.26 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -118.34 -15.43 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.288 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.91 -33.03 12.34 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -118.57 118.02 30.55 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.27 114.6 12.82 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.955 0.884 . . . . 0.0 109.43 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.11 143.06 25.47 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.48 -3.15 6.71 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 123.016 2.477 . . . . 0.0 110.417 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.24 174.67 4.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.739 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -103.87 118.87 37.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.528 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.04 139.87 19.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.95 0.9 . . . . 0.0 109.083 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.34 -16.35 24.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.33 -94.39 0.17 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.515 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 51.9 t80 -128.15 -51.42 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.7 Cg_endo -94.5 168.82 1.76 Allowed 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 120.93 1.087 . . . . 0.0 109.661 166.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.3 m -163.35 143.32 8.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 31.6 mt -107.38 134.93 47.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -136.38 132.5 35.62 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 3.3 tm? -101.88 115.07 29.74 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -99.58 96.18 4.32 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HG2' ' C ' ' A' ' 92' ' ' ALA . 11.8 Cg_endo -64.69 160.07 42.12 Favored 'Trans proline' 0 CA--C 1.46 -3.183 0 C-N-CA 122.066 1.844 . . . . 0.0 112.157 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -79.16 78.23 5.63 Favored 'General case' 0 N--CA 1.397 -3.08 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.263 173.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.71 -33.06 0.82 Allowed Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.697 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 94' ' ' GLY . . . -121.78 37.16 4.43 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.625 0.726 . . . . 0.0 111.349 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -69.0 16.69 0.05 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.27 1.028 . . . . 0.0 112.708 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -117.1 -2.46 18.37 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.457 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 13.6 pt20 -135.1 45.32 1.39 Allowed Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 115.215 -0.493 . . . . 0.0 109.987 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 69.6 Cg_exo -44.56 155.95 0.25 Allowed 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 124.549 3.5 . . . . 0.0 115.577 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.56 97.52 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 t -75.6 127.58 33.39 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.282 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 149.11 45.13 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.287 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.5 m -84.2 -30.35 25.85 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.33 0.586 . . . . 0.0 109.55 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.11 104.74 2.75 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.7 m -70.45 -5.78 31.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.718 0.807 . . . . 0.0 113.17 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 27.3 ttp180 64.22 29.2 13.93 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.233 1.016 . . . . 0.0 110.509 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 107' ' ' ASP . 7.3 p -123.68 159.33 29.59 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.689 -0.632 . . . . 0.0 111.881 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.73 -40.48 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.569 0.748 . . . . 0.0 109.137 174.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.461 ' HA ' HD13 ' A' ' 109' ' ' ILE . 23.7 mt-10 -65.44 -38.56 90.25 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 122.657 1.218 . . . . 0.0 110.03 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.9 t70 -76.5 -22.35 54.6 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.317 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.34 -44.98 64.02 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.096 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 106' ' ' GLU . 70.8 mt -53.47 -53.46 24.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 48.4 mmtt -70.02 -13.98 62.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.791 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -71.3 -63.77 1.05 Allowed 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.476 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 2.5 mt -69.52 -12.82 16.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 122.615 1.198 . . . . 0.0 108.503 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -88.26 -27.93 21.43 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.331 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -113.76 -27.61 7.73 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.712 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.791 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.4 m-80 -92.57 -27.69 17.2 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.583 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.25 160.21 47.67 Favored Glycine 0 N--CA 1.406 -3.327 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.824 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 90' ' ' ALA . 48.7 mtpt -93.68 -23.71 18.14 Favored 'General case' 0 CA--C 1.474 -1.957 0 CA-C-N 118.392 1.096 . . . . 0.0 109.537 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.607 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 4.7 m-85 -77.99 -15.84 58.61 Favored 'General case' 0 N--CA 1.405 -2.682 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.989 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 56.52 59.26 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.78 78.69 0.45 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -173.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.688 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.543 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.09 -45.04 43.72 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.975 2.45 . . . . 0.0 112.056 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -150.6 151.4 32.5 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.01 -81.1 0.36 Allowed Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 m -129.18 100.07 5.48 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.907 0.384 . . . . 0.0 110.238 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -90.7 115.89 28.14 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.166 0.508 . . . . 0.0 109.844 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.81 92.16 0.76 Allowed Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.6 Cg_endo -69.19 -35.66 13.89 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 122.325 2.017 . . . . 0.0 111.79 -173.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.432 HG23 ' C ' ' A' ' 65' ' ' ILE . 1.8 p -83.25 129.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.99 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.734 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 m -69.15 105.93 2.65 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.995 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -78.21 109.88 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 16' ' ' ASN . 43.2 t -113.63 115.36 49.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 15' ' ' LYS . 18.4 m -72.34 170.17 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.42 -3.12 13.06 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.528 0.68 . . . . 0.0 111.546 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' HB3' HG21 ' A' ' 13' ' ' VAL . 3.2 tppp? -78.27 -35.65 47.79 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.125 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.444 ' HB2' HG11 ' A' ' 12' ' ' VAL . 11.6 m-20 -112.02 -8.87 14.03 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.817 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.45 -27.84 27.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 9.9 p30 -83.71 -9.92 58.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 108.834 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -46.5 4.1 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.574 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.14 -49.87 13.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.317 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 30' ' ' ILE . 88.5 t -79.59 -26.91 12.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-O 121.53 0.681 . . . . 0.0 111.447 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -99.49 26.79 5.77 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-O 122.514 1.15 . . . . 0.0 108.552 -175.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.21 149.41 44.63 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.689 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.19 9.63 14.69 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.524 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -115.38 6.55 14.86 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.861 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -160.1 158.73 30.84 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.564 0.746 . . . . 0.0 108.994 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.8 m-20 -86.9 123.4 31.99 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 47.4 t -114.65 117.11 54.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.626 -0.671 . . . . 0.0 112.506 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HG ' HD21 ' A' ' 87' ' ' LEU . 6.6 mt -89.12 111.02 21.69 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 10.6 tt -103.6 143.6 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.33 -1.348 . . . . 0.0 112.208 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' CD ' ' HZ3' ' A' ' 67' ' ' LYS . 28.3 tt0 -117.66 113.16 21.49 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.148 175.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.434 ' CD1' HD12 ' A' ' 79' ' ' ILE . 96.6 m-85 -77.69 124.08 27.49 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 169.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.537 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 17.6 p90 -139.7 -176.96 4.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.304 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -147.31 148.07 30.49 Favored Pre-proline 0 N--CA 1.418 -2.071 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.403 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 9.7 Cg_endo -79.68 -20.78 9.02 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 121.365 1.377 . . . . 0.0 110.361 -173.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.403 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 1.9 p90 -97.53 8.01 45.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.247 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 27.7 t -81.76 124.04 29.29 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.971 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.85 99.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.347 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -68.28 -35.91 78.58 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.014 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 47.2 t -65.91 -37.1 85.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.34 0.59 . . . . 0.0 110.163 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.9 mtmt -71.38 -10.0 59.06 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.405 0.621 . . . . 0.0 111.116 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.77 -21.76 17.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.215 1.007 . . . . 0.0 109.061 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.671 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 95.7 mt -87.56 -23.42 24.35 Favored 'General case' 0 C--O 1.177 -2.761 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.51 -52.67 57.74 Favored Pre-proline 0 C--N 1.267 -3.021 0 C-N-CA 125.13 1.372 . . . . 0.0 114.151 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.51 -27.12 23.27 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 121.31 1.34 . . . . 0.0 112.353 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 3.8 ptpp? -85.67 -32.46 21.96 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.671 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -76.44 -33.48 58.76 Favored 'General case' 0 N--CA 1.402 -2.858 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.314 -171.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 46.4 mt-10 -83.11 -20.88 34.0 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.65 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.2 tt0 -86.14 -49.24 7.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.86 -36.79 64.88 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.86 -36.42 81.88 Favored Glycine 0 CA--C 1.476 -2.352 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.044 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -61.3 -55.05 36.22 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 88.4 mt -61.94 -39.66 92.86 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.617 -176.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 3.3 m-85 -84.16 -20.18 32.89 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.13 22.23 13.09 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.9 tppt? -142.5 -42.05 0.33 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.39 0.614 . . . . 0.0 110.036 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 44.7 m -88.53 -156.25 0.37 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.18 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.35 17.04 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -126.31 -1.97 6.93 Favored 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 121.477 -0.765 . . . . 0.0 109.874 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 23.2 pttm -70.45 -7.65 44.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.311 1.053 . . . . 0.0 110.059 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.55 -6.43 20.58 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.682 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -115.13 -48.14 2.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.147 0.975 . . . . 0.0 110.854 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.52 155.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.036 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 53.3 t -135.96 127.83 44.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 172.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.432 ' C ' HG23 ' A' ' 9' ' ' VAL . 32.1 mm -93.82 126.67 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.2 165.66 20.89 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.565 0.346 . . . . 0.0 111.556 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.442 ' HZ3' ' CD ' ' A' ' 31' ' ' GLU . 23.4 mtpp -144.39 148.74 35.07 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.68 135.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -82.63 106.85 14.82 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 -11.97 59.92 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 123.845 0.858 . . . . 0.0 112.023 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -105.43 -15.03 15.13 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.495 0.664 . . . . 0.0 111.01 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.16 -28.78 11.26 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -126.57 111.97 14.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.915 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.94 127.73 33.24 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.58 148.55 37.95 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.347 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -84.84 -6.78 9.59 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.859 2.373 . . . . 0.0 111.189 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.51 137.69 38.05 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.294 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -82.76 140.37 33.06 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.309 0.576 . . . . 0.0 110.306 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.516 HG22 ' OG1' ' A' ' 84' ' ' THR . 55.4 mt -126.9 132.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 124.225 1.01 . . . . 0.0 108.803 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -73.94 -29.32 61.96 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.54 0.685 . . . . 0.0 110.647 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.62 -114.37 1.9 Allowed Glycine 0 C--N 1.299 -1.503 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.5 t80 -123.84 -53.4 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.826 171.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -89.99 155.47 4.88 Favored 'Trans proline' 0 N--CA 1.419 -2.855 0 CA-C-N 120.154 1.091 . . . . 0.0 109.936 169.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.516 ' OG1' HG22 ' A' ' 79' ' ' ILE . 6.9 m -163.85 140.44 6.78 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.538 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 30.2 mt -107.89 134.65 49.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 86.8 mttt -135.86 129.46 32.39 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.461 HD21 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -100.46 115.97 31.32 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -99.27 97.84 5.87 Favored Pre-proline 0 C--N 1.292 -1.894 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HA ' ' OD1' ' A' ' 27' ' ' ASP . 11.3 Cg_endo -70.04 161.83 44.49 Favored 'Trans proline' 0 CA--C 1.465 -2.962 0 C-N-CA 121.986 1.791 . . . . 0.0 111.076 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.05 77.22 6.76 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-O 123.004 1.383 . . . . 0.0 109.107 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.15 -34.84 0.72 Allowed Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.779 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 89' ' ' PRO . . . -112.8 33.19 5.15 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.912 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 0.92 1.5 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.286 1.434 . . . . 0.0 112.787 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.76 -12.15 28.83 Favored Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.423 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 4.0 pt20 -134.63 51.07 5.58 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 122.87 0.468 . . . . 0.0 110.982 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 17.2 Cg_exo -45.28 157.08 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 124.512 3.475 . . . . 0.0 114.818 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 22.0 t -90.27 97.08 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.906 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -75.9 128.55 35.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.086 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.27 166.13 25.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.692 -172.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.5 t -98.85 -33.91 10.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 143.24 172.52 14.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.517 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.503 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.9 m -128.55 150.17 50.3 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -98.88 34.28 2.13 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.83 0.824 . . . . 0.0 109.692 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -146.11 149.13 33.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.209 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.4 -29.63 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.291 0.567 . . . . 0.0 109.513 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.14 -45.38 93.24 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 122.236 1.017 . . . . 0.0 110.126 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 26.3 t70 -71.97 -24.27 61.56 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.63 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.5 mt -71.92 -44.56 63.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.857 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.22 -51.49 62.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -68.06 -20.32 64.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.798 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.746 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.7 OUTLIER -69.06 -64.48 0.86 Allowed 'General case' 0 C--O 1.183 -2.416 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.416 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.0 mt -67.3 -15.28 19.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 122.758 1.266 . . . . 0.0 108.286 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.81 -21.22 29.98 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.816 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -117.87 -40.1 3.04 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 122.051 0.929 . . . . 0.0 109.818 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.746 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.5 m-80 -80.28 -26.08 39.1 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.916 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.41 164.58 45.68 Favored Glycine 0 N--CA 1.404 -3.448 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.238 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -94.23 -26.26 16.72 Favored 'General case' 0 CA--C 1.458 -2.572 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.445 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.8 m-85 -83.63 -11.64 57.02 Favored 'General case' 0 N--CA 1.379 -3.992 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.39 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 53.86 60.46 3.63 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.458 1.099 . . . . 0.0 108.772 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -47.82 24.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.274 -2.683 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.732 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -74.55 -2.81 12.92 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.936 2.424 . . . . 0.0 113.489 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 71.9 14.41 5.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.033 1.333 . . . . 0.0 111.286 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.68 154.6 25.65 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -75.75 -57.3 3.96 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 117.408 0.604 . . . . 0.0 110.278 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.66 93.19 4.11 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.699 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.84 104.86 1.78 Allowed Glycine 0 N--CA 1.421 -2.319 0 CA-C-N 115.338 -0.846 . . . . 0.0 114.669 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.93 -40.9 15.05 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.29 1.993 . . . . 0.0 107.191 168.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.509 HG22 ' C ' ' A' ' 65' ' ' ILE . 1.5 p -68.2 133.58 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.725 171.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 m -66.05 102.75 0.84 Allowed 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 121.448 0.642 . . . . 0.0 110.153 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.55 102.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 55.2 t -98.72 126.52 51.86 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.884 0 C-N-CA 125.915 1.686 . . . . 0.0 107.443 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 15' ' ' LYS . 27.7 m -79.03 173.87 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.21 -17.53 64.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.885 0.374 . . . . 0.0 110.916 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 13' ' ' VAL . 33.5 tttm -65.67 -45.14 84.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.401 0.62 . . . . 0.0 110.546 171.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 61.2 m-20 -93.79 -10.14 35.16 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.775 -165.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -58.9 -37.28 76.27 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.477 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 8.6 p30 -79.83 -7.22 58.56 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.867 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.9 pt-20 -105.75 -51.39 3.0 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 122.019 0.914 . . . . 0.0 110.882 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.464 HG12 ' HG3' ' A' ' 19' ' ' GLU . 35.4 mm -80.02 -52.96 13.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.409 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 28' ' ' VAL . 60.7 t -82.95 -21.24 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 CA-C-O 122.025 0.917 . . . . 0.0 111.002 -173.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -100.72 29.0 4.75 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.64 133.11 34.84 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -105.5 21.18 17.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -105.3 -8.25 18.37 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.291 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' HD2' HG21 ' A' ' 64' ' ' VAL . 20.3 pttm -154.81 159.55 40.66 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.835 0.854 . . . . 0.0 108.78 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 79.0 m-20 -80.93 120.31 24.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 21' ' ' VAL . 22.3 t -111.65 119.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.045 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.406 ' HG ' HD22 ' A' ' 87' ' ' LEU . 10.5 mt -88.07 123.21 32.53 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 9.3 tt -113.66 149.25 16.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 117.806 -1.557 . . . . 0.0 110.447 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.466 ' OE1' ' HB3' ' A' ' 43' ' ' LEU . 35.2 tt0 -130.66 113.17 13.85 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.371 0.605 . . . . 0.0 109.844 175.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.492 ' HD1' ' O ' ' A' ' 84' ' ' THR . 95.7 m-85 -75.33 131.68 40.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 173.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.498 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.8 p90 -147.67 -173.25 4.23 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.709 0.766 . . . . 0.0 111.652 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . . . -150.52 148.1 23.06 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.91 -16.87 8.56 Favored 'Trans proline' 0 CA--C 1.499 -1.269 0 C-N-CA 122.13 1.887 . . . . 0.0 110.299 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -91.19 -1.12 57.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.705 -1.588 . . . . 0.0 111.267 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 45.2 t -86.31 117.85 25.38 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.127 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.74 -28.82 73.47 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.623 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 20.1 t60 -63.14 -46.25 88.1 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 30.9 t -60.93 -33.06 72.57 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.252 0.548 . . . . 0.0 111.368 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 41.8 mmtt -63.68 -12.12 31.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.42 16.83 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.928 1.347 . . . . 0.0 108.862 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 39' ' ' HIS . 10.2 mp -99.0 -22.86 15.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.604 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -68.79 -44.28 30.49 Favored Pre-proline 0 C--N 1.283 -2.312 0 C-N-CA 124.637 1.175 . . . . 0.0 113.296 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 51.2 Cg_endo -64.5 -16.56 55.83 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.569 1.513 . . . . 0.0 113.116 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.08 -28.47 12.69 Favored 'General case' 0 CA--C 1.473 -2.015 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.647 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -73.87 -39.41 63.96 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.12 -174.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.17 -20.85 43.86 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 119.703 -0.799 . . . . 0.0 113.112 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.3 tt0 -85.44 -46.45 10.89 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -73.2 -40.89 64.38 Favored 'General case' 0 CA--C 1.467 -2.231 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.21 94.6 Favored Glycine 0 CA--C 1.461 -3.296 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.133 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.49 -56.09 25.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.4 mt -59.75 -43.01 94.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.194 -175.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.64 -42.72 33.81 Favored 'General case' 0 C--O 1.188 -2.153 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.55 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.1 16.54 8.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.0 tppt? -130.87 -33.01 1.61 Allowed 'General case' 0 C--N 1.316 -0.848 0 O-C-N 122.049 -0.407 . . . . 0.0 110.538 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.571 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 14.3 t -96.08 -160.82 0.82 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.222 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.16 15.19 0.07 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.541 1.136 . . . . 0.0 113.434 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.42 ' H ' ' C ' ' A' ' 57' ' ' SER . 13.4 m-85 -118.05 -3.16 11.14 Favored 'General case' 0 C--O 1.194 -1.868 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 57' ' ' SER . 60.8 pttt -71.75 -4.18 26.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.835 0.826 . . . . 0.0 112.848 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -110.35 -9.59 14.63 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -98.0 -49.96 4.57 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.239 1.019 . . . . 0.0 109.352 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.2 t -137.26 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.058 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.406 HG21 ' HD2' ' A' ' 26' ' ' LYS . 53.7 t -124.75 130.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.509 ' C ' HG22 ' A' ' 9' ' ' VAL . 34.9 mm -94.68 122.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -132.51 158.61 41.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 122.578 0.351 . . . . 0.0 110.703 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -151.93 139.36 19.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.654 -0.654 . . . . 0.0 109.955 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 11.1 p -116.44 139.87 41.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -85.58 110.28 19.13 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.84 -9.73 59.56 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 124.077 0.861 . . . . 0.0 112.331 -172.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -109.93 -18.17 13.45 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.436 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.28 -32.91 11.66 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -123.28 101.62 7.47 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.82 116.11 4.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.301 0.572 . . . . 0.0 110.6 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -91.96 144.97 30.05 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.502 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -90.24 0.11 5.41 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.168 2.579 . . . . 0.0 112.246 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -78.53 -179.02 6.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.071 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.66 106.37 14.43 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.017 0.913 . . . . 0.0 109.974 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.527 HG22 ' OG1' ' A' ' 84' ' ' THR . 43.9 mt -96.56 136.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.103 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -9.17 53.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.16 -116.46 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.502 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 78.3 t80 -118.16 -58.84 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.77 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.5 Cg_exo -87.85 156.67 7.38 Favored 'Trans proline' 0 N--CA 1.425 -2.519 0 CA-C-N 120.385 1.173 . . . . 0.0 109.414 167.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.527 ' OG1' HG22 ' A' ' 79' ' ' ILE . 17.6 m -159.25 136.93 10.1 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.843 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 42.8 mt -101.64 137.43 29.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.53 121.96 19.43 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.0 tm? -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 16.6 m-85 -96.57 100.43 7.1 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HA ' ' OD1' ' A' ' 27' ' ' ASP . 12.7 Cg_endo -65.97 159.36 49.53 Favored 'Trans proline' 0 CA--C 1.463 -3.045 0 C-N-CA 121.812 1.674 . . . . 0.0 109.92 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.6 77.23 8.47 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.892 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.18 -39.24 0.45 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 113.0 -1.909 . . . . 0.0 110.269 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -109.46 58.18 0.61 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.242 1.02 . . . . 0.0 110.493 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 8.13 3.36 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.167 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.53 -1.85 9.05 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.598 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 47.8 mt-30 -133.12 46.74 2.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.42 0.688 . . . . 0.0 110.803 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 85.6 Cg_exo -54.1 156.25 13.46 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 123.561 2.841 . . . . 0.0 113.245 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 t -95.37 95.68 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.133 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -72.19 128.45 35.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.434 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.44 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -141.31 170.85 14.95 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 125.289 1.436 . . . . 0.0 109.502 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.5 t -108.13 -31.13 8.05 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.162 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.65 110.79 0.61 Allowed Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.591 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.1 m -62.69 -26.43 68.66 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 123.751 0.821 . . . . 0.0 111.838 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 64.61 17.72 11.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.987 0.915 . . . . 0.0 112.254 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -152.04 153.41 33.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.258 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.2 -39.19 28.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 124.676 1.19 . . . . 0.0 109.739 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -55.75 -47.69 76.55 Favored 'General case' 0 C--O 1.251 1.184 0 C-N-CA 124.926 1.29 . . . . 0.0 110.936 -172.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.5 t70 -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.758 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 23.0 mt -70.7 -39.97 73.13 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.571 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.42 -52.62 54.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -70.07 -15.77 63.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.742 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.3 t80 -71.51 -62.74 1.3 Allowed 'General case' 0 C--O 1.191 -1.983 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.497 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.2 mt -65.94 -13.72 16.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.871 1.319 . . . . 0.0 108.015 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 111' ' ' PHE . . . -82.81 -33.5 27.2 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.681 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -109.06 -35.21 6.38 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.929 0.871 . . . . 0.0 109.39 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.742 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.7 m-80 -86.07 -30.0 22.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.267 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.91 163.92 51.3 Favored Glycine 0 N--CA 1.406 -3.331 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.873 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.433 ' HZ1' ' HB3' ' A' ' 117' ' ' LYS . 10.2 mtpm? -98.9 -23.33 15.38 Favored 'General case' 0 CA--C 1.452 -2.799 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.629 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.475 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.9 m-85 -80.04 -14.09 58.81 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.516 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 55.78 56.1 6.43 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 124.184 0.927 . . . . 0.0 110.011 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.37 38.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.43 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.298 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.37 -21.4 61.11 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 123.303 2.669 . . . . 0.0 112.88 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.7 mt -102.07 93.37 5.21 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.91 164.34 26.46 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.0 m -149.66 142.92 25.14 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.46 14.19 32.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.727 0.775 . . . . 0.0 110.035 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.52 171.57 25.81 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.9 -32.53 54.89 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 123.45 2.767 . . . . 0.0 110.79 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.556 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.3 p -73.0 133.12 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.927 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 18.9 m -74.9 107.96 7.32 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 121.735 0.778 . . . . 0.0 111.129 -173.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.73 108.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.8 t -109.82 110.49 32.33 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.643 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 15' ' ' LYS . 16.3 m -69.81 166.97 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.66 -23.53 63.14 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.152 0.501 . . . . 0.0 110.698 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB3' ' CG2' ' A' ' 13' ' ' VAL . 44.2 tttp -59.97 -42.4 94.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.396 173.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HB2' HG13 ' A' ' 12' ' ' VAL . 20.0 m-20 -105.75 -9.88 17.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.491 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -54.07 -27.52 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -86.46 -8.15 57.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.303 1.049 . . . . 0.0 108.939 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -105.86 -43.19 4.94 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.693 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mm -94.06 -54.7 6.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG22 HD11 ' A' ' 30' ' ' ILE . 78.3 t -72.98 -25.51 22.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 CA-C-O 121.885 0.85 . . . . 0.0 112.077 -174.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 22' ' ' LEU . 1.7 tm? -99.8 16.32 24.04 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 122.502 1.144 . . . . 0.0 108.974 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.47 150.7 23.59 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.122 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.519 ' HB3' ' CE ' ' A' ' 93' ' ' LYS . 6.3 p-10 -115.29 17.09 16.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -90.85 -14.23 32.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.677 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HG3' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.06 161.15 42.92 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.156 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 m-20 -78.47 126.21 30.44 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 21' ' ' VAL . 33.5 t -115.37 115.29 48.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.412 ' HG ' HD22 ' A' ' 87' ' ' LEU . 8.8 mt -85.72 128.51 34.81 Favored 'General case' 0 CA--C 1.467 -2.243 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 12.7 tt -115.9 144.76 22.8 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 C-N-CA 118.026 -1.469 . . . . 0.0 110.564 171.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -125.41 112.25 16.07 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -78.14 126.91 31.5 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.564 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.7 p90 -144.03 -175.79 4.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.111 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.1 144.23 21.18 Favored Pre-proline 0 N--CA 1.42 -1.954 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -80.1 -17.81 10.37 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 121.627 1.551 . . . . 0.0 110.249 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -89.65 1.16 56.39 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.638 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 42.0 t -83.68 118.89 24.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.346 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.11 -38.29 94.14 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.552 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.8 m80 -68.11 -36.99 80.65 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.857 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 34.8 t -64.91 -34.83 79.34 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.797 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 56.5 mtmt -69.07 -15.27 63.41 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.542 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.54 -10.31 32.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.075 0.94 . . . . 0.0 109.438 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 78.7 mt -97.77 -13.51 21.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.858 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.77 90.81 Favored Pre-proline 0 C--N 1.255 -3.543 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.531 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.44 -12.58 20.68 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.355 1.37 . . . . 0.0 113.059 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 9.8 ptmm? -92.27 -32.24 15.1 Favored 'General case' 0 CA--C 1.466 -2.268 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.556 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -82.95 -41.48 18.77 Favored 'General case' 1 N--CA 1.378 -4.075 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.078 -171.876 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -73.69 -42.39 61.32 Favored 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.682 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.632 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 tt0 -74.79 -38.4 62.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.791 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 108' ' ' LEU . 24.3 tp -72.79 -40.18 66.1 Favored 'General case' 0 CA--C 1.472 -2.027 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.66 96.69 Favored Glycine 0 CA--C 1.473 -2.573 0 CA-C-N 113.559 -1.655 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.78 -53.53 49.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.0 mt -52.35 -39.1 60.29 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 124.169 0.918 . . . . 0.0 110.968 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.281 4.1 m-30 -77.79 -49.86 13.49 Favored 'General case' 0 C--O 1.187 -2.213 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.071 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' C ' ' HE2' ' A' ' 56' ' ' LYS . . . -76.1 6.91 4.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -120.39 -43.97 2.49 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 124.369 1.068 . . . . 0.0 109.304 -177.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -91.68 -169.59 2.34 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -76.86 28.93 0.13 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -122.51 4.18 9.62 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -65.42 -16.65 63.84 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -119.35 5.09 11.18 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.735 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -95.33 -45.57 7.08 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.532 1.158 . . . . 0.0 109.245 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -135.0 142.99 38.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.866 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.391 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' A' ' 26' ' ' LYS . 51.4 t -119.21 119.54 61.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 9' ' ' VAL . 40.7 mm -86.6 116.14 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.737 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -127.24 160.71 30.45 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.174 0.511 . . . . 0.0 111.32 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -153.78 145.18 23.09 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 122.015 -0.428 . . . . 0.0 110.24 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.38 140.79 47.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.63 109.18 17.79 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.33 60.43 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.292 1.037 . . . . 0.0 112.681 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 t -111.36 -18.1 12.98 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.571 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.58 -30.37 13.33 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -131.53 83.29 2.09 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 131.52 46.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.849 0.833 . . . . 0.0 110.102 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.13 156.86 36.58 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.531 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.43 -7.69 11.72 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.768 2.312 . . . . 0.0 110.469 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -67.42 153.25 44.12 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.114 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.89 126.88 39.35 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -124.51 128.8 73.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.794 0.331 . . . . 0.0 110.479 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -81.03 -27.71 35.68 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.121 0.568 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.13 -120.22 3.83 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.527 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.3 t80 -133.22 -58.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.1 Cg_endo -87.67 149.33 7.37 Favored 'Trans proline' 0 N--CA 1.424 -2.613 0 CA-C-N 120.252 1.126 . . . . 0.0 109.188 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -162.45 149.99 13.9 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.6 mt -110.37 138.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 91.3 mttt -137.21 128.42 27.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.511 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 3.4 tm? -101.34 115.07 29.67 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.427 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 7.6 m-85 -98.67 97.51 4.93 Favored Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 88' ' ' TYR . 19.5 Cg_endo -66.65 158.1 57.62 Favored 'Trans proline' 0 CA--C 1.464 -3.01 0 C-N-CA 121.993 1.796 . . . . 0.0 111.14 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.94 77.91 8.71 Favored 'General case' 0 N--CA 1.394 -3.258 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.69 -23.17 0.34 Allowed Glycine 0 N--CA 1.422 -2.246 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.231 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.34 61.11 1.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.539 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.519 ' CE ' ' HB3' ' A' ' 24' ' ' ASP . 19.7 ptpt -77.81 5.28 9.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.283 0.633 . . . . 0.0 110.536 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.65 -11.83 25.94 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.419 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.0 pt20 -130.71 48.23 3.55 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 122.789 0.436 . . . . 0.0 110.831 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 28.8 Cg_exo -46.51 150.4 2.34 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.285 2.656 . . . . 0.0 113.365 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 18.7 t -93.82 98.92 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.542 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.1 t -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.447 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.48 160.0 40.65 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.938 -169.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 p -87.37 -58.71 2.48 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.531 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.16 121.77 4.77 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -80.54 22.3 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 59.41 22.12 10.55 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 t -137.73 159.13 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 122.282 -0.261 . . . . 0.0 110.343 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.0 t -77.18 -29.42 17.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 124.045 0.938 . . . . 0.0 110.257 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.24 -45.71 90.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 123.331 1.538 . . . . 0.0 108.869 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -62.1 -35.97 80.32 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 111.302 -2.681 . . . . 0.0 109.305 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.423 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.2 mt -75.16 -43.53 51.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.49 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.6 mt -55.14 -52.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -66.01 -22.87 66.47 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.382 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.738 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.5 OUTLIER -67.34 -63.73 1.0 Allowed 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.523 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.5 mt -71.81 -8.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.494 1.14 . . . . 0.0 108.953 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.8 -28.98 15.59 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.313 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.17 -43.92 6.46 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.738 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 61.4 m-80 -85.84 -29.93 23.35 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.166 -1.833 . . . . 0.0 109.833 -174.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -74.15 155.77 49.47 Favored Glycine 1 N--CA 1.392 -4.243 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.915 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -94.82 -23.11 17.63 Favored 'General case' 0 CA--C 1.468 -2.175 0 CA-C-O 121.753 0.787 . . . . 0.0 109.195 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.526 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 17.2 m-85 -82.21 -9.73 59.4 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 51.81 51.88 15.68 Favored 'General case' 0 C--N 1.365 1.242 0 C-N-CA 124.325 1.05 . . . . 0.0 110.376 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -75.1 90.42 2.51 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.185 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.459 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.86 112.63 2.51 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.693 2.262 . . . . 0.0 110.538 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.0 mt -85.46 129.57 34.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.667 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.21 -115.18 2.23 Favored Glycine 0 N--CA 1.419 -2.486 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m 62.67 103.71 0.03 OUTLIER 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.935 0.894 . . . . 0.0 109.887 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 6' ' ' GLU 0.268 0.1 OUTLIER -70.34 77.52 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -171.768 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.0 51.66 0.28 Allowed Glycine 0 N--CA 1.422 -2.294 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.522 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.56 -44.91 0.45 Allowed 'Trans proline' 0 C--N 1.376 2.026 0 CA-C-N 119.709 1.755 . . . . 0.0 109.536 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 65' ' ' ILE . 1.5 p -69.91 125.56 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 12' ' ' VAL . 20.2 m -72.96 106.72 4.97 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.0 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.6 114.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 16' ' ' ASN . 83.5 t -116.62 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.409 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 16.2 m -71.88 173.51 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.638 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.02 -26.95 66.5 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.471 0.708 . . . . 0.0 110.852 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB3' HG21 ' A' ' 13' ' ' VAL . 30.4 tttm -62.08 -50.99 69.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 54.0 m-20 -86.85 -14.49 41.92 Favored 'General case' 0 CA--C 1.464 -2.356 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.196 -168.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.404 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 6.7 t80 -57.79 -32.14 67.25 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -78.87 -17.93 54.78 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.9 pt-20 -104.49 -45.16 4.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.415 1.102 . . . . 0.0 111.213 -173.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.465 HG12 ' HG3' ' A' ' 19' ' ' GLU . 33.7 mm -83.91 -54.35 9.17 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.486 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.466 ' HA ' HG11 ' A' ' 28' ' ' VAL . 61.1 t -81.62 -37.15 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 121.474 0.654 . . . . 0.0 111.278 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.8 35.07 1.16 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.51 ' OD2' ' HD3' ' A' ' 26' ' ' LYS . 17.6 t70 -86.87 151.79 23.02 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.143 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.74 14.35 16.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 p -101.67 -23.12 14.29 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.319 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.51 ' HD3' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -142.33 164.85 29.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.527 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 74.4 m-20 -81.63 120.02 24.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.9 t -115.1 121.02 66.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.728 0.775 . . . . 0.0 111.227 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 tp -93.33 124.94 37.67 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 12.4 tt -115.1 147.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 C-N-CA 117.596 -1.642 . . . . 0.0 112.953 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 27.3 tt0 -117.15 114.37 23.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.419 ' HD2' ' O ' ' A' ' 84' ' ' THR . 97.4 m-85 -83.84 124.15 30.65 Favored 'General case' 0 CA--C 1.464 -2.344 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 170.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -142.41 -172.5 3.63 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.311 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.99 150.7 39.55 Favored Pre-proline 0 N--CA 1.419 -2.006 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -78.65 -20.12 10.87 Favored 'Trans proline' 0 CA--C 1.5 -1.223 0 C-N-CA 121.391 1.394 . . . . 0.0 110.152 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -89.28 -2.78 58.6 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.489 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 47.0 t -77.11 118.52 19.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.467 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.73 -37.23 93.92 Favored Glycine 0 C--O 1.236 0.225 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -64.84 -42.13 95.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.918 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.7 t -62.55 -43.14 99.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.079 0.466 . . . . 0.0 110.704 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 49.5 mtmt -66.65 -18.44 65.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.601 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 -18.96 25.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.596 0.712 . . . . 0.0 109.424 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.602 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 72.6 mt -88.47 -26.86 21.86 Favored 'General case' 0 C--O 1.196 -1.752 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.372 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.11 -51.57 61.08 Favored Pre-proline 0 C--N 1.286 -2.171 0 C-N-CA 125.813 1.645 . . . . 0.0 114.299 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -66.01 -30.81 47.47 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.066 1.178 . . . . 0.0 111.319 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' CB ' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -87.45 -28.9 21.81 Favored 'General case' 0 CA--C 1.43 -3.65 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.243 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.602 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -73.83 -36.33 64.91 Favored 'General case' 0 N--CA 1.386 -3.651 0 O-C-N 123.78 0.675 . . . . 0.0 109.61 -174.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.93 -49.48 61.55 Favored 'General case' 0 C--O 1.193 -1.912 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.595 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.622 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 40.8 mt-10 -75.15 -33.26 61.5 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -173.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 108' ' ' LEU . 13.0 tp -73.15 -41.69 63.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.81 -43.07 99.65 Favored Glycine 0 CA--C 1.475 -2.437 0 CA-C-N 112.922 -1.945 . . . . 0.0 112.271 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -62.8 -52.05 64.71 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 84.2 mt -60.35 -36.68 78.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.746 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.251 2.0 m-85 -76.42 -50.95 12.82 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 116.932 -1.907 . . . . 0.0 110.873 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -83.6 22.76 1.03 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -151.07 -31.26 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 176.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 m -87.06 -85.78 0.16 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.36 -5.33 9.87 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -126.41 23.48 6.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 19.3 pttp -69.89 -15.42 63.07 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.351 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -116.26 15.9 15.86 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -131.97 -110.46 0.24 Allowed 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 119.909 -0.717 . . . . 0.0 110.984 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.9 t -55.51 129.45 16.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 123.499 0.72 . . . . 0.0 111.853 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -114.48 123.99 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.022 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.5 mm -89.33 118.55 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -126.14 165.9 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -155.83 144.72 20.49 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 122.077 -0.389 . . . . 0.0 110.744 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.7 p -127.05 145.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.78 111.89 22.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.11 -14.7 61.02 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 t -107.98 -6.27 16.68 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.258 0.551 . . . . 0.0 111.492 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.05 -48.26 2.99 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -100.56 101.1 11.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.09 117.12 8.68 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.091 0.472 . . . . 0.0 110.886 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.24 150.0 36.32 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.626 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -89.94 -4.41 5.32 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.029 2.486 . . . . 0.0 112.273 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' CG ' ' HZ1' ' A' ' 86' ' ' LYS . 36.6 t70 -69.43 144.87 53.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.856 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.48 113.29 22.3 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.641 0.734 . . . . 0.0 109.455 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.51 HG23 ' OG1' ' A' ' 84' ' ' THR . 55.3 mt -106.32 144.93 14.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.373 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -80.78 -17.24 51.56 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.885 0.85 . . . . 0.0 111.318 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -144.38 -112.19 0.81 Allowed Glycine 0 C--N 1.278 -2.673 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.489 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 48.2 t80 -123.21 -54.68 0.03 OUTLIER Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.28 171.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.9 Cg_endo -89.36 155.06 5.48 Favored 'Trans proline' 0 N--CA 1.429 -2.284 0 CA-C-N 120.307 1.145 . . . . 0.0 110.324 170.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.51 ' OG1' HG23 ' A' ' 79' ' ' ILE . 15.9 m -165.84 143.3 5.56 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.7 mt -105.86 133.57 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.504 ' HZ1' ' CG ' ' A' ' 77' ' ' ASP . 94.4 mttt -135.95 124.02 22.92 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.193 0.52 . . . . 0.0 110.392 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 3.4 tm? -98.47 115.33 28.3 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -95.92 98.16 3.67 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.427 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -68.54 158.32 58.16 Favored 'Trans proline' 0 CA--C 1.461 -3.145 0 C-N-CA 121.586 1.524 . . . . 0.0 110.302 178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.91 77.47 8.73 Favored 'General case' 0 N--CA 1.402 -2.834 0 C-N-CA 118.632 -1.227 . . . . 0.0 107.974 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.95 -34.1 0.44 Allowed Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.915 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.65 35.98 4.71 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.109 0.957 . . . . 0.0 109.963 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 2.73 1.4 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 125.523 1.529 . . . . 0.0 112.126 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.15 25.94 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.4 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 4.0 pt20 -137.34 54.52 8.34 Favored Pre-proline 0 CA--C 1.578 2.034 0 C-N-CA 123.724 0.809 . . . . 0.0 110.808 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 12.9 Cg_exo -45.06 160.61 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 125.014 3.809 . . . . 0.0 115.137 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.4 98.6 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.329 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 14.2 t -73.52 132.49 42.93 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.651 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.71 164.41 30.29 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.184 -174.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -87.35 -68.55 0.74 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.74 129.17 1.26 Allowed Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -71.63 -37.19 70.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 117.195 0.498 . . . . 0.0 110.821 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 65.96 17.43 10.8 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.284 1.033 . . . . 0.0 111.375 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -150.18 161.7 41.89 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' A' ' 46' ' ' LYS . 61.8 t -86.2 -43.23 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.04 0.447 . . . . 0.0 109.955 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -54.4 -39.36 67.18 Favored 'General case' 0 N--CA 1.396 -3.165 0 C-N-CA 126.188 1.795 . . . . 0.0 112.665 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.6 t70 -80.75 -23.38 39.45 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.511 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 112' ' ' ILE . 17.3 mt -74.7 -41.6 59.91 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.713 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.62 -51.52 70.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -65.8 -21.34 66.48 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.029 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.754 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -68.22 -65.51 0.69 Allowed 'General case' 0 C--O 1.186 -2.27 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 108' ' ' LEU . 3.1 mt -67.72 -12.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.517 1.151 . . . . 0.0 108.806 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.77 -22.2 24.69 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.05 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -114.78 -35.39 4.84 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 122.261 1.029 . . . . 0.0 109.166 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.754 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 57.6 m-80 -88.97 -21.93 23.29 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.478 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.16 163.9 41.79 Favored Glycine 0 N--CA 1.404 -3.452 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.749 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.427 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 12.0 mmmm -93.68 -24.71 17.76 Favored 'General case' 0 CA--C 1.457 -2.61 0 CA-C-N 118.228 1.014 . . . . 0.0 108.406 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.527 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 20.6 m-85 -81.41 -14.0 57.64 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.549 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 54.68 55.91 7.37 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 123.989 0.806 . . . . 0.0 109.101 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.65 82.18 0.43 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.265 1.892 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.626 176.698 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.993 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -82.55 115.99 2.56 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.145 1.896 . . . . 0.0 111.572 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.5 -35.72 58.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.79 144.01 3.93 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.571 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.9 m 68.43 9.16 7.1 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.104 0.962 . . . . 0.0 112.464 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -97.36 96.02 8.08 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.044 0.925 . . . . 0.0 108.867 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.56 77.91 0.9 Allowed Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -170.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 17.8 Cg_endo -57.64 -42.03 64.58 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 123.599 2.866 . . . . 0.0 111.481 -175.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG23 ' CD2' ' A' ' 47' ' ' TYR . 1.6 p -70.44 118.61 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.904 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.926 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 m -63.23 107.11 0.99 Allowed 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.571 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.7 t -79.99 109.82 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.23 128.77 64.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 15' ' ' LYS . 18.9 m -75.27 166.94 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -60.99 -21.72 63.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 110.587 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HB3' HG23 ' A' ' 13' ' ' VAL . 46.0 tptt -62.44 -52.87 61.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.34 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -95.56 -3.33 46.69 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.524 -174.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -56.46 -24.05 43.05 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -87.96 -8.89 55.04 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 10.8 mt-10 -104.53 -51.74 3.03 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.363 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.63 -51.12 14.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.361 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' HG11 ' A' ' 28' ' ' VAL . 60.3 t -83.31 -28.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.88 0.848 . . . . 0.0 110.709 -172.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.56 26.35 6.22 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.212 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.72 141.32 28.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.574 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -109.0 21.64 16.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.4 p -93.07 -17.41 23.86 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.679 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -150.09 166.05 30.94 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 73.8 m-20 -80.52 130.42 35.13 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 21' ' ' VAL . 24.8 t -119.69 118.4 57.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.334 -0.854 . . . . 0.0 112.005 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.418 ' HG ' HD23 ' A' ' 87' ' ' LEU . 9.4 mt -87.8 116.34 25.88 Favored 'General case' 0 CA--C 1.473 -1.983 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.475 HG21 ' O ' ' A' ' 86' ' ' LYS . 12.6 tt -106.07 145.23 14.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 118.089 -1.445 . . . . 0.0 110.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HB3' ' HG2' ' A' ' 67' ' ' LYS . 37.1 tt0 -127.94 109.59 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 95.9 m-85 -73.01 128.38 35.29 Favored 'General case' 0 CA--C 1.465 -2.305 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.515 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 27.3 p90 -142.76 -170.95 3.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 124.014 0.821 . . . . 0.0 111.242 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -148.34 144.61 18.88 Favored Pre-proline 0 C--N 1.289 -2.06 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.56 -22.52 12.1 Favored 'Trans proline' 0 CA--C 1.503 -1.041 0 C-N-CA 121.629 1.553 . . . . 0.0 110.419 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -97.36 3.58 51.02 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 113.129 -1.85 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 36.7 t -77.76 129.31 35.33 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.62 99.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.549 ' O ' HD11 ' A' ' 43' ' ' LEU . 8.5 m-70 -65.42 -44.34 87.69 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.092 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 35.4 t -56.48 -41.15 76.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.201 0.524 . . . . 0.0 110.519 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.8 mtmt -73.17 -2.75 22.88 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.013 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -107.37 -18.65 13.81 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.857 1.313 . . . . 0.0 108.411 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.549 HD11 ' O ' ' A' ' 39' ' ' HIS . 10.6 mp -96.93 -11.02 25.18 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.504 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -46.89 47.55 Favored Pre-proline 0 C--N 1.278 -2.518 0 C-N-CA 125.754 1.621 . . . . 0.0 113.935 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -60.51 -29.54 88.83 Favored 'Trans proline' 0 C--N 1.381 2.253 0 CA-C-N 120.983 1.387 . . . . 0.0 111.926 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 2.6 pttm -84.56 -31.48 24.35 Favored 'General case' 0 C--O 1.188 -2.167 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.742 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.519 ' CD2' HG23 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -79.3 -33.37 43.33 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.003 -174.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.491 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 35.3 mm-40 -70.04 -48.19 58.94 Favored 'General case' 0 C--O 1.185 -2.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.7 tt0 -71.41 -47.41 56.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.211 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.58 -39.3 73.97 Favored 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.55 95.27 Favored Glycine 0 CA--C 1.467 -2.945 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.86 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.24 -55.73 22.47 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 95.9 mt -56.7 -43.62 80.71 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.665 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -78.89 -41.88 28.63 Favored 'General case' 0 C--O 1.194 -1.825 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.6 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.67 16.58 6.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 6.3 tppt? -128.46 -36.87 1.85 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.127 -0.358 . . . . 0.0 110.523 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.541 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 10.5 m -87.42 -168.4 2.22 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -174.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -74.78 22.97 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.404 0.621 . . . . 0.0 112.567 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 57' ' ' SER . 19.5 m-85 -120.96 2.1 10.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 57' ' ' SER . 58.8 pttt -74.75 -0.27 17.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.017 0.913 . . . . 0.0 112.242 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -120.21 4.53 10.81 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.672 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.452 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 76.6 ttt180 -99.15 -48.89 4.68 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.757 1.265 . . . . 0.0 107.734 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 2.5 p -147.57 138.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.175 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.404 HG23 ' HG3' ' A' ' 26' ' ' LYS . 78.2 t -117.07 131.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.425 ' C ' HG21 ' A' ' 9' ' ' VAL . 37.9 mm -93.41 119.11 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -126.94 165.76 18.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.358 0.599 . . . . 0.0 111.907 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.421 ' HG2' ' HB3' ' A' ' 31' ' ' GLU . 56.1 mtmt -143.96 160.61 40.53 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.68 144.62 21.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 172.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -88.18 118.41 27.75 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.18 54.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.025 0.53 . . . . 0.0 111.907 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -119.63 -23.63 6.49 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.602 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.49 -24.3 14.82 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.77 97.49 5.74 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.73 111.88 1.14 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.151 0.501 . . . . 0.0 111.258 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.32 143.22 26.01 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.932 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -94.09 2.18 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.326 2.684 . . . . 0.0 109.981 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -80.14 165.58 22.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.32 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -88.65 123.38 33.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.422 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.8 mm -105.43 140.43 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.627 1.171 . . . . 0.0 108.125 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.9 -29.21 16.03 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.36 0.6 . . . . 0.0 110.479 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.01 -108.5 1.15 Allowed Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.52 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 t80 -117.82 -53.16 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 166.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 3.2 Cg_exo -90.45 162.2 4.45 Favored 'Trans proline' 0 N--CA 1.43 -2.245 0 C-N-CA 121.151 1.234 . . . . 0.0 109.244 164.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 97.8 m -161.32 141.13 10.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 33.9 mt -106.36 128.97 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.475 ' O ' HG21 ' A' ' 30' ' ' ILE . 41.2 mtmt -135.34 129.18 33.02 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 121.292 0.568 . . . . 0.0 109.645 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.4 tm? -100.38 117.7 35.11 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -98.98 97.55 5.21 Favored Pre-proline 0 C--N 1.291 -1.978 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.457 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 14.3 Cg_endo -68.03 160.68 47.56 Favored 'Trans proline' 0 CA--C 1.464 -2.989 0 C-N-CA 121.973 1.782 . . . . 0.0 111.746 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.54 77.43 8.4 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 122.638 1.208 . . . . 0.0 108.564 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.02 -39.25 0.56 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.915 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 94' ' ' GLY . . . -113.66 31.23 6.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.492 0.663 . . . . 0.0 110.864 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 13.61 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.658 1.183 . . . . 0.0 113.677 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -108.03 -13.08 20.72 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -140.03 70.27 35.24 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 123.981 0.912 . . . . 0.0 108.558 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.4 Cg_exo -49.31 160.24 0.96 Allowed 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 123.926 3.084 . . . . 0.0 113.428 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 54.1 t -100.53 104.16 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.43 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 t -75.23 132.19 40.91 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.632 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 146.53 39.66 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.714 -175.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -73.69 -59.31 2.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.491 0.662 . . . . 0.0 110.49 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.55 125.69 0.85 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.2 m -71.06 -41.54 70.6 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 60.99 26.09 16.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.371 1.081 . . . . 0.0 108.93 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.7 t -161.51 157.37 24.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.908 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.9 -37.12 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 124.18 0.992 . . . . 0.0 110.005 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -57.78 -45.16 86.37 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.277 1.036 . . . . 0.0 110.918 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -68.32 -31.0 70.11 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.794 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 27.8 mt -72.16 -42.75 65.58 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.311 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.61 -51.05 70.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -21.5 66.32 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.88 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.725 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -69.98 -61.33 1.82 Allowed 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.428 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 2.5 mt -69.48 -9.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.579 1.181 . . . . 0.0 108.281 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 111' ' ' PHE . . . -91.04 -24.4 20.06 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.869 -177.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -104.4 -39.7 6.35 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-O 123.225 1.488 . . . . 0.0 108.71 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.725 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 59.3 m-80 -95.6 -26.14 15.88 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.432 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.36 157.63 40.75 Favored Glycine 0 N--CA 1.403 -3.525 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.922 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.471 ' HB3' ' HZ3' ' A' ' 117' ' ' LYS . 4.3 mmmp? -88.39 -27.28 21.7 Favored 'General case' 0 CA--C 1.466 -2.251 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.503 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 26.0 m-85 -79.98 -11.2 59.81 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.242 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 55.32 45.9 24.6 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 124.244 0.965 . . . . 0.0 109.396 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . . . -67.05 86.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.005 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.11 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.546 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.1 -46.69 30.95 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.996 3.13 . . . . 0.0 114.543 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.9 -17.83 45.85 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.658 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.96 16.12 61.75 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.953 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 m -82.32 69.65 9.1 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.676 0.751 . . . . 0.0 109.865 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -73.95 -32.59 63.56 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.24 101.74 2.29 Favored Glycine 0 N--CA 1.404 -3.445 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 43.5 Cg_endo -70.78 -35.44 9.63 Favored 'Trans proline' 0 CA--C 1.503 -1.048 0 C-N-CA 122.384 2.056 . . . . 0.0 110.572 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.4 p -83.65 137.66 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.1 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.929 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 m -75.01 93.92 2.79 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 122.248 1.023 . . . . 0.0 110.378 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.23 104.52 3.59 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.386 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 13' ' ' VAL . 23.4 t -102.21 141.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.448 ' O ' HG11 ' A' ' 12' ' ' VAL . 20.6 m -85.24 170.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -59.93 -31.22 69.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.073 0.463 . . . . 0.0 110.294 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HB3' HG21 ' A' ' 13' ' ' VAL . 29.4 tttm -53.93 -39.79 66.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.152 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -110.45 -2.54 16.51 Favored 'General case' 0 C--O 1.208 -1.109 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.744 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 2.7 t80 -58.6 -30.93 67.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 8.5 p30 -77.93 -13.19 59.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 12.3 pt-20 -106.57 -44.75 4.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.404 1.097 . . . . 0.0 111.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' HG3' ' A' ' 19' ' ' GLU . 19.0 mm -79.16 -54.88 10.81 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.677 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.487 ' HA ' HG11 ' A' ' 28' ' ' VAL . 60.1 t -84.72 -29.66 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 121.62 0.724 . . . . 0.0 111.304 -173.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -97.94 32.37 2.41 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.698 ' OD2' HG21 ' A' ' 25' ' ' THR . 30.6 t70 -96.57 150.01 21.13 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.162 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -116.86 20.33 13.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.698 HG21 ' OD2' ' A' ' 23' ' ' ASP . 13.9 t -98.64 -3.67 35.58 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.475 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HA ' ' CE2' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -150.9 161.99 41.64 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.1 m-20 -81.46 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.2 t -118.04 121.62 67.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.148 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.431 ' HG ' HD21 ' A' ' 87' ' ' LEU . 9.9 mt -90.31 116.79 28.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.633 HG13 ' N ' ' A' ' 31' ' ' GLU . 1.5 tp -104.45 145.28 13.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.633 ' N ' HG13 ' A' ' 30' ' ' ILE . 41.2 tt0 -126.39 104.34 8.12 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 124.151 0.907 . . . . 0.0 108.589 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 84' ' ' THR . 98.3 m-85 -76.34 128.03 34.04 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -142.47 -175.39 4.44 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.949 0.881 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 37' ' ' CYS . . . -138.36 153.25 72.68 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 174.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 59.8 Cg_endo -84.16 -14.78 7.0 Favored 'Trans proline' 0 C--N 1.326 -0.607 0 CA-C-N 121.8 1.678 . . . . 0.0 110.665 -173.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.425 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 56.3 p-90 -96.64 4.58 51.83 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.624 -1.626 . . . . 0.0 111.772 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 46.4 t -80.63 121.57 26.0 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.628 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.83 92.85 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 46.5 m80 -60.72 -45.26 94.95 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 15.0 p -70.74 -25.7 63.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.952 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 56.3 mtmt -74.48 -20.59 59.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.6 0.714 . . . . 0.0 110.228 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.36 -9.83 37.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.672 1.225 . . . . 0.0 108.248 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 39' ' ' HIS . 81.0 mt -97.83 -11.92 22.75 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.036 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.45 -50.5 73.15 Favored Pre-proline 0 C--N 1.255 -3.509 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.546 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.13 -16.5 31.9 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 121.453 1.435 . . . . 0.0 113.052 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HD3' ' HA ' ' A' ' 43' ' ' LEU . 8.8 ptmm? -86.58 -38.49 17.09 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -82.11 -26.51 33.51 Favored 'General case' 0 N--CA 1.396 -3.13 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.117 -171.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.58 -33.08 54.01 Favored 'General case' 0 C--O 1.18 -2.583 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.241 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -83.45 -47.86 10.94 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 tp -64.64 -46.25 83.33 Favored 'General case' 0 CA--C 1.469 -2.147 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.75 -20.54 73.63 Favored Glycine 0 CA--C 1.474 -2.505 0 CA-C-N 114.172 -1.376 . . . . 0.0 114.987 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.592 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -71.7 -50.41 30.62 Favored 'General case' 0 CA--C 1.477 -1.856 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.59 -45.13 69.33 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.165 -173.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 42.2 m-85 -74.91 -27.67 60.31 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.88 16.1 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -136.86 -33.05 0.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.441 -0.162 . . . . 0.0 111.163 176.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 22.2 m -84.62 -164.31 0.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.81 28.06 0.17 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.9 3.52 5.97 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 22.6 pttp -72.56 -12.56 61.11 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.805 0.812 . . . . 0.0 111.048 -174.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -109.85 5.65 22.73 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -106.22 -49.77 3.29 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.372 1.082 . . . . 0.0 109.1 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 2.5 p -138.82 135.58 43.0 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.172 -1.831 . . . . 0.0 109.309 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.58 127.28 69.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 9' ' ' VAL . 31.8 mm -90.56 121.19 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.656 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -130.06 161.37 31.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.282 0.563 . . . . 0.0 111.701 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -152.03 145.29 24.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.83 139.69 50.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 109.71 -176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -82.18 101.48 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.39 -9.08 58.38 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.389 1.075 . . . . 0.0 112.412 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 t -105.84 -19.72 13.66 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.726 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.36 -42.76 9.12 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -113.11 102.77 10.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.012 -1.449 . . . . 0.0 107.529 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -67.71 135.1 52.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.91 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 32' ' ' PHE . 29.7 m -113.53 143.23 28.99 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.26 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.05 -8.57 16.59 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 123.303 2.669 . . . . 0.0 113.759 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.45 174.2 10.84 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.91 139.91 35.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.399 0.619 . . . . 0.0 109.626 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.583 HG23 ' OG1' ' A' ' 84' ' ' THR . 59.5 mt -123.39 117.06 50.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -74.85 -9.41 58.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.56 -140.11 4.9 Favored Glycine 0 C--N 1.3 -1.433 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.508 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 4.9 t80 -100.54 -50.44 0.19 Allowed Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -92.58 171.12 2.41 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 121.097 1.198 . . . . 0.0 110.291 167.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.583 ' OG1' HG23 ' A' ' 79' ' ' ILE . 3.1 m -169.17 146.8 3.67 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 49.7 mt -110.63 140.5 29.48 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.324 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 30' ' ' ILE . 65.7 mttm -140.26 127.6 21.26 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.431 HD21 ' HG ' ' A' ' 29' ' ' LEU . 3.1 tm? -102.07 111.95 24.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 15.2 m-85 -94.75 101.9 7.89 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HA ' ' OD1' ' A' ' 27' ' ' ASP . 11.8 Cg_endo -65.65 161.03 40.5 Favored 'Trans proline' 0 CA--C 1.464 -2.986 0 C-N-CA 121.658 1.572 . . . . 0.0 110.051 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.401 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -81.5 77.5 8.36 Favored 'General case' 0 N--CA 1.395 -3.207 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.887 173.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.38 -45.31 0.41 Allowed Glycine 0 N--CA 1.415 -2.711 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.909 171.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -104.62 58.47 0.7 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.856 0.836 . . . . 0.0 111.166 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -2.89 13.29 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.878 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.85 1.5 19.79 Favored Glycine 0 CA--C 1.497 -1.093 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.642 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 14.8 mt-30 -135.58 45.79 1.49 Allowed Pre-proline 0 CA--C 1.552 1.019 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.642 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 72.7 Cg_exo -60.11 159.28 26.66 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.773 2.315 . . . . 0.0 112.296 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.5 t -97.15 91.14 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -72.89 130.3 40.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.03 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.36 171.9 13.5 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 125.192 1.397 . . . . 0.0 108.798 -170.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -107.28 -62.28 1.44 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.207 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.45 127.77 1.35 Allowed Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.901 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -98.22 -27.62 14.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.756 0.313 . . . . 0.0 111.21 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 61.93 12.63 4.98 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.841 1.256 . . . . 0.0 112.095 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -138.15 158.13 44.93 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 121.776 -0.578 . . . . 0.0 110.971 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.97 -34.38 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 124.277 1.031 . . . . 0.0 109.597 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -57.19 -47.9 80.11 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.105 1.362 . . . . 0.0 110.136 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 22.6 t70 -70.15 -29.11 65.93 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.642 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.43 HD13 ' NZ ' ' A' ' 46' ' ' LYS . 22.2 mt -74.41 -39.66 62.49 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.3 mt -56.31 -54.11 31.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.5 tptp -64.61 -21.91 66.83 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.546 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.733 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.2 t80 -69.62 -64.83 0.8 Allowed 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 mt -65.58 -16.68 20.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.758 1.266 . . . . 0.0 108.272 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.43 -19.16 31.74 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.459 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 31.7 mt-10 -115.3 -44.86 2.96 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.963 0.887 . . . . 0.0 109.694 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.733 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.0 m-80 -79.33 -26.81 42.12 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.563 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.64 162.48 41.46 Favored Glycine 0 N--CA 1.404 -3.439 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.412 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 43.1 mtpt -96.99 -21.79 17.21 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.184 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.7 m-85 -77.56 -17.45 57.87 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.309 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 57.76 47.33 15.71 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 124.001 0.813 . . . . 0.0 109.504 175.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.23 96.28 1.38 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.11 -173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.21 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.682 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.84 107.68 1.35 Allowed 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.711 2.274 . . . . 0.0 112.003 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.1 tp -88.65 122.59 32.25 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.602 0.715 . . . . 0.0 109.994 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.58 178.31 32.48 Favored Glycine 0 N--CA 1.421 -2.334 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 m -84.69 -52.61 5.95 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 118.397 1.098 . . . . 0.0 109.868 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.52 -22.04 15.66 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.797 0.808 . . . . 0.0 109.857 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.35 178.24 15.23 Favored Glycine 0 C--N 1.294 -1.776 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.352 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -66.57 -41.39 11.55 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.885 2.39 . . . . 0.0 110.787 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.508 HG23 ' CD2' ' A' ' 47' ' ' TYR . 2.6 p -71.37 131.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.339 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 13.7 m -69.58 102.89 1.94 Allowed 'General case' 0 N--CA 1.415 -2.225 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.958 -175.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.55 113.79 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.474 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.7 t -113.28 119.13 59.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 15' ' ' LYS . 28.7 m -71.45 170.45 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -26.19 67.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 110.79 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB3' HG23 ' A' ' 13' ' ' VAL . 2.8 tppp? -60.74 -53.04 62.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.759 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 39.7 m-20 -86.43 -15.52 40.02 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.257 -169.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.55 -32.23 49.85 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 4.2 p30 -75.05 -18.46 60.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 13.0 pt-20 -105.81 -45.64 4.33 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.161 0.981 . . . . 0.0 111.311 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.444 HG12 ' HG3' ' A' ' 19' ' ' GLU . 26.3 mm -78.25 -55.8 9.15 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.108 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.93 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' HG11 ' A' ' 28' ' ' VAL . 63.4 t -80.0 -35.91 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 111.495 -174.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -96.39 37.52 1.26 Allowed 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 26' ' ' LYS . 12.4 t70 -78.42 155.57 29.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.709 174.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -115.67 5.27 14.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -124.5 14.22 8.82 Favored 'General case' 0 C--O 1.249 1.078 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.875 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 23' ' ' ASP . 21.3 pttm -153.18 148.19 26.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 79.4 m-20 -80.63 119.32 23.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 21' ' ' VAL . 17.4 t -115.91 121.64 67.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.36 117.89 30.8 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 11.6 tt -112.26 145.79 17.89 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 C-N-CA 117.571 -1.652 . . . . 0.0 111.346 176.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.461 ' OE2' HD22 ' A' ' 43' ' ' LEU . 34.5 tt0 -127.55 108.21 10.6 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.505 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 91.5 m-85 -69.31 130.08 41.59 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.641 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 34.2 p90 -144.28 -172.57 3.81 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.608 0.718 . . . . 0.0 111.454 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 37' ' ' CYS . . . -153.33 150.43 23.63 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 3.4 Cg_endo -78.16 -24.85 7.75 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 121.607 1.538 . . . . 0.0 109.184 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.41 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 2.2 p90 -93.6 15.02 17.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 112.984 -1.916 . . . . 0.0 111.757 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 43.2 t -95.3 120.2 35.13 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.112 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.11 -35.01 82.63 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.635 ' O ' HD13 ' A' ' 43' ' ' LEU . 10.1 t60 -60.47 -53.21 60.24 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 11.8 t -54.65 -40.42 68.99 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -67.72 -12.27 60.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.93 -10.4 24.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.762 1.267 . . . . 0.0 108.708 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.8 mp -101.52 -17.62 16.32 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.722 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.95 -41.86 48.46 Favored Pre-proline 0 C--N 1.283 -2.316 0 C-N-CA 124.435 1.094 . . . . 0.0 113.225 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 35.7 Cg_endo -63.99 -20.26 67.59 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.739 1.3 . . . . 0.0 112.383 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 1.6 pttm -91.03 -32.73 15.79 Favored 'General case' 0 C--O 1.173 -2.963 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.51 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -73.32 -37.02 66.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.363 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.31 -17.34 46.15 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -87.84 -45.25 10.45 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 8.3 tp -69.59 -46.44 66.31 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.84 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.13 -31.01 71.77 Favored Glycine 0 CA--C 1.465 -3.034 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.996 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -62.56 -52.47 63.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 1.6 pp -64.21 -42.27 96.69 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.727 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.511 ' OH ' ' HA ' ' A' ' 109' ' ' ILE . 19.3 m-85 -66.97 -43.93 81.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.171 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.417 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . . . -93.55 16.12 14.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.3 tppt? -131.95 -26.07 1.99 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.681 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 29.1 t -85.53 -170.61 3.2 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.742 0.306 . . . . 0.0 110.181 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -72.42 12.21 0.5 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.872 1.269 . . . . 0.0 113.552 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.414 ' CE2' ' HA ' ' A' ' 54' ' ' TYR . 11.5 p90 -132.04 11.17 4.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 57' ' ' SER . 21.9 pttp -67.36 -13.31 61.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.016 0.912 . . . . 0.0 111.463 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.54 17.5 19.17 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.075 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HE ' ' HB3' ' A' ' 118' ' ' TYR . 16.4 ttp180 -125.7 -45.14 1.78 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 122.546 1.165 . . . . 0.0 108.963 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 112' ' ' ILE . 1.7 p -131.88 143.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 C-N-CA 126.556 1.942 . . . . 0.0 108.142 173.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.51 130.6 70.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 9' ' ' VAL . 46.2 mm -89.37 117.17 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -123.62 161.16 25.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.34 143.12 22.92 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.33 139.31 50.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -83.09 109.48 17.19 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.29 -11.73 59.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.193 0.933 . . . . 0.0 112.413 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 t -106.59 -27.09 11.07 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.656 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.29 -34.27 17.74 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -119.08 104.09 10.14 Favored 'General case' 0 N--CA 1.403 -2.784 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.74 118.8 13.06 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.302 0.572 . . . . 0.0 110.588 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.23 145.62 31.89 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.702 -174.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.1 -8.73 12.99 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.1 2.533 . . . . 0.0 111.282 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.82 -172.72 4.13 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.088 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.74 129.96 56.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.186 0.517 . . . . 0.0 110.67 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -84.14 129.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.71 -22.81 22.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.397 0.618 . . . . 0.0 110.837 -174.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.99 -105.42 0.62 Allowed Glycine 0 C--N 1.31 -0.899 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.539 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.6 t80 -117.82 -57.34 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.3 Cg_exo -91.5 164.41 3.53 Favored 'Trans proline' 0 N--CA 1.418 -2.963 0 N-CA-C 108.54 -1.369 . . . . 0.0 108.54 162.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.486 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 98.9 m -153.64 135.27 14.4 Favored 'General case' 0 C--N 1.27 -2.848 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.933 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 34.1 mt -98.9 136.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.502 ' O ' HG21 ' A' ' 30' ' ' ILE . 45.7 mtpt -139.19 117.38 11.86 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.3 tm? -96.89 114.41 26.03 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.409 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 31.7 m-85 -97.64 96.72 3.42 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 12.1 Cg_endo -68.78 158.98 55.64 Favored 'Trans proline' 0 CA--C 1.461 -3.173 0 C-N-CA 121.841 1.694 . . . . 0.0 111.143 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 77.34 8.23 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.79 -27.09 0.58 Allowed Glycine 0 C--N 1.298 -1.58 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.113 173.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 94' ' ' GLY . . . -124.64 31.72 5.63 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.833 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 13.24 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 124.815 1.246 . . . . 0.0 112.963 176.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -109.77 -12.54 18.43 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -147.7 71.72 11.56 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 34.9 Cg_exo -49.3 163.33 0.39 Allowed 'Trans proline' 0 C--O 1.25 1.104 0 C-N-CA 124.291 3.327 . . . . 0.0 113.824 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 28.8 t -97.5 102.23 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 t -81.1 128.74 34.07 Favored 'General case' 0 N--CA 1.427 -1.619 0 O-C-N 124.206 0.941 . . . . 0.0 109.981 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.432 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -137.04 158.01 45.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.47 -173.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -90.18 -3.25 57.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.432 0.634 . . . . 0.0 110.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.2 117.14 4.08 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -68.71 -33.05 73.28 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 65.73 13.61 9.06 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.509 1.147 . . . . 0.0 110.953 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 t -143.3 155.14 44.39 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.43 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.5 t -82.33 -39.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 124.958 1.303 . . . . 0.0 110.419 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -59.32 -44.75 92.56 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 121.937 0.875 . . . . 0.0 111.282 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 36.2 t70 -70.3 -25.76 63.47 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.956 -177.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 112' ' ' ILE . 18.4 mt -77.89 -38.98 44.63 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.511 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 69.8 mt -59.06 -50.07 81.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.599 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.8 tptp -63.49 -24.9 68.02 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.102 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.759 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.5 t80 -68.77 -65.49 0.7 Allowed 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.433 HG23 ' CG2' ' A' ' 63' ' ' VAL . 3.4 mt -66.7 -14.33 17.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.49 1.138 . . . . 0.0 108.743 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . . . -91.18 -11.93 36.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.485 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 46.8 mt-10 -120.42 -41.45 2.61 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.202 1.001 . . . . 0.0 109.384 174.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.759 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.9 m-80 -86.07 -24.6 26.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.652 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.17 168.18 51.67 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.424 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 13.4 mmmm -100.2 -24.64 14.51 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.883 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.468 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.5 m-85 -84.39 -12.76 53.88 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.899 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 35.0 mmtp 52.82 59.68 4.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.304 1.002 . . . . 0.0 110.016 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 81.52 0.78 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.779 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' CB ' ' HA ' ' A' ' 52' ' ' ALA . 13.9 Cg_endo . . . . . 0 C--O 1.24 0.591 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.7 p -67.42 130.1 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.806 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 m -73.52 106.45 5.31 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.377 0.608 . . . . 0.0 111.015 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.58 111.02 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 16' ' ' ASN . 47.4 t -106.45 129.21 60.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 15' ' ' LYS . 15.5 m -79.94 172.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.63 -24.55 67.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.166 0.508 . . . . 0.0 110.419 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' HG23 ' A' ' 13' ' ' VAL . 16.5 tptp -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.808 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.735 ' HB2' HG13 ' A' ' 12' ' ' VAL . 30.8 m-20 -99.96 -14.21 18.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.9 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -40.43 58.19 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.9 -11.09 59.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.269 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.5 pt-20 -106.45 -41.5 5.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.33 1.062 . . . . 0.0 111.198 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.446 HG12 ' HG3' ' A' ' 19' ' ' GLU . 31.7 mm -84.41 -57.33 4.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 CA-C-N 113.045 -1.888 . . . . 0.0 112.229 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.619 ' HA ' HG11 ' A' ' 28' ' ' VAL . 65.8 t -82.21 -32.77 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.442 0 CA-C-O 122.006 0.907 . . . . 0.0 111.578 -172.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 27.4 2.71 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -94.32 139.6 30.87 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.775 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -105.79 15.2 27.1 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.127 0.571 . . . . 0.0 111.483 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.6 p -81.19 -13.07 58.96 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.42 0.629 . . . . 0.0 109.439 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -160.55 161.85 32.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.936 0.894 . . . . 0.0 108.61 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.1 m-20 -82.43 128.8 34.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.5 t -119.38 123.06 70.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.692 0.758 . . . . 0.0 111.612 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' OH ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -94.36 114.08 26.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.589 HD12 HG21 ' A' ' 21' ' ' VAL . 10.8 tt -108.53 144.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.284 -1.366 . . . . 0.0 112.739 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 38.4 tt0 -120.66 121.28 37.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.786 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.418 ' HB2' ' H ' ' A' ' 84' ' ' THR . 97.5 m-85 -91.43 121.85 33.5 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -141.26 -173.47 3.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.786 0.803 . . . . 0.0 112.314 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -142.92 148.49 45.86 Favored Pre-proline 0 N--CA 1.429 -1.509 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -83.93 -12.62 8.34 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.004 1.802 . . . . 0.0 110.463 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -95.56 0.95 53.56 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.605 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 53.8 t -83.37 117.24 22.89 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.562 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.47 -29.54 74.9 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 65.1 m80 -67.33 -39.92 85.88 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.43 -32.92 74.8 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.201 0.524 . . . . 0.0 110.489 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 64.4 mmtt -65.83 -18.68 65.5 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.612 0.72 . . . . 0.0 111.396 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.85 -11.76 21.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.895 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.741 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 97.0 mt -97.02 -26.74 14.9 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.267 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.63 97.33 Favored Pre-proline 0 C--N 1.284 -2.271 0 C-N-CA 124.665 1.186 . . . . 0.0 113.641 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.33 0.96 8.42 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.574 1.516 . . . . 0.0 112.781 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 13.2 pttm -109.4 -32.3 7.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.47 -43.9 20.1 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.293 -171.3 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.56 -12.59 59.85 Favored 'General case' 0 N--CA 1.409 -2.515 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.564 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.97 -52.01 5.18 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HB2' HG13 ' A' ' 105' ' ' VAL . 3.3 tm? -73.92 -34.5 64.39 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.37 93.89 Favored Glycine 0 CA--C 1.479 -2.209 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.771 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.489 ' HA ' ' CB ' ' A' ' 8' ' ' PRO . . . -58.39 -53.31 59.73 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -54.53 -42.59 71.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.61 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -76.77 -45.99 26.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.99 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.74 17.7 3.84 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 9.1 tppt? -128.93 -36.11 1.81 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.661 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 21.8 t -100.76 -155.53 0.52 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -57.21 -0.22 0.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -114.19 3.12 15.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 57' ' ' SER . 57.8 pttt -74.96 -6.33 48.69 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.892 0.853 . . . . 0.0 111.096 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.76 -2.34 17.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.371 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -117.78 -130.1 0.3 Allowed 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 112' ' ' ILE . 2.1 p -53.88 130.62 15.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.697 0.761 . . . . 0.0 112.071 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -114.78 128.47 71.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.001 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.9 mm -85.21 123.32 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -131.29 163.48 27.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 48.9 pttt -157.15 143.66 18.14 Favored 'General case' 0 CA--C 1.48 -1.73 0 O-C-N 121.87 -0.519 . . . . 0.0 112.303 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 10.9 p -121.69 144.3 31.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -84.67 113.55 21.37 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.72 -0.11 46.02 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.143 -171.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.7 t -127.3 -7.12 5.87 Favored 'General case' 0 N--CA 1.424 -1.757 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.767 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.74 -33.73 9.73 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -119.15 132.78 56.01 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.455 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.34 106.33 12.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -87.17 141.97 33.29 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.507 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.81 2.38 7.11 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 123.282 2.655 . . . . 0.0 110.598 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -79.33 -175.86 4.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.471 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -105.51 131.6 52.71 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 125.653 1.581 . . . . 0.0 109.012 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 81' ' ' GLY . 32.3 mm -109.28 124.28 65.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.34 28.24 6.58 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.395 1.093 . . . . 0.0 112.441 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.482 ' H ' HG22 ' A' ' 79' ' ' ILE . . . -179.6 -120.33 0.67 Allowed Glycine 0 C--N 1.296 -1.641 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 36.7 t80 -115.36 -52.55 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 165.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 6.3 Cg_exo -91.37 170.82 3.08 Favored 'Trans proline' 0 N--CA 1.423 -2.641 0 N-CA-C 109.42 -1.031 . . . . 0.0 109.42 165.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.418 ' H ' ' HB2' ' A' ' 32' ' ' PHE . 97.6 m -163.04 152.17 14.89 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.0 mt -121.91 137.3 55.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.473 ' O ' HG22 ' A' ' 30' ' ' ILE . 94.1 mttt -140.63 128.15 21.4 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.193 0.521 . . . . 0.0 110.73 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.469 HD13 ' HD3' ' A' ' 89' ' ' PRO . 3.4 tm? -98.53 117.02 32.01 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -100.55 96.31 5.21 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -66.52 160.39 46.08 Favored 'Trans proline' 0 CA--C 1.465 -2.936 0 C-N-CA 122.024 1.816 . . . . 0.0 111.67 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.31 77.12 8.22 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.0 -20.35 0.67 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.185 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -137.22 55.27 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.926 0.87 . . . . 0.0 111.462 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.45 -1.99 29.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.201 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.3 -16.2 35.68 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -138.47 63.88 35.88 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.508 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.33 160.36 0.94 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.749 3.633 . . . . 0.0 113.196 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 115' ' ' ASN . 38.3 t -96.51 97.93 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.3 t -74.52 132.91 42.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.46 168.53 19.56 Favored 'General case' 0 C--N 1.278 -2.51 0 C-N-CA 125.999 1.72 . . . . 0.0 108.975 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.3 m -115.56 -18.89 10.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.107 0.479 . . . . 0.0 110.567 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.77 115.13 1.82 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.915 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -83.67 -10.96 57.82 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 111.435 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 65.68 18.18 11.11 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.203 1.001 . . . . 0.0 113.011 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 107' ' ' ASP . 9.0 t -138.3 150.94 47.11 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.292 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 50' ' ' LEU . 94.2 t -73.48 -33.76 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 125.507 1.523 . . . . 0.0 109.632 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' A' ' 106' ' ' GLU . 28.7 mt-10 -58.25 -45.88 86.98 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 122.825 1.298 . . . . 0.0 109.957 -176.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 25.9 t70 -73.7 -27.84 61.42 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 112.115 -2.312 . . . . 0.0 109.696 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 112' ' ' ILE . 17.5 mt -69.67 -43.36 72.7 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.26 -53.45 39.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 110' ' ' LYS . 2.7 tmmm? -60.64 -32.78 71.94 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.908 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.605 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -59.97 -71.17 0.14 Allowed 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.713 -176.212 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.576 HG21 HG21 ' A' ' 63' ' ' VAL . 4.0 mp -70.9 -8.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.612 1.196 . . . . 0.0 109.34 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -86.83 -23.68 25.23 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.555 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 -37.7 4.51 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 122.122 0.963 . . . . 0.0 108.941 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.605 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 58.1 m-80 -87.22 -27.65 22.85 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 113.2 -1.818 . . . . 0.0 109.648 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.79 158.31 42.72 Favored Glycine 0 N--CA 1.408 -3.216 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.523 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 31.3 mmmt -87.76 -26.01 23.12 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.593 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.9 m-85 -80.59 -16.19 54.75 Favored 'General case' 0 N--CA 1.388 -3.544 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.92 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 58.2 57.85 3.78 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.44 86.15 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.426 ' CG ' ' HA ' ' A' ' 48' ' ' GLU . 47.4 Cg_endo . . . . . 0 CA--C 1.516 -0.383 0 CA-C-O 121.792 0.663 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 47' ' ' TYR . 1.2 p -81.11 124.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.926 175.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 48.1 m -63.11 108.96 1.36 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.746 0.784 . . . . 0.0 111.39 -173.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.5 t -79.15 107.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 16' ' ' ASN . 46.3 t -103.71 129.01 56.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.669 HG23 ' HB3' ' A' ' 15' ' ' LYS . 17.1 m -78.77 170.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.308 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -26.29 66.66 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.669 ' HB3' HG23 ' A' ' 13' ' ' VAL . 32.0 tttm -55.72 -51.42 67.39 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.611 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -100.46 -3.89 29.98 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.355 -172.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -54.28 -38.69 66.17 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -81.07 -5.2 57.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.592 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 12.3 pt-20 -106.26 -44.68 4.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.574 1.178 . . . . 0.0 110.841 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.492 HG12 ' HG3' ' A' ' 19' ' ' GLU . 23.2 mm -81.43 -54.74 9.39 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.367 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.617 HG21 HD12 ' A' ' 30' ' ' ILE . 83.9 t -81.34 -30.99 11.31 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 CA-C-O 121.28 0.562 . . . . 0.0 111.643 -174.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.452 ' HG ' ' CE2' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -95.16 32.17 1.77 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -96.75 151.65 19.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.09 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' HB3' ' HD3' ' A' ' 93' ' ' LYS . 7.7 p-10 -115.45 17.88 16.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.712 0.291 . . . . 0.0 111.512 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 p -71.36 -37.27 71.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HA ' ' CE1' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -146.66 176.23 10.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.9 m-20 -82.02 141.35 33.3 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 21' ' ' VAL . 38.2 t -126.01 119.53 54.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.732 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HG ' HD23 ' A' ' 87' ' ' LEU . 9.2 mt -86.57 121.08 28.6 Favored 'General case' 0 CA--C 1.468 -2.211 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.617 HD12 HG21 ' A' ' 21' ' ' VAL . 9.6 tt -114.0 144.87 20.69 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 117.518 -1.673 . . . . 0.0 110.289 173.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -129.83 113.61 14.89 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.356 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' HD1' ' O ' ' A' ' 84' ' ' THR . 28.5 m-85 -78.91 134.2 36.9 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -145.02 -171.71 3.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.296 0.997 . . . . 0.0 110.435 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -141.98 155.94 65.42 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -84.4 -16.35 5.9 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.641 1.56 . . . . 0.0 110.261 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -96.18 2.86 53.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.039 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.685 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.5 t -84.43 119.05 24.68 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.489 -173.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.17 -23.94 76.08 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.445 ' O ' HD13 ' A' ' 43' ' ' LEU . 35.8 m80 -76.0 -42.69 47.3 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 122.722 -0.281 . . . . 0.0 111.472 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 20.5 p -68.5 -25.14 64.81 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.587 0.708 . . . . 0.0 109.911 -178.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 53.5 mtmt -75.3 -5.24 43.66 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.504 0.668 . . . . 0.0 110.863 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB1' ' HD2' ' A' ' 103' ' ' ARG . . . -94.7 -16.04 23.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.561 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 11.2 mp -93.27 -10.96 33.72 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.228 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.29 -45.27 54.64 Favored Pre-proline 0 C--N 1.287 -2.131 0 C-N-CA 125.005 1.322 . . . . 0.0 113.219 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -67.82 -30.92 32.92 Favored 'Trans proline' 0 C--N 1.378 2.107 0 CA-C-N 120.136 1.084 . . . . 0.0 110.92 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 2.2 ptmm? -75.38 -33.18 61.01 Favored 'General case' 0 C--O 1.201 -1.494 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.435 ' HB3' HG11 ' A' ' 9' ' ' VAL . 13.9 m-85 -68.75 -50.97 46.16 Favored 'General case' 0 CA--C 1.465 -2.323 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.031 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.426 ' HA ' ' CG ' ' A' ' 8' ' ' PRO . 41.4 mt-10 -69.73 -36.47 75.89 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.219 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 17.1 mm-40 -85.28 -46.61 10.85 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.086 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.595 HD23 HG13 ' A' ' 105' ' ' VAL . 2.4 tm? -76.16 -39.52 54.74 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.71 -30.66 59.47 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 118.781 -1.676 . . . . 0.0 112.754 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.61 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -68.4 -47.12 68.15 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.363 173.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 89.5 mt -62.62 -41.11 98.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.253 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -80.47 -46.88 15.16 Favored 'General case' 0 N--CA 1.414 -2.236 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.926 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.76 12.71 12.2 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 45.6 mtmt -134.47 -19.37 1.89 Allowed 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 123.235 0.614 . . . . 0.0 112.556 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.709 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 50.6 m -100.53 -170.84 1.92 Allowed 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.24 9.87 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.75 -5.26 29.01 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.4 pttp -76.91 -11.1 59.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.236 1.017 . . . . 0.0 109.221 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.67 -16.91 26.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.51 -133.9 0.34 Allowed 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 3.1 p -58.6 133.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.74 0.781 . . . . 0.0 112.752 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.97 133.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.427 HD12 HD12 ' A' ' 29' ' ' LEU . 22.1 mm -95.18 113.2 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 175.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' THR . . . -118.47 156.97 28.12 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 123.529 0.518 . . . . 0.0 110.567 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -147.63 140.51 24.9 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 p -126.2 141.0 47.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -88.11 115.81 25.85 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.42 -12.62 59.98 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.93 0.892 . . . . 0.0 112.288 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 t -112.85 -18.73 12.2 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.281 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.04 -26.23 18.43 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -133.0 95.62 3.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.331 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.08 133.61 49.25 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.795 0.807 . . . . 0.0 111.657 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.69 152.05 42.64 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.251 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.07 -1.63 9.4 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 123.506 2.804 . . . . 0.0 112.11 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -83.42 144.13 29.81 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.432 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.75 133.6 35.14 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.408 0.623 . . . . 0.0 109.47 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.617 HG23 ' OG1' ' A' ' 84' ' ' THR . 31.2 mt -111.03 128.13 67.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.706 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -68.24 -36.36 79.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.22 -126.35 3.76 Favored Glycine 0 C--N 1.295 -1.704 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.474 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 11.8 t80 -112.91 -49.04 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 6.1 Cg_exo -88.62 168.19 5.95 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.436 1.424 . . . . 0.0 110.226 168.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.617 ' OG1' HG23 ' A' ' 79' ' ' ILE . 22.9 m -161.6 138.04 8.21 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 19.8 mt -106.75 139.74 27.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 50.6 mtmt -143.5 121.87 12.35 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 121.061 0.458 . . . . 0.0 110.136 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.529 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tm? -98.25 112.87 24.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.555 ' CE2' ' HG3' ' A' ' 96' ' ' PRO . 27.5 m-85 -97.22 97.76 4.1 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 19.3 Cg_endo -70.0 161.94 44.07 Favored 'Trans proline' 0 CA--C 1.468 -2.791 0 C-N-CA 121.557 1.505 . . . . 0.0 111.719 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.84 77.64 7.7 Favored 'General case' 0 N--CA 1.399 -2.975 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.01 -19.92 0.75 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.237 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.444 ' H ' ' HG2' ' A' ' 89' ' ' PRO . . . -135.06 39.61 2.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.897 0.856 . . . . 0.0 110.529 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HD3' ' HB3' ' A' ' 24' ' ' ASP . 42.1 pttt -67.45 -5.67 15.92 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.638 1.175 . . . . 0.0 110.872 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.96 -20.58 49.53 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.05 67.68 27.22 Favored Pre-proline 0 N--CA 1.433 -1.288 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.555 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 22.9 Cg_exo -49.26 164.71 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 124.298 3.332 . . . . 0.0 113.056 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 115' ' ' ASN . 18.6 t -92.78 89.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -73.14 126.11 29.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.176 -1.375 . . . . 0.0 111.782 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.67 176.0 9.25 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.658 -174.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -108.82 -53.23 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.59 136.87 2.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.728 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.6 p -108.37 -7.95 15.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 20.5 ttp85 65.81 8.37 5.24 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.911 0.885 . . . . 0.0 112.234 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 107' ' ' ASP . 4.7 t -123.56 146.88 47.79 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.653 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.595 HG13 HD23 ' A' ' 50' ' ' LEU . 78.2 t -77.78 -35.35 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 125.687 1.595 . . . . 0.0 110.078 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.413 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.1 mt-10 -62.92 -43.83 97.73 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.198 0.999 . . . . 0.0 110.45 -173.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.7 t70 -69.25 -28.76 66.61 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 113.261 -1.79 . . . . 0.0 109.988 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.516 HD22 HD13 ' A' ' 29' ' ' LEU . 32.3 mt -68.98 -46.12 68.88 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 106' ' ' GLU . 64.0 mt -55.15 -53.86 30.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 22.2 tptp -62.64 -25.16 67.97 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.74 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.3 t80 -69.11 -62.35 1.42 Allowed 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.455 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.4 mt -71.63 -9.82 13.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.554 1.169 . . . . 0.0 108.544 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -90.92 -19.71 23.01 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.534 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 42.8 mt-10 -110.42 -43.27 3.92 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 122.461 1.124 . . . . 0.0 108.361 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 60.8 m-80 -85.27 -29.74 24.36 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.017 -1.902 . . . . 0.0 109.909 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.9 149.29 28.09 Favored Glycine 0 N--CA 1.397 -3.965 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.617 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -89.78 -20.24 23.76 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.186 0.993 . . . . 0.0 108.774 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 26' ' ' LYS . 21.3 m-85 -85.24 -5.46 59.32 Favored 'General case' 0 N--CA 1.393 -3.295 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.602 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 34.4 mmtp 48.76 52.43 14.06 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.545 1.153 . . . . 0.0 110.871 173.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.03 93.15 3.24 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.269 2.089 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.459 -0.549 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 65' ' ' ILE . 2.3 p -69.64 129.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.554 -1.203 . . . . 0.0 107.922 175.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -76.18 110.65 10.85 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.872 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.5 105.83 6.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.631 HG13 ' HB2' ' A' ' 16' ' ' ASN . 47.6 t -108.59 114.15 45.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.643 HG23 ' HB3' ' A' ' 15' ' ' LYS . 31.3 m -68.91 168.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -23.18 65.49 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.258 0.552 . . . . 0.0 110.918 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.643 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -60.95 -46.01 92.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.189 174.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.631 ' HB2' HG13 ' A' ' 12' ' ' VAL . 13.8 m-20 -99.96 -13.51 19.08 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.936 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.02 -33.44 25.15 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -74.47 -13.2 60.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.045 0.45 . . . . 0.0 111.624 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.6 pt-20 -105.96 -52.47 2.8 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.642 0.734 . . . . 0.0 110.92 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.494 HG12 ' HG3' ' A' ' 19' ' ' GLU . 20.6 mm -74.35 -57.83 5.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.889 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.665 HG21 HD12 ' A' ' 30' ' ' ILE . 91.6 t -74.93 -33.27 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.23 1.014 . . . . 0.0 110.777 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.0 tp -96.06 23.72 6.22 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.548 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.452 ' OD1' HG22 ' A' ' 25' ' ' THR . 7.6 t70 -75.02 167.69 21.43 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.522 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -115.94 -3.71 12.12 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.202 -0.936 . . . . 0.0 112.679 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.452 HG22 ' OD1' ' A' ' 23' ' ' ASP . 14.8 t -111.74 3.16 17.58 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.204 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 25' ' ' THR . 66.1 mmtt -135.64 138.75 43.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.603 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 71.0 m-20 -76.47 116.9 17.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 171.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 21' ' ' VAL . 39.9 t -112.92 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.714 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.451 ' HG ' HD23 ' A' ' 87' ' ' LEU . 8.0 mt -84.12 124.63 31.34 Favored 'General case' 0 CA--C 1.464 -2.361 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.665 HD12 HG21 ' A' ' 21' ' ' VAL . 13.3 tt -116.1 143.76 25.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.229 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 29.2 tt0 -115.78 117.18 29.5 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -84.44 121.11 27.11 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -141.47 -171.53 3.33 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.865 0.841 . . . . 0.0 112.705 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -151.79 154.17 32.64 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 11.2 Cg_endo -80.7 -20.51 7.84 Favored 'Trans proline' 0 CA--C 1.505 -0.932 0 C-N-CA 121.675 1.583 . . . . 0.0 109.947 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.414 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 64.7 p-90 -91.82 4.69 52.28 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.125 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 42.7 t -82.78 117.19 22.5 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.829 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.3 -35.75 92.07 Favored Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.545 ' O ' HD13 ' A' ' 43' ' ' LEU . 79.6 t60 -65.32 -45.36 84.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.806 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.89 -41.52 91.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -70.94 -2.93 16.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.496 ' O ' ' HE2' ' A' ' 46' ' ' LYS . . . -102.23 -22.17 14.22 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.664 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 10.8 mp -92.44 -16.26 26.11 Favored 'General case' 0 C--O 1.195 -1.805 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.005 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.59 92.6 Favored Pre-proline 0 C--N 1.275 -2.639 0 C-N-CA 124.702 1.201 . . . . 0.0 112.967 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.8 Cg_exo -63.75 -35.21 58.64 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.14 1.226 . . . . 0.0 111.632 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -81.75 -30.97 32.19 Favored 'General case' 0 C--O 1.177 -2.754 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.905 -175.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.664 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -77.53 -29.6 52.41 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.065 -174.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -83.43 -29.55 27.99 Favored 'General case' 0 C--O 1.191 -1.982 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.964 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.572 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 52.6 mt-10 -79.95 -45.06 19.18 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.909 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.99 -39.1 63.9 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.39 -37.06 90.09 Favored Glycine 0 CA--C 1.479 -2.169 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.027 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -64.88 -50.79 65.17 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 96.0 mt -57.49 -40.11 77.91 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -76.99 -46.75 22.83 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.655 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -86.63 19.44 2.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -137.15 -27.49 0.97 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.885 -0.509 . . . . 0.0 110.358 176.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.684 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 27.5 t -94.38 -157.07 0.53 Allowed 'General case' 0 C--O 1.208 -1.127 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.79 1.56 0.86 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.15 2.61 21.15 Favored 'General case' 0 CA--C 1.481 -1.709 0 O-C-N 121.336 -0.853 . . . . 0.0 109.118 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.0 pttp -75.21 -9.34 58.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 122.204 1.002 . . . . 0.0 109.546 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -104.53 -0.58 27.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.041 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.75 -132.33 0.24 Allowed 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.638 HG21 HG21 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -43.3 128.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.49 1.516 . . . . 0.0 112.798 176.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -107.61 131.54 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mm -95.3 118.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 172.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -133.13 161.26 34.89 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.029 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 31' ' ' GLU 0.256 61.4 pttt -156.41 146.95 21.64 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.654 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.17 140.37 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.893 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.11 115.65 22.49 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.27 -4.97 55.4 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.986 0.914 . . . . 0.0 112.26 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -118.34 -15.43 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.288 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.91 -33.03 12.34 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -118.57 118.02 30.55 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.27 114.6 12.82 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.955 0.884 . . . . 0.0 109.43 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.11 143.06 25.47 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.48 -3.15 6.71 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 123.016 2.477 . . . . 0.0 110.417 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.24 174.67 4.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.739 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -103.87 118.87 37.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.528 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.04 139.87 19.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.95 0.9 . . . . 0.0 109.083 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.34 -16.35 24.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.33 -94.39 0.17 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 51.9 t80 -128.15 -51.42 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.7 Cg_endo -94.5 168.82 1.76 Allowed 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 120.93 1.087 . . . . 0.0 109.661 166.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.3 m -163.35 143.32 8.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 31.6 mt -107.38 134.93 47.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -136.38 132.5 35.62 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.451 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -101.88 115.07 29.74 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.403 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 46.6 m-85 -99.58 96.18 4.32 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.427 ' HG2' ' C ' ' A' ' 92' ' ' ALA . 11.8 Cg_endo -64.69 160.07 42.12 Favored 'Trans proline' 0 CA--C 1.46 -3.183 0 C-N-CA 122.066 1.844 . . . . 0.0 112.157 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.42 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -79.16 78.23 5.63 Favored 'General case' 0 N--CA 1.397 -3.08 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.263 173.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.71 -33.06 0.82 Allowed Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.697 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.427 ' C ' ' HG2' ' A' ' 89' ' ' PRO . . . -121.78 37.16 4.43 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.625 0.726 . . . . 0.0 111.349 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -69.0 16.69 0.05 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.27 1.028 . . . . 0.0 112.708 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.1 -2.46 18.37 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.459 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 13.6 pt20 -135.1 45.32 1.39 Allowed Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 115.215 -0.493 . . . . 0.0 109.987 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 69.6 Cg_exo -44.56 155.95 0.25 Allowed 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 124.549 3.5 . . . . 0.0 115.577 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 115' ' ' ASN . 44.5 t -91.56 97.52 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 t -75.6 127.58 33.39 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.282 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 149.11 45.13 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.287 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.5 m -84.2 -30.35 25.85 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.33 0.586 . . . . 0.0 109.55 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.11 104.74 2.75 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.7 m -70.45 -5.78 31.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.718 0.807 . . . . 0.0 113.17 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 27.3 ttp180 64.22 29.2 13.93 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.233 1.016 . . . . 0.0 110.509 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.498 ' OG1' ' HB3' ' A' ' 107' ' ' ASP . 7.3 p -123.68 159.33 29.59 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.689 -0.632 . . . . 0.0 111.881 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 46' ' ' LYS . 59.6 t -95.73 -40.48 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.569 0.748 . . . . 0.0 109.137 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.521 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.7 mt-10 -65.44 -38.56 90.25 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 122.657 1.218 . . . . 0.0 110.03 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.9 t70 -76.5 -22.35 54.6 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.317 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.34 -44.98 64.02 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.096 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' A' ' 106' ' ' GLU . 70.8 mt -53.47 -53.46 24.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 48.4 mmtt -70.02 -13.98 62.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.638 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -71.3 -63.77 1.05 Allowed 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.638 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -69.52 -12.82 16.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 122.615 1.198 . . . . 0.0 108.503 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -88.26 -27.93 21.43 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.331 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -113.76 -27.61 7.73 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.712 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.638 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.4 m-80 -92.57 -27.69 17.2 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.583 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.25 160.21 47.67 Favored Glycine 0 N--CA 1.406 -3.327 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.824 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 90' ' ' ALA . 48.7 mtpt -93.68 -23.71 18.14 Favored 'General case' 0 CA--C 1.474 -1.957 0 CA-C-N 118.392 1.096 . . . . 0.0 109.537 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.603 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 4.7 m-85 -77.99 -15.84 58.61 Favored 'General case' 0 N--CA 1.405 -2.682 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.989 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 56.52 59.26 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.78 78.69 0.45 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -173.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.688 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.58 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.6 Cg_endo . . . . . 0 CA--C 1.507 -0.828 0 CA-C-O 121.753 0.647 . . . . 0.0 111.79 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 65' ' ' ILE . 1.8 p -83.25 129.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.99 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.734 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 m -69.15 105.93 2.65 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.995 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -78.21 109.88 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 16' ' ' ASN . 43.2 t -113.63 115.36 49.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.629 HG23 ' HB3' ' A' ' 15' ' ' LYS . 18.4 m -72.34 170.17 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.42 -3.12 13.06 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.528 0.68 . . . . 0.0 111.546 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB3' HG23 ' A' ' 13' ' ' VAL . 3.2 tppp? -78.27 -35.65 47.79 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.125 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.592 ' HB2' HG13 ' A' ' 12' ' ' VAL . 11.6 m-20 -112.02 -8.87 14.03 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.817 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.45 -27.84 27.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 9.9 p30 -83.71 -9.92 58.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 108.834 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -46.5 4.1 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.574 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.14 -49.87 13.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.317 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.728 HG21 HD12 ' A' ' 30' ' ' ILE . 88.5 t -79.59 -26.91 12.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-O 121.53 0.681 . . . . 0.0 111.447 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -99.49 26.79 5.77 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-O 122.514 1.15 . . . . 0.0 108.552 -175.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.21 149.41 44.63 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.689 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.19 9.63 14.69 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.524 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -115.38 6.55 14.86 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.861 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.413 ' HD2' HG23 ' A' ' 64' ' ' VAL . 16.3 pttm -160.1 158.73 30.84 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.564 0.746 . . . . 0.0 108.994 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.8 m-20 -86.9 123.4 31.99 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 21' ' ' VAL . 47.4 t -114.65 117.11 54.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.626 -0.671 . . . . 0.0 112.506 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HG ' HD23 ' A' ' 87' ' ' LEU . 6.6 mt -89.12 111.02 21.69 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.728 HD12 HG21 ' A' ' 21' ' ' VAL . 10.6 tt -103.6 143.6 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.33 -1.348 . . . . 0.0 112.208 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -117.66 113.16 21.49 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.148 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.432 ' CD1' HD11 ' A' ' 79' ' ' ILE . 96.6 m-85 -77.69 124.08 27.49 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 169.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.559 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 17.6 p90 -139.7 -176.96 4.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.304 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -147.31 148.07 30.49 Favored Pre-proline 0 N--CA 1.418 -2.071 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.68 -20.78 9.02 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 121.365 1.377 . . . . 0.0 110.361 -173.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -97.53 8.01 45.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.247 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 27.7 t -81.76 124.04 29.29 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.971 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.85 99.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.347 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -68.28 -35.91 78.58 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.014 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 47.2 t -65.91 -37.1 85.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.34 0.59 . . . . 0.0 110.163 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.9 mtmt -71.38 -10.0 59.06 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.405 0.621 . . . . 0.0 111.116 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.77 -21.76 17.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.215 1.007 . . . . 0.0 109.061 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.678 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 95.7 mt -87.56 -23.42 24.35 Favored 'General case' 0 C--O 1.177 -2.761 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.51 -52.67 57.74 Favored Pre-proline 0 C--N 1.267 -3.021 0 C-N-CA 125.13 1.372 . . . . 0.0 114.151 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.51 -27.12 23.27 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 121.31 1.34 . . . . 0.0 112.353 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HE2' ' O ' ' A' ' 102' ' ' SER . 3.8 ptpp? -85.67 -32.46 21.96 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.678 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -76.44 -33.48 58.76 Favored 'General case' 0 N--CA 1.402 -2.858 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.314 -171.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -83.11 -20.88 34.0 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.65 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.2 tt0 -86.14 -49.24 7.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.86 -36.79 64.88 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.86 -36.42 81.88 Favored Glycine 0 CA--C 1.476 -2.352 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.044 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -61.3 -55.05 36.22 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 88.4 mt -61.94 -39.66 92.86 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.617 -176.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 3.3 m-85 -84.16 -20.18 32.89 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.13 22.23 13.09 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 60' ' ' LYS . 4.9 tppt? -142.5 -42.05 0.33 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.39 0.614 . . . . 0.0 110.036 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 44.7 m -88.53 -156.25 0.37 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.18 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.35 17.04 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . 14.8 m-85 -126.31 -1.97 6.93 Favored 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 121.477 -0.765 . . . . 0.0 109.874 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 23.2 pttm -70.45 -7.65 44.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.311 1.053 . . . . 0.0 110.059 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.55 -6.43 20.58 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.682 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -115.13 -48.14 2.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.147 0.975 . . . . 0.0 110.854 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 120' ' ' ALA . 47.5 t -128.52 155.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.036 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 53.3 t -135.96 127.83 44.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 172.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.442 ' C ' HG23 ' A' ' 9' ' ' VAL . 32.1 mm -93.82 126.67 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.2 165.66 20.89 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.565 0.346 . . . . 0.0 111.556 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -144.39 148.74 35.07 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' A' ' 30' ' ' ILE . 9.0 p -131.68 135.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -82.63 106.85 14.82 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 -11.97 59.92 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 123.845 0.858 . . . . 0.0 112.023 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -105.43 -15.03 15.13 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.495 0.664 . . . . 0.0 111.01 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.16 -28.78 11.26 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -126.57 111.97 14.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.915 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.94 127.73 33.24 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.58 148.55 37.95 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.347 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -84.84 -6.78 9.59 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.859 2.373 . . . . 0.0 111.189 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.51 137.69 38.05 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.294 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -82.76 140.37 33.06 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.309 0.576 . . . . 0.0 110.306 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.527 HG23 ' OG1' ' A' ' 84' ' ' THR . 55.4 mt -126.9 132.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 124.225 1.01 . . . . 0.0 108.803 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -73.94 -29.32 61.96 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.54 0.685 . . . . 0.0 110.647 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.62 -114.37 1.9 Allowed Glycine 0 C--N 1.299 -1.503 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.5 t80 -123.84 -53.4 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.826 171.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -89.99 155.47 4.88 Favored 'Trans proline' 0 N--CA 1.419 -2.855 0 CA-C-N 120.154 1.091 . . . . 0.0 109.936 169.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.527 ' OG1' HG23 ' A' ' 79' ' ' ILE . 6.9 m -163.85 140.44 6.78 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.538 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 30.2 mt -107.89 134.65 49.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 86.8 mttt -135.86 129.46 32.39 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.524 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -100.46 115.97 31.32 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -99.27 97.84 5.87 Favored Pre-proline 0 C--N 1.292 -1.894 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.3 Cg_endo -70.04 161.83 44.49 Favored 'Trans proline' 0 CA--C 1.465 -2.962 0 C-N-CA 121.986 1.791 . . . . 0.0 111.076 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.05 77.22 6.76 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-O 123.004 1.383 . . . . 0.0 109.107 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.15 -34.84 0.72 Allowed Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.779 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -112.8 33.19 5.15 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.912 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' H ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -65.79 0.92 1.5 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.286 1.434 . . . . 0.0 112.787 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.76 -12.15 28.83 Favored Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.421 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 11.8 pt20 -134.63 51.07 5.58 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 122.87 0.468 . . . . 0.0 110.982 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 17.2 Cg_exo -45.28 157.08 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 124.512 3.475 . . . . 0.0 114.818 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 22.0 t -90.27 97.08 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.906 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.447 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 8.8 t -75.9 128.55 35.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.086 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.27 166.13 25.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.692 -172.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.5 t -98.85 -33.91 10.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 143.24 172.52 14.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.517 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.496 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.9 m -128.55 150.17 50.3 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -98.88 34.28 2.13 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.83 0.824 . . . . 0.0 109.692 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -146.11 149.13 33.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.209 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 46' ' ' LYS . 66.2 t -80.4 -29.63 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.291 0.567 . . . . 0.0 109.513 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.14 -45.38 93.24 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 122.236 1.017 . . . . 0.0 110.126 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 26.3 t70 -71.97 -24.27 61.56 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.63 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 108' ' ' LEU . 21.5 mt -71.92 -44.56 63.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.857 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.22 -51.49 62.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 16.2 tppt? -68.06 -20.32 64.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.798 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.7 OUTLIER -69.06 -64.48 0.86 Allowed 'General case' 0 C--O 1.183 -2.416 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.421 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.0 mt -67.3 -15.28 19.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 122.758 1.266 . . . . 0.0 108.286 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -84.81 -21.22 29.98 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.816 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -117.87 -40.1 3.04 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 122.051 0.929 . . . . 0.0 109.818 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.5 m-80 -80.28 -26.08 39.1 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.916 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.41 164.58 45.68 Favored Glycine 0 N--CA 1.404 -3.448 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.238 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.539 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 8.9 mmmm -94.23 -26.26 16.72 Favored 'General case' 0 CA--C 1.458 -2.572 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.421 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.8 m-85 -83.63 -11.64 57.02 Favored 'General case' 0 N--CA 1.379 -3.992 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.39 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 53.86 60.46 3.63 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.458 1.099 . . . . 0.0 108.772 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 63' ' ' VAL . . . -47.82 24.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.274 -2.683 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.258 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 18.8 Cg_endo . . . . . 0 CA--C 1.516 -0.418 0 N-CA-C 107.191 -1.888 . . . . 0.0 107.191 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 65' ' ' ILE . 1.5 p -68.2 133.58 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.725 171.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 m -66.05 102.75 0.84 Allowed 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 121.448 0.642 . . . . 0.0 110.153 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.55 102.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 16' ' ' ASN . 55.2 t -98.72 126.52 51.86 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.884 0 C-N-CA 125.915 1.686 . . . . 0.0 107.443 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 15' ' ' LYS . 27.7 m -79.03 173.87 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.21 -17.53 64.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.885 0.374 . . . . 0.0 110.916 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB3' HG23 ' A' ' 13' ' ' VAL . 33.5 tttm -65.67 -45.14 84.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.401 0.62 . . . . 0.0 110.546 171.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.789 ' HB2' HG13 ' A' ' 12' ' ' VAL . 61.2 m-20 -93.79 -10.14 35.16 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.775 -165.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -58.9 -37.28 76.27 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.83 -7.22 58.56 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.867 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.9 pt-20 -105.75 -51.39 3.0 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 122.019 0.914 . . . . 0.0 110.882 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.516 HG12 ' HG3' ' A' ' 19' ' ' GLU . 35.4 mm -80.02 -52.96 13.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.409 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 30' ' ' ILE . 60.7 t -82.95 -21.24 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 CA-C-O 122.025 0.917 . . . . 0.0 111.002 -173.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.72 29.0 4.75 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.64 133.11 34.84 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -105.5 21.18 17.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -105.3 -8.25 18.37 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.291 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.513 ' HD2' HG23 ' A' ' 64' ' ' VAL . 20.3 pttm -154.81 159.55 40.66 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.835 0.854 . . . . 0.0 108.78 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 79.0 m-20 -80.93 120.31 24.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 21' ' ' VAL . 22.3 t -111.65 119.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.045 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HG ' HD23 ' A' ' 87' ' ' LEU . 10.5 mt -88.07 123.21 32.53 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.657 HD12 HG21 ' A' ' 21' ' ' VAL . 9.3 tt -113.66 149.25 16.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 117.806 -1.557 . . . . 0.0 110.447 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' A' ' 43' ' ' LEU . 35.2 tt0 -130.66 113.17 13.85 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.371 0.605 . . . . 0.0 109.844 175.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 84' ' ' THR . 95.7 m-85 -75.33 131.68 40.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 173.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.517 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.8 p90 -147.67 -173.25 4.23 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.709 0.766 . . . . 0.0 111.652 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -150.52 148.1 23.06 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.91 -16.87 8.56 Favored 'Trans proline' 0 CA--C 1.499 -1.269 0 C-N-CA 122.13 1.887 . . . . 0.0 110.299 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -91.19 -1.12 57.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.705 -1.588 . . . . 0.0 111.267 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 45.2 t -86.31 117.85 25.38 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.127 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.74 -28.82 73.47 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.644 ' O ' HD13 ' A' ' 43' ' ' LEU . 20.1 t60 -63.14 -46.25 88.1 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 30.9 t -60.93 -33.06 72.57 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.252 0.548 . . . . 0.0 111.368 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 41.8 mmtt -63.68 -12.12 31.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.42 16.83 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.928 1.347 . . . . 0.0 108.862 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.2 mp -99.0 -22.86 15.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.604 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.452 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -68.79 -44.28 30.49 Favored Pre-proline 0 C--N 1.283 -2.312 0 C-N-CA 124.637 1.175 . . . . 0.0 113.296 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 51.2 Cg_endo -64.5 -16.56 55.83 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.569 1.513 . . . . 0.0 113.116 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -101.08 -28.47 12.69 Favored 'General case' 0 CA--C 1.473 -2.015 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.647 177.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -73.87 -39.41 63.96 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.12 -174.038 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 2.1 mp0 -80.17 -20.85 43.86 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 119.703 -0.799 . . . . 0.0 113.112 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.3 tt0 -85.44 -46.45 10.89 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -73.2 -40.89 64.38 Favored 'General case' 0 CA--C 1.467 -2.231 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.21 94.6 Favored Glycine 0 CA--C 1.461 -3.296 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.133 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.49 -56.09 25.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.4 mt -59.75 -43.01 94.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.194 -175.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.64 -42.72 33.81 Favored 'General case' 0 C--O 1.188 -2.153 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.55 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.1 16.54 8.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.0 tppt? -130.87 -33.01 1.61 Allowed 'General case' 0 C--N 1.316 -0.848 0 O-C-N 122.049 -0.407 . . . . 0.0 110.538 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.581 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 14.3 t -96.08 -160.82 0.82 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.222 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.16 15.19 0.07 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.541 1.136 . . . . 0.0 113.434 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -118.05 -3.16 11.14 Favored 'General case' 0 C--O 1.194 -1.868 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 57' ' ' SER . 60.8 pttt -71.75 -4.18 26.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.835 0.826 . . . . 0.0 112.848 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -110.35 -9.59 14.63 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -98.0 -49.96 4.57 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.239 1.019 . . . . 0.0 109.352 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.2 t -137.26 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.058 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.513 HG23 ' HD2' ' A' ' 26' ' ' LYS . 53.7 t -124.75 130.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.523 ' C ' HG23 ' A' ' 9' ' ' VAL . 34.9 mm -94.68 122.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -132.51 158.61 41.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 122.578 0.351 . . . . 0.0 110.703 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -151.93 139.36 19.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.654 -0.654 . . . . 0.0 109.955 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 11.1 p -116.44 139.87 41.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -85.58 110.28 19.13 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.84 -9.73 59.56 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 124.077 0.861 . . . . 0.0 112.331 -172.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -109.93 -18.17 13.45 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.436 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.28 -32.91 11.66 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -123.28 101.62 7.47 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.82 116.11 4.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.301 0.572 . . . . 0.0 110.6 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 32' ' ' PHE . 33.2 m -91.96 144.97 30.05 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.502 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -90.24 0.11 5.41 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.168 2.579 . . . . 0.0 112.246 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -78.53 -179.02 6.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.071 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.66 106.37 14.43 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.017 0.913 . . . . 0.0 109.974 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.54 HG23 ' OG1' ' A' ' 84' ' ' THR . 43.9 mt -96.56 136.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.103 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -88.3 -9.17 53.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.16 -116.46 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.577 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 78.3 t80 -118.16 -58.84 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.77 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.5 Cg_exo -87.85 156.67 7.38 Favored 'Trans proline' 0 N--CA 1.425 -2.519 0 CA-C-N 120.385 1.173 . . . . 0.0 109.414 167.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.54 ' OG1' HG23 ' A' ' 79' ' ' ILE . 17.6 m -159.25 136.93 10.1 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.843 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 42.8 mt -101.64 137.43 29.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.53 121.96 19.43 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.0 tm? -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.57 100.43 7.1 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.421 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 12.7 Cg_endo -65.97 159.36 49.53 Favored 'Trans proline' 0 CA--C 1.463 -3.045 0 C-N-CA 121.812 1.674 . . . . 0.0 109.92 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.6 77.23 8.47 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.892 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.18 -39.24 0.45 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 113.0 -1.909 . . . . 0.0 110.269 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.421 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -109.46 58.18 0.61 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.242 1.02 . . . . 0.0 110.493 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 8.13 3.36 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.167 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.53 -1.85 9.05 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.614 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 47.8 mt-30 -133.12 46.74 2.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.42 0.688 . . . . 0.0 110.803 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 85.6 Cg_exo -54.1 156.25 13.46 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 123.561 2.841 . . . . 0.0 113.245 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 115' ' ' ASN . 15.0 t -95.37 95.68 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.133 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -72.19 128.45 35.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.434 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.31 170.85 14.95 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 125.289 1.436 . . . . 0.0 109.502 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.5 t -108.13 -31.13 8.05 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.162 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.65 110.79 0.61 Allowed Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.591 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.1 m -62.69 -26.43 68.66 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 123.751 0.821 . . . . 0.0 111.838 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.41 ' HG2' HD12 ' A' ' 43' ' ' LEU . 70.2 mtm180 64.61 17.72 11.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.987 0.915 . . . . 0.0 112.254 -175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -152.04 153.41 33.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.258 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 46' ' ' LYS . 60.2 t -77.2 -39.19 28.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 124.676 1.19 . . . . 0.0 109.739 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -55.75 -47.69 76.55 Favored 'General case' 0 C--O 1.251 1.184 0 C-N-CA 124.926 1.29 . . . . 0.0 110.936 -172.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.5 t70 -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.758 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 23.0 mt -70.7 -39.97 73.13 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.571 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.42 -52.62 54.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 45.2 tptt -70.07 -15.77 63.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.3 t80 -71.51 -62.74 1.3 Allowed 'General case' 0 C--O 1.191 -1.983 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.494 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.2 mt -65.94 -13.72 16.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.871 1.319 . . . . 0.0 108.015 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -82.81 -33.5 27.2 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.681 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -109.06 -35.21 6.38 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.929 0.871 . . . . 0.0 109.39 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.7 m-80 -86.07 -30.0 22.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.267 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.91 163.92 51.3 Favored Glycine 0 N--CA 1.406 -3.331 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.873 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -98.9 -23.33 15.38 Favored 'General case' 0 CA--C 1.452 -2.799 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.629 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.464 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.9 m-85 -80.04 -14.09 58.81 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.516 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 55.78 56.1 6.43 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 124.184 0.927 . . . . 0.0 110.011 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.37 38.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.482 0.828 0 CA-C-O 121.663 0.61 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.571 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.3 p -73.0 133.12 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.927 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 18.9 m -74.9 107.96 7.32 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 121.735 0.778 . . . . 0.0 111.129 -173.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.73 108.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.613 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.8 t -109.82 110.49 32.33 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.643 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 15' ' ' LYS . 16.3 m -69.81 166.97 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.66 -23.53 63.14 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.152 0.501 . . . . 0.0 110.698 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.639 ' HB3' HG23 ' A' ' 13' ' ' VAL . 44.2 tttp -59.97 -42.4 94.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.396 173.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HB2' HG13 ' A' ' 12' ' ' VAL . 20.0 m-20 -105.75 -9.88 17.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.491 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -54.07 -27.52 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -86.46 -8.15 57.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.303 1.049 . . . . 0.0 108.939 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -105.86 -43.19 4.94 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.693 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mm -94.06 -54.7 6.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.717 HG21 HD12 ' A' ' 30' ' ' ILE . 78.3 t -72.98 -25.51 22.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 CA-C-O 121.885 0.85 . . . . 0.0 112.077 -174.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 22' ' ' LEU . 1.7 tm? -99.8 16.32 24.04 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 122.502 1.144 . . . . 0.0 108.974 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.47 150.7 23.59 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.122 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.509 ' HB3' ' CE ' ' A' ' 93' ' ' LYS . 6.3 p-10 -115.29 17.09 16.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -90.85 -14.23 32.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.677 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.625 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.06 161.15 42.92 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.156 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 m-20 -78.47 126.21 30.44 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 21' ' ' VAL . 33.5 t -115.37 115.29 48.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.46 ' HG ' HD23 ' A' ' 87' ' ' LEU . 8.8 mt -85.72 128.51 34.81 Favored 'General case' 0 CA--C 1.467 -2.243 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 21' ' ' VAL . 12.7 tt -115.9 144.76 22.8 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 C-N-CA 118.026 -1.469 . . . . 0.0 110.564 171.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 39.8 tt0 -125.41 112.25 16.07 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -78.14 126.91 31.5 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.58 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.7 p90 -144.03 -175.79 4.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.111 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -146.1 144.23 21.18 Favored Pre-proline 0 N--CA 1.42 -1.954 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -80.1 -17.81 10.37 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 121.627 1.551 . . . . 0.0 110.249 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -89.65 1.16 56.39 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.638 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 42.0 t -83.68 118.89 24.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.346 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.11 -38.29 94.14 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.561 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.8 m80 -68.11 -36.99 80.65 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.857 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 34.8 t -64.91 -34.83 79.34 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.797 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -69.07 -15.27 63.41 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.542 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.54 -10.31 32.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.075 0.94 . . . . 0.0 109.438 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 78.7 mt -97.77 -13.51 21.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.858 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.77 90.81 Favored Pre-proline 0 C--N 1.255 -3.543 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.531 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.44 -12.58 20.68 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.355 1.37 . . . . 0.0 113.059 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 43' ' ' LEU . 9.8 ptmm? -92.27 -32.24 15.1 Favored 'General case' 0 CA--C 1.466 -2.268 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.571 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -82.95 -41.48 18.77 Favored 'General case' 1 N--CA 1.378 -4.075 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.078 -171.876 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -73.69 -42.39 61.32 Favored 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.682 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 tt0 -74.79 -38.4 62.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.791 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 108' ' ' LEU . 24.3 tp -72.79 -40.18 66.1 Favored 'General case' 0 CA--C 1.472 -2.027 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.66 96.69 Favored Glycine 0 CA--C 1.473 -2.573 0 CA-C-N 113.559 -1.655 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.78 -53.53 49.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.0 mt -52.35 -39.1 60.29 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 124.169 0.918 . . . . 0.0 110.968 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.281 4.1 m-30 -77.79 -49.86 13.49 Favored 'General case' 0 C--O 1.187 -2.213 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.071 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.525 ' C ' ' HE2' ' A' ' 56' ' ' LYS . . . -76.1 6.91 4.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -120.39 -43.97 2.49 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 124.369 1.068 . . . . 0.0 109.304 -177.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -91.68 -169.59 2.34 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -76.86 28.93 0.13 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -122.51 4.18 9.62 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -65.42 -16.65 63.84 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -119.35 5.09 11.18 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.735 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -95.33 -45.57 7.08 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.532 1.158 . . . . 0.0 109.245 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -135.0 142.99 38.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.866 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.391 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 26' ' ' LYS . 51.4 t -119.21 119.54 61.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mm -86.6 116.14 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.737 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -127.24 160.71 30.45 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.174 0.511 . . . . 0.0 111.32 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -153.78 145.18 23.09 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 122.015 -0.428 . . . . 0.0 110.24 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.38 140.79 47.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.63 109.18 17.79 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.33 60.43 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.292 1.037 . . . . 0.0 112.681 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 t -111.36 -18.1 12.98 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.571 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.58 -30.37 13.33 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -131.53 83.29 2.09 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 131.52 46.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.849 0.833 . . . . 0.0 110.102 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.13 156.86 36.58 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.531 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.43 -7.69 11.72 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.768 2.312 . . . . 0.0 110.469 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -67.42 153.25 44.12 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.114 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.89 126.88 39.35 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -124.51 128.8 73.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.794 0.331 . . . . 0.0 110.479 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -81.03 -27.71 35.68 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.121 0.568 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.13 -120.22 3.83 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.597 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.3 t80 -133.22 -58.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.1 Cg_endo -87.67 149.33 7.37 Favored 'Trans proline' 0 N--CA 1.424 -2.613 0 CA-C-N 120.252 1.126 . . . . 0.0 109.188 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -162.45 149.99 13.9 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.6 mt -110.37 138.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 91.3 mttt -137.21 128.42 27.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.46 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.4 tm? -101.34 115.07 29.67 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -98.67 97.51 4.93 Favored Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 19.5 Cg_endo -66.65 158.1 57.62 Favored 'Trans proline' 0 CA--C 1.464 -3.01 0 C-N-CA 121.993 1.796 . . . . 0.0 111.14 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.94 77.91 8.71 Favored 'General case' 0 N--CA 1.394 -3.258 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.69 -23.17 0.34 Allowed Glycine 0 N--CA 1.422 -2.246 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.231 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.413 ' H ' ' HG2' ' A' ' 89' ' ' PRO . . . -138.34 61.11 1.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.539 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 24' ' ' ASP . 19.7 ptpt -77.81 5.28 9.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.283 0.633 . . . . 0.0 110.536 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.65 -11.83 25.94 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.41 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 19.0 pt20 -130.71 48.23 3.55 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 122.789 0.436 . . . . 0.0 110.831 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 28.8 Cg_exo -46.51 150.4 2.34 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.285 2.656 . . . . 0.0 113.365 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 18.7 t -93.82 98.92 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.542 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.446 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 11.1 t -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.447 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.48 160.0 40.65 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.938 -169.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 p -87.37 -58.71 2.48 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.531 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.16 121.77 4.77 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -80.54 22.3 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 59.41 22.12 10.55 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 t -137.73 159.13 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 122.282 -0.261 . . . . 0.0 110.343 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG13 HD13 ' A' ' 50' ' ' LEU . 96.0 t -77.18 -29.42 17.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 124.045 0.938 . . . . 0.0 110.257 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 27.0 mt-10 -59.24 -45.71 90.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 123.331 1.538 . . . . 0.0 108.869 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -62.1 -35.97 80.32 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 111.302 -2.681 . . . . 0.0 109.305 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.2 mt -75.16 -43.53 51.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.49 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.6 mt -55.14 -52.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -66.01 -22.87 66.47 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.382 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.607 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.5 OUTLIER -67.34 -63.73 1.0 Allowed 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.548 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.5 mt -71.81 -8.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.494 1.14 . . . . 0.0 108.953 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.8 -28.98 15.59 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.313 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.17 -43.92 6.46 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 61.4 m-80 -85.84 -29.93 23.35 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.166 -1.833 . . . . 0.0 109.833 -174.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -74.15 155.77 49.47 Favored Glycine 1 N--CA 1.392 -4.243 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.915 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -94.82 -23.11 17.63 Favored 'General case' 0 CA--C 1.468 -2.175 0 CA-C-O 121.753 0.787 . . . . 0.0 109.195 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.51 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 17.2 m-85 -82.21 -9.73 59.4 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 51.81 51.88 15.68 Favored 'General case' 0 C--N 1.365 1.242 0 C-N-CA 124.325 1.05 . . . . 0.0 110.376 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -75.1 90.42 2.51 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.185 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 C--O 1.245 0.839 0 N-CA-C 109.536 -0.986 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 65' ' ' ILE . 1.5 p -69.91 125.56 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 12' ' ' VAL . 20.2 m -72.96 106.72 4.97 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.0 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.6 114.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.772 HG13 ' HB2' ' A' ' 16' ' ' ASN . 83.5 t -116.62 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 15' ' ' LYS . 16.2 m -71.88 173.51 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.638 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.582 ' H ' ' HB3' ' A' ' 73' ' ' ASN . . . -60.02 -26.95 66.5 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.471 0.708 . . . . 0.0 110.852 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 13' ' ' VAL . 30.4 tttm -62.08 -50.99 69.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.772 ' HB2' HG13 ' A' ' 12' ' ' VAL . 54.0 m-20 -86.85 -14.49 41.92 Favored 'General case' 0 CA--C 1.464 -2.356 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.196 -168.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -57.79 -32.14 67.25 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -78.87 -17.93 54.78 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.9 pt-20 -104.49 -45.16 4.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.415 1.102 . . . . 0.0 111.213 -173.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.513 HG12 ' HG3' ' A' ' 19' ' ' GLU . 33.7 mm -83.91 -54.35 9.17 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.486 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.638 HG21 HD12 ' A' ' 30' ' ' ILE . 61.1 t -81.62 -37.15 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 121.474 0.654 . . . . 0.0 111.278 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.8 35.07 1.16 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.519 ' OD2' ' HD3' ' A' ' 26' ' ' LYS . 17.6 t70 -86.87 151.79 23.02 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.143 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.74 14.35 16.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 p -101.67 -23.12 14.29 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.319 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HD3' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -142.33 164.85 29.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 74.4 m-20 -81.63 120.02 24.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.9 t -115.1 121.02 66.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.728 0.775 . . . . 0.0 111.227 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.584 HD21 HD22 ' A' ' 108' ' ' LEU . 18.4 tp -93.33 124.94 37.67 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.638 HD12 HG21 ' A' ' 21' ' ' VAL . 12.4 tt -115.1 147.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 C-N-CA 117.596 -1.642 . . . . 0.0 112.953 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 27.3 tt0 -117.15 114.37 23.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.417 ' HD2' ' O ' ' A' ' 84' ' ' THR . 97.4 m-85 -83.84 124.15 30.65 Favored 'General case' 0 CA--C 1.464 -2.344 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 170.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -142.41 -172.5 3.63 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.311 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.99 150.7 39.55 Favored Pre-proline 0 N--CA 1.419 -2.006 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -78.65 -20.12 10.87 Favored 'Trans proline' 0 CA--C 1.5 -1.223 0 C-N-CA 121.391 1.394 . . . . 0.0 110.152 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -89.28 -2.78 58.6 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.489 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 47.0 t -77.11 118.52 19.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.467 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.73 -37.23 93.92 Favored Glycine 0 C--O 1.236 0.225 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -64.84 -42.13 95.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.918 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.7 t -62.55 -43.14 99.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.079 0.466 . . . . 0.0 110.704 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 49.5 mtmt -66.65 -18.44 65.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.601 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 -18.96 25.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.596 0.712 . . . . 0.0 109.424 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 72.6 mt -88.47 -26.86 21.86 Favored 'General case' 0 C--O 1.196 -1.752 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.372 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.11 -51.57 61.08 Favored Pre-proline 0 C--N 1.286 -2.171 0 C-N-CA 125.813 1.645 . . . . 0.0 114.299 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -66.01 -30.81 47.47 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.066 1.178 . . . . 0.0 111.319 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.484 ' CB ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -87.45 -28.9 21.81 Favored 'General case' 0 CA--C 1.43 -3.65 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.243 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -73.83 -36.33 64.91 Favored 'General case' 0 N--CA 1.386 -3.651 0 O-C-N 123.78 0.675 . . . . 0.0 109.61 -174.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.93 -49.48 61.55 Favored 'General case' 0 C--O 1.193 -1.912 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.595 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.62 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 40.8 mt-10 -75.15 -33.26 61.5 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -173.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 108' ' ' LEU . 13.0 tp -73.15 -41.69 63.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.81 -43.07 99.65 Favored Glycine 0 CA--C 1.475 -2.437 0 CA-C-N 112.922 -1.945 . . . . 0.0 112.271 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -62.8 -52.05 64.71 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 84.2 mt -60.35 -36.68 78.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.746 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.251 2.0 m-85 -76.42 -50.95 12.82 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 116.932 -1.907 . . . . 0.0 110.873 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -83.6 22.76 1.03 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -151.07 -31.26 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 176.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 m -87.06 -85.78 0.16 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.36 -5.33 9.87 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -126.41 23.48 6.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 19.3 pttp -69.89 -15.42 63.07 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.351 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -116.26 15.9 15.86 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.652 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -131.97 -110.46 0.24 Allowed 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 119.909 -0.717 . . . . 0.0 110.984 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 112' ' ' ILE . 92.9 t -55.51 129.45 16.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 123.499 0.72 . . . . 0.0 111.853 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 26' ' ' LYS . 96.0 t -114.48 123.99 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.022 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.5 mm -89.33 118.55 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -126.14 165.9 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -155.83 144.72 20.49 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 122.077 -0.389 . . . . 0.0 110.744 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.405 HG12 HD11 ' A' ' 30' ' ' ILE . 11.7 p -127.05 145.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.78 111.89 22.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.11 -14.7 61.02 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.409 ' HB ' ' CZ ' ' A' ' 82' ' ' PHE . 9.9 t -107.98 -6.27 16.68 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.258 0.551 . . . . 0.0 111.492 -175.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.05 -48.26 2.99 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.582 ' HB3' ' H ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -100.56 101.1 11.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.09 117.12 8.68 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.091 0.472 . . . . 0.0 110.886 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.24 150.0 36.32 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.626 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -89.94 -4.41 5.32 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.029 2.486 . . . . 0.0 112.273 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.43 144.87 53.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.856 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.48 113.29 22.3 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.641 0.734 . . . . 0.0 109.455 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.522 HG23 ' OG1' ' A' ' 84' ' ' THR . 55.3 mt -106.32 144.93 14.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.373 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -80.78 -17.24 51.56 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.885 0.85 . . . . 0.0 111.318 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.489 ' H ' HG22 ' A' ' 79' ' ' ILE . . . -144.38 -112.19 0.81 Allowed Glycine 0 C--N 1.278 -2.673 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.541 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 48.2 t80 -123.21 -54.68 0.03 OUTLIER Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.28 171.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.9 Cg_endo -89.36 155.06 5.48 Favored 'Trans proline' 0 N--CA 1.429 -2.284 0 CA-C-N 120.307 1.145 . . . . 0.0 110.324 170.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.522 ' OG1' HG23 ' A' ' 79' ' ' ILE . 15.9 m -165.84 143.3 5.56 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.7 mt -105.86 133.57 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 94.4 mttt -135.95 124.02 22.92 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.193 0.52 . . . . 0.0 110.392 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -98.47 115.33 28.3 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -95.92 98.16 3.67 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.55 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -68.54 158.32 58.16 Favored 'Trans proline' 0 CA--C 1.461 -3.145 0 C-N-CA 121.586 1.524 . . . . 0.0 110.302 178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.91 77.47 8.73 Favored 'General case' 0 N--CA 1.402 -2.834 0 C-N-CA 118.632 -1.227 . . . . 0.0 107.974 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.95 -34.1 0.44 Allowed Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.915 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -120.65 35.98 4.71 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.109 0.957 . . . . 0.0 109.963 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.12 2.73 1.4 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 125.523 1.529 . . . . 0.0 112.126 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.15 25.94 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.406 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 14.0 pt20 -137.34 54.52 8.34 Favored Pre-proline 0 CA--C 1.578 2.034 0 C-N-CA 123.724 0.809 . . . . 0.0 110.808 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 12.9 Cg_exo -45.06 160.61 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 125.014 3.809 . . . . 0.0 115.137 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 115' ' ' ASN . 24.8 t -94.4 98.6 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.329 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.472 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 14.2 t -73.52 132.49 42.93 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.651 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.71 164.41 30.29 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.184 -174.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -87.35 -68.55 0.74 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.74 129.17 1.26 Allowed Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -71.63 -37.19 70.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 117.195 0.498 . . . . 0.0 110.821 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 65.96 17.43 10.8 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.284 1.033 . . . . 0.0 111.375 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -150.18 161.7 41.89 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 46' ' ' LYS . 61.8 t -86.2 -43.23 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.04 0.447 . . . . 0.0 109.955 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -54.4 -39.36 67.18 Favored 'General case' 0 N--CA 1.396 -3.165 0 C-N-CA 126.188 1.795 . . . . 0.0 112.665 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.6 t70 -80.75 -23.38 39.45 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.511 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.584 HD22 HD21 ' A' ' 29' ' ' LEU . 17.3 mt -74.7 -41.6 59.91 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.713 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.62 -51.52 70.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 45.5 tptt -65.8 -21.34 66.48 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.029 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.606 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -68.22 -65.51 0.69 Allowed 'General case' 0 C--O 1.186 -2.27 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.569 HG21 HG11 ' A' ' 63' ' ' VAL . 3.1 mt -67.72 -12.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.517 1.151 . . . . 0.0 108.806 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -87.77 -22.2 24.69 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.05 -176.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -114.78 -35.39 4.84 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 122.261 1.029 . . . . 0.0 109.166 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.606 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 57.6 m-80 -88.97 -21.93 23.29 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.478 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -83.16 163.9 41.79 Favored Glycine 0 N--CA 1.404 -3.452 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.749 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.55 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 12.0 mmmm -93.68 -24.71 17.76 Favored 'General case' 0 CA--C 1.457 -2.61 0 CA-C-N 118.228 1.014 . . . . 0.0 108.406 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.51 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 20.6 m-85 -81.41 -14.0 57.64 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.549 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 54.68 55.91 7.37 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 123.989 0.806 . . . . 0.0 109.101 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.65 82.18 0.43 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.265 1.892 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.626 176.698 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 17.8 Cg_endo . . . . . 0 CA--C 1.509 -0.771 0 CA-C-O 121.673 0.614 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.6 p -70.44 118.61 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.904 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.926 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 m -63.23 107.11 0.99 Allowed 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.571 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.404 HG22 ' HE3' ' A' ' 67' ' ' LYS . 44.7 t -79.99 109.82 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 16' ' ' ASN . 21.0 t -109.23 128.77 64.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.568 HG23 ' HB3' ' A' ' 15' ' ' LYS . 18.9 m -75.27 166.94 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 73' ' ' ASN . . . -60.99 -21.72 63.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 110.587 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' HG23 ' A' ' 13' ' ' VAL . 46.0 tptt -62.44 -52.87 61.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.34 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -95.56 -3.33 46.69 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.524 -174.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -24.05 43.05 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -87.96 -8.89 55.04 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 10.8 mt-10 -104.53 -51.74 3.03 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.363 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.63 -51.12 14.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.361 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.591 ' HA ' HG11 ' A' ' 28' ' ' VAL . 60.3 t -83.31 -28.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.88 0.848 . . . . 0.0 110.709 -172.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.56 26.35 6.22 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.212 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.72 141.32 28.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.574 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 8.7 p-10 -109.0 21.64 16.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.4 p -93.07 -17.41 23.86 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.679 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.09 166.05 30.94 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 73.8 m-20 -80.52 130.42 35.13 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' ' 21' ' ' VAL . 24.8 t -119.69 118.4 57.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.334 -0.854 . . . . 0.0 112.005 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 108' ' ' LEU . 9.4 mt -87.8 116.34 25.88 Favored 'General case' 0 CA--C 1.473 -1.983 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 21' ' ' VAL . 12.6 tt -106.07 145.23 14.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 118.089 -1.445 . . . . 0.0 110.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 67' ' ' LYS . 37.1 tt0 -127.94 109.59 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 84' ' ' THR . 95.9 m-85 -73.01 128.38 35.29 Favored 'General case' 0 CA--C 1.465 -2.305 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.528 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 27.3 p90 -142.76 -170.95 3.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 124.014 0.821 . . . . 0.0 111.242 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -148.34 144.61 18.88 Favored Pre-proline 0 C--N 1.289 -2.06 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.56 -22.52 12.1 Favored 'Trans proline' 0 CA--C 1.503 -1.041 0 C-N-CA 121.629 1.553 . . . . 0.0 110.419 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -97.36 3.58 51.02 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 113.129 -1.85 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.579 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 36.7 t -77.76 129.31 35.33 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.62 99.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.554 ' O ' HD13 ' A' ' 43' ' ' LEU . 8.5 m-70 -65.42 -44.34 87.69 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.092 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 35.4 t -56.48 -41.15 76.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.201 0.524 . . . . 0.0 110.519 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.8 mtmt -73.17 -2.75 22.88 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.013 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -107.37 -18.65 13.81 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.857 1.313 . . . . 0.0 108.411 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.6 mp -96.93 -11.02 25.18 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.504 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -46.89 47.55 Favored Pre-proline 0 C--N 1.278 -2.518 0 C-N-CA 125.754 1.621 . . . . 0.0 113.935 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -60.51 -29.54 88.83 Favored 'Trans proline' 0 C--N 1.381 2.253 0 CA-C-N 120.983 1.387 . . . . 0.0 111.926 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 2.6 pttm -84.56 -31.48 24.35 Favored 'General case' 0 C--O 1.188 -2.167 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.742 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -79.3 -33.37 43.33 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.003 -174.325 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 35.3 mm-40 -70.04 -48.19 58.94 Favored 'General case' 0 C--O 1.185 -2.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.7 tt0 -71.41 -47.41 56.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.211 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.58 -39.3 73.97 Favored 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.55 95.27 Favored Glycine 0 CA--C 1.467 -2.945 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.86 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.24 -55.73 22.47 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 95.9 mt -56.7 -43.62 80.71 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.665 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -78.89 -41.88 28.63 Favored 'General case' 0 C--O 1.194 -1.825 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.6 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.67 16.58 6.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 6.3 tppt? -128.46 -36.87 1.85 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.127 -0.358 . . . . 0.0 110.523 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 10.5 m -87.42 -168.4 2.22 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -174.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -74.78 22.97 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.404 0.621 . . . . 0.0 112.567 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -120.96 2.1 10.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 57' ' ' SER . 58.8 pttt -74.75 -0.27 17.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.017 0.913 . . . . 0.0 112.242 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -120.21 4.53 10.81 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.672 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 76.6 ttt180 -99.15 -48.89 4.68 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.757 1.265 . . . . 0.0 107.734 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.533 HG21 HG21 ' A' ' 112' ' ' ILE . 2.5 p -147.57 138.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.175 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' A' ' 26' ' ' LYS . 78.2 t -117.07 131.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.435 ' C ' HG23 ' A' ' 9' ' ' VAL . 37.9 mm -93.41 119.11 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.94 165.76 18.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.358 0.599 . . . . 0.0 111.907 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 31' ' ' GLU . 56.1 mtmt -143.96 160.61 40.53 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.405 ' CG1' HD11 ' A' ' 30' ' ' ILE . 9.4 p -144.68 144.62 21.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 172.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -88.18 118.41 27.75 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.18 54.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.025 0.53 . . . . 0.0 111.907 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -119.63 -23.63 6.49 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.602 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.49 -24.3 14.82 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -118.77 97.49 5.74 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.73 111.88 1.14 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.151 0.501 . . . . 0.0 111.258 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 14' ' ' ALA . 35.8 m -99.32 143.22 26.01 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.932 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -94.09 2.18 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.326 2.684 . . . . 0.0 109.981 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -80.14 165.58 22.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.32 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -88.65 123.38 33.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.422 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.8 mm -105.43 140.43 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.627 1.171 . . . . 0.0 108.125 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.9 -29.21 16.03 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.36 0.6 . . . . 0.0 110.479 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.01 -108.5 1.15 Allowed Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 t80 -117.82 -53.16 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 166.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 3.2 Cg_exo -90.45 162.2 4.45 Favored 'Trans proline' 0 N--CA 1.43 -2.245 0 C-N-CA 121.151 1.234 . . . . 0.0 109.244 164.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.427 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 97.8 m -161.32 141.13 10.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 33.9 mt -106.36 128.97 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 30' ' ' ILE . 41.2 mtmt -135.34 129.18 33.02 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 121.292 0.568 . . . . 0.0 109.645 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.4 tm? -100.38 117.7 35.11 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -98.98 97.55 5.21 Favored Pre-proline 0 C--N 1.291 -1.978 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.604 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 14.3 Cg_endo -68.03 160.68 47.56 Favored 'Trans proline' 0 CA--C 1.464 -2.989 0 C-N-CA 121.973 1.782 . . . . 0.0 111.746 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.54 77.43 8.4 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 122.638 1.208 . . . . 0.0 108.564 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.02 -39.25 0.56 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.915 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 94' ' ' GLY . . . -113.66 31.23 6.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.492 0.663 . . . . 0.0 110.864 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -64.72 13.61 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.658 1.183 . . . . 0.0 113.677 177.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -108.03 -13.08 20.72 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -140.03 70.27 35.24 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 123.981 0.912 . . . . 0.0 108.558 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.4 Cg_exo -49.31 160.24 0.96 Allowed 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 123.926 3.084 . . . . 0.0 113.428 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.461 HG11 ' OD1' ' A' ' 115' ' ' ASN . 54.1 t -100.53 104.16 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.43 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.451 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 8.7 t -75.23 132.19 40.91 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.632 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 146.53 39.66 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.714 -175.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -73.69 -59.31 2.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.491 0.662 . . . . 0.0 110.49 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.55 125.69 0.85 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 15.2 m -71.06 -41.54 70.6 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 60.99 26.09 16.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.371 1.081 . . . . 0.0 108.93 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.7 t -161.51 157.37 24.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.908 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 46' ' ' LYS . 58.1 t -83.9 -37.12 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 124.18 0.992 . . . . 0.0 110.005 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -57.78 -45.16 86.37 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.277 1.036 . . . . 0.0 110.918 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -68.32 -31.0 70.11 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.794 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 29' ' ' LEU . 27.8 mt -72.16 -42.75 65.58 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.311 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.61 -51.05 70.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -66.19 -21.5 66.32 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.88 -178.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -69.98 -61.33 1.82 Allowed 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -69.48 -9.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.579 1.181 . . . . 0.0 108.281 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -91.04 -24.4 20.06 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.869 -177.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -104.4 -39.7 6.35 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-O 123.225 1.488 . . . . 0.0 108.71 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 59.3 m-80 -95.6 -26.14 15.88 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.432 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.36 157.63 40.75 Favored Glycine 0 N--CA 1.403 -3.525 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.922 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.604 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 4.3 mmmp? -88.39 -27.28 21.7 Favored 'General case' 0 CA--C 1.466 -2.251 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.474 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 26.0 m-85 -79.98 -11.2 59.81 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.242 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 55.32 45.9 24.6 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 124.244 0.965 . . . . 0.0 109.396 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . . . -67.05 86.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.005 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.11 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 43.5 Cg_endo . . . . . 0 CA--C 1.503 -1.048 0 CA-C-O 121.777 0.657 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.4 p -83.65 137.66 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.1 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.929 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 m -75.01 93.92 2.79 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 122.248 1.023 . . . . 0.0 110.378 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.23 104.52 3.59 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.386 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 13' ' ' VAL . 23.4 t -102.21 141.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.599 HG23 ' HB3' ' A' ' 15' ' ' LYS . 20.6 m -85.24 170.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.93 -31.22 69.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.073 0.463 . . . . 0.0 110.294 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.599 ' HB3' HG23 ' A' ' 13' ' ' VAL . 29.4 tttm -53.93 -39.79 66.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.152 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -110.45 -2.54 16.51 Favored 'General case' 0 C--O 1.208 -1.109 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.744 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -58.6 -30.93 67.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -77.93 -13.19 59.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 12.3 pt-20 -106.57 -44.75 4.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.404 1.097 . . . . 0.0 111.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.441 HG12 ' HG3' ' A' ' 19' ' ' GLU . 19.0 mm -79.16 -54.88 10.81 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.677 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.634 HG21 HD13 ' A' ' 30' ' ' ILE . 60.1 t -84.72 -29.66 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 121.62 0.724 . . . . 0.0 111.304 -173.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.94 32.37 2.41 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.703 ' OD2' HG22 ' A' ' 25' ' ' THR . 30.6 t70 -96.57 150.01 21.13 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.162 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -116.86 20.33 13.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.703 HG22 ' OD2' ' A' ' 23' ' ' ASP . 13.9 t -98.64 -3.67 35.58 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.475 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.9 161.99 41.64 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.386 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.1 m-20 -81.46 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.606 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.2 t -118.04 121.62 67.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.148 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HG ' HD23 ' A' ' 87' ' ' LEU . 9.9 mt -90.31 116.79 28.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.634 HD13 HG21 ' A' ' 21' ' ' VAL . 1.5 tp -104.45 145.28 13.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.615 ' N ' HG13 ' A' ' 30' ' ' ILE . 41.2 tt0 -126.39 104.34 8.12 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 124.151 0.907 . . . . 0.0 108.589 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 84' ' ' THR . 98.3 m-85 -76.34 128.03 34.04 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -142.47 -175.39 4.44 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.949 0.881 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -138.36 153.25 72.68 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 174.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 59.8 Cg_endo -84.16 -14.78 7.0 Favored 'Trans proline' 0 C--N 1.326 -0.607 0 CA-C-N 121.8 1.678 . . . . 0.0 110.665 -173.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.42 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 56.3 p-90 -96.64 4.58 51.83 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.624 -1.626 . . . . 0.0 111.772 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 46.4 t -80.63 121.57 26.0 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.628 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.83 92.85 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 46.5 m80 -60.72 -45.26 94.95 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 15.0 p -70.74 -25.7 63.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.952 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 56.3 mtmt -74.48 -20.59 59.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.6 0.714 . . . . 0.0 110.228 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.36 -9.83 37.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.672 1.225 . . . . 0.0 108.248 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.589 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 81.0 mt -97.83 -11.92 22.75 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.036 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.45 -50.5 73.15 Favored Pre-proline 0 C--N 1.255 -3.509 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.546 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.13 -16.5 31.9 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 121.453 1.435 . . . . 0.0 113.052 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 43' ' ' LEU . 8.8 ptmm? -86.58 -38.49 17.09 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -82.11 -26.51 33.51 Favored 'General case' 0 N--CA 1.396 -3.13 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.117 -171.164 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 42.4 mt-10 -77.58 -33.08 54.01 Favored 'General case' 0 C--O 1.18 -2.583 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.241 175.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -83.45 -47.86 10.94 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.523 HD22 HD13 ' A' ' 108' ' ' LEU . 7.0 tp -64.64 -46.25 83.33 Favored 'General case' 0 CA--C 1.469 -2.147 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -77.75 -20.54 73.63 Favored Glycine 0 CA--C 1.474 -2.505 0 CA-C-N 114.172 -1.376 . . . . 0.0 114.987 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -71.7 -50.41 30.62 Favored 'General case' 0 CA--C 1.477 -1.856 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.59 -45.13 69.33 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.165 -173.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 42.2 m-85 -74.91 -27.67 60.31 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' GLY . . . -107.88 16.1 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -136.86 -33.05 0.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.441 -0.162 . . . . 0.0 111.163 176.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 22.2 m -84.62 -164.31 0.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.81 28.06 0.17 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.9 3.52 5.97 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 22.6 pttp -72.56 -12.56 61.11 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.805 0.812 . . . . 0.0 111.048 -174.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -109.85 5.65 22.73 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -106.22 -49.77 3.29 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.372 1.082 . . . . 0.0 109.1 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG21 HG21 ' A' ' 112' ' ' ILE . 2.5 p -138.82 135.58 43.0 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.172 -1.831 . . . . 0.0 109.309 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 26' ' ' LYS . 75.6 t -112.58 127.28 69.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 9' ' ' VAL . 31.8 mm -90.56 121.19 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.656 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -130.06 161.37 31.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.282 0.563 . . . . 0.0 111.701 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' ' HD2' ' A' ' 47' ' ' TYR . 14.5 ptmt -152.03 145.29 24.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.414 HG12 HD11 ' A' ' 30' ' ' ILE . 7.6 p -129.83 139.69 50.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 109.71 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -82.18 101.48 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.39 -9.08 58.38 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.389 1.075 . . . . 0.0 112.412 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 t -105.84 -19.72 13.66 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.726 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.36 -42.76 9.12 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -113.11 102.77 10.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.012 -1.449 . . . . 0.0 107.529 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -67.71 135.1 52.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.91 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 32' ' ' PHE . 29.7 m -113.53 143.23 28.99 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.26 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.05 -8.57 16.59 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 123.303 2.669 . . . . 0.0 113.759 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.45 174.2 10.84 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.91 139.91 35.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.399 0.619 . . . . 0.0 109.626 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.596 HG23 ' OG1' ' A' ' 84' ' ' THR . 59.5 mt -123.39 117.06 50.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -74.85 -9.41 58.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.56 -140.11 4.9 Favored Glycine 0 C--N 1.3 -1.433 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.559 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 4.9 t80 -100.54 -50.44 0.19 Allowed Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -92.58 171.12 2.41 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 121.097 1.198 . . . . 0.0 110.291 167.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.596 ' OG1' HG23 ' A' ' 79' ' ' ILE . 3.1 m -169.17 146.8 3.67 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 49.7 mt -110.63 140.5 29.48 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.324 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' HG22 ' A' ' 30' ' ' ILE . 65.7 mttm -140.26 127.6 21.26 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.481 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.1 tm? -102.07 111.95 24.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -94.75 101.9 7.89 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HB2' ' HG3' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -65.65 161.03 40.5 Favored 'Trans proline' 0 CA--C 1.464 -2.986 0 C-N-CA 121.658 1.572 . . . . 0.0 110.051 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -81.5 77.5 8.36 Favored 'General case' 0 N--CA 1.395 -3.207 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.887 173.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.38 -45.31 0.41 Allowed Glycine 0 N--CA 1.415 -2.711 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.909 171.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -104.62 58.47 0.7 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.856 0.836 . . . . 0.0 111.166 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -69.78 -2.89 13.29 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.878 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' C ' ' HD3' ' A' ' 96' ' ' PRO . . . -116.85 1.5 19.79 Favored Glycine 0 CA--C 1.497 -1.093 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.652 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 70.6 mt-30 -135.58 45.79 1.49 Allowed Pre-proline 0 CA--C 1.552 1.019 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 72.7 Cg_exo -60.11 159.28 26.66 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.773 2.315 . . . . 0.0 112.296 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 115' ' ' ASN . 13.5 t -97.15 91.14 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -72.89 130.3 40.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.03 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.36 171.9 13.5 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 125.192 1.397 . . . . 0.0 108.798 -170.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -107.28 -62.28 1.44 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.207 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.45 127.77 1.35 Allowed Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.901 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -98.22 -27.62 14.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.756 0.313 . . . . 0.0 111.21 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 61.93 12.63 4.98 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.841 1.256 . . . . 0.0 112.095 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -138.15 158.13 44.93 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 121.776 -0.578 . . . . 0.0 110.971 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.97 -34.38 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 124.277 1.031 . . . . 0.0 109.597 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -57.19 -47.9 80.11 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.105 1.362 . . . . 0.0 110.136 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 22.6 t70 -70.15 -29.11 65.93 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.642 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 50' ' ' LEU . 22.2 mt -74.41 -39.66 62.49 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.3 mt -56.31 -54.11 31.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.5 tptp -64.61 -21.91 66.83 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.546 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.2 t80 -69.62 -64.83 0.8 Allowed 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.517 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -65.58 -16.68 20.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.758 1.266 . . . . 0.0 108.272 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.43 -19.16 31.74 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.459 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 31.7 mt-10 -115.3 -44.86 2.96 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.963 0.887 . . . . 0.0 109.694 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.0 m-80 -79.33 -26.81 42.12 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.563 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.64 162.48 41.46 Favored Glycine 0 N--CA 1.404 -3.439 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 43.1 mtpt -96.99 -21.79 17.21 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.184 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.517 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.7 m-85 -77.56 -17.45 57.87 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.309 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 57.76 47.33 15.71 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 124.001 0.813 . . . . 0.0 109.504 175.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.23 96.28 1.38 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.11 -173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.21 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 24.6 Cg_endo . . . . . 0 N--CA 1.483 0.855 0 CA-C-O 122.033 0.764 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.6 p -71.37 131.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.339 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 13.7 m -69.58 102.89 1.94 Allowed 'General case' 0 N--CA 1.415 -2.225 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.958 -175.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.55 113.79 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.7 t -113.28 119.13 59.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 15' ' ' LYS . 28.7 m -71.45 170.45 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -26.19 67.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 110.79 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB3' HG23 ' A' ' 13' ' ' VAL . 2.8 tppp? -60.74 -53.04 62.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.759 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.662 ' HB2' HG13 ' A' ' 12' ' ' VAL . 39.7 m-20 -86.43 -15.52 40.02 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.257 -169.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.55 -32.23 49.85 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 4.2 p30 -75.05 -18.46 60.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 13.0 pt-20 -105.81 -45.64 4.33 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.161 0.981 . . . . 0.0 111.311 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.474 HG12 ' HG3' ' A' ' 19' ' ' GLU . 26.3 mm -78.25 -55.8 9.15 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.108 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.93 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.649 ' HA ' HG11 ' A' ' 28' ' ' VAL . 63.4 t -80.0 -35.91 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 111.495 -174.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -96.39 37.52 1.26 Allowed 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.42 155.57 29.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.709 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -115.67 5.27 14.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -124.5 14.22 8.82 Favored 'General case' 0 C--O 1.249 1.078 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.875 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -153.18 148.19 26.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 79.4 m-20 -80.63 119.32 23.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.649 HG11 ' HA ' ' A' ' 21' ' ' VAL . 17.4 t -115.91 121.64 67.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.757 HD21 HD22 ' A' ' 108' ' ' LEU . 19.1 tp -94.36 117.89 30.8 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 21' ' ' VAL . 11.6 tt -112.26 145.79 17.89 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 C-N-CA 117.571 -1.652 . . . . 0.0 111.346 176.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' OE2' HD23 ' A' ' 43' ' ' LEU . 34.5 tt0 -127.55 108.21 10.6 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HD1' ' O ' ' A' ' 84' ' ' THR . 91.5 m-85 -69.31 130.08 41.59 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.662 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 34.2 p90 -144.28 -172.57 3.81 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.608 0.718 . . . . 0.0 111.454 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -153.33 150.43 23.63 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -78.16 -24.85 7.75 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 121.607 1.538 . . . . 0.0 109.184 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -93.6 15.02 17.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 112.984 -1.916 . . . . 0.0 111.757 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 43.2 t -95.3 120.2 35.13 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.112 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.11 -35.01 82.63 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.643 ' O ' HD13 ' A' ' 43' ' ' LEU . 10.1 t60 -60.47 -53.21 60.24 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 11.8 t -54.65 -40.42 68.99 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -67.72 -12.27 60.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.93 -10.4 24.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.762 1.267 . . . . 0.0 108.708 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.8 mp -101.52 -17.62 16.32 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.722 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.95 -41.86 48.46 Favored Pre-proline 0 C--N 1.283 -2.316 0 C-N-CA 124.435 1.094 . . . . 0.0 113.225 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 35.7 Cg_endo -63.99 -20.26 67.59 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.739 1.3 . . . . 0.0 112.383 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 1.6 pttm -91.03 -32.73 15.79 Favored 'General case' 0 C--O 1.173 -2.963 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -73.32 -37.02 66.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.363 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.31 -17.34 46.15 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -87.84 -45.25 10.45 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 8.3 tp -69.59 -46.44 66.31 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.84 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.13 -31.01 71.77 Favored Glycine 0 CA--C 1.465 -3.034 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.996 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -62.56 -52.47 63.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 1.6 pp -64.21 -42.27 96.69 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.727 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.532 ' OH ' ' HA ' ' A' ' 109' ' ' ILE . 19.3 m-85 -66.97 -43.93 81.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.171 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . . . -93.55 16.12 14.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.3 tppt? -131.95 -26.07 1.99 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.681 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 29.1 t -85.53 -170.61 3.2 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.742 0.306 . . . . 0.0 110.181 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -72.42 12.21 0.5 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.872 1.269 . . . . 0.0 113.552 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.432 ' CE2' ' HA ' ' A' ' 54' ' ' TYR . 11.5 p90 -132.04 11.17 4.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 57' ' ' SER . 21.9 pttp -67.36 -13.31 61.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.016 0.912 . . . . 0.0 111.463 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.54 17.5 19.17 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.075 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HE ' ' HB3' ' A' ' 118' ' ' TYR . 16.4 ttp180 -125.7 -45.14 1.78 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 122.546 1.165 . . . . 0.0 108.963 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.631 HG21 HG21 ' A' ' 112' ' ' ILE . 1.7 p -131.88 143.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 C-N-CA 126.556 1.942 . . . . 0.0 108.142 173.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.51 130.6 70.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 9' ' ' VAL . 46.2 mm -89.37 117.17 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -123.62 161.16 25.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.34 143.12 22.92 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 30' ' ' ILE . 7.8 p -123.33 139.31 50.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.403 ' HB3' ' ND2' ' A' ' 73' ' ' ASN . 10.0 t0 -83.09 109.48 17.19 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.29 -11.73 59.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.193 0.933 . . . . 0.0 112.413 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 t -106.59 -27.09 11.07 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.656 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.29 -34.27 17.74 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 69' ' ' ASP . 8.1 m-80 -119.08 104.09 10.14 Favored 'General case' 0 N--CA 1.403 -2.784 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.74 118.8 13.06 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.302 0.572 . . . . 0.0 110.588 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.23 145.62 31.89 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.702 -174.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.1 -8.73 12.99 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.1 2.533 . . . . 0.0 111.282 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.82 -172.72 4.13 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.088 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.74 129.96 56.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.186 0.517 . . . . 0.0 110.67 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -84.14 129.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -89.71 -22.81 22.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.397 0.618 . . . . 0.0 110.837 -174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.99 -105.42 0.62 Allowed Glycine 0 C--N 1.31 -0.899 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.64 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.6 t80 -117.82 -57.34 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.3 Cg_exo -91.5 164.41 3.53 Favored 'Trans proline' 0 N--CA 1.418 -2.963 0 N-CA-C 108.54 -1.369 . . . . 0.0 108.54 162.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.484 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 98.9 m -153.64 135.27 14.4 Favored 'General case' 0 C--N 1.27 -2.848 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.933 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 34.1 mt -98.9 136.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 30' ' ' ILE . 45.7 mtpt -139.19 117.38 11.86 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.3 tm? -96.89 114.41 26.03 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -97.64 96.72 3.42 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.592 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 12.1 Cg_endo -68.78 158.98 55.64 Favored 'Trans proline' 0 CA--C 1.461 -3.173 0 C-N-CA 121.841 1.694 . . . . 0.0 111.143 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 77.34 8.23 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.79 -27.09 0.58 Allowed Glycine 0 C--N 1.298 -1.58 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.113 173.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.479 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -124.64 31.72 5.63 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.833 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -64.44 13.24 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 124.815 1.246 . . . . 0.0 112.963 176.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -109.77 -12.54 18.43 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -147.7 71.72 11.56 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 34.9 Cg_exo -49.3 163.33 0.39 Allowed 'Trans proline' 0 C--O 1.25 1.104 0 C-N-CA 124.291 3.327 . . . . 0.0 113.824 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 115' ' ' ASN . 28.8 t -97.5 102.23 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 t -81.1 128.74 34.07 Favored 'General case' 0 N--CA 1.427 -1.619 0 O-C-N 124.206 0.941 . . . . 0.0 109.981 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.04 158.01 45.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.47 -173.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -90.18 -3.25 57.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.432 0.634 . . . . 0.0 110.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' HA3' HD21 ' A' ' 43' ' ' LEU . . . 108.2 117.14 4.08 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -68.71 -33.05 73.28 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 65.73 13.61 9.06 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.509 1.147 . . . . 0.0 110.953 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 107' ' ' ASP . 5.7 t -143.3 155.14 44.39 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.43 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 46' ' ' LYS . 92.5 t -82.33 -39.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 124.958 1.303 . . . . 0.0 110.419 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -59.32 -44.75 92.56 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 121.937 0.875 . . . . 0.0 111.282 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 36.2 t70 -70.3 -25.76 63.47 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.956 -177.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.757 HD22 HD21 ' A' ' 29' ' ' LEU . 18.4 mt -77.89 -38.98 44.63 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.532 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 69.8 mt -59.06 -50.07 81.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.8 tptp -63.49 -24.9 68.02 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.102 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.602 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.5 t80 -68.77 -65.49 0.7 Allowed 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.631 HG21 HG21 ' A' ' 63' ' ' VAL . 3.4 mt -66.7 -14.33 17.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.49 1.138 . . . . 0.0 108.743 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . . . -91.18 -11.93 36.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.485 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 46.8 mt-10 -120.42 -41.45 2.61 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.202 1.001 . . . . 0.0 109.384 174.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.602 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.9 m-80 -86.07 -24.6 26.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.652 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.17 168.18 51.67 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.592 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 13.4 mmmm -100.2 -24.64 14.51 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.883 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.45 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.5 m-85 -84.39 -12.76 53.88 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.899 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 35.0 mmtp 52.82 59.68 4.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.304 1.002 . . . . 0.0 110.016 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 81.52 0.78 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.779 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.757 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.16 -41.08 63.62 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.519 2.146 . . . . 0.0 111.419 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.1 mt -114.02 93.21 4.26 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.47 17.99 2.06 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 p -81.95 167.94 18.39 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.014 -0.593 . . . . 0.0 111.076 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.79 97.38 2.21 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 122.014 0.911 . . . . 0.0 111.08 -174.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.83 66.2 0.01 OUTLIER Glycine 0 C--N 1.281 -2.527 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.936 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' CB ' ' HA ' ' A' ' 52' ' ' ALA . 13.9 Cg_endo -62.73 -48.31 7.33 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.931 1.754 . . . . 0.0 108.648 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.7 p -67.42 130.1 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.806 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 m -73.52 106.45 5.31 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.377 0.608 . . . . 0.0 111.015 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.58 111.02 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 16' ' ' ASN . 47.4 t -106.45 129.21 60.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 15' ' ' LYS . 15.5 m -79.94 172.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.63 -24.55 67.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.166 0.508 . . . . 0.0 110.419 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' HG23 ' A' ' 13' ' ' VAL . 16.5 tptp -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.808 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.735 ' HB2' HG13 ' A' ' 12' ' ' VAL . 30.8 m-20 -99.96 -14.21 18.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.9 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -40.43 58.19 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.9 -11.09 59.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.269 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.5 pt-20 -106.45 -41.5 5.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.33 1.062 . . . . 0.0 111.198 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.446 HG12 ' HG3' ' A' ' 19' ' ' GLU . 31.7 mm -84.41 -57.33 4.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 CA-C-N 113.045 -1.888 . . . . 0.0 112.229 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.619 ' HA ' HG11 ' A' ' 28' ' ' VAL . 65.8 t -82.21 -32.77 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.442 0 CA-C-O 122.006 0.907 . . . . 0.0 111.578 -172.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 27.4 2.71 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -94.32 139.6 30.87 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.775 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -105.79 15.2 27.1 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.127 0.571 . . . . 0.0 111.483 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.6 p -81.19 -13.07 58.96 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.42 0.629 . . . . 0.0 109.439 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -160.55 161.85 32.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.936 0.894 . . . . 0.0 108.61 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.1 m-20 -82.43 128.8 34.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.5 t -119.38 123.06 70.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.692 0.758 . . . . 0.0 111.612 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' OH ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -94.36 114.08 26.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.589 HD12 HG21 ' A' ' 21' ' ' VAL . 10.8 tt -108.53 144.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.284 -1.366 . . . . 0.0 112.739 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 38.4 tt0 -120.66 121.28 37.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.786 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.418 ' HB2' ' H ' ' A' ' 84' ' ' THR . 97.5 m-85 -91.43 121.85 33.5 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -141.26 -173.47 3.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.786 0.803 . . . . 0.0 112.314 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -142.92 148.49 45.86 Favored Pre-proline 0 N--CA 1.429 -1.509 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -83.93 -12.62 8.34 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.004 1.802 . . . . 0.0 110.463 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -95.56 0.95 53.56 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.605 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 53.8 t -83.37 117.24 22.89 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.562 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.47 -29.54 74.9 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 65.1 m80 -67.33 -39.92 85.88 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.43 -32.92 74.8 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.201 0.524 . . . . 0.0 110.489 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 64.4 mmtt -65.83 -18.68 65.5 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.612 0.72 . . . . 0.0 111.396 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.85 -11.76 21.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.895 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.741 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 97.0 mt -97.02 -26.74 14.9 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.267 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.63 97.33 Favored Pre-proline 0 C--N 1.284 -2.271 0 C-N-CA 124.665 1.186 . . . . 0.0 113.641 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.33 0.96 8.42 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.574 1.516 . . . . 0.0 112.781 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 13.2 pttm -109.4 -32.3 7.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.47 -43.9 20.1 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.293 -171.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.56 -12.59 59.85 Favored 'General case' 0 N--CA 1.409 -2.515 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.564 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.97 -52.01 5.18 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HB2' HG13 ' A' ' 105' ' ' VAL . 3.3 tm? -73.92 -34.5 64.39 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.37 93.89 Favored Glycine 0 CA--C 1.479 -2.209 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.771 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.489 ' HA ' ' CB ' ' A' ' 8' ' ' PRO . . . -58.39 -53.31 59.73 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -54.53 -42.59 71.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.61 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -76.77 -45.99 26.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.99 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.74 17.7 3.84 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 9.1 tppt? -128.93 -36.11 1.81 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.661 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 21.8 t -100.76 -155.53 0.52 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -57.21 -0.22 0.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -114.19 3.12 15.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 57' ' ' SER . 57.8 pttt -74.96 -6.33 48.69 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.892 0.853 . . . . 0.0 111.096 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.76 -2.34 17.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.371 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -117.78 -130.1 0.3 Allowed 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 112' ' ' ILE . 2.1 p -53.88 130.62 15.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.697 0.761 . . . . 0.0 112.071 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -114.78 128.47 71.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.001 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.9 mm -85.21 123.32 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -131.29 163.48 27.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 48.9 pttt -157.15 143.66 18.14 Favored 'General case' 0 CA--C 1.48 -1.73 0 O-C-N 121.87 -0.519 . . . . 0.0 112.303 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 10.9 p -121.69 144.3 31.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -84.67 113.55 21.37 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.72 -0.11 46.02 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.143 -171.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.7 t -127.3 -7.12 5.87 Favored 'General case' 0 N--CA 1.424 -1.757 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.767 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.74 -33.73 9.73 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -119.15 132.78 56.01 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.455 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.34 106.33 12.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -87.17 141.97 33.29 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.507 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.81 2.38 7.11 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 123.282 2.655 . . . . 0.0 110.598 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -79.33 -175.86 4.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.471 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -105.51 131.6 52.71 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 125.653 1.581 . . . . 0.0 109.012 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 81' ' ' GLY . 32.3 mm -109.28 124.28 65.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.34 28.24 6.58 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.395 1.093 . . . . 0.0 112.441 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.482 ' H ' HG22 ' A' ' 79' ' ' ILE . . . -179.6 -120.33 0.67 Allowed Glycine 0 C--N 1.296 -1.641 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 36.7 t80 -115.36 -52.55 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 165.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 6.3 Cg_exo -91.37 170.82 3.08 Favored 'Trans proline' 0 N--CA 1.423 -2.641 0 N-CA-C 109.42 -1.031 . . . . 0.0 109.42 165.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.418 ' H ' ' HB2' ' A' ' 32' ' ' PHE . 97.6 m -163.04 152.17 14.89 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.0 mt -121.91 137.3 55.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.473 ' O ' HG22 ' A' ' 30' ' ' ILE . 94.1 mttt -140.63 128.15 21.4 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.193 0.521 . . . . 0.0 110.73 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.469 HD13 ' HD3' ' A' ' 89' ' ' PRO . 3.4 tm? -98.53 117.02 32.01 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -100.55 96.31 5.21 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -66.52 160.39 46.08 Favored 'Trans proline' 0 CA--C 1.465 -2.936 0 C-N-CA 122.024 1.816 . . . . 0.0 111.67 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.31 77.12 8.22 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.0 -20.35 0.67 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.185 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -137.22 55.27 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.926 0.87 . . . . 0.0 111.462 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.45 -1.99 29.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.201 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.3 -16.2 35.68 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -138.47 63.88 35.88 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.508 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.33 160.36 0.94 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.749 3.633 . . . . 0.0 113.196 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 115' ' ' ASN . 38.3 t -96.51 97.93 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.3 t -74.52 132.91 42.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.46 168.53 19.56 Favored 'General case' 0 C--N 1.278 -2.51 0 C-N-CA 125.999 1.72 . . . . 0.0 108.975 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.3 m -115.56 -18.89 10.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.107 0.479 . . . . 0.0 110.567 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.77 115.13 1.82 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.915 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -83.67 -10.96 57.82 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 111.435 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 65.68 18.18 11.11 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.203 1.001 . . . . 0.0 113.011 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 107' ' ' ASP . 9.0 t -138.3 150.94 47.11 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.292 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 50' ' ' LEU . 94.2 t -73.48 -33.76 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 125.507 1.523 . . . . 0.0 109.632 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' A' ' 106' ' ' GLU . 28.7 mt-10 -58.25 -45.88 86.98 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 122.825 1.298 . . . . 0.0 109.957 -176.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 25.9 t70 -73.7 -27.84 61.42 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 112.115 -2.312 . . . . 0.0 109.696 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 112' ' ' ILE . 17.5 mt -69.67 -43.36 72.7 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.26 -53.45 39.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 110' ' ' LYS . 2.7 tmmm? -60.64 -32.78 71.94 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.908 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.605 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -59.97 -71.17 0.14 Allowed 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.713 -176.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.576 HG21 HG21 ' A' ' 63' ' ' VAL . 4.0 mp -70.9 -8.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.612 1.196 . . . . 0.0 109.34 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -86.83 -23.68 25.23 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.555 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 -37.7 4.51 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 122.122 0.963 . . . . 0.0 108.941 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.605 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 58.1 m-80 -87.22 -27.65 22.85 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 113.2 -1.818 . . . . 0.0 109.648 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.79 158.31 42.72 Favored Glycine 0 N--CA 1.408 -3.216 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.523 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 31.3 mmmt -87.76 -26.01 23.12 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.593 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.9 m-85 -80.59 -16.19 54.75 Favored 'General case' 0 N--CA 1.388 -3.544 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.92 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 58.2 57.85 3.78 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.44 86.15 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.51 -53.24 3.58 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.528 2.152 . . . . 0.0 111.587 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.8 tp -117.3 115.44 25.27 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.12 149.9 7.94 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.2 m -83.63 93.44 7.89 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.358 0.599 . . . . 0.0 109.918 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -97.4 145.48 26.12 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.09 116.71 4.86 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.426 ' CG ' ' HA ' ' A' ' 48' ' ' GLU . 47.4 Cg_endo -72.26 -36.1 5.94 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 121.798 1.666 . . . . 0.0 110.88 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 47' ' ' TYR . 1.2 p -81.11 124.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.926 175.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 48.1 m -63.11 108.96 1.36 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.746 0.784 . . . . 0.0 111.39 -173.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.5 t -79.15 107.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 16' ' ' ASN . 46.3 t -103.71 129.01 56.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.669 HG23 ' HB3' ' A' ' 15' ' ' LYS . 17.1 m -78.77 170.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.308 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -26.29 66.66 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.669 ' HB3' HG23 ' A' ' 13' ' ' VAL . 32.0 tttm -55.72 -51.42 67.39 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.611 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -100.46 -3.89 29.98 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.355 -172.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -54.28 -38.69 66.17 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -81.07 -5.2 57.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.592 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 12.3 pt-20 -106.26 -44.68 4.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.574 1.178 . . . . 0.0 110.841 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.492 HG12 ' HG3' ' A' ' 19' ' ' GLU . 23.2 mm -81.43 -54.74 9.39 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.367 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.617 HG21 HD12 ' A' ' 30' ' ' ILE . 83.9 t -81.34 -30.99 11.31 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 CA-C-O 121.28 0.562 . . . . 0.0 111.643 -174.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.452 ' HG ' ' CE2' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -95.16 32.17 1.77 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -96.75 151.65 19.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.09 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' HB3' ' HD3' ' A' ' 93' ' ' LYS . 7.7 p-10 -115.45 17.88 16.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.712 0.291 . . . . 0.0 111.512 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 p -71.36 -37.27 71.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HA ' ' CE1' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -146.66 176.23 10.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.9 m-20 -82.02 141.35 33.3 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 21' ' ' VAL . 38.2 t -126.01 119.53 54.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.732 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HG ' HD23 ' A' ' 87' ' ' LEU . 9.2 mt -86.57 121.08 28.6 Favored 'General case' 0 CA--C 1.468 -2.211 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.617 HD12 HG21 ' A' ' 21' ' ' VAL . 9.6 tt -114.0 144.87 20.69 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 117.518 -1.673 . . . . 0.0 110.289 173.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -129.83 113.61 14.89 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.356 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' HD1' ' O ' ' A' ' 84' ' ' THR . 28.5 m-85 -78.91 134.2 36.9 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -145.02 -171.71 3.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.296 0.997 . . . . 0.0 110.435 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -141.98 155.94 65.42 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -84.4 -16.35 5.9 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.641 1.56 . . . . 0.0 110.261 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -96.18 2.86 53.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.039 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.685 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.5 t -84.43 119.05 24.68 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.489 -173.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.17 -23.94 76.08 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.445 ' O ' HD13 ' A' ' 43' ' ' LEU . 35.8 m80 -76.0 -42.69 47.3 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 122.722 -0.281 . . . . 0.0 111.472 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 20.5 p -68.5 -25.14 64.81 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.587 0.708 . . . . 0.0 109.911 -178.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 53.5 mtmt -75.3 -5.24 43.66 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.504 0.668 . . . . 0.0 110.863 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB1' ' HD2' ' A' ' 103' ' ' ARG . . . -94.7 -16.04 23.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.561 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 11.2 mp -93.27 -10.96 33.72 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.228 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.29 -45.27 54.64 Favored Pre-proline 0 C--N 1.287 -2.131 0 C-N-CA 125.005 1.322 . . . . 0.0 113.219 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -67.82 -30.92 32.92 Favored 'Trans proline' 0 C--N 1.378 2.107 0 CA-C-N 120.136 1.084 . . . . 0.0 110.92 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 2.2 ptmm? -75.38 -33.18 61.01 Favored 'General case' 0 C--O 1.201 -1.494 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.435 ' HB3' HG11 ' A' ' 9' ' ' VAL . 13.9 m-85 -68.75 -50.97 46.16 Favored 'General case' 0 CA--C 1.465 -2.323 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.031 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.426 ' HA ' ' CG ' ' A' ' 8' ' ' PRO . 41.4 mt-10 -69.73 -36.47 75.89 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.219 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 17.1 mm-40 -85.28 -46.61 10.85 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.086 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.595 HD23 HG13 ' A' ' 105' ' ' VAL . 2.4 tm? -76.16 -39.52 54.74 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.71 -30.66 59.47 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 118.781 -1.676 . . . . 0.0 112.754 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.61 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -68.4 -47.12 68.15 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.363 173.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 89.5 mt -62.62 -41.11 98.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.253 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -80.47 -46.88 15.16 Favored 'General case' 0 N--CA 1.414 -2.236 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.926 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.76 12.71 12.2 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 45.6 mtmt -134.47 -19.37 1.89 Allowed 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 123.235 0.614 . . . . 0.0 112.556 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.709 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 50.6 m -100.53 -170.84 1.92 Allowed 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.24 9.87 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.75 -5.26 29.01 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.4 pttp -76.91 -11.1 59.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.236 1.017 . . . . 0.0 109.221 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.67 -16.91 26.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.51 -133.9 0.34 Allowed 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 3.1 p -58.6 133.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.74 0.781 . . . . 0.0 112.752 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.97 133.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.427 HD12 HD12 ' A' ' 29' ' ' LEU . 22.1 mm -95.18 113.2 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 175.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' THR . . . -118.47 156.97 28.12 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 123.529 0.518 . . . . 0.0 110.567 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -147.63 140.51 24.9 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 p -126.2 141.0 47.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -88.11 115.81 25.85 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.42 -12.62 59.98 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.93 0.892 . . . . 0.0 112.288 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 t -112.85 -18.73 12.2 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.281 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.04 -26.23 18.43 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -133.0 95.62 3.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.331 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.08 133.61 49.25 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.795 0.807 . . . . 0.0 111.657 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.69 152.05 42.64 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.251 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.07 -1.63 9.4 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 123.506 2.804 . . . . 0.0 112.11 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -83.42 144.13 29.81 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.432 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.75 133.6 35.14 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.408 0.623 . . . . 0.0 109.47 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.617 HG23 ' OG1' ' A' ' 84' ' ' THR . 31.2 mt -111.03 128.13 67.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.706 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -68.24 -36.36 79.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.22 -126.35 3.76 Favored Glycine 0 C--N 1.295 -1.704 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.474 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 11.8 t80 -112.91 -49.04 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 6.1 Cg_exo -88.62 168.19 5.95 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.436 1.424 . . . . 0.0 110.226 168.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.617 ' OG1' HG23 ' A' ' 79' ' ' ILE . 22.9 m -161.6 138.04 8.21 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 19.8 mt -106.75 139.74 27.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 50.6 mtmt -143.5 121.87 12.35 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 121.061 0.458 . . . . 0.0 110.136 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.529 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tm? -98.25 112.87 24.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.555 ' CE2' ' HG3' ' A' ' 96' ' ' PRO . 27.5 m-85 -97.22 97.76 4.1 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 19.3 Cg_endo -70.0 161.94 44.07 Favored 'Trans proline' 0 CA--C 1.468 -2.791 0 C-N-CA 121.557 1.505 . . . . 0.0 111.719 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.84 77.64 7.7 Favored 'General case' 0 N--CA 1.399 -2.975 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.01 -19.92 0.75 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.237 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.444 ' H ' ' HG2' ' A' ' 89' ' ' PRO . . . -135.06 39.61 2.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.897 0.856 . . . . 0.0 110.529 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HD3' ' HB3' ' A' ' 24' ' ' ASP . 42.1 pttt -67.45 -5.67 15.92 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.638 1.175 . . . . 0.0 110.872 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.96 -20.58 49.53 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.05 67.68 27.22 Favored Pre-proline 0 N--CA 1.433 -1.288 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.555 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 22.9 Cg_exo -49.26 164.71 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 124.298 3.332 . . . . 0.0 113.056 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 115' ' ' ASN . 18.6 t -92.78 89.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -73.14 126.11 29.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.176 -1.375 . . . . 0.0 111.782 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.67 176.0 9.25 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.658 -174.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -108.82 -53.23 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.59 136.87 2.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.728 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.6 p -108.37 -7.95 15.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 20.5 ttp85 65.81 8.37 5.24 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.911 0.885 . . . . 0.0 112.234 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 107' ' ' ASP . 4.7 t -123.56 146.88 47.79 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.653 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.595 HG13 HD23 ' A' ' 50' ' ' LEU . 78.2 t -77.78 -35.35 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 125.687 1.595 . . . . 0.0 110.078 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.413 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.1 mt-10 -62.92 -43.83 97.73 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.198 0.999 . . . . 0.0 110.45 -173.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.7 t70 -69.25 -28.76 66.61 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 113.261 -1.79 . . . . 0.0 109.988 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.516 HD22 HD13 ' A' ' 29' ' ' LEU . 32.3 mt -68.98 -46.12 68.88 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 106' ' ' GLU . 64.0 mt -55.15 -53.86 30.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 22.2 tptp -62.64 -25.16 67.97 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.74 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.3 t80 -69.11 -62.35 1.42 Allowed 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.455 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.4 mt -71.63 -9.82 13.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.554 1.169 . . . . 0.0 108.544 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -90.92 -19.71 23.01 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.534 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 42.8 mt-10 -110.42 -43.27 3.92 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 122.461 1.124 . . . . 0.0 108.361 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 60.8 m-80 -85.27 -29.74 24.36 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.017 -1.902 . . . . 0.0 109.909 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.9 149.29 28.09 Favored Glycine 0 N--CA 1.397 -3.965 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.617 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -89.78 -20.24 23.76 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.186 0.993 . . . . 0.0 108.774 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 26' ' ' LYS . 21.3 m-85 -85.24 -5.46 59.32 Favored 'General case' 0 N--CA 1.393 -3.295 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.602 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 34.4 mmtp 48.76 52.43 14.06 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.545 1.153 . . . . 0.0 110.871 173.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.03 93.15 3.24 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.269 2.089 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.828 0 CA-C-O 119.238 -0.757 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -73.53 43.25 0.75 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 124.45 3.433 . . . . 0.0 113.486 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.0 tp -85.06 1.76 46.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.523 1.154 . . . . 0.0 107.983 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.71 -144.68 4.68 Favored Glycine 0 N--CA 1.416 -2.693 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -91.61 12.31 21.45 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.823 0.82 . . . . 0.0 110.825 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.7 151.24 21.32 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.668 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.77 -178.25 30.01 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.17 -48.21 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.312 2.008 . . . . 0.0 110.515 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 65' ' ' ILE . 2.3 p -69.64 129.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.554 -1.203 . . . . 0.0 107.922 175.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -76.18 110.65 10.85 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.872 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.5 105.83 6.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.631 HG13 ' HB2' ' A' ' 16' ' ' ASN . 47.6 t -108.59 114.15 45.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.643 HG23 ' HB3' ' A' ' 15' ' ' LYS . 31.3 m -68.91 168.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -23.18 65.49 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.258 0.552 . . . . 0.0 110.918 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.643 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -60.95 -46.01 92.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.189 174.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.631 ' HB2' HG13 ' A' ' 12' ' ' VAL . 13.8 m-20 -99.96 -13.51 19.08 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.936 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.02 -33.44 25.15 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -74.47 -13.2 60.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.045 0.45 . . . . 0.0 111.624 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.6 pt-20 -105.96 -52.47 2.8 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.642 0.734 . . . . 0.0 110.92 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.494 HG12 ' HG3' ' A' ' 19' ' ' GLU . 20.6 mm -74.35 -57.83 5.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.889 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.665 HG21 HD12 ' A' ' 30' ' ' ILE . 91.6 t -74.93 -33.27 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.23 1.014 . . . . 0.0 110.777 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.0 tp -96.06 23.72 6.22 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.548 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.452 ' OD1' HG22 ' A' ' 25' ' ' THR . 7.6 t70 -75.02 167.69 21.43 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.522 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -115.94 -3.71 12.12 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.202 -0.936 . . . . 0.0 112.679 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.452 HG22 ' OD1' ' A' ' 23' ' ' ASP . 14.8 t -111.74 3.16 17.58 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.204 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 25' ' ' THR . 66.1 mmtt -135.64 138.75 43.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.603 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 71.0 m-20 -76.47 116.9 17.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 171.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 21' ' ' VAL . 39.9 t -112.92 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.714 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.451 ' HG ' HD23 ' A' ' 87' ' ' LEU . 8.0 mt -84.12 124.63 31.34 Favored 'General case' 0 CA--C 1.464 -2.361 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.665 HD12 HG21 ' A' ' 21' ' ' VAL . 13.3 tt -116.1 143.76 25.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.229 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 29.2 tt0 -115.78 117.18 29.5 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -84.44 121.11 27.11 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -141.47 -171.53 3.33 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.865 0.841 . . . . 0.0 112.705 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -151.79 154.17 32.64 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 11.2 Cg_endo -80.7 -20.51 7.84 Favored 'Trans proline' 0 CA--C 1.505 -0.932 0 C-N-CA 121.675 1.583 . . . . 0.0 109.947 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.414 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 64.7 p-90 -91.82 4.69 52.28 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.125 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 42.7 t -82.78 117.19 22.5 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.829 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.3 -35.75 92.07 Favored Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.545 ' O ' HD13 ' A' ' 43' ' ' LEU . 79.6 t60 -65.32 -45.36 84.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.806 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.89 -41.52 91.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -70.94 -2.93 16.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' O ' ' HE2' ' A' ' 46' ' ' LYS . . . -102.23 -22.17 14.22 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.664 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 10.8 mp -92.44 -16.26 26.11 Favored 'General case' 0 C--O 1.195 -1.805 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.005 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.59 92.6 Favored Pre-proline 0 C--N 1.275 -2.639 0 C-N-CA 124.702 1.201 . . . . 0.0 112.967 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.8 Cg_exo -63.75 -35.21 58.64 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.14 1.226 . . . . 0.0 111.632 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -81.75 -30.97 32.19 Favored 'General case' 0 C--O 1.177 -2.754 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.905 -175.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.664 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -77.53 -29.6 52.41 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.065 -174.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -83.43 -29.55 27.99 Favored 'General case' 0 C--O 1.191 -1.982 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.964 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.572 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 52.6 mt-10 -79.95 -45.06 19.18 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.909 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.99 -39.1 63.9 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.39 -37.06 90.09 Favored Glycine 0 CA--C 1.479 -2.169 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.027 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -64.88 -50.79 65.17 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 96.0 mt -57.49 -40.11 77.91 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -76.99 -46.75 22.83 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.655 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -86.63 19.44 2.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -137.15 -27.49 0.97 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.885 -0.509 . . . . 0.0 110.358 176.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.684 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 27.5 t -94.38 -157.07 0.53 Allowed 'General case' 0 C--O 1.208 -1.127 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.79 1.56 0.86 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.15 2.61 21.15 Favored 'General case' 0 CA--C 1.481 -1.709 0 O-C-N 121.336 -0.853 . . . . 0.0 109.118 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.0 pttp -75.21 -9.34 58.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 122.204 1.002 . . . . 0.0 109.546 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -104.53 -0.58 27.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.041 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.75 -132.33 0.24 Allowed 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.638 HG21 HG21 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -43.3 128.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.49 1.516 . . . . 0.0 112.798 176.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -107.61 131.54 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mm -95.3 118.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 172.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -133.13 161.26 34.89 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.029 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 31' ' ' GLU 0.256 61.4 pttt -156.41 146.95 21.64 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.654 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.17 140.37 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.893 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.11 115.65 22.49 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.27 -4.97 55.4 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.986 0.914 . . . . 0.0 112.26 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -118.34 -15.43 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.288 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.91 -33.03 12.34 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -118.57 118.02 30.55 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.27 114.6 12.82 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.955 0.884 . . . . 0.0 109.43 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.11 143.06 25.47 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.48 -3.15 6.71 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 123.016 2.477 . . . . 0.0 110.417 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.24 174.67 4.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.739 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -103.87 118.87 37.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.528 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.04 139.87 19.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.95 0.9 . . . . 0.0 109.083 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.34 -16.35 24.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.33 -94.39 0.17 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 51.9 t80 -128.15 -51.42 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.7 Cg_endo -94.5 168.82 1.76 Allowed 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 120.93 1.087 . . . . 0.0 109.661 166.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.3 m -163.35 143.32 8.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 31.6 mt -107.38 134.93 47.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -136.38 132.5 35.62 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.451 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -101.88 115.07 29.74 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.403 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 46.6 m-85 -99.58 96.18 4.32 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.427 ' HG2' ' C ' ' A' ' 92' ' ' ALA . 11.8 Cg_endo -64.69 160.07 42.12 Favored 'Trans proline' 0 CA--C 1.46 -3.183 0 C-N-CA 122.066 1.844 . . . . 0.0 112.157 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.42 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -79.16 78.23 5.63 Favored 'General case' 0 N--CA 1.397 -3.08 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.263 173.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.71 -33.06 0.82 Allowed Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.697 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.427 ' C ' ' HG2' ' A' ' 89' ' ' PRO . . . -121.78 37.16 4.43 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.625 0.726 . . . . 0.0 111.349 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -69.0 16.69 0.05 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.27 1.028 . . . . 0.0 112.708 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.1 -2.46 18.37 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.459 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 13.6 pt20 -135.1 45.32 1.39 Allowed Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 115.215 -0.493 . . . . 0.0 109.987 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 69.6 Cg_exo -44.56 155.95 0.25 Allowed 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 124.549 3.5 . . . . 0.0 115.577 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 115' ' ' ASN . 44.5 t -91.56 97.52 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 t -75.6 127.58 33.39 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.282 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 149.11 45.13 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.287 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.5 m -84.2 -30.35 25.85 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.33 0.586 . . . . 0.0 109.55 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.11 104.74 2.75 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.7 m -70.45 -5.78 31.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.718 0.807 . . . . 0.0 113.17 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 27.3 ttp180 64.22 29.2 13.93 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.233 1.016 . . . . 0.0 110.509 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.498 ' OG1' ' HB3' ' A' ' 107' ' ' ASP . 7.3 p -123.68 159.33 29.59 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.689 -0.632 . . . . 0.0 111.881 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 46' ' ' LYS . 59.6 t -95.73 -40.48 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.569 0.748 . . . . 0.0 109.137 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.521 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.7 mt-10 -65.44 -38.56 90.25 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 122.657 1.218 . . . . 0.0 110.03 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.9 t70 -76.5 -22.35 54.6 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.317 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.34 -44.98 64.02 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.096 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' A' ' 106' ' ' GLU . 70.8 mt -53.47 -53.46 24.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 48.4 mmtt -70.02 -13.98 62.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.638 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -71.3 -63.77 1.05 Allowed 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.638 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -69.52 -12.82 16.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 122.615 1.198 . . . . 0.0 108.503 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -88.26 -27.93 21.43 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.331 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -113.76 -27.61 7.73 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.712 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.638 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.4 m-80 -92.57 -27.69 17.2 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.583 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.25 160.21 47.67 Favored Glycine 0 N--CA 1.406 -3.327 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.824 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 90' ' ' ALA . 48.7 mtpt -93.68 -23.71 18.14 Favored 'General case' 0 CA--C 1.474 -1.957 0 CA-C-N 118.392 1.096 . . . . 0.0 109.537 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.603 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 4.7 m-85 -77.99 -15.84 58.61 Favored 'General case' 0 N--CA 1.405 -2.682 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.989 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 56.52 59.26 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.78 78.69 0.45 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -173.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.688 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.543 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.09 -45.04 43.72 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.975 2.45 . . . . 0.0 112.056 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -150.6 151.4 32.5 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.01 -81.1 0.36 Allowed Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 m -129.18 100.07 5.48 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.907 0.384 . . . . 0.0 110.238 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -90.7 115.89 28.14 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.166 0.508 . . . . 0.0 109.844 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.81 92.16 0.76 Allowed Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.58 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.6 Cg_endo -69.19 -35.66 13.89 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 122.325 2.017 . . . . 0.0 111.79 -173.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 65' ' ' ILE . 1.8 p -83.25 129.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.99 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.734 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 m -69.15 105.93 2.65 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.995 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -78.21 109.88 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 16' ' ' ASN . 43.2 t -113.63 115.36 49.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.629 HG23 ' HB3' ' A' ' 15' ' ' LYS . 18.4 m -72.34 170.17 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.42 -3.12 13.06 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.528 0.68 . . . . 0.0 111.546 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB3' HG23 ' A' ' 13' ' ' VAL . 3.2 tppp? -78.27 -35.65 47.79 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.125 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.592 ' HB2' HG13 ' A' ' 12' ' ' VAL . 11.6 m-20 -112.02 -8.87 14.03 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.817 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.45 -27.84 27.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 9.9 p30 -83.71 -9.92 58.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 108.834 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -46.5 4.1 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.574 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.14 -49.87 13.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.317 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.728 HG21 HD12 ' A' ' 30' ' ' ILE . 88.5 t -79.59 -26.91 12.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-O 121.53 0.681 . . . . 0.0 111.447 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -99.49 26.79 5.77 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-O 122.514 1.15 . . . . 0.0 108.552 -175.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.21 149.41 44.63 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.689 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.19 9.63 14.69 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.524 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -115.38 6.55 14.86 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.861 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.413 ' HD2' HG23 ' A' ' 64' ' ' VAL . 16.3 pttm -160.1 158.73 30.84 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.564 0.746 . . . . 0.0 108.994 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.8 m-20 -86.9 123.4 31.99 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 21' ' ' VAL . 47.4 t -114.65 117.11 54.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.626 -0.671 . . . . 0.0 112.506 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HG ' HD23 ' A' ' 87' ' ' LEU . 6.6 mt -89.12 111.02 21.69 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.728 HD12 HG21 ' A' ' 21' ' ' VAL . 10.6 tt -103.6 143.6 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.33 -1.348 . . . . 0.0 112.208 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -117.66 113.16 21.49 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.148 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.432 ' CD1' HD11 ' A' ' 79' ' ' ILE . 96.6 m-85 -77.69 124.08 27.49 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 169.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.559 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 17.6 p90 -139.7 -176.96 4.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.304 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -147.31 148.07 30.49 Favored Pre-proline 0 N--CA 1.418 -2.071 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.68 -20.78 9.02 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 121.365 1.377 . . . . 0.0 110.361 -173.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -97.53 8.01 45.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.247 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 27.7 t -81.76 124.04 29.29 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.971 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.85 99.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.347 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -68.28 -35.91 78.58 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.014 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 47.2 t -65.91 -37.1 85.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.34 0.59 . . . . 0.0 110.163 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.9 mtmt -71.38 -10.0 59.06 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.405 0.621 . . . . 0.0 111.116 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.77 -21.76 17.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.215 1.007 . . . . 0.0 109.061 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.678 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 95.7 mt -87.56 -23.42 24.35 Favored 'General case' 0 C--O 1.177 -2.761 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.51 -52.67 57.74 Favored Pre-proline 0 C--N 1.267 -3.021 0 C-N-CA 125.13 1.372 . . . . 0.0 114.151 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.51 -27.12 23.27 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 121.31 1.34 . . . . 0.0 112.353 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HE2' ' O ' ' A' ' 102' ' ' SER . 3.8 ptpp? -85.67 -32.46 21.96 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.678 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -76.44 -33.48 58.76 Favored 'General case' 0 N--CA 1.402 -2.858 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.314 -171.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -83.11 -20.88 34.0 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.65 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.2 tt0 -86.14 -49.24 7.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.86 -36.79 64.88 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.86 -36.42 81.88 Favored Glycine 0 CA--C 1.476 -2.352 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.044 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -61.3 -55.05 36.22 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 88.4 mt -61.94 -39.66 92.86 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.617 -176.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 3.3 m-85 -84.16 -20.18 32.89 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.13 22.23 13.09 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 60' ' ' LYS . 4.9 tppt? -142.5 -42.05 0.33 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.39 0.614 . . . . 0.0 110.036 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 44.7 m -88.53 -156.25 0.37 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.18 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.35 17.04 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . 14.8 m-85 -126.31 -1.97 6.93 Favored 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 121.477 -0.765 . . . . 0.0 109.874 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 23.2 pttm -70.45 -7.65 44.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.311 1.053 . . . . 0.0 110.059 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.55 -6.43 20.58 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.682 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -115.13 -48.14 2.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.147 0.975 . . . . 0.0 110.854 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 120' ' ' ALA . 47.5 t -128.52 155.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.036 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 53.3 t -135.96 127.83 44.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 172.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.442 ' C ' HG23 ' A' ' 9' ' ' VAL . 32.1 mm -93.82 126.67 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.2 165.66 20.89 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.565 0.346 . . . . 0.0 111.556 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -144.39 148.74 35.07 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' A' ' 30' ' ' ILE . 9.0 p -131.68 135.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -82.63 106.85 14.82 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 -11.97 59.92 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 123.845 0.858 . . . . 0.0 112.023 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -105.43 -15.03 15.13 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.495 0.664 . . . . 0.0 111.01 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.16 -28.78 11.26 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -126.57 111.97 14.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.915 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.94 127.73 33.24 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.58 148.55 37.95 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.347 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -84.84 -6.78 9.59 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.859 2.373 . . . . 0.0 111.189 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.51 137.69 38.05 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.294 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -82.76 140.37 33.06 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.309 0.576 . . . . 0.0 110.306 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.527 HG23 ' OG1' ' A' ' 84' ' ' THR . 55.4 mt -126.9 132.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 124.225 1.01 . . . . 0.0 108.803 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -73.94 -29.32 61.96 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.54 0.685 . . . . 0.0 110.647 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.62 -114.37 1.9 Allowed Glycine 0 C--N 1.299 -1.503 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.5 t80 -123.84 -53.4 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.826 171.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -89.99 155.47 4.88 Favored 'Trans proline' 0 N--CA 1.419 -2.855 0 CA-C-N 120.154 1.091 . . . . 0.0 109.936 169.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.527 ' OG1' HG23 ' A' ' 79' ' ' ILE . 6.9 m -163.85 140.44 6.78 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.538 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 30.2 mt -107.89 134.65 49.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 86.8 mttt -135.86 129.46 32.39 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.524 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -100.46 115.97 31.32 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -99.27 97.84 5.87 Favored Pre-proline 0 C--N 1.292 -1.894 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.3 Cg_endo -70.04 161.83 44.49 Favored 'Trans proline' 0 CA--C 1.465 -2.962 0 C-N-CA 121.986 1.791 . . . . 0.0 111.076 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.05 77.22 6.76 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-O 123.004 1.383 . . . . 0.0 109.107 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.15 -34.84 0.72 Allowed Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.779 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -112.8 33.19 5.15 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.912 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' H ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -65.79 0.92 1.5 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.286 1.434 . . . . 0.0 112.787 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.76 -12.15 28.83 Favored Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.421 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 11.8 pt20 -134.63 51.07 5.58 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 122.87 0.468 . . . . 0.0 110.982 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 17.2 Cg_exo -45.28 157.08 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 124.512 3.475 . . . . 0.0 114.818 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 22.0 t -90.27 97.08 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.906 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.447 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 8.8 t -75.9 128.55 35.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.086 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.27 166.13 25.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.692 -172.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.5 t -98.85 -33.91 10.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 143.24 172.52 14.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.517 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.496 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.9 m -128.55 150.17 50.3 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -98.88 34.28 2.13 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.83 0.824 . . . . 0.0 109.692 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -146.11 149.13 33.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.209 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 46' ' ' LYS . 66.2 t -80.4 -29.63 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.291 0.567 . . . . 0.0 109.513 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.14 -45.38 93.24 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 122.236 1.017 . . . . 0.0 110.126 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 26.3 t70 -71.97 -24.27 61.56 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.63 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 108' ' ' LEU . 21.5 mt -71.92 -44.56 63.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.857 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.22 -51.49 62.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 16.2 tppt? -68.06 -20.32 64.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.798 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.7 OUTLIER -69.06 -64.48 0.86 Allowed 'General case' 0 C--O 1.183 -2.416 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.421 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.0 mt -67.3 -15.28 19.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 122.758 1.266 . . . . 0.0 108.286 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -84.81 -21.22 29.98 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.816 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -117.87 -40.1 3.04 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 122.051 0.929 . . . . 0.0 109.818 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.5 m-80 -80.28 -26.08 39.1 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.916 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.41 164.58 45.68 Favored Glycine 0 N--CA 1.404 -3.448 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.238 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.539 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 8.9 mmmm -94.23 -26.26 16.72 Favored 'General case' 0 CA--C 1.458 -2.572 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.421 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.8 m-85 -83.63 -11.64 57.02 Favored 'General case' 0 N--CA 1.379 -3.992 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.39 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 53.86 60.46 3.63 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.458 1.099 . . . . 0.0 108.772 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 63' ' ' VAL . . . -47.82 24.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.274 -2.683 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.258 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.732 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -74.55 -2.81 12.92 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.936 2.424 . . . . 0.0 113.489 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 71.9 14.41 5.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.033 1.333 . . . . 0.0 111.286 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.68 154.6 25.65 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -75.75 -57.3 3.96 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 117.408 0.604 . . . . 0.0 110.278 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.66 93.19 4.11 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.699 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.408 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 93.84 104.86 1.78 Allowed Glycine 0 N--CA 1.421 -2.319 0 CA-C-N 115.338 -0.846 . . . . 0.0 114.669 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -65.93 -40.9 15.05 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.29 1.993 . . . . 0.0 107.191 168.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 65' ' ' ILE . 1.5 p -68.2 133.58 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.725 171.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 m -66.05 102.75 0.84 Allowed 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 121.448 0.642 . . . . 0.0 110.153 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.55 102.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 16' ' ' ASN . 55.2 t -98.72 126.52 51.86 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.884 0 C-N-CA 125.915 1.686 . . . . 0.0 107.443 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 15' ' ' LYS . 27.7 m -79.03 173.87 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.21 -17.53 64.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.885 0.374 . . . . 0.0 110.916 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB3' HG23 ' A' ' 13' ' ' VAL . 33.5 tttm -65.67 -45.14 84.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.401 0.62 . . . . 0.0 110.546 171.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.789 ' HB2' HG13 ' A' ' 12' ' ' VAL . 61.2 m-20 -93.79 -10.14 35.16 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.775 -165.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -58.9 -37.28 76.27 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.83 -7.22 58.56 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.867 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.9 pt-20 -105.75 -51.39 3.0 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 122.019 0.914 . . . . 0.0 110.882 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.516 HG12 ' HG3' ' A' ' 19' ' ' GLU . 35.4 mm -80.02 -52.96 13.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.409 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 30' ' ' ILE . 60.7 t -82.95 -21.24 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 CA-C-O 122.025 0.917 . . . . 0.0 111.002 -173.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.72 29.0 4.75 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.64 133.11 34.84 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -105.5 21.18 17.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -105.3 -8.25 18.37 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.291 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.513 ' HD2' HG23 ' A' ' 64' ' ' VAL . 20.3 pttm -154.81 159.55 40.66 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.835 0.854 . . . . 0.0 108.78 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 79.0 m-20 -80.93 120.31 24.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 21' ' ' VAL . 22.3 t -111.65 119.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.045 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HG ' HD23 ' A' ' 87' ' ' LEU . 10.5 mt -88.07 123.21 32.53 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.657 HD12 HG21 ' A' ' 21' ' ' VAL . 9.3 tt -113.66 149.25 16.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 117.806 -1.557 . . . . 0.0 110.447 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' A' ' 43' ' ' LEU . 35.2 tt0 -130.66 113.17 13.85 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.371 0.605 . . . . 0.0 109.844 175.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 84' ' ' THR . 95.7 m-85 -75.33 131.68 40.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 173.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.517 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.8 p90 -147.67 -173.25 4.23 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.709 0.766 . . . . 0.0 111.652 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -150.52 148.1 23.06 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.91 -16.87 8.56 Favored 'Trans proline' 0 CA--C 1.499 -1.269 0 C-N-CA 122.13 1.887 . . . . 0.0 110.299 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -91.19 -1.12 57.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.705 -1.588 . . . . 0.0 111.267 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 45.2 t -86.31 117.85 25.38 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.127 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.74 -28.82 73.47 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.644 ' O ' HD13 ' A' ' 43' ' ' LEU . 20.1 t60 -63.14 -46.25 88.1 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 30.9 t -60.93 -33.06 72.57 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.252 0.548 . . . . 0.0 111.368 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 41.8 mmtt -63.68 -12.12 31.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.42 16.83 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.928 1.347 . . . . 0.0 108.862 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.2 mp -99.0 -22.86 15.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.604 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.452 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -68.79 -44.28 30.49 Favored Pre-proline 0 C--N 1.283 -2.312 0 C-N-CA 124.637 1.175 . . . . 0.0 113.296 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 51.2 Cg_endo -64.5 -16.56 55.83 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.569 1.513 . . . . 0.0 113.116 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -101.08 -28.47 12.69 Favored 'General case' 0 CA--C 1.473 -2.015 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.647 177.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -73.87 -39.41 63.96 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.12 -174.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 2.1 mp0 -80.17 -20.85 43.86 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 119.703 -0.799 . . . . 0.0 113.112 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.3 tt0 -85.44 -46.45 10.89 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -73.2 -40.89 64.38 Favored 'General case' 0 CA--C 1.467 -2.231 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.21 94.6 Favored Glycine 0 CA--C 1.461 -3.296 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.133 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.49 -56.09 25.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.4 mt -59.75 -43.01 94.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.194 -175.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.64 -42.72 33.81 Favored 'General case' 0 C--O 1.188 -2.153 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.55 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.1 16.54 8.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.0 tppt? -130.87 -33.01 1.61 Allowed 'General case' 0 C--N 1.316 -0.848 0 O-C-N 122.049 -0.407 . . . . 0.0 110.538 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.581 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 14.3 t -96.08 -160.82 0.82 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.222 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.16 15.19 0.07 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.541 1.136 . . . . 0.0 113.434 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -118.05 -3.16 11.14 Favored 'General case' 0 C--O 1.194 -1.868 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 57' ' ' SER . 60.8 pttt -71.75 -4.18 26.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.835 0.826 . . . . 0.0 112.848 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -110.35 -9.59 14.63 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -98.0 -49.96 4.57 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.239 1.019 . . . . 0.0 109.352 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.2 t -137.26 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.058 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.513 HG23 ' HD2' ' A' ' 26' ' ' LYS . 53.7 t -124.75 130.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.523 ' C ' HG23 ' A' ' 9' ' ' VAL . 34.9 mm -94.68 122.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -132.51 158.61 41.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 122.578 0.351 . . . . 0.0 110.703 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -151.93 139.36 19.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.654 -0.654 . . . . 0.0 109.955 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 11.1 p -116.44 139.87 41.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -85.58 110.28 19.13 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.84 -9.73 59.56 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 124.077 0.861 . . . . 0.0 112.331 -172.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -109.93 -18.17 13.45 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.436 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.28 -32.91 11.66 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -123.28 101.62 7.47 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.82 116.11 4.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.301 0.572 . . . . 0.0 110.6 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 32' ' ' PHE . 33.2 m -91.96 144.97 30.05 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.502 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -90.24 0.11 5.41 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.168 2.579 . . . . 0.0 112.246 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -78.53 -179.02 6.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.071 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.66 106.37 14.43 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.017 0.913 . . . . 0.0 109.974 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.54 HG23 ' OG1' ' A' ' 84' ' ' THR . 43.9 mt -96.56 136.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.103 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -88.3 -9.17 53.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.16 -116.46 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.577 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 78.3 t80 -118.16 -58.84 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.77 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.5 Cg_exo -87.85 156.67 7.38 Favored 'Trans proline' 0 N--CA 1.425 -2.519 0 CA-C-N 120.385 1.173 . . . . 0.0 109.414 167.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.54 ' OG1' HG23 ' A' ' 79' ' ' ILE . 17.6 m -159.25 136.93 10.1 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.843 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 42.8 mt -101.64 137.43 29.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.53 121.96 19.43 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.0 tm? -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.57 100.43 7.1 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.421 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 12.7 Cg_endo -65.97 159.36 49.53 Favored 'Trans proline' 0 CA--C 1.463 -3.045 0 C-N-CA 121.812 1.674 . . . . 0.0 109.92 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.6 77.23 8.47 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.892 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.18 -39.24 0.45 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 113.0 -1.909 . . . . 0.0 110.269 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.421 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -109.46 58.18 0.61 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.242 1.02 . . . . 0.0 110.493 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 8.13 3.36 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.167 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.53 -1.85 9.05 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.614 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 47.8 mt-30 -133.12 46.74 2.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.42 0.688 . . . . 0.0 110.803 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 85.6 Cg_exo -54.1 156.25 13.46 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 123.561 2.841 . . . . 0.0 113.245 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 115' ' ' ASN . 15.0 t -95.37 95.68 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.133 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -72.19 128.45 35.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.434 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.31 170.85 14.95 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 125.289 1.436 . . . . 0.0 109.502 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.5 t -108.13 -31.13 8.05 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.162 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.65 110.79 0.61 Allowed Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.591 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.1 m -62.69 -26.43 68.66 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 123.751 0.821 . . . . 0.0 111.838 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.41 ' HG2' HD12 ' A' ' 43' ' ' LEU . 70.2 mtm180 64.61 17.72 11.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.987 0.915 . . . . 0.0 112.254 -175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -152.04 153.41 33.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.258 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 46' ' ' LYS . 60.2 t -77.2 -39.19 28.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 124.676 1.19 . . . . 0.0 109.739 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -55.75 -47.69 76.55 Favored 'General case' 0 C--O 1.251 1.184 0 C-N-CA 124.926 1.29 . . . . 0.0 110.936 -172.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.5 t70 -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.758 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 23.0 mt -70.7 -39.97 73.13 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.571 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.42 -52.62 54.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 45.2 tptt -70.07 -15.77 63.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.3 t80 -71.51 -62.74 1.3 Allowed 'General case' 0 C--O 1.191 -1.983 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.494 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.2 mt -65.94 -13.72 16.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.871 1.319 . . . . 0.0 108.015 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -82.81 -33.5 27.2 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.681 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -109.06 -35.21 6.38 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.929 0.871 . . . . 0.0 109.39 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.7 m-80 -86.07 -30.0 22.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.267 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.91 163.92 51.3 Favored Glycine 0 N--CA 1.406 -3.331 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.873 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -98.9 -23.33 15.38 Favored 'General case' 0 CA--C 1.452 -2.799 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.629 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.464 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.9 m-85 -80.04 -14.09 58.81 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.516 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 55.78 56.1 6.43 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 124.184 0.927 . . . . 0.0 110.011 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.37 38.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.298 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.37 -21.4 61.11 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 123.303 2.669 . . . . 0.0 112.88 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.7 mt -102.07 93.37 5.21 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.91 164.34 26.46 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.0 m -149.66 142.92 25.14 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.46 14.19 32.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.727 0.775 . . . . 0.0 110.035 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.52 171.57 25.81 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.9 -32.53 54.89 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 123.45 2.767 . . . . 0.0 110.79 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.571 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.3 p -73.0 133.12 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.927 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 18.9 m -74.9 107.96 7.32 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 121.735 0.778 . . . . 0.0 111.129 -173.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.73 108.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.613 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.8 t -109.82 110.49 32.33 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.643 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 15' ' ' LYS . 16.3 m -69.81 166.97 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.66 -23.53 63.14 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.152 0.501 . . . . 0.0 110.698 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.639 ' HB3' HG23 ' A' ' 13' ' ' VAL . 44.2 tttp -59.97 -42.4 94.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.396 173.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HB2' HG13 ' A' ' 12' ' ' VAL . 20.0 m-20 -105.75 -9.88 17.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.491 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -54.07 -27.52 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -86.46 -8.15 57.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.303 1.049 . . . . 0.0 108.939 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -105.86 -43.19 4.94 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.693 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mm -94.06 -54.7 6.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.717 HG21 HD12 ' A' ' 30' ' ' ILE . 78.3 t -72.98 -25.51 22.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 CA-C-O 121.885 0.85 . . . . 0.0 112.077 -174.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 22' ' ' LEU . 1.7 tm? -99.8 16.32 24.04 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 122.502 1.144 . . . . 0.0 108.974 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.47 150.7 23.59 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.122 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.509 ' HB3' ' CE ' ' A' ' 93' ' ' LYS . 6.3 p-10 -115.29 17.09 16.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -90.85 -14.23 32.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.677 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.625 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.06 161.15 42.92 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.156 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 m-20 -78.47 126.21 30.44 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 21' ' ' VAL . 33.5 t -115.37 115.29 48.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.46 ' HG ' HD23 ' A' ' 87' ' ' LEU . 8.8 mt -85.72 128.51 34.81 Favored 'General case' 0 CA--C 1.467 -2.243 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 21' ' ' VAL . 12.7 tt -115.9 144.76 22.8 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 C-N-CA 118.026 -1.469 . . . . 0.0 110.564 171.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 39.8 tt0 -125.41 112.25 16.07 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -78.14 126.91 31.5 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.58 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.7 p90 -144.03 -175.79 4.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.111 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -146.1 144.23 21.18 Favored Pre-proline 0 N--CA 1.42 -1.954 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -80.1 -17.81 10.37 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 121.627 1.551 . . . . 0.0 110.249 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -89.65 1.16 56.39 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.638 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 42.0 t -83.68 118.89 24.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.346 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.11 -38.29 94.14 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.561 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.8 m80 -68.11 -36.99 80.65 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.857 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 34.8 t -64.91 -34.83 79.34 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.797 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -69.07 -15.27 63.41 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.542 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.54 -10.31 32.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.075 0.94 . . . . 0.0 109.438 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 78.7 mt -97.77 -13.51 21.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.858 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.77 90.81 Favored Pre-proline 0 C--N 1.255 -3.543 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.531 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.44 -12.58 20.68 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.355 1.37 . . . . 0.0 113.059 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 43' ' ' LEU . 9.8 ptmm? -92.27 -32.24 15.1 Favored 'General case' 0 CA--C 1.466 -2.268 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.571 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -82.95 -41.48 18.77 Favored 'General case' 1 N--CA 1.378 -4.075 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.078 -171.876 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -73.69 -42.39 61.32 Favored 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.682 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 tt0 -74.79 -38.4 62.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.791 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 108' ' ' LEU . 24.3 tp -72.79 -40.18 66.1 Favored 'General case' 0 CA--C 1.472 -2.027 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.66 96.69 Favored Glycine 0 CA--C 1.473 -2.573 0 CA-C-N 113.559 -1.655 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.78 -53.53 49.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.0 mt -52.35 -39.1 60.29 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 124.169 0.918 . . . . 0.0 110.968 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.281 4.1 m-30 -77.79 -49.86 13.49 Favored 'General case' 0 C--O 1.187 -2.213 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.071 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.525 ' C ' ' HE2' ' A' ' 56' ' ' LYS . . . -76.1 6.91 4.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -120.39 -43.97 2.49 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 124.369 1.068 . . . . 0.0 109.304 -177.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -91.68 -169.59 2.34 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -76.86 28.93 0.13 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -122.51 4.18 9.62 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -65.42 -16.65 63.84 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -119.35 5.09 11.18 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.735 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -95.33 -45.57 7.08 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.532 1.158 . . . . 0.0 109.245 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -135.0 142.99 38.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.866 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.391 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 26' ' ' LYS . 51.4 t -119.21 119.54 61.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mm -86.6 116.14 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.737 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -127.24 160.71 30.45 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.174 0.511 . . . . 0.0 111.32 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -153.78 145.18 23.09 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 122.015 -0.428 . . . . 0.0 110.24 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.38 140.79 47.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.63 109.18 17.79 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.33 60.43 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.292 1.037 . . . . 0.0 112.681 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 t -111.36 -18.1 12.98 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.571 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.58 -30.37 13.33 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -131.53 83.29 2.09 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 131.52 46.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.849 0.833 . . . . 0.0 110.102 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.13 156.86 36.58 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.531 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.43 -7.69 11.72 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.768 2.312 . . . . 0.0 110.469 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -67.42 153.25 44.12 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.114 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.89 126.88 39.35 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -124.51 128.8 73.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.794 0.331 . . . . 0.0 110.479 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -81.03 -27.71 35.68 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.121 0.568 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.13 -120.22 3.83 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.597 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.3 t80 -133.22 -58.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.1 Cg_endo -87.67 149.33 7.37 Favored 'Trans proline' 0 N--CA 1.424 -2.613 0 CA-C-N 120.252 1.126 . . . . 0.0 109.188 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -162.45 149.99 13.9 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.6 mt -110.37 138.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 91.3 mttt -137.21 128.42 27.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.46 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.4 tm? -101.34 115.07 29.67 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -98.67 97.51 4.93 Favored Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 19.5 Cg_endo -66.65 158.1 57.62 Favored 'Trans proline' 0 CA--C 1.464 -3.01 0 C-N-CA 121.993 1.796 . . . . 0.0 111.14 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.94 77.91 8.71 Favored 'General case' 0 N--CA 1.394 -3.258 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.69 -23.17 0.34 Allowed Glycine 0 N--CA 1.422 -2.246 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.231 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.413 ' H ' ' HG2' ' A' ' 89' ' ' PRO . . . -138.34 61.11 1.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.539 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 24' ' ' ASP . 19.7 ptpt -77.81 5.28 9.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.283 0.633 . . . . 0.0 110.536 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.65 -11.83 25.94 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.41 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 19.0 pt20 -130.71 48.23 3.55 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 122.789 0.436 . . . . 0.0 110.831 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 28.8 Cg_exo -46.51 150.4 2.34 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.285 2.656 . . . . 0.0 113.365 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 18.7 t -93.82 98.92 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.542 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.446 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 11.1 t -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.447 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.48 160.0 40.65 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.938 -169.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 p -87.37 -58.71 2.48 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.531 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.16 121.77 4.77 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -80.54 22.3 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 59.41 22.12 10.55 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 t -137.73 159.13 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 122.282 -0.261 . . . . 0.0 110.343 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG13 HD13 ' A' ' 50' ' ' LEU . 96.0 t -77.18 -29.42 17.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 124.045 0.938 . . . . 0.0 110.257 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 27.0 mt-10 -59.24 -45.71 90.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 123.331 1.538 . . . . 0.0 108.869 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -62.1 -35.97 80.32 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 111.302 -2.681 . . . . 0.0 109.305 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.2 mt -75.16 -43.53 51.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.49 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.6 mt -55.14 -52.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -66.01 -22.87 66.47 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.382 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.607 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.5 OUTLIER -67.34 -63.73 1.0 Allowed 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.548 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.5 mt -71.81 -8.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.494 1.14 . . . . 0.0 108.953 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.8 -28.98 15.59 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.313 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.17 -43.92 6.46 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 61.4 m-80 -85.84 -29.93 23.35 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.166 -1.833 . . . . 0.0 109.833 -174.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -74.15 155.77 49.47 Favored Glycine 1 N--CA 1.392 -4.243 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.915 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -94.82 -23.11 17.63 Favored 'General case' 0 CA--C 1.468 -2.175 0 CA-C-O 121.753 0.787 . . . . 0.0 109.195 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.51 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 17.2 m-85 -82.21 -9.73 59.4 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 51.81 51.88 15.68 Favored 'General case' 0 C--N 1.365 1.242 0 C-N-CA 124.325 1.05 . . . . 0.0 110.376 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -75.1 90.42 2.51 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.185 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.459 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.86 112.63 2.51 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.693 2.262 . . . . 0.0 110.538 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.0 mt -85.46 129.57 34.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.667 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.21 -115.18 2.23 Favored Glycine 0 N--CA 1.419 -2.486 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m 62.67 103.71 0.03 OUTLIER 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.935 0.894 . . . . 0.0 109.887 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 6' ' ' GLU 0.268 0.1 OUTLIER -70.34 77.52 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -171.768 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.0 51.66 0.28 Allowed Glycine 0 N--CA 1.422 -2.294 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.522 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.56 -44.91 0.45 Allowed 'Trans proline' 0 C--N 1.376 2.026 0 CA-C-N 119.709 1.755 . . . . 0.0 109.536 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 65' ' ' ILE . 1.5 p -69.91 125.56 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 12' ' ' VAL . 20.2 m -72.96 106.72 4.97 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.0 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.6 114.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.772 HG13 ' HB2' ' A' ' 16' ' ' ASN . 83.5 t -116.62 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 15' ' ' LYS . 16.2 m -71.88 173.51 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.638 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.582 ' H ' ' HB3' ' A' ' 73' ' ' ASN . . . -60.02 -26.95 66.5 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.471 0.708 . . . . 0.0 110.852 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 13' ' ' VAL . 30.4 tttm -62.08 -50.99 69.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.772 ' HB2' HG13 ' A' ' 12' ' ' VAL . 54.0 m-20 -86.85 -14.49 41.92 Favored 'General case' 0 CA--C 1.464 -2.356 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.196 -168.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -57.79 -32.14 67.25 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -78.87 -17.93 54.78 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.9 pt-20 -104.49 -45.16 4.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.415 1.102 . . . . 0.0 111.213 -173.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.513 HG12 ' HG3' ' A' ' 19' ' ' GLU . 33.7 mm -83.91 -54.35 9.17 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.486 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.638 HG21 HD12 ' A' ' 30' ' ' ILE . 61.1 t -81.62 -37.15 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 121.474 0.654 . . . . 0.0 111.278 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.8 35.07 1.16 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.519 ' OD2' ' HD3' ' A' ' 26' ' ' LYS . 17.6 t70 -86.87 151.79 23.02 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.143 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.74 14.35 16.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 p -101.67 -23.12 14.29 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.319 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HD3' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -142.33 164.85 29.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 74.4 m-20 -81.63 120.02 24.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.9 t -115.1 121.02 66.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.728 0.775 . . . . 0.0 111.227 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.584 HD21 HD22 ' A' ' 108' ' ' LEU . 18.4 tp -93.33 124.94 37.67 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.638 HD12 HG21 ' A' ' 21' ' ' VAL . 12.4 tt -115.1 147.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 C-N-CA 117.596 -1.642 . . . . 0.0 112.953 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 27.3 tt0 -117.15 114.37 23.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.417 ' HD2' ' O ' ' A' ' 84' ' ' THR . 97.4 m-85 -83.84 124.15 30.65 Favored 'General case' 0 CA--C 1.464 -2.344 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 170.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -142.41 -172.5 3.63 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.311 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.99 150.7 39.55 Favored Pre-proline 0 N--CA 1.419 -2.006 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -78.65 -20.12 10.87 Favored 'Trans proline' 0 CA--C 1.5 -1.223 0 C-N-CA 121.391 1.394 . . . . 0.0 110.152 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -89.28 -2.78 58.6 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.489 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 47.0 t -77.11 118.52 19.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.467 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.73 -37.23 93.92 Favored Glycine 0 C--O 1.236 0.225 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -64.84 -42.13 95.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.918 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.7 t -62.55 -43.14 99.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.079 0.466 . . . . 0.0 110.704 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 49.5 mtmt -66.65 -18.44 65.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.601 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 -18.96 25.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.596 0.712 . . . . 0.0 109.424 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 72.6 mt -88.47 -26.86 21.86 Favored 'General case' 0 C--O 1.196 -1.752 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.372 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.11 -51.57 61.08 Favored Pre-proline 0 C--N 1.286 -2.171 0 C-N-CA 125.813 1.645 . . . . 0.0 114.299 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -66.01 -30.81 47.47 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.066 1.178 . . . . 0.0 111.319 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.484 ' CB ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -87.45 -28.9 21.81 Favored 'General case' 0 CA--C 1.43 -3.65 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.243 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -73.83 -36.33 64.91 Favored 'General case' 0 N--CA 1.386 -3.651 0 O-C-N 123.78 0.675 . . . . 0.0 109.61 -174.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.93 -49.48 61.55 Favored 'General case' 0 C--O 1.193 -1.912 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.595 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.62 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 40.8 mt-10 -75.15 -33.26 61.5 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -173.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 108' ' ' LEU . 13.0 tp -73.15 -41.69 63.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.81 -43.07 99.65 Favored Glycine 0 CA--C 1.475 -2.437 0 CA-C-N 112.922 -1.945 . . . . 0.0 112.271 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -62.8 -52.05 64.71 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 84.2 mt -60.35 -36.68 78.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.746 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.251 2.0 m-85 -76.42 -50.95 12.82 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 116.932 -1.907 . . . . 0.0 110.873 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -83.6 22.76 1.03 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -151.07 -31.26 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 176.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 m -87.06 -85.78 0.16 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.36 -5.33 9.87 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -126.41 23.48 6.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 19.3 pttp -69.89 -15.42 63.07 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.351 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -116.26 15.9 15.86 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.652 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -131.97 -110.46 0.24 Allowed 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 119.909 -0.717 . . . . 0.0 110.984 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 112' ' ' ILE . 92.9 t -55.51 129.45 16.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 123.499 0.72 . . . . 0.0 111.853 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 26' ' ' LYS . 96.0 t -114.48 123.99 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.022 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.5 mm -89.33 118.55 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -126.14 165.9 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -155.83 144.72 20.49 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 122.077 -0.389 . . . . 0.0 110.744 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.405 HG12 HD11 ' A' ' 30' ' ' ILE . 11.7 p -127.05 145.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.78 111.89 22.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.11 -14.7 61.02 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.409 ' HB ' ' CZ ' ' A' ' 82' ' ' PHE . 9.9 t -107.98 -6.27 16.68 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.258 0.551 . . . . 0.0 111.492 -175.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.05 -48.26 2.99 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.582 ' HB3' ' H ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -100.56 101.1 11.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.09 117.12 8.68 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.091 0.472 . . . . 0.0 110.886 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.24 150.0 36.32 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.626 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -89.94 -4.41 5.32 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.029 2.486 . . . . 0.0 112.273 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.43 144.87 53.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.856 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.48 113.29 22.3 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.641 0.734 . . . . 0.0 109.455 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.522 HG23 ' OG1' ' A' ' 84' ' ' THR . 55.3 mt -106.32 144.93 14.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.373 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -80.78 -17.24 51.56 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.885 0.85 . . . . 0.0 111.318 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.489 ' H ' HG22 ' A' ' 79' ' ' ILE . . . -144.38 -112.19 0.81 Allowed Glycine 0 C--N 1.278 -2.673 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.541 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 48.2 t80 -123.21 -54.68 0.03 OUTLIER Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.28 171.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.9 Cg_endo -89.36 155.06 5.48 Favored 'Trans proline' 0 N--CA 1.429 -2.284 0 CA-C-N 120.307 1.145 . . . . 0.0 110.324 170.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.522 ' OG1' HG23 ' A' ' 79' ' ' ILE . 15.9 m -165.84 143.3 5.56 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.7 mt -105.86 133.57 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 94.4 mttt -135.95 124.02 22.92 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.193 0.52 . . . . 0.0 110.392 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -98.47 115.33 28.3 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -95.92 98.16 3.67 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.55 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -68.54 158.32 58.16 Favored 'Trans proline' 0 CA--C 1.461 -3.145 0 C-N-CA 121.586 1.524 . . . . 0.0 110.302 178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.91 77.47 8.73 Favored 'General case' 0 N--CA 1.402 -2.834 0 C-N-CA 118.632 -1.227 . . . . 0.0 107.974 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.95 -34.1 0.44 Allowed Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.915 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -120.65 35.98 4.71 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.109 0.957 . . . . 0.0 109.963 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.12 2.73 1.4 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 125.523 1.529 . . . . 0.0 112.126 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.15 25.94 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.406 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 14.0 pt20 -137.34 54.52 8.34 Favored Pre-proline 0 CA--C 1.578 2.034 0 C-N-CA 123.724 0.809 . . . . 0.0 110.808 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 12.9 Cg_exo -45.06 160.61 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 125.014 3.809 . . . . 0.0 115.137 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 115' ' ' ASN . 24.8 t -94.4 98.6 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.329 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.472 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 14.2 t -73.52 132.49 42.93 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.651 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.71 164.41 30.29 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.184 -174.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -87.35 -68.55 0.74 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.74 129.17 1.26 Allowed Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -71.63 -37.19 70.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 117.195 0.498 . . . . 0.0 110.821 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 65.96 17.43 10.8 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.284 1.033 . . . . 0.0 111.375 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -150.18 161.7 41.89 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 46' ' ' LYS . 61.8 t -86.2 -43.23 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.04 0.447 . . . . 0.0 109.955 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -54.4 -39.36 67.18 Favored 'General case' 0 N--CA 1.396 -3.165 0 C-N-CA 126.188 1.795 . . . . 0.0 112.665 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.6 t70 -80.75 -23.38 39.45 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.511 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.584 HD22 HD21 ' A' ' 29' ' ' LEU . 17.3 mt -74.7 -41.6 59.91 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.713 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.62 -51.52 70.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 45.5 tptt -65.8 -21.34 66.48 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.029 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.606 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -68.22 -65.51 0.69 Allowed 'General case' 0 C--O 1.186 -2.27 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.569 HG21 HG11 ' A' ' 63' ' ' VAL . 3.1 mt -67.72 -12.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.517 1.151 . . . . 0.0 108.806 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -87.77 -22.2 24.69 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.05 -176.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -114.78 -35.39 4.84 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 122.261 1.029 . . . . 0.0 109.166 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.606 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 57.6 m-80 -88.97 -21.93 23.29 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.478 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -83.16 163.9 41.79 Favored Glycine 0 N--CA 1.404 -3.452 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.749 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.55 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 12.0 mmmm -93.68 -24.71 17.76 Favored 'General case' 0 CA--C 1.457 -2.61 0 CA-C-N 118.228 1.014 . . . . 0.0 108.406 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.51 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 20.6 m-85 -81.41 -14.0 57.64 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.549 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 54.68 55.91 7.37 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 123.989 0.806 . . . . 0.0 109.101 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.65 82.18 0.43 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.265 1.892 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.626 176.698 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.993 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -82.55 115.99 2.56 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.145 1.896 . . . . 0.0 111.572 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.5 -35.72 58.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.79 144.01 3.93 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.571 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.9 m 68.43 9.16 7.1 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.104 0.962 . . . . 0.0 112.464 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -97.36 96.02 8.08 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.044 0.925 . . . . 0.0 108.867 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.56 77.91 0.9 Allowed Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -170.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 17.8 Cg_endo -57.64 -42.03 64.58 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 123.599 2.866 . . . . 0.0 111.481 -175.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.6 p -70.44 118.61 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.904 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.926 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 m -63.23 107.11 0.99 Allowed 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.571 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.404 HG22 ' HE3' ' A' ' 67' ' ' LYS . 44.7 t -79.99 109.82 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 16' ' ' ASN . 21.0 t -109.23 128.77 64.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.568 HG23 ' HB3' ' A' ' 15' ' ' LYS . 18.9 m -75.27 166.94 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 73' ' ' ASN . . . -60.99 -21.72 63.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 110.587 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' HG23 ' A' ' 13' ' ' VAL . 46.0 tptt -62.44 -52.87 61.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.34 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -95.56 -3.33 46.69 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.524 -174.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -24.05 43.05 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -87.96 -8.89 55.04 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 10.8 mt-10 -104.53 -51.74 3.03 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.363 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.63 -51.12 14.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.361 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.591 ' HA ' HG11 ' A' ' 28' ' ' VAL . 60.3 t -83.31 -28.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.88 0.848 . . . . 0.0 110.709 -172.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.56 26.35 6.22 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.212 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.72 141.32 28.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.574 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 8.7 p-10 -109.0 21.64 16.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.4 p -93.07 -17.41 23.86 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.679 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.09 166.05 30.94 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 73.8 m-20 -80.52 130.42 35.13 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' ' 21' ' ' VAL . 24.8 t -119.69 118.4 57.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.334 -0.854 . . . . 0.0 112.005 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 108' ' ' LEU . 9.4 mt -87.8 116.34 25.88 Favored 'General case' 0 CA--C 1.473 -1.983 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 21' ' ' VAL . 12.6 tt -106.07 145.23 14.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 118.089 -1.445 . . . . 0.0 110.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 67' ' ' LYS . 37.1 tt0 -127.94 109.59 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 84' ' ' THR . 95.9 m-85 -73.01 128.38 35.29 Favored 'General case' 0 CA--C 1.465 -2.305 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.528 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 27.3 p90 -142.76 -170.95 3.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 124.014 0.821 . . . . 0.0 111.242 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -148.34 144.61 18.88 Favored Pre-proline 0 C--N 1.289 -2.06 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.56 -22.52 12.1 Favored 'Trans proline' 0 CA--C 1.503 -1.041 0 C-N-CA 121.629 1.553 . . . . 0.0 110.419 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -97.36 3.58 51.02 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 113.129 -1.85 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.579 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 36.7 t -77.76 129.31 35.33 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.62 99.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.554 ' O ' HD13 ' A' ' 43' ' ' LEU . 8.5 m-70 -65.42 -44.34 87.69 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.092 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 35.4 t -56.48 -41.15 76.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.201 0.524 . . . . 0.0 110.519 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.8 mtmt -73.17 -2.75 22.88 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.013 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -107.37 -18.65 13.81 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.857 1.313 . . . . 0.0 108.411 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.6 mp -96.93 -11.02 25.18 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.504 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -46.89 47.55 Favored Pre-proline 0 C--N 1.278 -2.518 0 C-N-CA 125.754 1.621 . . . . 0.0 113.935 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -60.51 -29.54 88.83 Favored 'Trans proline' 0 C--N 1.381 2.253 0 CA-C-N 120.983 1.387 . . . . 0.0 111.926 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 2.6 pttm -84.56 -31.48 24.35 Favored 'General case' 0 C--O 1.188 -2.167 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.742 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -79.3 -33.37 43.33 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.003 -174.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 35.3 mm-40 -70.04 -48.19 58.94 Favored 'General case' 0 C--O 1.185 -2.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.7 tt0 -71.41 -47.41 56.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.211 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.58 -39.3 73.97 Favored 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.55 95.27 Favored Glycine 0 CA--C 1.467 -2.945 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.86 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.24 -55.73 22.47 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 95.9 mt -56.7 -43.62 80.71 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.665 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -78.89 -41.88 28.63 Favored 'General case' 0 C--O 1.194 -1.825 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.6 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.67 16.58 6.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 6.3 tppt? -128.46 -36.87 1.85 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.127 -0.358 . . . . 0.0 110.523 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 10.5 m -87.42 -168.4 2.22 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -174.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -74.78 22.97 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.404 0.621 . . . . 0.0 112.567 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -120.96 2.1 10.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 57' ' ' SER . 58.8 pttt -74.75 -0.27 17.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.017 0.913 . . . . 0.0 112.242 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -120.21 4.53 10.81 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.672 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 76.6 ttt180 -99.15 -48.89 4.68 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.757 1.265 . . . . 0.0 107.734 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.533 HG21 HG21 ' A' ' 112' ' ' ILE . 2.5 p -147.57 138.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.175 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' A' ' 26' ' ' LYS . 78.2 t -117.07 131.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.435 ' C ' HG23 ' A' ' 9' ' ' VAL . 37.9 mm -93.41 119.11 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.94 165.76 18.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.358 0.599 . . . . 0.0 111.907 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 31' ' ' GLU . 56.1 mtmt -143.96 160.61 40.53 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.405 ' CG1' HD11 ' A' ' 30' ' ' ILE . 9.4 p -144.68 144.62 21.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 172.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -88.18 118.41 27.75 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.18 54.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.025 0.53 . . . . 0.0 111.907 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -119.63 -23.63 6.49 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.602 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.49 -24.3 14.82 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -118.77 97.49 5.74 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.73 111.88 1.14 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.151 0.501 . . . . 0.0 111.258 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 14' ' ' ALA . 35.8 m -99.32 143.22 26.01 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.932 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -94.09 2.18 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.326 2.684 . . . . 0.0 109.981 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -80.14 165.58 22.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.32 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -88.65 123.38 33.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.422 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.8 mm -105.43 140.43 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.627 1.171 . . . . 0.0 108.125 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.9 -29.21 16.03 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.36 0.6 . . . . 0.0 110.479 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.01 -108.5 1.15 Allowed Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 t80 -117.82 -53.16 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 166.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 3.2 Cg_exo -90.45 162.2 4.45 Favored 'Trans proline' 0 N--CA 1.43 -2.245 0 C-N-CA 121.151 1.234 . . . . 0.0 109.244 164.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.427 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 97.8 m -161.32 141.13 10.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 33.9 mt -106.36 128.97 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 30' ' ' ILE . 41.2 mtmt -135.34 129.18 33.02 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 121.292 0.568 . . . . 0.0 109.645 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.4 tm? -100.38 117.7 35.11 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -98.98 97.55 5.21 Favored Pre-proline 0 C--N 1.291 -1.978 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.604 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 14.3 Cg_endo -68.03 160.68 47.56 Favored 'Trans proline' 0 CA--C 1.464 -2.989 0 C-N-CA 121.973 1.782 . . . . 0.0 111.746 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.54 77.43 8.4 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 122.638 1.208 . . . . 0.0 108.564 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.02 -39.25 0.56 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.915 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 94' ' ' GLY . . . -113.66 31.23 6.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.492 0.663 . . . . 0.0 110.864 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -64.72 13.61 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.658 1.183 . . . . 0.0 113.677 177.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -108.03 -13.08 20.72 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -140.03 70.27 35.24 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 123.981 0.912 . . . . 0.0 108.558 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.4 Cg_exo -49.31 160.24 0.96 Allowed 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 123.926 3.084 . . . . 0.0 113.428 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.461 HG11 ' OD1' ' A' ' 115' ' ' ASN . 54.1 t -100.53 104.16 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.43 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.451 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 8.7 t -75.23 132.19 40.91 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.632 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 146.53 39.66 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.714 -175.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -73.69 -59.31 2.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.491 0.662 . . . . 0.0 110.49 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.55 125.69 0.85 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 15.2 m -71.06 -41.54 70.6 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 60.99 26.09 16.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.371 1.081 . . . . 0.0 108.93 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.7 t -161.51 157.37 24.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.908 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 46' ' ' LYS . 58.1 t -83.9 -37.12 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 124.18 0.992 . . . . 0.0 110.005 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -57.78 -45.16 86.37 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.277 1.036 . . . . 0.0 110.918 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -68.32 -31.0 70.11 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.794 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 29' ' ' LEU . 27.8 mt -72.16 -42.75 65.58 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.311 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.61 -51.05 70.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -66.19 -21.5 66.32 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.88 -178.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -69.98 -61.33 1.82 Allowed 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -69.48 -9.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.579 1.181 . . . . 0.0 108.281 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -91.04 -24.4 20.06 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.869 -177.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -104.4 -39.7 6.35 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-O 123.225 1.488 . . . . 0.0 108.71 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 59.3 m-80 -95.6 -26.14 15.88 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.432 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.36 157.63 40.75 Favored Glycine 0 N--CA 1.403 -3.525 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.922 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.604 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 4.3 mmmp? -88.39 -27.28 21.7 Favored 'General case' 0 CA--C 1.466 -2.251 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.474 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 26.0 m-85 -79.98 -11.2 59.81 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.242 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 55.32 45.9 24.6 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 124.244 0.965 . . . . 0.0 109.396 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . . . -67.05 86.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.005 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.11 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.546 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.1 -46.69 30.95 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.996 3.13 . . . . 0.0 114.543 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.9 -17.83 45.85 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.658 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.96 16.12 61.75 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.953 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 m -82.32 69.65 9.1 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.676 0.751 . . . . 0.0 109.865 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -73.95 -32.59 63.56 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.24 101.74 2.29 Favored Glycine 0 N--CA 1.404 -3.445 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 43.5 Cg_endo -70.78 -35.44 9.63 Favored 'Trans proline' 0 CA--C 1.503 -1.048 0 C-N-CA 122.384 2.056 . . . . 0.0 110.572 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.4 p -83.65 137.66 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.1 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.929 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 m -75.01 93.92 2.79 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 122.248 1.023 . . . . 0.0 110.378 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.23 104.52 3.59 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.386 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 13' ' ' VAL . 23.4 t -102.21 141.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.599 HG23 ' HB3' ' A' ' 15' ' ' LYS . 20.6 m -85.24 170.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.93 -31.22 69.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.073 0.463 . . . . 0.0 110.294 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.599 ' HB3' HG23 ' A' ' 13' ' ' VAL . 29.4 tttm -53.93 -39.79 66.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.152 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -110.45 -2.54 16.51 Favored 'General case' 0 C--O 1.208 -1.109 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.744 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -58.6 -30.93 67.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -77.93 -13.19 59.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 12.3 pt-20 -106.57 -44.75 4.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.404 1.097 . . . . 0.0 111.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.441 HG12 ' HG3' ' A' ' 19' ' ' GLU . 19.0 mm -79.16 -54.88 10.81 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.677 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.634 HG21 HD13 ' A' ' 30' ' ' ILE . 60.1 t -84.72 -29.66 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 121.62 0.724 . . . . 0.0 111.304 -173.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.94 32.37 2.41 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.703 ' OD2' HG22 ' A' ' 25' ' ' THR . 30.6 t70 -96.57 150.01 21.13 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.162 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -116.86 20.33 13.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.703 HG22 ' OD2' ' A' ' 23' ' ' ASP . 13.9 t -98.64 -3.67 35.58 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.475 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.9 161.99 41.64 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.1 m-20 -81.46 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.606 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.2 t -118.04 121.62 67.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.148 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HG ' HD23 ' A' ' 87' ' ' LEU . 9.9 mt -90.31 116.79 28.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.634 HD13 HG21 ' A' ' 21' ' ' VAL . 1.5 tp -104.45 145.28 13.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.615 ' N ' HG13 ' A' ' 30' ' ' ILE . 41.2 tt0 -126.39 104.34 8.12 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 124.151 0.907 . . . . 0.0 108.589 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 84' ' ' THR . 98.3 m-85 -76.34 128.03 34.04 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -142.47 -175.39 4.44 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.949 0.881 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -138.36 153.25 72.68 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 174.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 59.8 Cg_endo -84.16 -14.78 7.0 Favored 'Trans proline' 0 C--N 1.326 -0.607 0 CA-C-N 121.8 1.678 . . . . 0.0 110.665 -173.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.42 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 56.3 p-90 -96.64 4.58 51.83 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.624 -1.626 . . . . 0.0 111.772 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 46.4 t -80.63 121.57 26.0 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.628 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.83 92.85 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 46.5 m80 -60.72 -45.26 94.95 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 15.0 p -70.74 -25.7 63.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.952 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 56.3 mtmt -74.48 -20.59 59.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.6 0.714 . . . . 0.0 110.228 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.36 -9.83 37.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.672 1.225 . . . . 0.0 108.248 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.589 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 81.0 mt -97.83 -11.92 22.75 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.036 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.45 -50.5 73.15 Favored Pre-proline 0 C--N 1.255 -3.509 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.546 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.13 -16.5 31.9 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 121.453 1.435 . . . . 0.0 113.052 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 43' ' ' LEU . 8.8 ptmm? -86.58 -38.49 17.09 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -82.11 -26.51 33.51 Favored 'General case' 0 N--CA 1.396 -3.13 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.117 -171.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 42.4 mt-10 -77.58 -33.08 54.01 Favored 'General case' 0 C--O 1.18 -2.583 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.241 175.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -83.45 -47.86 10.94 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.523 HD22 HD13 ' A' ' 108' ' ' LEU . 7.0 tp -64.64 -46.25 83.33 Favored 'General case' 0 CA--C 1.469 -2.147 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -77.75 -20.54 73.63 Favored Glycine 0 CA--C 1.474 -2.505 0 CA-C-N 114.172 -1.376 . . . . 0.0 114.987 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -71.7 -50.41 30.62 Favored 'General case' 0 CA--C 1.477 -1.856 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.59 -45.13 69.33 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.165 -173.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 42.2 m-85 -74.91 -27.67 60.31 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' GLY . . . -107.88 16.1 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -136.86 -33.05 0.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.441 -0.162 . . . . 0.0 111.163 176.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 22.2 m -84.62 -164.31 0.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.81 28.06 0.17 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.9 3.52 5.97 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 22.6 pttp -72.56 -12.56 61.11 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.805 0.812 . . . . 0.0 111.048 -174.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -109.85 5.65 22.73 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -106.22 -49.77 3.29 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.372 1.082 . . . . 0.0 109.1 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG21 HG21 ' A' ' 112' ' ' ILE . 2.5 p -138.82 135.58 43.0 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.172 -1.831 . . . . 0.0 109.309 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 26' ' ' LYS . 75.6 t -112.58 127.28 69.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 9' ' ' VAL . 31.8 mm -90.56 121.19 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.656 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -130.06 161.37 31.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.282 0.563 . . . . 0.0 111.701 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' ' HD2' ' A' ' 47' ' ' TYR . 14.5 ptmt -152.03 145.29 24.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.414 HG12 HD11 ' A' ' 30' ' ' ILE . 7.6 p -129.83 139.69 50.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 109.71 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -82.18 101.48 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.39 -9.08 58.38 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.389 1.075 . . . . 0.0 112.412 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 t -105.84 -19.72 13.66 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.726 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.36 -42.76 9.12 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -113.11 102.77 10.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.012 -1.449 . . . . 0.0 107.529 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -67.71 135.1 52.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.91 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 32' ' ' PHE . 29.7 m -113.53 143.23 28.99 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.26 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.05 -8.57 16.59 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 123.303 2.669 . . . . 0.0 113.759 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.45 174.2 10.84 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.91 139.91 35.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.399 0.619 . . . . 0.0 109.626 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.596 HG23 ' OG1' ' A' ' 84' ' ' THR . 59.5 mt -123.39 117.06 50.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -74.85 -9.41 58.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.56 -140.11 4.9 Favored Glycine 0 C--N 1.3 -1.433 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.559 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 4.9 t80 -100.54 -50.44 0.19 Allowed Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -92.58 171.12 2.41 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 121.097 1.198 . . . . 0.0 110.291 167.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.596 ' OG1' HG23 ' A' ' 79' ' ' ILE . 3.1 m -169.17 146.8 3.67 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 49.7 mt -110.63 140.5 29.48 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.324 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' HG22 ' A' ' 30' ' ' ILE . 65.7 mttm -140.26 127.6 21.26 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.481 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.1 tm? -102.07 111.95 24.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -94.75 101.9 7.89 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HB2' ' HG3' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -65.65 161.03 40.5 Favored 'Trans proline' 0 CA--C 1.464 -2.986 0 C-N-CA 121.658 1.572 . . . . 0.0 110.051 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -81.5 77.5 8.36 Favored 'General case' 0 N--CA 1.395 -3.207 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.887 173.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.38 -45.31 0.41 Allowed Glycine 0 N--CA 1.415 -2.711 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.909 171.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -104.62 58.47 0.7 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.856 0.836 . . . . 0.0 111.166 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -69.78 -2.89 13.29 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.878 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' C ' ' HD3' ' A' ' 96' ' ' PRO . . . -116.85 1.5 19.79 Favored Glycine 0 CA--C 1.497 -1.093 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.652 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 70.6 mt-30 -135.58 45.79 1.49 Allowed Pre-proline 0 CA--C 1.552 1.019 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 72.7 Cg_exo -60.11 159.28 26.66 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.773 2.315 . . . . 0.0 112.296 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 115' ' ' ASN . 13.5 t -97.15 91.14 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -72.89 130.3 40.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.03 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.36 171.9 13.5 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 125.192 1.397 . . . . 0.0 108.798 -170.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -107.28 -62.28 1.44 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.207 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.45 127.77 1.35 Allowed Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.901 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -98.22 -27.62 14.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.756 0.313 . . . . 0.0 111.21 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 61.93 12.63 4.98 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.841 1.256 . . . . 0.0 112.095 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -138.15 158.13 44.93 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 121.776 -0.578 . . . . 0.0 110.971 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.97 -34.38 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 124.277 1.031 . . . . 0.0 109.597 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -57.19 -47.9 80.11 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.105 1.362 . . . . 0.0 110.136 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 22.6 t70 -70.15 -29.11 65.93 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.642 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 50' ' ' LEU . 22.2 mt -74.41 -39.66 62.49 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.3 mt -56.31 -54.11 31.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.5 tptp -64.61 -21.91 66.83 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.546 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.2 t80 -69.62 -64.83 0.8 Allowed 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.517 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -65.58 -16.68 20.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.758 1.266 . . . . 0.0 108.272 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.43 -19.16 31.74 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.459 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 31.7 mt-10 -115.3 -44.86 2.96 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.963 0.887 . . . . 0.0 109.694 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.0 m-80 -79.33 -26.81 42.12 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.563 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.64 162.48 41.46 Favored Glycine 0 N--CA 1.404 -3.439 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 43.1 mtpt -96.99 -21.79 17.21 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.184 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.517 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.7 m-85 -77.56 -17.45 57.87 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.309 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 57.76 47.33 15.71 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 124.001 0.813 . . . . 0.0 109.504 175.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.23 96.28 1.38 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.11 -173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.21 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.682 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.84 107.68 1.35 Allowed 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.711 2.274 . . . . 0.0 112.003 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.1 tp -88.65 122.59 32.25 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.602 0.715 . . . . 0.0 109.994 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.58 178.31 32.48 Favored Glycine 0 N--CA 1.421 -2.334 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 m -84.69 -52.61 5.95 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 118.397 1.098 . . . . 0.0 109.868 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.52 -22.04 15.66 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.797 0.808 . . . . 0.0 109.857 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.35 178.24 15.23 Favored Glycine 0 C--N 1.294 -1.776 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.352 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 24.6 Cg_endo -66.57 -41.39 11.55 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.885 2.39 . . . . 0.0 110.787 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.6 p -71.37 131.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.339 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 13.7 m -69.58 102.89 1.94 Allowed 'General case' 0 N--CA 1.415 -2.225 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.958 -175.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.55 113.79 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.7 t -113.28 119.13 59.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 15' ' ' LYS . 28.7 m -71.45 170.45 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -26.19 67.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 110.79 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB3' HG23 ' A' ' 13' ' ' VAL . 2.8 tppp? -60.74 -53.04 62.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.759 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.662 ' HB2' HG13 ' A' ' 12' ' ' VAL . 39.7 m-20 -86.43 -15.52 40.02 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.257 -169.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.55 -32.23 49.85 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 4.2 p30 -75.05 -18.46 60.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 13.0 pt-20 -105.81 -45.64 4.33 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.161 0.981 . . . . 0.0 111.311 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.474 HG12 ' HG3' ' A' ' 19' ' ' GLU . 26.3 mm -78.25 -55.8 9.15 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.108 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.93 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.649 ' HA ' HG11 ' A' ' 28' ' ' VAL . 63.4 t -80.0 -35.91 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 111.495 -174.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -96.39 37.52 1.26 Allowed 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.42 155.57 29.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.709 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -115.67 5.27 14.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -124.5 14.22 8.82 Favored 'General case' 0 C--O 1.249 1.078 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.875 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -153.18 148.19 26.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 79.4 m-20 -80.63 119.32 23.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.649 HG11 ' HA ' ' A' ' 21' ' ' VAL . 17.4 t -115.91 121.64 67.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.757 HD21 HD22 ' A' ' 108' ' ' LEU . 19.1 tp -94.36 117.89 30.8 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 21' ' ' VAL . 11.6 tt -112.26 145.79 17.89 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 C-N-CA 117.571 -1.652 . . . . 0.0 111.346 176.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' OE2' HD23 ' A' ' 43' ' ' LEU . 34.5 tt0 -127.55 108.21 10.6 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HD1' ' O ' ' A' ' 84' ' ' THR . 91.5 m-85 -69.31 130.08 41.59 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.662 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 34.2 p90 -144.28 -172.57 3.81 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.608 0.718 . . . . 0.0 111.454 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -153.33 150.43 23.63 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -78.16 -24.85 7.75 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 121.607 1.538 . . . . 0.0 109.184 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -93.6 15.02 17.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 112.984 -1.916 . . . . 0.0 111.757 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 43.2 t -95.3 120.2 35.13 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.112 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.11 -35.01 82.63 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.643 ' O ' HD13 ' A' ' 43' ' ' LEU . 10.1 t60 -60.47 -53.21 60.24 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 11.8 t -54.65 -40.42 68.99 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -67.72 -12.27 60.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.93 -10.4 24.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.762 1.267 . . . . 0.0 108.708 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.8 mp -101.52 -17.62 16.32 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.722 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.95 -41.86 48.46 Favored Pre-proline 0 C--N 1.283 -2.316 0 C-N-CA 124.435 1.094 . . . . 0.0 113.225 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 35.7 Cg_endo -63.99 -20.26 67.59 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.739 1.3 . . . . 0.0 112.383 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 1.6 pttm -91.03 -32.73 15.79 Favored 'General case' 0 C--O 1.173 -2.963 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -73.32 -37.02 66.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.363 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.31 -17.34 46.15 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -87.84 -45.25 10.45 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 8.3 tp -69.59 -46.44 66.31 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.84 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.13 -31.01 71.77 Favored Glycine 0 CA--C 1.465 -3.034 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.996 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -62.56 -52.47 63.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 1.6 pp -64.21 -42.27 96.69 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.727 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.532 ' OH ' ' HA ' ' A' ' 109' ' ' ILE . 19.3 m-85 -66.97 -43.93 81.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.171 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . . . -93.55 16.12 14.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.3 tppt? -131.95 -26.07 1.99 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.681 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 29.1 t -85.53 -170.61 3.2 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.742 0.306 . . . . 0.0 110.181 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -72.42 12.21 0.5 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.872 1.269 . . . . 0.0 113.552 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.432 ' CE2' ' HA ' ' A' ' 54' ' ' TYR . 11.5 p90 -132.04 11.17 4.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 57' ' ' SER . 21.9 pttp -67.36 -13.31 61.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.016 0.912 . . . . 0.0 111.463 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.54 17.5 19.17 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.075 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HE ' ' HB3' ' A' ' 118' ' ' TYR . 16.4 ttp180 -125.7 -45.14 1.78 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 122.546 1.165 . . . . 0.0 108.963 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.631 HG21 HG21 ' A' ' 112' ' ' ILE . 1.7 p -131.88 143.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 C-N-CA 126.556 1.942 . . . . 0.0 108.142 173.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.51 130.6 70.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 9' ' ' VAL . 46.2 mm -89.37 117.17 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -123.62 161.16 25.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.34 143.12 22.92 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 30' ' ' ILE . 7.8 p -123.33 139.31 50.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.403 ' HB3' ' ND2' ' A' ' 73' ' ' ASN . 10.0 t0 -83.09 109.48 17.19 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.29 -11.73 59.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.193 0.933 . . . . 0.0 112.413 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 t -106.59 -27.09 11.07 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.656 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.29 -34.27 17.74 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 69' ' ' ASP . 8.1 m-80 -119.08 104.09 10.14 Favored 'General case' 0 N--CA 1.403 -2.784 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.74 118.8 13.06 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.302 0.572 . . . . 0.0 110.588 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.23 145.62 31.89 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.702 -174.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.1 -8.73 12.99 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.1 2.533 . . . . 0.0 111.282 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.82 -172.72 4.13 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.088 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.74 129.96 56.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.186 0.517 . . . . 0.0 110.67 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -84.14 129.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -89.71 -22.81 22.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.397 0.618 . . . . 0.0 110.837 -174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.99 -105.42 0.62 Allowed Glycine 0 C--N 1.31 -0.899 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.64 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.6 t80 -117.82 -57.34 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.3 Cg_exo -91.5 164.41 3.53 Favored 'Trans proline' 0 N--CA 1.418 -2.963 0 N-CA-C 108.54 -1.369 . . . . 0.0 108.54 162.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.484 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 98.9 m -153.64 135.27 14.4 Favored 'General case' 0 C--N 1.27 -2.848 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.933 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 34.1 mt -98.9 136.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 30' ' ' ILE . 45.7 mtpt -139.19 117.38 11.86 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.3 tm? -96.89 114.41 26.03 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -97.64 96.72 3.42 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.592 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 12.1 Cg_endo -68.78 158.98 55.64 Favored 'Trans proline' 0 CA--C 1.461 -3.173 0 C-N-CA 121.841 1.694 . . . . 0.0 111.143 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 77.34 8.23 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.79 -27.09 0.58 Allowed Glycine 0 C--N 1.298 -1.58 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.113 173.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.479 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -124.64 31.72 5.63 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.833 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -64.44 13.24 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 124.815 1.246 . . . . 0.0 112.963 176.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -109.77 -12.54 18.43 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -147.7 71.72 11.56 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 34.9 Cg_exo -49.3 163.33 0.39 Allowed 'Trans proline' 0 C--O 1.25 1.104 0 C-N-CA 124.291 3.327 . . . . 0.0 113.824 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 115' ' ' ASN . 28.8 t -97.5 102.23 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 t -81.1 128.74 34.07 Favored 'General case' 0 N--CA 1.427 -1.619 0 O-C-N 124.206 0.941 . . . . 0.0 109.981 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.04 158.01 45.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.47 -173.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -90.18 -3.25 57.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.432 0.634 . . . . 0.0 110.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' HA3' HD21 ' A' ' 43' ' ' LEU . . . 108.2 117.14 4.08 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -68.71 -33.05 73.28 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 65.73 13.61 9.06 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.509 1.147 . . . . 0.0 110.953 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 107' ' ' ASP . 5.7 t -143.3 155.14 44.39 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.43 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 46' ' ' LYS . 92.5 t -82.33 -39.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 124.958 1.303 . . . . 0.0 110.419 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -59.32 -44.75 92.56 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 121.937 0.875 . . . . 0.0 111.282 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 36.2 t70 -70.3 -25.76 63.47 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.956 -177.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.757 HD22 HD21 ' A' ' 29' ' ' LEU . 18.4 mt -77.89 -38.98 44.63 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.532 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 69.8 mt -59.06 -50.07 81.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.8 tptp -63.49 -24.9 68.02 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.102 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.602 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.5 t80 -68.77 -65.49 0.7 Allowed 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.631 HG21 HG21 ' A' ' 63' ' ' VAL . 3.4 mt -66.7 -14.33 17.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.49 1.138 . . . . 0.0 108.743 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . . . -91.18 -11.93 36.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.485 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 46.8 mt-10 -120.42 -41.45 2.61 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.202 1.001 . . . . 0.0 109.384 174.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.602 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.9 m-80 -86.07 -24.6 26.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.652 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.17 168.18 51.67 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.592 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 13.4 mmmm -100.2 -24.64 14.51 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.883 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.45 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.5 m-85 -84.39 -12.76 53.88 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.899 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 35.0 mmtp 52.82 59.68 4.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.304 1.002 . . . . 0.0 110.016 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 81.52 0.78 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.779 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' CB ' ' HA ' ' A' ' 52' ' ' ALA . 13.9 Cg_endo . . . . . 0 C--O 1.24 0.591 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.7 p -67.42 130.1 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.806 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 m -73.52 106.45 5.31 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.377 0.608 . . . . 0.0 111.015 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.58 111.02 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 16' ' ' ASN . 47.4 t -106.45 129.21 60.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 15' ' ' LYS . 15.5 m -79.94 172.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.63 -24.55 67.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.166 0.508 . . . . 0.0 110.419 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' HG23 ' A' ' 13' ' ' VAL . 16.5 tptp -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.808 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.735 ' HB2' HG13 ' A' ' 12' ' ' VAL . 30.8 m-20 -99.96 -14.21 18.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.9 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -40.43 58.19 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.9 -11.09 59.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.269 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.5 pt-20 -106.45 -41.5 5.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.33 1.062 . . . . 0.0 111.198 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.446 HG12 ' HG3' ' A' ' 19' ' ' GLU . 31.7 mm -84.41 -57.33 4.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 CA-C-N 113.045 -1.888 . . . . 0.0 112.229 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.619 ' HA ' HG11 ' A' ' 28' ' ' VAL . 65.8 t -82.21 -32.77 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.442 0 CA-C-O 122.006 0.907 . . . . 0.0 111.578 -172.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 27.4 2.71 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -94.32 139.6 30.87 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.775 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -105.79 15.2 27.1 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.127 0.571 . . . . 0.0 111.483 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.6 p -81.19 -13.07 58.96 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.42 0.629 . . . . 0.0 109.439 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -160.55 161.85 32.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.936 0.894 . . . . 0.0 108.61 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.1 m-20 -82.43 128.8 34.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.5 t -119.38 123.06 70.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.692 0.758 . . . . 0.0 111.612 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' OH ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -94.36 114.08 26.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.589 HD12 HG21 ' A' ' 21' ' ' VAL . 10.8 tt -108.53 144.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.284 -1.366 . . . . 0.0 112.739 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 38.4 tt0 -120.66 121.28 37.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.786 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.418 ' HB2' ' H ' ' A' ' 84' ' ' THR . 97.5 m-85 -91.43 121.85 33.5 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -141.26 -173.47 3.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.786 0.803 . . . . 0.0 112.314 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -142.92 148.49 45.86 Favored Pre-proline 0 N--CA 1.429 -1.509 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -83.93 -12.62 8.34 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.004 1.802 . . . . 0.0 110.463 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -95.56 0.95 53.56 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.605 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 53.8 t -83.37 117.24 22.89 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.562 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.47 -29.54 74.9 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 65.1 m80 -67.33 -39.92 85.88 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.43 -32.92 74.8 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.201 0.524 . . . . 0.0 110.489 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 64.4 mmtt -65.83 -18.68 65.5 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.612 0.72 . . . . 0.0 111.396 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.85 -11.76 21.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.895 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.741 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 97.0 mt -97.02 -26.74 14.9 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.267 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.63 97.33 Favored Pre-proline 0 C--N 1.284 -2.271 0 C-N-CA 124.665 1.186 . . . . 0.0 113.641 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.33 0.96 8.42 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.574 1.516 . . . . 0.0 112.781 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 13.2 pttm -109.4 -32.3 7.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.47 -43.9 20.1 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.293 -171.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.56 -12.59 59.85 Favored 'General case' 0 N--CA 1.409 -2.515 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.564 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.97 -52.01 5.18 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HB2' HG13 ' A' ' 105' ' ' VAL . 3.3 tm? -73.92 -34.5 64.39 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.37 93.89 Favored Glycine 0 CA--C 1.479 -2.209 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.771 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.489 ' HA ' ' CB ' ' A' ' 8' ' ' PRO . . . -58.39 -53.31 59.73 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -54.53 -42.59 71.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.61 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -76.77 -45.99 26.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.99 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.74 17.7 3.84 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 9.1 tppt? -128.93 -36.11 1.81 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.661 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 21.8 t -100.76 -155.53 0.52 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -57.21 -0.22 0.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -114.19 3.12 15.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 57' ' ' SER . 57.8 pttt -74.96 -6.33 48.69 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.892 0.853 . . . . 0.0 111.096 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.76 -2.34 17.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.371 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -117.78 -130.1 0.3 Allowed 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 112' ' ' ILE . 2.1 p -53.88 130.62 15.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.697 0.761 . . . . 0.0 112.071 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -114.78 128.47 71.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.001 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.9 mm -85.21 123.32 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -131.29 163.48 27.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 48.9 pttt -157.15 143.66 18.14 Favored 'General case' 0 CA--C 1.48 -1.73 0 O-C-N 121.87 -0.519 . . . . 0.0 112.303 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 10.9 p -121.69 144.3 31.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -84.67 113.55 21.37 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.72 -0.11 46.02 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.143 -171.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.7 t -127.3 -7.12 5.87 Favored 'General case' 0 N--CA 1.424 -1.757 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.767 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.74 -33.73 9.73 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -119.15 132.78 56.01 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.455 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.34 106.33 12.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -87.17 141.97 33.29 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.507 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.81 2.38 7.11 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 123.282 2.655 . . . . 0.0 110.598 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -79.33 -175.86 4.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.471 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -105.51 131.6 52.71 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 125.653 1.581 . . . . 0.0 109.012 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 81' ' ' GLY . 32.3 mm -109.28 124.28 65.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.34 28.24 6.58 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.395 1.093 . . . . 0.0 112.441 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.482 ' H ' HG22 ' A' ' 79' ' ' ILE . . . -179.6 -120.33 0.67 Allowed Glycine 0 C--N 1.296 -1.641 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 36.7 t80 -115.36 -52.55 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 165.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 6.3 Cg_exo -91.37 170.82 3.08 Favored 'Trans proline' 0 N--CA 1.423 -2.641 0 N-CA-C 109.42 -1.031 . . . . 0.0 109.42 165.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.418 ' H ' ' HB2' ' A' ' 32' ' ' PHE . 97.6 m -163.04 152.17 14.89 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.0 mt -121.91 137.3 55.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.473 ' O ' HG22 ' A' ' 30' ' ' ILE . 94.1 mttt -140.63 128.15 21.4 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.193 0.521 . . . . 0.0 110.73 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.469 HD13 ' HD3' ' A' ' 89' ' ' PRO . 3.4 tm? -98.53 117.02 32.01 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -100.55 96.31 5.21 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -66.52 160.39 46.08 Favored 'Trans proline' 0 CA--C 1.465 -2.936 0 C-N-CA 122.024 1.816 . . . . 0.0 111.67 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.31 77.12 8.22 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.0 -20.35 0.67 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.185 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -137.22 55.27 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.926 0.87 . . . . 0.0 111.462 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.45 -1.99 29.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.201 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.3 -16.2 35.68 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -138.47 63.88 35.88 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.508 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.33 160.36 0.94 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.749 3.633 . . . . 0.0 113.196 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 115' ' ' ASN . 38.3 t -96.51 97.93 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.3 t -74.52 132.91 42.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.46 168.53 19.56 Favored 'General case' 0 C--N 1.278 -2.51 0 C-N-CA 125.999 1.72 . . . . 0.0 108.975 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.3 m -115.56 -18.89 10.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.107 0.479 . . . . 0.0 110.567 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.77 115.13 1.82 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.915 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -83.67 -10.96 57.82 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 111.435 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 65.68 18.18 11.11 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.203 1.001 . . . . 0.0 113.011 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 107' ' ' ASP . 9.0 t -138.3 150.94 47.11 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.292 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 50' ' ' LEU . 94.2 t -73.48 -33.76 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 125.507 1.523 . . . . 0.0 109.632 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' A' ' 106' ' ' GLU . 28.7 mt-10 -58.25 -45.88 86.98 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 122.825 1.298 . . . . 0.0 109.957 -176.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 25.9 t70 -73.7 -27.84 61.42 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 112.115 -2.312 . . . . 0.0 109.696 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 112' ' ' ILE . 17.5 mt -69.67 -43.36 72.7 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.26 -53.45 39.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 110' ' ' LYS . 2.7 tmmm? -60.64 -32.78 71.94 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.908 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.605 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -59.97 -71.17 0.14 Allowed 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.713 -176.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.576 HG21 HG21 ' A' ' 63' ' ' VAL . 4.0 mp -70.9 -8.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.612 1.196 . . . . 0.0 109.34 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -86.83 -23.68 25.23 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.555 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 -37.7 4.51 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 122.122 0.963 . . . . 0.0 108.941 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.605 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 58.1 m-80 -87.22 -27.65 22.85 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 113.2 -1.818 . . . . 0.0 109.648 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.79 158.31 42.72 Favored Glycine 0 N--CA 1.408 -3.216 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.523 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 31.3 mmmt -87.76 -26.01 23.12 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.593 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.9 m-85 -80.59 -16.19 54.75 Favored 'General case' 0 N--CA 1.388 -3.544 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.92 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 58.2 57.85 3.78 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.44 86.15 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.426 ' CG ' ' HA ' ' A' ' 48' ' ' GLU . 47.4 Cg_endo . . . . . 0 CA--C 1.516 -0.383 0 CA-C-O 121.792 0.663 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 47' ' ' TYR . 1.2 p -81.11 124.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.926 175.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 48.1 m -63.11 108.96 1.36 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.746 0.784 . . . . 0.0 111.39 -173.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.5 t -79.15 107.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 16' ' ' ASN . 46.3 t -103.71 129.01 56.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.669 HG23 ' HB3' ' A' ' 15' ' ' LYS . 17.1 m -78.77 170.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.308 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -26.29 66.66 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.669 ' HB3' HG23 ' A' ' 13' ' ' VAL . 32.0 tttm -55.72 -51.42 67.39 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.611 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -100.46 -3.89 29.98 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.355 -172.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -54.28 -38.69 66.17 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -81.07 -5.2 57.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.592 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 12.3 pt-20 -106.26 -44.68 4.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.574 1.178 . . . . 0.0 110.841 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.492 HG12 ' HG3' ' A' ' 19' ' ' GLU . 23.2 mm -81.43 -54.74 9.39 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.367 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.617 HG21 HD12 ' A' ' 30' ' ' ILE . 83.9 t -81.34 -30.99 11.31 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 CA-C-O 121.28 0.562 . . . . 0.0 111.643 -174.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.452 ' HG ' ' CE2' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -95.16 32.17 1.77 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -96.75 151.65 19.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.09 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' HB3' ' HD3' ' A' ' 93' ' ' LYS . 7.7 p-10 -115.45 17.88 16.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.712 0.291 . . . . 0.0 111.512 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 p -71.36 -37.27 71.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HA ' ' CE1' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -146.66 176.23 10.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.9 m-20 -82.02 141.35 33.3 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 21' ' ' VAL . 38.2 t -126.01 119.53 54.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.732 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HG ' HD23 ' A' ' 87' ' ' LEU . 9.2 mt -86.57 121.08 28.6 Favored 'General case' 0 CA--C 1.468 -2.211 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.617 HD12 HG21 ' A' ' 21' ' ' VAL . 9.6 tt -114.0 144.87 20.69 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 117.518 -1.673 . . . . 0.0 110.289 173.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -129.83 113.61 14.89 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.356 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' HD1' ' O ' ' A' ' 84' ' ' THR . 28.5 m-85 -78.91 134.2 36.9 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -145.02 -171.71 3.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.296 0.997 . . . . 0.0 110.435 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -141.98 155.94 65.42 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -84.4 -16.35 5.9 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.641 1.56 . . . . 0.0 110.261 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -96.18 2.86 53.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.039 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.685 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.5 t -84.43 119.05 24.68 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.489 -173.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.17 -23.94 76.08 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.445 ' O ' HD13 ' A' ' 43' ' ' LEU . 35.8 m80 -76.0 -42.69 47.3 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 122.722 -0.281 . . . . 0.0 111.472 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 20.5 p -68.5 -25.14 64.81 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.587 0.708 . . . . 0.0 109.911 -178.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 53.5 mtmt -75.3 -5.24 43.66 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.504 0.668 . . . . 0.0 110.863 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB1' ' HD2' ' A' ' 103' ' ' ARG . . . -94.7 -16.04 23.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.561 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 11.2 mp -93.27 -10.96 33.72 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.228 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.29 -45.27 54.64 Favored Pre-proline 0 C--N 1.287 -2.131 0 C-N-CA 125.005 1.322 . . . . 0.0 113.219 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -67.82 -30.92 32.92 Favored 'Trans proline' 0 C--N 1.378 2.107 0 CA-C-N 120.136 1.084 . . . . 0.0 110.92 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 2.2 ptmm? -75.38 -33.18 61.01 Favored 'General case' 0 C--O 1.201 -1.494 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.435 ' HB3' HG11 ' A' ' 9' ' ' VAL . 13.9 m-85 -68.75 -50.97 46.16 Favored 'General case' 0 CA--C 1.465 -2.323 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.031 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.426 ' HA ' ' CG ' ' A' ' 8' ' ' PRO . 41.4 mt-10 -69.73 -36.47 75.89 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.219 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 17.1 mm-40 -85.28 -46.61 10.85 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.086 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.595 HD23 HG13 ' A' ' 105' ' ' VAL . 2.4 tm? -76.16 -39.52 54.74 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.71 -30.66 59.47 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 118.781 -1.676 . . . . 0.0 112.754 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.61 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -68.4 -47.12 68.15 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.363 173.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 89.5 mt -62.62 -41.11 98.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.253 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -80.47 -46.88 15.16 Favored 'General case' 0 N--CA 1.414 -2.236 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.926 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.76 12.71 12.2 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 45.6 mtmt -134.47 -19.37 1.89 Allowed 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 123.235 0.614 . . . . 0.0 112.556 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.709 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 50.6 m -100.53 -170.84 1.92 Allowed 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.24 9.87 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.75 -5.26 29.01 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.4 pttp -76.91 -11.1 59.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.236 1.017 . . . . 0.0 109.221 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.67 -16.91 26.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.51 -133.9 0.34 Allowed 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 3.1 p -58.6 133.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.74 0.781 . . . . 0.0 112.752 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.97 133.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.427 HD12 HD12 ' A' ' 29' ' ' LEU . 22.1 mm -95.18 113.2 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 175.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' THR . . . -118.47 156.97 28.12 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 123.529 0.518 . . . . 0.0 110.567 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -147.63 140.51 24.9 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 p -126.2 141.0 47.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -88.11 115.81 25.85 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.42 -12.62 59.98 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.93 0.892 . . . . 0.0 112.288 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 t -112.85 -18.73 12.2 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.281 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.04 -26.23 18.43 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -133.0 95.62 3.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.331 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.08 133.61 49.25 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.795 0.807 . . . . 0.0 111.657 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.69 152.05 42.64 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.251 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.07 -1.63 9.4 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 123.506 2.804 . . . . 0.0 112.11 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -83.42 144.13 29.81 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.432 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.75 133.6 35.14 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.408 0.623 . . . . 0.0 109.47 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.617 HG23 ' OG1' ' A' ' 84' ' ' THR . 31.2 mt -111.03 128.13 67.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.706 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.546 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 1.7 mp0 -68.24 -36.36 79.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.22 -126.35 3.76 Favored Glycine 0 C--N 1.295 -1.704 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.474 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 11.8 t80 -112.91 -49.04 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 6.1 Cg_exo -88.62 168.19 5.95 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.436 1.424 . . . . 0.0 110.226 168.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.617 ' OG1' HG23 ' A' ' 79' ' ' ILE . 22.9 m -161.6 138.04 8.21 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 19.8 mt -106.75 139.74 27.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 50.6 mtmt -143.5 121.87 12.35 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 121.061 0.458 . . . . 0.0 110.136 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.529 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tm? -98.25 112.87 24.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.555 ' CE2' ' HG3' ' A' ' 96' ' ' PRO . 27.5 m-85 -97.22 97.76 4.1 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 19.3 Cg_endo -70.0 161.94 44.07 Favored 'Trans proline' 0 CA--C 1.468 -2.791 0 C-N-CA 121.557 1.505 . . . . 0.0 111.719 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.84 77.64 7.7 Favored 'General case' 0 N--CA 1.399 -2.975 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.01 -19.92 0.75 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.237 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.444 ' H ' ' HG2' ' A' ' 89' ' ' PRO . . . -135.06 39.61 2.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.897 0.856 . . . . 0.0 110.529 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HD3' ' HB3' ' A' ' 24' ' ' ASP . 42.1 pttt -67.45 -5.67 15.92 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.638 1.175 . . . . 0.0 110.872 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.96 -20.58 49.53 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.05 67.68 27.22 Favored Pre-proline 0 N--CA 1.433 -1.288 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.555 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 22.9 Cg_exo -49.26 164.71 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 124.298 3.332 . . . . 0.0 113.056 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 115' ' ' ASN . 18.6 t -92.78 89.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -73.14 126.11 29.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.176 -1.375 . . . . 0.0 111.782 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.67 176.0 9.25 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.658 -174.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -108.82 -53.23 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.59 136.87 2.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.728 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.6 p -108.37 -7.95 15.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 20.5 ttp85 65.81 8.37 5.24 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.911 0.885 . . . . 0.0 112.234 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 107' ' ' ASP . 4.7 t -123.56 146.88 47.79 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.653 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.595 HG13 HD23 ' A' ' 50' ' ' LEU . 78.2 t -77.78 -35.35 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 125.687 1.595 . . . . 0.0 110.078 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.413 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.1 mt-10 -62.92 -43.83 97.73 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.198 0.999 . . . . 0.0 110.45 -173.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.7 t70 -69.25 -28.76 66.61 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 113.261 -1.79 . . . . 0.0 109.988 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.516 HD22 HD13 ' A' ' 29' ' ' LEU . 32.3 mt -68.98 -46.12 68.88 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 106' ' ' GLU . 64.0 mt -55.15 -53.86 30.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 22.2 tptp -62.64 -25.16 67.97 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.74 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.3 t80 -69.11 -62.35 1.42 Allowed 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.455 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.4 mt -71.63 -9.82 13.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.554 1.169 . . . . 0.0 108.544 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -90.92 -19.71 23.01 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.534 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 42.8 mt-10 -110.42 -43.27 3.92 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 122.461 1.124 . . . . 0.0 108.361 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 60.8 m-80 -85.27 -29.74 24.36 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.017 -1.902 . . . . 0.0 109.909 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.9 149.29 28.09 Favored Glycine 0 N--CA 1.397 -3.965 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.617 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -89.78 -20.24 23.76 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.186 0.993 . . . . 0.0 108.774 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 26' ' ' LYS . 21.3 m-85 -85.24 -5.46 59.32 Favored 'General case' 0 N--CA 1.393 -3.295 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.602 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 34.4 mmtp 48.76 52.43 14.06 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.545 1.153 . . . . 0.0 110.871 173.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.03 93.15 3.24 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.269 2.089 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.459 -0.549 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 65' ' ' ILE . 2.3 p -69.64 129.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.554 -1.203 . . . . 0.0 107.922 175.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -76.18 110.65 10.85 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.872 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.5 105.83 6.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.631 HG13 ' HB2' ' A' ' 16' ' ' ASN . 47.6 t -108.59 114.15 45.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.643 HG23 ' HB3' ' A' ' 15' ' ' LYS . 31.3 m -68.91 168.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -23.18 65.49 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.258 0.552 . . . . 0.0 110.918 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.643 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -60.95 -46.01 92.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.189 174.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.631 ' HB2' HG13 ' A' ' 12' ' ' VAL . 13.8 m-20 -99.96 -13.51 19.08 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.936 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.02 -33.44 25.15 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -74.47 -13.2 60.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.045 0.45 . . . . 0.0 111.624 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.6 pt-20 -105.96 -52.47 2.8 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.642 0.734 . . . . 0.0 110.92 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.494 HG12 ' HG3' ' A' ' 19' ' ' GLU . 20.6 mm -74.35 -57.83 5.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.889 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.665 HG21 HD12 ' A' ' 30' ' ' ILE . 91.6 t -74.93 -33.27 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.23 1.014 . . . . 0.0 110.777 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.0 tp -96.06 23.72 6.22 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.548 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.452 ' OD1' HG22 ' A' ' 25' ' ' THR . 7.6 t70 -75.02 167.69 21.43 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.522 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -115.94 -3.71 12.12 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.202 -0.936 . . . . 0.0 112.679 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.452 HG22 ' OD1' ' A' ' 23' ' ' ASP . 14.8 t -111.74 3.16 17.58 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.204 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 25' ' ' THR . 66.1 mmtt -135.64 138.75 43.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.603 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 71.0 m-20 -76.47 116.9 17.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 171.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 21' ' ' VAL . 39.9 t -112.92 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.714 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.451 ' HG ' HD23 ' A' ' 87' ' ' LEU . 8.0 mt -84.12 124.63 31.34 Favored 'General case' 0 CA--C 1.464 -2.361 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.665 HD12 HG21 ' A' ' 21' ' ' VAL . 13.3 tt -116.1 143.76 25.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.229 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 29.2 tt0 -115.78 117.18 29.5 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -84.44 121.11 27.11 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -141.47 -171.53 3.33 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.865 0.841 . . . . 0.0 112.705 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -151.79 154.17 32.64 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 11.2 Cg_endo -80.7 -20.51 7.84 Favored 'Trans proline' 0 CA--C 1.505 -0.932 0 C-N-CA 121.675 1.583 . . . . 0.0 109.947 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.414 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 64.7 p-90 -91.82 4.69 52.28 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.125 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 42.7 t -82.78 117.19 22.5 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.829 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.3 -35.75 92.07 Favored Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.545 ' O ' HD13 ' A' ' 43' ' ' LEU . 79.6 t60 -65.32 -45.36 84.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.806 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.89 -41.52 91.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -70.94 -2.93 16.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.496 ' O ' ' HE2' ' A' ' 46' ' ' LYS . . . -102.23 -22.17 14.22 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.664 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 10.8 mp -92.44 -16.26 26.11 Favored 'General case' 0 C--O 1.195 -1.805 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.005 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.59 92.6 Favored Pre-proline 0 C--N 1.275 -2.639 0 C-N-CA 124.702 1.201 . . . . 0.0 112.967 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.8 Cg_exo -63.75 -35.21 58.64 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.14 1.226 . . . . 0.0 111.632 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -81.75 -30.97 32.19 Favored 'General case' 0 C--O 1.177 -2.754 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.905 -175.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.664 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -77.53 -29.6 52.41 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.065 -174.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -83.43 -29.55 27.99 Favored 'General case' 0 C--O 1.191 -1.982 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.964 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.572 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 52.6 mt-10 -79.95 -45.06 19.18 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.909 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.99 -39.1 63.9 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.39 -37.06 90.09 Favored Glycine 0 CA--C 1.479 -2.169 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.027 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -64.88 -50.79 65.17 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 96.0 mt -57.49 -40.11 77.91 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -76.99 -46.75 22.83 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.655 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -86.63 19.44 2.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -137.15 -27.49 0.97 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.885 -0.509 . . . . 0.0 110.358 176.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.684 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 27.5 t -94.38 -157.07 0.53 Allowed 'General case' 0 C--O 1.208 -1.127 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.79 1.56 0.86 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.15 2.61 21.15 Favored 'General case' 0 CA--C 1.481 -1.709 0 O-C-N 121.336 -0.853 . . . . 0.0 109.118 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.0 pttp -75.21 -9.34 58.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 122.204 1.002 . . . . 0.0 109.546 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -104.53 -0.58 27.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.041 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.75 -132.33 0.24 Allowed 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.638 HG21 HG21 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -43.3 128.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.49 1.516 . . . . 0.0 112.798 176.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -107.61 131.54 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mm -95.3 118.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 172.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -133.13 161.26 34.89 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.029 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 31' ' ' GLU 0.256 61.4 pttt -156.41 146.95 21.64 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.17 140.37 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.893 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.11 115.65 22.49 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.27 -4.97 55.4 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.986 0.914 . . . . 0.0 112.26 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -118.34 -15.43 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.288 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.91 -33.03 12.34 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -118.57 118.02 30.55 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.27 114.6 12.82 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.955 0.884 . . . . 0.0 109.43 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.11 143.06 25.47 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.48 -3.15 6.71 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 123.016 2.477 . . . . 0.0 110.417 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.24 174.67 4.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.739 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -103.87 118.87 37.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.528 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.04 139.87 19.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.95 0.9 . . . . 0.0 109.083 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.34 -16.35 24.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.33 -94.39 0.17 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 51.9 t80 -128.15 -51.42 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.7 Cg_endo -94.5 168.82 1.76 Allowed 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 120.93 1.087 . . . . 0.0 109.661 166.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.3 m -163.35 143.32 8.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 31.6 mt -107.38 134.93 47.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -136.38 132.5 35.62 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.451 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -101.88 115.07 29.74 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.403 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 46.6 m-85 -99.58 96.18 4.32 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.427 ' HG2' ' C ' ' A' ' 92' ' ' ALA . 11.8 Cg_endo -64.69 160.07 42.12 Favored 'Trans proline' 0 CA--C 1.46 -3.183 0 C-N-CA 122.066 1.844 . . . . 0.0 112.157 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.42 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -79.16 78.23 5.63 Favored 'General case' 0 N--CA 1.397 -3.08 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.263 173.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.71 -33.06 0.82 Allowed Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.697 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.427 ' C ' ' HG2' ' A' ' 89' ' ' PRO . . . -121.78 37.16 4.43 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.625 0.726 . . . . 0.0 111.349 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -69.0 16.69 0.05 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.27 1.028 . . . . 0.0 112.708 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.1 -2.46 18.37 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.459 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 13.6 pt20 -135.1 45.32 1.39 Allowed Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 115.215 -0.493 . . . . 0.0 109.987 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 69.6 Cg_exo -44.56 155.95 0.25 Allowed 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 124.549 3.5 . . . . 0.0 115.577 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 115' ' ' ASN . 44.5 t -91.56 97.52 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 t -75.6 127.58 33.39 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.282 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 149.11 45.13 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.287 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.5 m -84.2 -30.35 25.85 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.33 0.586 . . . . 0.0 109.55 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.11 104.74 2.75 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.7 m -70.45 -5.78 31.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.718 0.807 . . . . 0.0 113.17 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 27.3 ttp180 64.22 29.2 13.93 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.233 1.016 . . . . 0.0 110.509 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.498 ' OG1' ' HB3' ' A' ' 107' ' ' ASP . 7.3 p -123.68 159.33 29.59 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.689 -0.632 . . . . 0.0 111.881 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 46' ' ' LYS . 59.6 t -95.73 -40.48 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.569 0.748 . . . . 0.0 109.137 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.521 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.7 mt-10 -65.44 -38.56 90.25 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 122.657 1.218 . . . . 0.0 110.03 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.9 t70 -76.5 -22.35 54.6 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.317 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.34 -44.98 64.02 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.096 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' A' ' 106' ' ' GLU . 70.8 mt -53.47 -53.46 24.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 48.4 mmtt -70.02 -13.98 62.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.638 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -71.3 -63.77 1.05 Allowed 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.638 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -69.52 -12.82 16.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 122.615 1.198 . . . . 0.0 108.503 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -88.26 -27.93 21.43 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.331 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -113.76 -27.61 7.73 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.712 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.638 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.4 m-80 -92.57 -27.69 17.2 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.583 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.25 160.21 47.67 Favored Glycine 0 N--CA 1.406 -3.327 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.824 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 90' ' ' ALA . 48.7 mtpt -93.68 -23.71 18.14 Favored 'General case' 0 CA--C 1.474 -1.957 0 CA-C-N 118.392 1.096 . . . . 0.0 109.537 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.603 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 4.7 m-85 -77.99 -15.84 58.61 Favored 'General case' 0 N--CA 1.405 -2.682 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.989 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 56.52 59.26 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.78 78.69 0.45 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -173.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.688 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.58 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.6 Cg_endo . . . . . 0 CA--C 1.507 -0.828 0 CA-C-O 121.753 0.647 . . . . 0.0 111.79 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 65' ' ' ILE . 1.8 p -83.25 129.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.99 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.734 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 m -69.15 105.93 2.65 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.995 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -78.21 109.88 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 16' ' ' ASN . 43.2 t -113.63 115.36 49.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.629 HG23 ' HB3' ' A' ' 15' ' ' LYS . 18.4 m -72.34 170.17 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.42 -3.12 13.06 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.528 0.68 . . . . 0.0 111.546 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB3' HG23 ' A' ' 13' ' ' VAL . 3.2 tppp? -78.27 -35.65 47.79 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.125 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.592 ' HB2' HG13 ' A' ' 12' ' ' VAL . 11.6 m-20 -112.02 -8.87 14.03 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.817 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.45 -27.84 27.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 9.9 p30 -83.71 -9.92 58.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 108.834 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -46.5 4.1 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.574 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.14 -49.87 13.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.317 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.728 HG21 HD12 ' A' ' 30' ' ' ILE . 88.5 t -79.59 -26.91 12.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-O 121.53 0.681 . . . . 0.0 111.447 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -99.49 26.79 5.77 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-O 122.514 1.15 . . . . 0.0 108.552 -175.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.21 149.41 44.63 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.689 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.19 9.63 14.69 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.524 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -115.38 6.55 14.86 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.861 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.413 ' HD2' HG23 ' A' ' 64' ' ' VAL . 16.3 pttm -160.1 158.73 30.84 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.564 0.746 . . . . 0.0 108.994 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.8 m-20 -86.9 123.4 31.99 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 21' ' ' VAL . 47.4 t -114.65 117.11 54.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.626 -0.671 . . . . 0.0 112.506 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HG ' HD23 ' A' ' 87' ' ' LEU . 6.6 mt -89.12 111.02 21.69 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.728 HD12 HG21 ' A' ' 21' ' ' VAL . 10.6 tt -103.6 143.6 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.33 -1.348 . . . . 0.0 112.208 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -117.66 113.16 21.49 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.148 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.432 ' CD1' HD11 ' A' ' 79' ' ' ILE . 96.6 m-85 -77.69 124.08 27.49 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 169.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.559 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 17.6 p90 -139.7 -176.96 4.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.304 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -147.31 148.07 30.49 Favored Pre-proline 0 N--CA 1.418 -2.071 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.68 -20.78 9.02 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 121.365 1.377 . . . . 0.0 110.361 -173.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -97.53 8.01 45.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.247 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 27.7 t -81.76 124.04 29.29 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.971 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.85 99.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.347 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -68.28 -35.91 78.58 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.014 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 47.2 t -65.91 -37.1 85.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.34 0.59 . . . . 0.0 110.163 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.9 mtmt -71.38 -10.0 59.06 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.405 0.621 . . . . 0.0 111.116 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.77 -21.76 17.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.215 1.007 . . . . 0.0 109.061 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.678 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 95.7 mt -87.56 -23.42 24.35 Favored 'General case' 0 C--O 1.177 -2.761 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.51 -52.67 57.74 Favored Pre-proline 0 C--N 1.267 -3.021 0 C-N-CA 125.13 1.372 . . . . 0.0 114.151 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.51 -27.12 23.27 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 121.31 1.34 . . . . 0.0 112.353 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HE2' ' O ' ' A' ' 102' ' ' SER . 3.8 ptpp? -85.67 -32.46 21.96 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.678 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -76.44 -33.48 58.76 Favored 'General case' 0 N--CA 1.402 -2.858 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.314 -171.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -83.11 -20.88 34.0 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.65 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.2 tt0 -86.14 -49.24 7.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.86 -36.79 64.88 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.86 -36.42 81.88 Favored Glycine 0 CA--C 1.476 -2.352 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.044 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -61.3 -55.05 36.22 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 88.4 mt -61.94 -39.66 92.86 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.617 -176.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 3.3 m-85 -84.16 -20.18 32.89 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.13 22.23 13.09 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 60' ' ' LYS . 4.9 tppt? -142.5 -42.05 0.33 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.39 0.614 . . . . 0.0 110.036 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 44.7 m -88.53 -156.25 0.37 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.18 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.35 17.04 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . 14.8 m-85 -126.31 -1.97 6.93 Favored 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 121.477 -0.765 . . . . 0.0 109.874 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 23.2 pttm -70.45 -7.65 44.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.311 1.053 . . . . 0.0 110.059 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.55 -6.43 20.58 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.682 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -115.13 -48.14 2.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.147 0.975 . . . . 0.0 110.854 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 120' ' ' ALA . 47.5 t -128.52 155.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.036 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 53.3 t -135.96 127.83 44.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 172.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.442 ' C ' HG23 ' A' ' 9' ' ' VAL . 32.1 mm -93.82 126.67 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.2 165.66 20.89 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.565 0.346 . . . . 0.0 111.556 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -144.39 148.74 35.07 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' A' ' 30' ' ' ILE . 9.0 p -131.68 135.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.402 ' HB3' HD22 ' A' ' 73' ' ' ASN . 10.5 t0 -82.63 106.85 14.82 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 -11.97 59.92 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 123.845 0.858 . . . . 0.0 112.023 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -105.43 -15.03 15.13 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.495 0.664 . . . . 0.0 111.01 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.16 -28.78 11.26 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.402 HD22 ' HB3' ' A' ' 69' ' ' ASP . 11.4 m-80 -126.57 111.97 14.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.915 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.94 127.73 33.24 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.58 148.55 37.95 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.347 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -84.84 -6.78 9.59 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.859 2.373 . . . . 0.0 111.189 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.51 137.69 38.05 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.294 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -82.76 140.37 33.06 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.309 0.576 . . . . 0.0 110.306 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.527 HG23 ' OG1' ' A' ' 84' ' ' THR . 55.4 mt -126.9 132.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 124.225 1.01 . . . . 0.0 108.803 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -73.94 -29.32 61.96 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.54 0.685 . . . . 0.0 110.647 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.62 -114.37 1.9 Allowed Glycine 0 C--N 1.299 -1.503 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.5 t80 -123.84 -53.4 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.826 171.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -89.99 155.47 4.88 Favored 'Trans proline' 0 N--CA 1.419 -2.855 0 CA-C-N 120.154 1.091 . . . . 0.0 109.936 169.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.527 ' OG1' HG23 ' A' ' 79' ' ' ILE . 6.9 m -163.85 140.44 6.78 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.538 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 30.2 mt -107.89 134.65 49.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 86.8 mttt -135.86 129.46 32.39 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.524 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -100.46 115.97 31.32 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -99.27 97.84 5.87 Favored Pre-proline 0 C--N 1.292 -1.894 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.3 Cg_endo -70.04 161.83 44.49 Favored 'Trans proline' 0 CA--C 1.465 -2.962 0 C-N-CA 121.986 1.791 . . . . 0.0 111.076 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.05 77.22 6.76 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-O 123.004 1.383 . . . . 0.0 109.107 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.15 -34.84 0.72 Allowed Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.779 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -112.8 33.19 5.15 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.912 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' H ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -65.79 0.92 1.5 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.286 1.434 . . . . 0.0 112.787 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.76 -12.15 28.83 Favored Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.421 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 4.0 pt20 -134.63 51.07 5.58 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 122.87 0.468 . . . . 0.0 110.982 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 17.2 Cg_exo -45.28 157.08 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 124.512 3.475 . . . . 0.0 114.818 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 22.0 t -90.27 97.08 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.906 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.447 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 8.8 t -75.9 128.55 35.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.086 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.27 166.13 25.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.692 -172.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.5 t -98.85 -33.91 10.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 143.24 172.52 14.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.517 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.496 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.9 m -128.55 150.17 50.3 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -98.88 34.28 2.13 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.83 0.824 . . . . 0.0 109.692 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -146.11 149.13 33.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.209 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 46' ' ' LYS . 66.2 t -80.4 -29.63 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.291 0.567 . . . . 0.0 109.513 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.14 -45.38 93.24 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 122.236 1.017 . . . . 0.0 110.126 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 26.3 t70 -71.97 -24.27 61.56 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.63 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 108' ' ' LEU . 21.5 mt -71.92 -44.56 63.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.857 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.22 -51.49 62.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 16.2 tppt? -68.06 -20.32 64.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.798 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.7 OUTLIER -69.06 -64.48 0.86 Allowed 'General case' 0 C--O 1.183 -2.416 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.421 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.0 mt -67.3 -15.28 19.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 122.758 1.266 . . . . 0.0 108.286 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -84.81 -21.22 29.98 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.816 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -117.87 -40.1 3.04 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 122.051 0.929 . . . . 0.0 109.818 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.5 m-80 -80.28 -26.08 39.1 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.916 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.41 164.58 45.68 Favored Glycine 0 N--CA 1.404 -3.448 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.238 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.539 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 8.9 mmmm -94.23 -26.26 16.72 Favored 'General case' 0 CA--C 1.458 -2.572 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.421 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.8 m-85 -83.63 -11.64 57.02 Favored 'General case' 0 N--CA 1.379 -3.992 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.39 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 53.86 60.46 3.63 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.458 1.099 . . . . 0.0 108.772 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 63' ' ' VAL . . . -47.82 24.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.274 -2.683 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 18.8 Cg_endo . . . . . 0 CA--C 1.516 -0.418 0 N-CA-C 107.191 -1.888 . . . . 0.0 107.191 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 65' ' ' ILE . 1.5 p -68.2 133.58 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.725 171.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 m -66.05 102.75 0.84 Allowed 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 121.448 0.642 . . . . 0.0 110.153 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.55 102.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 16' ' ' ASN . 55.2 t -98.72 126.52 51.86 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.884 0 C-N-CA 125.915 1.686 . . . . 0.0 107.443 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 15' ' ' LYS . 27.7 m -79.03 173.87 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.21 -17.53 64.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.885 0.374 . . . . 0.0 110.916 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB3' HG23 ' A' ' 13' ' ' VAL . 33.5 tttm -65.67 -45.14 84.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.401 0.62 . . . . 0.0 110.546 171.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.789 ' HB2' HG13 ' A' ' 12' ' ' VAL . 61.2 m-20 -93.79 -10.14 35.16 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.775 -165.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -58.9 -37.28 76.27 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.83 -7.22 58.56 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.867 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.9 pt-20 -105.75 -51.39 3.0 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 122.019 0.914 . . . . 0.0 110.882 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.516 HG12 ' HG3' ' A' ' 19' ' ' GLU . 35.4 mm -80.02 -52.96 13.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.409 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 30' ' ' ILE . 60.7 t -82.95 -21.24 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 CA-C-O 122.025 0.917 . . . . 0.0 111.002 -173.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.72 29.0 4.75 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.64 133.11 34.84 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -105.5 21.18 17.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -105.3 -8.25 18.37 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.291 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.513 ' HD2' HG23 ' A' ' 64' ' ' VAL . 20.3 pttm -154.81 159.55 40.66 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.835 0.854 . . . . 0.0 108.78 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 79.0 m-20 -80.93 120.31 24.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 21' ' ' VAL . 22.3 t -111.65 119.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.045 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HG ' HD23 ' A' ' 87' ' ' LEU . 10.5 mt -88.07 123.21 32.53 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.657 HD12 HG21 ' A' ' 21' ' ' VAL . 9.3 tt -113.66 149.25 16.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 117.806 -1.557 . . . . 0.0 110.447 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' A' ' 43' ' ' LEU . 35.2 tt0 -130.66 113.17 13.85 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.371 0.605 . . . . 0.0 109.844 175.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 84' ' ' THR . 95.7 m-85 -75.33 131.68 40.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 173.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.517 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.8 p90 -147.67 -173.25 4.23 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.709 0.766 . . . . 0.0 111.652 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -150.52 148.1 23.06 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.91 -16.87 8.56 Favored 'Trans proline' 0 CA--C 1.499 -1.269 0 C-N-CA 122.13 1.887 . . . . 0.0 110.299 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -91.19 -1.12 57.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.705 -1.588 . . . . 0.0 111.267 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 45.2 t -86.31 117.85 25.38 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.127 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.74 -28.82 73.47 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.644 ' O ' HD13 ' A' ' 43' ' ' LEU . 20.1 t60 -63.14 -46.25 88.1 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 30.9 t -60.93 -33.06 72.57 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.252 0.548 . . . . 0.0 111.368 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 41.8 mmtt -63.68 -12.12 31.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.42 16.83 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.928 1.347 . . . . 0.0 108.862 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.2 mp -99.0 -22.86 15.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.604 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.452 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -68.79 -44.28 30.49 Favored Pre-proline 0 C--N 1.283 -2.312 0 C-N-CA 124.637 1.175 . . . . 0.0 113.296 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 51.2 Cg_endo -64.5 -16.56 55.83 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.569 1.513 . . . . 0.0 113.116 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -101.08 -28.47 12.69 Favored 'General case' 0 CA--C 1.473 -2.015 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.647 177.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -73.87 -39.41 63.96 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.12 -174.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 2.1 mp0 -80.17 -20.85 43.86 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 119.703 -0.799 . . . . 0.0 113.112 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.3 tt0 -85.44 -46.45 10.89 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -73.2 -40.89 64.38 Favored 'General case' 0 CA--C 1.467 -2.231 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.21 94.6 Favored Glycine 0 CA--C 1.461 -3.296 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.133 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.49 -56.09 25.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.4 mt -59.75 -43.01 94.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.194 -175.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.64 -42.72 33.81 Favored 'General case' 0 C--O 1.188 -2.153 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.55 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.1 16.54 8.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.0 tppt? -130.87 -33.01 1.61 Allowed 'General case' 0 C--N 1.316 -0.848 0 O-C-N 122.049 -0.407 . . . . 0.0 110.538 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.581 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 14.3 t -96.08 -160.82 0.82 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.222 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.16 15.19 0.07 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.541 1.136 . . . . 0.0 113.434 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -118.05 -3.16 11.14 Favored 'General case' 0 C--O 1.194 -1.868 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 57' ' ' SER . 60.8 pttt -71.75 -4.18 26.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.835 0.826 . . . . 0.0 112.848 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -110.35 -9.59 14.63 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -98.0 -49.96 4.57 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.239 1.019 . . . . 0.0 109.352 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.2 t -137.26 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.058 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.513 HG23 ' HD2' ' A' ' 26' ' ' LYS . 53.7 t -124.75 130.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.523 ' C ' HG23 ' A' ' 9' ' ' VAL . 34.9 mm -94.68 122.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -132.51 158.61 41.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 122.578 0.351 . . . . 0.0 110.703 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -151.93 139.36 19.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.654 -0.654 . . . . 0.0 109.955 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 11.1 p -116.44 139.87 41.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -85.58 110.28 19.13 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.84 -9.73 59.56 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 124.077 0.861 . . . . 0.0 112.331 -172.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -109.93 -18.17 13.45 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.436 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.28 -32.91 11.66 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -123.28 101.62 7.47 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.82 116.11 4.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.301 0.572 . . . . 0.0 110.6 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 32' ' ' PHE . 33.2 m -91.96 144.97 30.05 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.502 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -90.24 0.11 5.41 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.168 2.579 . . . . 0.0 112.246 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -78.53 -179.02 6.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.071 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.66 106.37 14.43 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.017 0.913 . . . . 0.0 109.974 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.54 HG23 ' OG1' ' A' ' 84' ' ' THR . 43.9 mt -96.56 136.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.103 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.438 HE21 ' C ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -88.3 -9.17 53.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.16 -116.46 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.577 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 78.3 t80 -118.16 -58.84 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.77 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.5 Cg_exo -87.85 156.67 7.38 Favored 'Trans proline' 0 N--CA 1.425 -2.519 0 CA-C-N 120.385 1.173 . . . . 0.0 109.414 167.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.54 ' OG1' HG23 ' A' ' 79' ' ' ILE . 17.6 m -159.25 136.93 10.1 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.843 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 42.8 mt -101.64 137.43 29.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.53 121.96 19.43 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.0 tm? -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.57 100.43 7.1 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.421 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 12.7 Cg_endo -65.97 159.36 49.53 Favored 'Trans proline' 0 CA--C 1.463 -3.045 0 C-N-CA 121.812 1.674 . . . . 0.0 109.92 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.6 77.23 8.47 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.892 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.18 -39.24 0.45 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 113.0 -1.909 . . . . 0.0 110.269 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.421 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -109.46 58.18 0.61 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.242 1.02 . . . . 0.0 110.493 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 8.13 3.36 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.167 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.53 -1.85 9.05 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.614 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 47.8 mt-30 -133.12 46.74 2.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.42 0.688 . . . . 0.0 110.803 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 85.6 Cg_exo -54.1 156.25 13.46 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 123.561 2.841 . . . . 0.0 113.245 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 115' ' ' ASN . 15.0 t -95.37 95.68 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.133 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -72.19 128.45 35.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.434 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.31 170.85 14.95 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 125.289 1.436 . . . . 0.0 109.502 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.5 t -108.13 -31.13 8.05 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.162 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.65 110.79 0.61 Allowed Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.591 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.1 m -62.69 -26.43 68.66 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 123.751 0.821 . . . . 0.0 111.838 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.41 ' HG2' HD12 ' A' ' 43' ' ' LEU . 70.2 mtm180 64.61 17.72 11.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.987 0.915 . . . . 0.0 112.254 -175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -152.04 153.41 33.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.258 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 46' ' ' LYS . 60.2 t -77.2 -39.19 28.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 124.676 1.19 . . . . 0.0 109.739 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -55.75 -47.69 76.55 Favored 'General case' 0 C--O 1.251 1.184 0 C-N-CA 124.926 1.29 . . . . 0.0 110.936 -172.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.5 t70 -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.758 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 23.0 mt -70.7 -39.97 73.13 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.571 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.42 -52.62 54.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 45.2 tptt -70.07 -15.77 63.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.3 t80 -71.51 -62.74 1.3 Allowed 'General case' 0 C--O 1.191 -1.983 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.494 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.2 mt -65.94 -13.72 16.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.871 1.319 . . . . 0.0 108.015 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -82.81 -33.5 27.2 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.681 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -109.06 -35.21 6.38 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.929 0.871 . . . . 0.0 109.39 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.7 m-80 -86.07 -30.0 22.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.267 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.91 163.92 51.3 Favored Glycine 0 N--CA 1.406 -3.331 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.873 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -98.9 -23.33 15.38 Favored 'General case' 0 CA--C 1.452 -2.799 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.629 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.464 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.9 m-85 -80.04 -14.09 58.81 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.516 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 55.78 56.1 6.43 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 124.184 0.927 . . . . 0.0 110.011 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.37 38.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.482 0.828 0 CA-C-O 121.663 0.61 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.571 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.3 p -73.0 133.12 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.927 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 18.9 m -74.9 107.96 7.32 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 121.735 0.778 . . . . 0.0 111.129 -173.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.73 108.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.613 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.8 t -109.82 110.49 32.33 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.643 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 15' ' ' LYS . 16.3 m -69.81 166.97 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.66 -23.53 63.14 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.152 0.501 . . . . 0.0 110.698 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.639 ' HB3' HG23 ' A' ' 13' ' ' VAL . 44.2 tttp -59.97 -42.4 94.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.396 173.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HB2' HG13 ' A' ' 12' ' ' VAL . 20.0 m-20 -105.75 -9.88 17.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.491 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -54.07 -27.52 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -86.46 -8.15 57.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.303 1.049 . . . . 0.0 108.939 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -105.86 -43.19 4.94 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.693 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mm -94.06 -54.7 6.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.717 HG21 HD12 ' A' ' 30' ' ' ILE . 78.3 t -72.98 -25.51 22.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 CA-C-O 121.885 0.85 . . . . 0.0 112.077 -174.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 22' ' ' LEU . 1.7 tm? -99.8 16.32 24.04 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 122.502 1.144 . . . . 0.0 108.974 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.47 150.7 23.59 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.122 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.509 ' HB3' ' CE ' ' A' ' 93' ' ' LYS . 6.3 p-10 -115.29 17.09 16.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -90.85 -14.23 32.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.677 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.625 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.06 161.15 42.92 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.156 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 m-20 -78.47 126.21 30.44 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 21' ' ' VAL . 33.5 t -115.37 115.29 48.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.46 ' HG ' HD23 ' A' ' 87' ' ' LEU . 8.8 mt -85.72 128.51 34.81 Favored 'General case' 0 CA--C 1.467 -2.243 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 21' ' ' VAL . 12.7 tt -115.9 144.76 22.8 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 C-N-CA 118.026 -1.469 . . . . 0.0 110.564 171.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 39.8 tt0 -125.41 112.25 16.07 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -78.14 126.91 31.5 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.58 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.7 p90 -144.03 -175.79 4.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.111 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -146.1 144.23 21.18 Favored Pre-proline 0 N--CA 1.42 -1.954 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -80.1 -17.81 10.37 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 121.627 1.551 . . . . 0.0 110.249 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -89.65 1.16 56.39 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.638 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 42.0 t -83.68 118.89 24.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.346 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.11 -38.29 94.14 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.561 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.8 m80 -68.11 -36.99 80.65 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.857 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 34.8 t -64.91 -34.83 79.34 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.797 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -69.07 -15.27 63.41 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.542 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.54 -10.31 32.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.075 0.94 . . . . 0.0 109.438 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 78.7 mt -97.77 -13.51 21.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.858 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.77 90.81 Favored Pre-proline 0 C--N 1.255 -3.543 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.531 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.44 -12.58 20.68 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.355 1.37 . . . . 0.0 113.059 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 43' ' ' LEU . 9.8 ptmm? -92.27 -32.24 15.1 Favored 'General case' 0 CA--C 1.466 -2.268 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.571 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -82.95 -41.48 18.77 Favored 'General case' 1 N--CA 1.378 -4.075 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.078 -171.876 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -73.69 -42.39 61.32 Favored 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.682 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 tt0 -74.79 -38.4 62.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.791 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 108' ' ' LEU . 24.3 tp -72.79 -40.18 66.1 Favored 'General case' 0 CA--C 1.472 -2.027 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.66 96.69 Favored Glycine 0 CA--C 1.473 -2.573 0 CA-C-N 113.559 -1.655 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.78 -53.53 49.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.0 mt -52.35 -39.1 60.29 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 124.169 0.918 . . . . 0.0 110.968 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.281 4.1 m-30 -77.79 -49.86 13.49 Favored 'General case' 0 C--O 1.187 -2.213 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.071 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.525 ' C ' ' HE2' ' A' ' 56' ' ' LYS . . . -76.1 6.91 4.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -120.39 -43.97 2.49 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 124.369 1.068 . . . . 0.0 109.304 -177.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -91.68 -169.59 2.34 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -76.86 28.93 0.13 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -122.51 4.18 9.62 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -65.42 -16.65 63.84 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -119.35 5.09 11.18 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.735 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -95.33 -45.57 7.08 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.532 1.158 . . . . 0.0 109.245 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -135.0 142.99 38.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.866 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.391 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 26' ' ' LYS . 51.4 t -119.21 119.54 61.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mm -86.6 116.14 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.737 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -127.24 160.71 30.45 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.174 0.511 . . . . 0.0 111.32 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -153.78 145.18 23.09 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 122.015 -0.428 . . . . 0.0 110.24 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.38 140.79 47.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.63 109.18 17.79 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.33 60.43 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.292 1.037 . . . . 0.0 112.681 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 t -111.36 -18.1 12.98 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.571 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.58 -30.37 13.33 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -131.53 83.29 2.09 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 131.52 46.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.849 0.833 . . . . 0.0 110.102 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.13 156.86 36.58 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.531 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.43 -7.69 11.72 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.768 2.312 . . . . 0.0 110.469 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -67.42 153.25 44.12 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.114 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.89 126.88 39.35 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -124.51 128.8 73.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.794 0.331 . . . . 0.0 110.479 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -81.03 -27.71 35.68 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.121 0.568 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.13 -120.22 3.83 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.597 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.3 t80 -133.22 -58.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.1 Cg_endo -87.67 149.33 7.37 Favored 'Trans proline' 0 N--CA 1.424 -2.613 0 CA-C-N 120.252 1.126 . . . . 0.0 109.188 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -162.45 149.99 13.9 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.6 mt -110.37 138.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 91.3 mttt -137.21 128.42 27.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.46 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.4 tm? -101.34 115.07 29.67 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -98.67 97.51 4.93 Favored Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 19.5 Cg_endo -66.65 158.1 57.62 Favored 'Trans proline' 0 CA--C 1.464 -3.01 0 C-N-CA 121.993 1.796 . . . . 0.0 111.14 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.94 77.91 8.71 Favored 'General case' 0 N--CA 1.394 -3.258 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.69 -23.17 0.34 Allowed Glycine 0 N--CA 1.422 -2.246 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.231 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.413 ' H ' ' HG2' ' A' ' 89' ' ' PRO . . . -138.34 61.11 1.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.539 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 24' ' ' ASP . 19.7 ptpt -77.81 5.28 9.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.283 0.633 . . . . 0.0 110.536 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.65 -11.83 25.94 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.41 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.0 pt20 -130.71 48.23 3.55 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 122.789 0.436 . . . . 0.0 110.831 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 28.8 Cg_exo -46.51 150.4 2.34 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.285 2.656 . . . . 0.0 113.365 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 18.7 t -93.82 98.92 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.542 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.446 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 11.1 t -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.447 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.48 160.0 40.65 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.938 -169.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 p -87.37 -58.71 2.48 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.531 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.16 121.77 4.77 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -80.54 22.3 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 59.41 22.12 10.55 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 t -137.73 159.13 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 122.282 -0.261 . . . . 0.0 110.343 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG13 HD13 ' A' ' 50' ' ' LEU . 96.0 t -77.18 -29.42 17.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 124.045 0.938 . . . . 0.0 110.257 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 27.0 mt-10 -59.24 -45.71 90.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 123.331 1.538 . . . . 0.0 108.869 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -62.1 -35.97 80.32 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 111.302 -2.681 . . . . 0.0 109.305 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.2 mt -75.16 -43.53 51.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.49 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.6 mt -55.14 -52.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -66.01 -22.87 66.47 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.382 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.607 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.5 OUTLIER -67.34 -63.73 1.0 Allowed 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.548 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.5 mt -71.81 -8.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.494 1.14 . . . . 0.0 108.953 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.8 -28.98 15.59 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.313 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.17 -43.92 6.46 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 61.4 m-80 -85.84 -29.93 23.35 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.166 -1.833 . . . . 0.0 109.833 -174.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -74.15 155.77 49.47 Favored Glycine 1 N--CA 1.392 -4.243 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.915 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -94.82 -23.11 17.63 Favored 'General case' 0 CA--C 1.468 -2.175 0 CA-C-O 121.753 0.787 . . . . 0.0 109.195 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.51 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 17.2 m-85 -82.21 -9.73 59.4 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 51.81 51.88 15.68 Favored 'General case' 0 C--N 1.365 1.242 0 C-N-CA 124.325 1.05 . . . . 0.0 110.376 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -75.1 90.42 2.51 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.185 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 C--O 1.245 0.839 0 N-CA-C 109.536 -0.986 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 65' ' ' ILE . 1.5 p -69.91 125.56 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 12' ' ' VAL . 20.2 m -72.96 106.72 4.97 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.0 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.6 114.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.772 HG13 ' HB2' ' A' ' 16' ' ' ASN . 83.5 t -116.62 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 15' ' ' LYS . 16.2 m -71.88 173.51 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.638 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.582 ' H ' ' HB3' ' A' ' 73' ' ' ASN . . . -60.02 -26.95 66.5 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.471 0.708 . . . . 0.0 110.852 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 13' ' ' VAL . 30.4 tttm -62.08 -50.99 69.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.772 ' HB2' HG13 ' A' ' 12' ' ' VAL . 54.0 m-20 -86.85 -14.49 41.92 Favored 'General case' 0 CA--C 1.464 -2.356 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.196 -168.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -57.79 -32.14 67.25 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -78.87 -17.93 54.78 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.9 pt-20 -104.49 -45.16 4.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.415 1.102 . . . . 0.0 111.213 -173.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.513 HG12 ' HG3' ' A' ' 19' ' ' GLU . 33.7 mm -83.91 -54.35 9.17 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.486 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.638 HG21 HD12 ' A' ' 30' ' ' ILE . 61.1 t -81.62 -37.15 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 121.474 0.654 . . . . 0.0 111.278 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.8 35.07 1.16 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.519 ' OD2' ' HD3' ' A' ' 26' ' ' LYS . 17.6 t70 -86.87 151.79 23.02 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.143 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.74 14.35 16.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 p -101.67 -23.12 14.29 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.319 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HD3' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -142.33 164.85 29.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 74.4 m-20 -81.63 120.02 24.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.9 t -115.1 121.02 66.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.728 0.775 . . . . 0.0 111.227 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.584 HD21 HD22 ' A' ' 108' ' ' LEU . 18.4 tp -93.33 124.94 37.67 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.638 HD12 HG21 ' A' ' 21' ' ' VAL . 12.4 tt -115.1 147.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 C-N-CA 117.596 -1.642 . . . . 0.0 112.953 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 27.3 tt0 -117.15 114.37 23.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.417 ' HD2' ' O ' ' A' ' 84' ' ' THR . 97.4 m-85 -83.84 124.15 30.65 Favored 'General case' 0 CA--C 1.464 -2.344 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 170.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -142.41 -172.5 3.63 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.311 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.99 150.7 39.55 Favored Pre-proline 0 N--CA 1.419 -2.006 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -78.65 -20.12 10.87 Favored 'Trans proline' 0 CA--C 1.5 -1.223 0 C-N-CA 121.391 1.394 . . . . 0.0 110.152 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -89.28 -2.78 58.6 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.489 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 47.0 t -77.11 118.52 19.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.467 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.73 -37.23 93.92 Favored Glycine 0 C--O 1.236 0.225 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -64.84 -42.13 95.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.918 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.7 t -62.55 -43.14 99.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.079 0.466 . . . . 0.0 110.704 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 49.5 mtmt -66.65 -18.44 65.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.601 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 -18.96 25.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.596 0.712 . . . . 0.0 109.424 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 72.6 mt -88.47 -26.86 21.86 Favored 'General case' 0 C--O 1.196 -1.752 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.372 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.11 -51.57 61.08 Favored Pre-proline 0 C--N 1.286 -2.171 0 C-N-CA 125.813 1.645 . . . . 0.0 114.299 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -66.01 -30.81 47.47 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.066 1.178 . . . . 0.0 111.319 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.484 ' CB ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -87.45 -28.9 21.81 Favored 'General case' 0 CA--C 1.43 -3.65 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.243 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -73.83 -36.33 64.91 Favored 'General case' 0 N--CA 1.386 -3.651 0 O-C-N 123.78 0.675 . . . . 0.0 109.61 -174.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.93 -49.48 61.55 Favored 'General case' 0 C--O 1.193 -1.912 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.595 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.62 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 40.8 mt-10 -75.15 -33.26 61.5 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -173.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 108' ' ' LEU . 13.0 tp -73.15 -41.69 63.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.81 -43.07 99.65 Favored Glycine 0 CA--C 1.475 -2.437 0 CA-C-N 112.922 -1.945 . . . . 0.0 112.271 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -62.8 -52.05 64.71 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 84.2 mt -60.35 -36.68 78.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.746 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.251 2.0 m-85 -76.42 -50.95 12.82 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 116.932 -1.907 . . . . 0.0 110.873 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -83.6 22.76 1.03 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -151.07 -31.26 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 176.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 m -87.06 -85.78 0.16 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.36 -5.33 9.87 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -126.41 23.48 6.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 19.3 pttp -69.89 -15.42 63.07 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.351 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -116.26 15.9 15.86 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.652 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -131.97 -110.46 0.24 Allowed 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 119.909 -0.717 . . . . 0.0 110.984 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 112' ' ' ILE . 92.9 t -55.51 129.45 16.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 123.499 0.72 . . . . 0.0 111.853 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 26' ' ' LYS . 96.0 t -114.48 123.99 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.022 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.5 mm -89.33 118.55 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -126.14 165.9 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -155.83 144.72 20.49 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 122.077 -0.389 . . . . 0.0 110.744 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.405 HG12 HD11 ' A' ' 30' ' ' ILE . 11.7 p -127.05 145.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.78 111.89 22.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.11 -14.7 61.02 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.409 ' HB ' ' CZ ' ' A' ' 82' ' ' PHE . 9.9 t -107.98 -6.27 16.68 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.258 0.551 . . . . 0.0 111.492 -175.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.05 -48.26 2.99 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.582 ' HB3' ' H ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -100.56 101.1 11.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.09 117.12 8.68 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.091 0.472 . . . . 0.0 110.886 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.24 150.0 36.32 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.626 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -89.94 -4.41 5.32 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.029 2.486 . . . . 0.0 112.273 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.43 144.87 53.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.856 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.48 113.29 22.3 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.641 0.734 . . . . 0.0 109.455 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.522 HG23 ' OG1' ' A' ' 84' ' ' THR . 55.3 mt -106.32 144.93 14.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.373 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -80.78 -17.24 51.56 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.885 0.85 . . . . 0.0 111.318 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.489 ' H ' HG22 ' A' ' 79' ' ' ILE . . . -144.38 -112.19 0.81 Allowed Glycine 0 C--N 1.278 -2.673 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.541 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 48.2 t80 -123.21 -54.68 0.03 OUTLIER Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.28 171.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.9 Cg_endo -89.36 155.06 5.48 Favored 'Trans proline' 0 N--CA 1.429 -2.284 0 CA-C-N 120.307 1.145 . . . . 0.0 110.324 170.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.522 ' OG1' HG23 ' A' ' 79' ' ' ILE . 15.9 m -165.84 143.3 5.56 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.7 mt -105.86 133.57 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 94.4 mttt -135.95 124.02 22.92 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.193 0.52 . . . . 0.0 110.392 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -98.47 115.33 28.3 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -95.92 98.16 3.67 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.55 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -68.54 158.32 58.16 Favored 'Trans proline' 0 CA--C 1.461 -3.145 0 C-N-CA 121.586 1.524 . . . . 0.0 110.302 178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.91 77.47 8.73 Favored 'General case' 0 N--CA 1.402 -2.834 0 C-N-CA 118.632 -1.227 . . . . 0.0 107.974 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.95 -34.1 0.44 Allowed Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.915 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -120.65 35.98 4.71 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.109 0.957 . . . . 0.0 109.963 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.12 2.73 1.4 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 125.523 1.529 . . . . 0.0 112.126 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.15 25.94 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.406 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 4.0 pt20 -137.34 54.52 8.34 Favored Pre-proline 0 CA--C 1.578 2.034 0 C-N-CA 123.724 0.809 . . . . 0.0 110.808 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 12.9 Cg_exo -45.06 160.61 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 125.014 3.809 . . . . 0.0 115.137 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 115' ' ' ASN . 24.8 t -94.4 98.6 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.329 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.472 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 14.2 t -73.52 132.49 42.93 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.651 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.71 164.41 30.29 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.184 -174.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -87.35 -68.55 0.74 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.74 129.17 1.26 Allowed Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -71.63 -37.19 70.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 117.195 0.498 . . . . 0.0 110.821 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 65.96 17.43 10.8 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.284 1.033 . . . . 0.0 111.375 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -150.18 161.7 41.89 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 46' ' ' LYS . 61.8 t -86.2 -43.23 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.04 0.447 . . . . 0.0 109.955 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -54.4 -39.36 67.18 Favored 'General case' 0 N--CA 1.396 -3.165 0 C-N-CA 126.188 1.795 . . . . 0.0 112.665 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.6 t70 -80.75 -23.38 39.45 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.511 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.584 HD22 HD21 ' A' ' 29' ' ' LEU . 17.3 mt -74.7 -41.6 59.91 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.713 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.62 -51.52 70.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 45.5 tptt -65.8 -21.34 66.48 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.029 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.606 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -68.22 -65.51 0.69 Allowed 'General case' 0 C--O 1.186 -2.27 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.569 HG21 HG11 ' A' ' 63' ' ' VAL . 3.1 mt -67.72 -12.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.517 1.151 . . . . 0.0 108.806 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -87.77 -22.2 24.69 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.05 -176.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -114.78 -35.39 4.84 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 122.261 1.029 . . . . 0.0 109.166 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.606 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 57.6 m-80 -88.97 -21.93 23.29 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.478 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -83.16 163.9 41.79 Favored Glycine 0 N--CA 1.404 -3.452 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.749 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.55 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 12.0 mmmm -93.68 -24.71 17.76 Favored 'General case' 0 CA--C 1.457 -2.61 0 CA-C-N 118.228 1.014 . . . . 0.0 108.406 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.51 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 20.6 m-85 -81.41 -14.0 57.64 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.549 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 54.68 55.91 7.37 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 123.989 0.806 . . . . 0.0 109.101 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.65 82.18 0.43 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.265 1.892 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.626 176.698 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 17.8 Cg_endo . . . . . 0 CA--C 1.509 -0.771 0 CA-C-O 121.673 0.614 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.6 p -70.44 118.61 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.904 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.926 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 m -63.23 107.11 0.99 Allowed 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.571 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.404 HG22 ' HE3' ' A' ' 67' ' ' LYS . 44.7 t -79.99 109.82 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 16' ' ' ASN . 21.0 t -109.23 128.77 64.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.568 HG23 ' HB3' ' A' ' 15' ' ' LYS . 18.9 m -75.27 166.94 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 73' ' ' ASN . . . -60.99 -21.72 63.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 110.587 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' HG23 ' A' ' 13' ' ' VAL . 46.0 tptt -62.44 -52.87 61.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.34 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -95.56 -3.33 46.69 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.524 -174.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -24.05 43.05 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -87.96 -8.89 55.04 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 10.8 mt-10 -104.53 -51.74 3.03 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.363 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.63 -51.12 14.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.361 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.591 ' HA ' HG11 ' A' ' 28' ' ' VAL . 60.3 t -83.31 -28.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.88 0.848 . . . . 0.0 110.709 -172.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.56 26.35 6.22 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.212 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.72 141.32 28.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.574 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 8.7 p-10 -109.0 21.64 16.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.4 p -93.07 -17.41 23.86 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.679 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.09 166.05 30.94 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 73.8 m-20 -80.52 130.42 35.13 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' ' 21' ' ' VAL . 24.8 t -119.69 118.4 57.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.334 -0.854 . . . . 0.0 112.005 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 108' ' ' LEU . 9.4 mt -87.8 116.34 25.88 Favored 'General case' 0 CA--C 1.473 -1.983 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 21' ' ' VAL . 12.6 tt -106.07 145.23 14.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 118.089 -1.445 . . . . 0.0 110.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 67' ' ' LYS . 37.1 tt0 -127.94 109.59 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 84' ' ' THR . 95.9 m-85 -73.01 128.38 35.29 Favored 'General case' 0 CA--C 1.465 -2.305 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.528 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 27.3 p90 -142.76 -170.95 3.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 124.014 0.821 . . . . 0.0 111.242 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -148.34 144.61 18.88 Favored Pre-proline 0 C--N 1.289 -2.06 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.56 -22.52 12.1 Favored 'Trans proline' 0 CA--C 1.503 -1.041 0 C-N-CA 121.629 1.553 . . . . 0.0 110.419 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -97.36 3.58 51.02 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 113.129 -1.85 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.579 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 36.7 t -77.76 129.31 35.33 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.62 99.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.554 ' O ' HD13 ' A' ' 43' ' ' LEU . 8.5 m-70 -65.42 -44.34 87.69 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.092 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 35.4 t -56.48 -41.15 76.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.201 0.524 . . . . 0.0 110.519 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.8 mtmt -73.17 -2.75 22.88 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.013 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -107.37 -18.65 13.81 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.857 1.313 . . . . 0.0 108.411 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.6 mp -96.93 -11.02 25.18 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.504 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -46.89 47.55 Favored Pre-proline 0 C--N 1.278 -2.518 0 C-N-CA 125.754 1.621 . . . . 0.0 113.935 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -60.51 -29.54 88.83 Favored 'Trans proline' 0 C--N 1.381 2.253 0 CA-C-N 120.983 1.387 . . . . 0.0 111.926 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 2.6 pttm -84.56 -31.48 24.35 Favored 'General case' 0 C--O 1.188 -2.167 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.742 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -79.3 -33.37 43.33 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.003 -174.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 35.3 mm-40 -70.04 -48.19 58.94 Favored 'General case' 0 C--O 1.185 -2.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.7 tt0 -71.41 -47.41 56.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.211 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.58 -39.3 73.97 Favored 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.55 95.27 Favored Glycine 0 CA--C 1.467 -2.945 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.86 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.24 -55.73 22.47 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 95.9 mt -56.7 -43.62 80.71 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.665 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -78.89 -41.88 28.63 Favored 'General case' 0 C--O 1.194 -1.825 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.6 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.67 16.58 6.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 6.3 tppt? -128.46 -36.87 1.85 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.127 -0.358 . . . . 0.0 110.523 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 10.5 m -87.42 -168.4 2.22 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -174.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -74.78 22.97 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.404 0.621 . . . . 0.0 112.567 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -120.96 2.1 10.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 57' ' ' SER . 58.8 pttt -74.75 -0.27 17.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.017 0.913 . . . . 0.0 112.242 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -120.21 4.53 10.81 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.672 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 76.6 ttt180 -99.15 -48.89 4.68 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.757 1.265 . . . . 0.0 107.734 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.533 HG21 HG21 ' A' ' 112' ' ' ILE . 2.5 p -147.57 138.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.175 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' A' ' 26' ' ' LYS . 78.2 t -117.07 131.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.435 ' C ' HG23 ' A' ' 9' ' ' VAL . 37.9 mm -93.41 119.11 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.94 165.76 18.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.358 0.599 . . . . 0.0 111.907 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 31' ' ' GLU . 56.1 mtmt -143.96 160.61 40.53 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.405 ' CG1' HD11 ' A' ' 30' ' ' ILE . 9.4 p -144.68 144.62 21.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 172.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -88.18 118.41 27.75 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.18 54.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.025 0.53 . . . . 0.0 111.907 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -119.63 -23.63 6.49 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.602 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.49 -24.3 14.82 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -118.77 97.49 5.74 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.73 111.88 1.14 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.151 0.501 . . . . 0.0 111.258 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 14' ' ' ALA . 35.8 m -99.32 143.22 26.01 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.932 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -94.09 2.18 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.326 2.684 . . . . 0.0 109.981 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -80.14 165.58 22.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.32 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -88.65 123.38 33.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.422 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.8 mm -105.43 140.43 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.627 1.171 . . . . 0.0 108.125 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.9 -29.21 16.03 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.36 0.6 . . . . 0.0 110.479 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.01 -108.5 1.15 Allowed Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 t80 -117.82 -53.16 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 166.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 3.2 Cg_exo -90.45 162.2 4.45 Favored 'Trans proline' 0 N--CA 1.43 -2.245 0 C-N-CA 121.151 1.234 . . . . 0.0 109.244 164.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.427 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 97.8 m -161.32 141.13 10.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 33.9 mt -106.36 128.97 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 30' ' ' ILE . 41.2 mtmt -135.34 129.18 33.02 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 121.292 0.568 . . . . 0.0 109.645 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.4 tm? -100.38 117.7 35.11 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -98.98 97.55 5.21 Favored Pre-proline 0 C--N 1.291 -1.978 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.604 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 14.3 Cg_endo -68.03 160.68 47.56 Favored 'Trans proline' 0 CA--C 1.464 -2.989 0 C-N-CA 121.973 1.782 . . . . 0.0 111.746 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.54 77.43 8.4 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 122.638 1.208 . . . . 0.0 108.564 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.02 -39.25 0.56 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.915 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 94' ' ' GLY . . . -113.66 31.23 6.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.492 0.663 . . . . 0.0 110.864 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -64.72 13.61 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.658 1.183 . . . . 0.0 113.677 177.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -108.03 -13.08 20.72 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -140.03 70.27 35.24 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 123.981 0.912 . . . . 0.0 108.558 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.4 Cg_exo -49.31 160.24 0.96 Allowed 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 123.926 3.084 . . . . 0.0 113.428 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.461 HG11 ' OD1' ' A' ' 115' ' ' ASN . 54.1 t -100.53 104.16 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.43 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.451 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 8.7 t -75.23 132.19 40.91 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.632 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 146.53 39.66 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.714 -175.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -73.69 -59.31 2.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.491 0.662 . . . . 0.0 110.49 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.55 125.69 0.85 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 15.2 m -71.06 -41.54 70.6 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 60.99 26.09 16.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.371 1.081 . . . . 0.0 108.93 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.7 t -161.51 157.37 24.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.908 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 46' ' ' LYS . 58.1 t -83.9 -37.12 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 124.18 0.992 . . . . 0.0 110.005 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -57.78 -45.16 86.37 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.277 1.036 . . . . 0.0 110.918 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -68.32 -31.0 70.11 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.794 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 29' ' ' LEU . 27.8 mt -72.16 -42.75 65.58 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.311 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.61 -51.05 70.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -66.19 -21.5 66.32 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.88 -178.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -69.98 -61.33 1.82 Allowed 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -69.48 -9.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.579 1.181 . . . . 0.0 108.281 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -91.04 -24.4 20.06 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.869 -177.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -104.4 -39.7 6.35 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-O 123.225 1.488 . . . . 0.0 108.71 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 59.3 m-80 -95.6 -26.14 15.88 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.432 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.36 157.63 40.75 Favored Glycine 0 N--CA 1.403 -3.525 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.922 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.604 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 4.3 mmmp? -88.39 -27.28 21.7 Favored 'General case' 0 CA--C 1.466 -2.251 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.474 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 26.0 m-85 -79.98 -11.2 59.81 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.242 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 55.32 45.9 24.6 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 124.244 0.965 . . . . 0.0 109.396 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . . . -67.05 86.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.005 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.11 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 43.5 Cg_endo . . . . . 0 CA--C 1.503 -1.048 0 CA-C-O 121.777 0.657 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.4 p -83.65 137.66 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.1 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.929 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 m -75.01 93.92 2.79 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 122.248 1.023 . . . . 0.0 110.378 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.23 104.52 3.59 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.386 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 13' ' ' VAL . 23.4 t -102.21 141.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.599 HG23 ' HB3' ' A' ' 15' ' ' LYS . 20.6 m -85.24 170.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.93 -31.22 69.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.073 0.463 . . . . 0.0 110.294 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.599 ' HB3' HG23 ' A' ' 13' ' ' VAL . 29.4 tttm -53.93 -39.79 66.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.152 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -110.45 -2.54 16.51 Favored 'General case' 0 C--O 1.208 -1.109 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.744 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -58.6 -30.93 67.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -77.93 -13.19 59.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 12.3 pt-20 -106.57 -44.75 4.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.404 1.097 . . . . 0.0 111.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.441 HG12 ' HG3' ' A' ' 19' ' ' GLU . 19.0 mm -79.16 -54.88 10.81 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.677 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.634 HG21 HD13 ' A' ' 30' ' ' ILE . 60.1 t -84.72 -29.66 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 121.62 0.724 . . . . 0.0 111.304 -173.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.94 32.37 2.41 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.703 ' OD2' HG22 ' A' ' 25' ' ' THR . 30.6 t70 -96.57 150.01 21.13 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.162 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -116.86 20.33 13.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.703 HG22 ' OD2' ' A' ' 23' ' ' ASP . 13.9 t -98.64 -3.67 35.58 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.475 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.9 161.99 41.64 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.1 m-20 -81.46 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.606 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.2 t -118.04 121.62 67.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.148 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HG ' HD23 ' A' ' 87' ' ' LEU . 9.9 mt -90.31 116.79 28.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.634 HD13 HG21 ' A' ' 21' ' ' VAL . 1.5 tp -104.45 145.28 13.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.615 ' N ' HG13 ' A' ' 30' ' ' ILE . 41.2 tt0 -126.39 104.34 8.12 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 124.151 0.907 . . . . 0.0 108.589 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 84' ' ' THR . 98.3 m-85 -76.34 128.03 34.04 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -142.47 -175.39 4.44 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.949 0.881 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -138.36 153.25 72.68 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 174.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 59.8 Cg_endo -84.16 -14.78 7.0 Favored 'Trans proline' 0 C--N 1.326 -0.607 0 CA-C-N 121.8 1.678 . . . . 0.0 110.665 -173.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.42 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 56.3 p-90 -96.64 4.58 51.83 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.624 -1.626 . . . . 0.0 111.772 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 46.4 t -80.63 121.57 26.0 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.628 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.83 92.85 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 46.5 m80 -60.72 -45.26 94.95 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 15.0 p -70.74 -25.7 63.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.952 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 56.3 mtmt -74.48 -20.59 59.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.6 0.714 . . . . 0.0 110.228 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.36 -9.83 37.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.672 1.225 . . . . 0.0 108.248 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.589 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 81.0 mt -97.83 -11.92 22.75 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.036 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.45 -50.5 73.15 Favored Pre-proline 0 C--N 1.255 -3.509 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.546 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.13 -16.5 31.9 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 121.453 1.435 . . . . 0.0 113.052 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 43' ' ' LEU . 8.8 ptmm? -86.58 -38.49 17.09 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -82.11 -26.51 33.51 Favored 'General case' 0 N--CA 1.396 -3.13 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.117 -171.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 42.4 mt-10 -77.58 -33.08 54.01 Favored 'General case' 0 C--O 1.18 -2.583 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.241 175.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -83.45 -47.86 10.94 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.523 HD22 HD13 ' A' ' 108' ' ' LEU . 7.0 tp -64.64 -46.25 83.33 Favored 'General case' 0 CA--C 1.469 -2.147 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -77.75 -20.54 73.63 Favored Glycine 0 CA--C 1.474 -2.505 0 CA-C-N 114.172 -1.376 . . . . 0.0 114.987 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -71.7 -50.41 30.62 Favored 'General case' 0 CA--C 1.477 -1.856 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.59 -45.13 69.33 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.165 -173.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 42.2 m-85 -74.91 -27.67 60.31 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' GLY . . . -107.88 16.1 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -136.86 -33.05 0.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.441 -0.162 . . . . 0.0 111.163 176.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 22.2 m -84.62 -164.31 0.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.81 28.06 0.17 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.9 3.52 5.97 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 22.6 pttp -72.56 -12.56 61.11 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.805 0.812 . . . . 0.0 111.048 -174.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -109.85 5.65 22.73 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -106.22 -49.77 3.29 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.372 1.082 . . . . 0.0 109.1 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG21 HG21 ' A' ' 112' ' ' ILE . 2.5 p -138.82 135.58 43.0 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.172 -1.831 . . . . 0.0 109.309 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 26' ' ' LYS . 75.6 t -112.58 127.28 69.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 9' ' ' VAL . 31.8 mm -90.56 121.19 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.656 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -130.06 161.37 31.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.282 0.563 . . . . 0.0 111.701 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' ' HD2' ' A' ' 47' ' ' TYR . 14.5 ptmt -152.03 145.29 24.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.414 HG12 HD11 ' A' ' 30' ' ' ILE . 7.6 p -129.83 139.69 50.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 109.71 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -82.18 101.48 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.39 -9.08 58.38 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.389 1.075 . . . . 0.0 112.412 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 t -105.84 -19.72 13.66 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.726 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.36 -42.76 9.12 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -113.11 102.77 10.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.012 -1.449 . . . . 0.0 107.529 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -67.71 135.1 52.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.91 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 32' ' ' PHE . 29.7 m -113.53 143.23 28.99 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.26 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.05 -8.57 16.59 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 123.303 2.669 . . . . 0.0 113.759 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.45 174.2 10.84 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.91 139.91 35.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.399 0.619 . . . . 0.0 109.626 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.596 HG23 ' OG1' ' A' ' 84' ' ' THR . 59.5 mt -123.39 117.06 50.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -74.85 -9.41 58.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.56 -140.11 4.9 Favored Glycine 0 C--N 1.3 -1.433 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.559 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 4.9 t80 -100.54 -50.44 0.19 Allowed Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -92.58 171.12 2.41 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 121.097 1.198 . . . . 0.0 110.291 167.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.596 ' OG1' HG23 ' A' ' 79' ' ' ILE . 3.1 m -169.17 146.8 3.67 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 49.7 mt -110.63 140.5 29.48 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.324 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' HG22 ' A' ' 30' ' ' ILE . 65.7 mttm -140.26 127.6 21.26 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.481 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.1 tm? -102.07 111.95 24.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -94.75 101.9 7.89 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HB2' ' HG3' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -65.65 161.03 40.5 Favored 'Trans proline' 0 CA--C 1.464 -2.986 0 C-N-CA 121.658 1.572 . . . . 0.0 110.051 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -81.5 77.5 8.36 Favored 'General case' 0 N--CA 1.395 -3.207 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.887 173.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.38 -45.31 0.41 Allowed Glycine 0 N--CA 1.415 -2.711 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.909 171.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -104.62 58.47 0.7 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.856 0.836 . . . . 0.0 111.166 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -69.78 -2.89 13.29 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.878 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' C ' ' HD3' ' A' ' 96' ' ' PRO . . . -116.85 1.5 19.79 Favored Glycine 0 CA--C 1.497 -1.093 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.652 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 14.8 mt-30 -135.58 45.79 1.49 Allowed Pre-proline 0 CA--C 1.552 1.019 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 72.7 Cg_exo -60.11 159.28 26.66 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.773 2.315 . . . . 0.0 112.296 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 115' ' ' ASN . 13.5 t -97.15 91.14 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -72.89 130.3 40.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.03 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.36 171.9 13.5 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 125.192 1.397 . . . . 0.0 108.798 -170.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -107.28 -62.28 1.44 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.207 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.45 127.77 1.35 Allowed Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.901 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -98.22 -27.62 14.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.756 0.313 . . . . 0.0 111.21 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 61.93 12.63 4.98 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.841 1.256 . . . . 0.0 112.095 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -138.15 158.13 44.93 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 121.776 -0.578 . . . . 0.0 110.971 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.97 -34.38 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 124.277 1.031 . . . . 0.0 109.597 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -57.19 -47.9 80.11 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.105 1.362 . . . . 0.0 110.136 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 22.6 t70 -70.15 -29.11 65.93 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.642 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 50' ' ' LEU . 22.2 mt -74.41 -39.66 62.49 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.3 mt -56.31 -54.11 31.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.5 tptp -64.61 -21.91 66.83 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.546 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.2 t80 -69.62 -64.83 0.8 Allowed 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.517 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -65.58 -16.68 20.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.758 1.266 . . . . 0.0 108.272 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.43 -19.16 31.74 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.459 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 31.7 mt-10 -115.3 -44.86 2.96 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.963 0.887 . . . . 0.0 109.694 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.0 m-80 -79.33 -26.81 42.12 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.563 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.64 162.48 41.46 Favored Glycine 0 N--CA 1.404 -3.439 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 43.1 mtpt -96.99 -21.79 17.21 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.184 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.517 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.7 m-85 -77.56 -17.45 57.87 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.309 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 57.76 47.33 15.71 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 124.001 0.813 . . . . 0.0 109.504 175.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.23 96.28 1.38 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.11 -173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.21 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 24.6 Cg_endo . . . . . 0 N--CA 1.483 0.855 0 CA-C-O 122.033 0.764 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.6 p -71.37 131.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.339 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 13.7 m -69.58 102.89 1.94 Allowed 'General case' 0 N--CA 1.415 -2.225 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.958 -175.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.55 113.79 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.7 t -113.28 119.13 59.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 15' ' ' LYS . 28.7 m -71.45 170.45 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -26.19 67.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 110.79 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB3' HG23 ' A' ' 13' ' ' VAL . 2.8 tppp? -60.74 -53.04 62.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.759 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.662 ' HB2' HG13 ' A' ' 12' ' ' VAL . 39.7 m-20 -86.43 -15.52 40.02 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.257 -169.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.55 -32.23 49.85 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 4.2 p30 -75.05 -18.46 60.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 13.0 pt-20 -105.81 -45.64 4.33 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.161 0.981 . . . . 0.0 111.311 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.474 HG12 ' HG3' ' A' ' 19' ' ' GLU . 26.3 mm -78.25 -55.8 9.15 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.108 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.93 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.649 ' HA ' HG11 ' A' ' 28' ' ' VAL . 63.4 t -80.0 -35.91 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 111.495 -174.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -96.39 37.52 1.26 Allowed 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.42 155.57 29.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.709 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -115.67 5.27 14.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -124.5 14.22 8.82 Favored 'General case' 0 C--O 1.249 1.078 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.875 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -153.18 148.19 26.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 79.4 m-20 -80.63 119.32 23.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.649 HG11 ' HA ' ' A' ' 21' ' ' VAL . 17.4 t -115.91 121.64 67.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.757 HD21 HD22 ' A' ' 108' ' ' LEU . 19.1 tp -94.36 117.89 30.8 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 21' ' ' VAL . 11.6 tt -112.26 145.79 17.89 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 C-N-CA 117.571 -1.652 . . . . 0.0 111.346 176.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' OE2' HD23 ' A' ' 43' ' ' LEU . 34.5 tt0 -127.55 108.21 10.6 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HD1' ' O ' ' A' ' 84' ' ' THR . 91.5 m-85 -69.31 130.08 41.59 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.662 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 34.2 p90 -144.28 -172.57 3.81 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.608 0.718 . . . . 0.0 111.454 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -153.33 150.43 23.63 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -78.16 -24.85 7.75 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 121.607 1.538 . . . . 0.0 109.184 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -93.6 15.02 17.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 112.984 -1.916 . . . . 0.0 111.757 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 43.2 t -95.3 120.2 35.13 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.112 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.11 -35.01 82.63 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.643 ' O ' HD13 ' A' ' 43' ' ' LEU . 10.1 t60 -60.47 -53.21 60.24 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 11.8 t -54.65 -40.42 68.99 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -67.72 -12.27 60.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.93 -10.4 24.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.762 1.267 . . . . 0.0 108.708 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.8 mp -101.52 -17.62 16.32 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.722 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.95 -41.86 48.46 Favored Pre-proline 0 C--N 1.283 -2.316 0 C-N-CA 124.435 1.094 . . . . 0.0 113.225 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 35.7 Cg_endo -63.99 -20.26 67.59 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.739 1.3 . . . . 0.0 112.383 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 1.6 pttm -91.03 -32.73 15.79 Favored 'General case' 0 C--O 1.173 -2.963 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -73.32 -37.02 66.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.363 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.31 -17.34 46.15 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -87.84 -45.25 10.45 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 8.3 tp -69.59 -46.44 66.31 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.84 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.13 -31.01 71.77 Favored Glycine 0 CA--C 1.465 -3.034 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.996 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -62.56 -52.47 63.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 1.6 pp -64.21 -42.27 96.69 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.727 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.532 ' OH ' ' HA ' ' A' ' 109' ' ' ILE . 19.3 m-85 -66.97 -43.93 81.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.171 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . . . -93.55 16.12 14.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.3 tppt? -131.95 -26.07 1.99 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.681 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 29.1 t -85.53 -170.61 3.2 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.742 0.306 . . . . 0.0 110.181 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -72.42 12.21 0.5 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.872 1.269 . . . . 0.0 113.552 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.432 ' CE2' ' HA ' ' A' ' 54' ' ' TYR . 11.5 p90 -132.04 11.17 4.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 57' ' ' SER . 21.9 pttp -67.36 -13.31 61.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.016 0.912 . . . . 0.0 111.463 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.54 17.5 19.17 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.075 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HE ' ' HB3' ' A' ' 118' ' ' TYR . 16.4 ttp180 -125.7 -45.14 1.78 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 122.546 1.165 . . . . 0.0 108.963 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.631 HG21 HG21 ' A' ' 112' ' ' ILE . 1.7 p -131.88 143.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 C-N-CA 126.556 1.942 . . . . 0.0 108.142 173.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.51 130.6 70.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 9' ' ' VAL . 46.2 mm -89.37 117.17 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -123.62 161.16 25.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.34 143.12 22.92 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 30' ' ' ILE . 7.8 p -123.33 139.31 50.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.403 ' HB3' ' ND2' ' A' ' 73' ' ' ASN . 10.0 t0 -83.09 109.48 17.19 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.29 -11.73 59.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.193 0.933 . . . . 0.0 112.413 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 t -106.59 -27.09 11.07 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.656 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.29 -34.27 17.74 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 69' ' ' ASP . 8.1 m-80 -119.08 104.09 10.14 Favored 'General case' 0 N--CA 1.403 -2.784 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.74 118.8 13.06 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.302 0.572 . . . . 0.0 110.588 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.23 145.62 31.89 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.702 -174.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.1 -8.73 12.99 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.1 2.533 . . . . 0.0 111.282 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.82 -172.72 4.13 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.088 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.74 129.96 56.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.186 0.517 . . . . 0.0 110.67 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -84.14 129.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.71 -22.81 22.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.397 0.618 . . . . 0.0 110.837 -174.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.99 -105.42 0.62 Allowed Glycine 0 C--N 1.31 -0.899 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.64 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.6 t80 -117.82 -57.34 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.3 Cg_exo -91.5 164.41 3.53 Favored 'Trans proline' 0 N--CA 1.418 -2.963 0 N-CA-C 108.54 -1.369 . . . . 0.0 108.54 162.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.484 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 98.9 m -153.64 135.27 14.4 Favored 'General case' 0 C--N 1.27 -2.848 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.933 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 34.1 mt -98.9 136.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 30' ' ' ILE . 45.7 mtpt -139.19 117.38 11.86 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.3 tm? -96.89 114.41 26.03 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -97.64 96.72 3.42 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.592 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 12.1 Cg_endo -68.78 158.98 55.64 Favored 'Trans proline' 0 CA--C 1.461 -3.173 0 C-N-CA 121.841 1.694 . . . . 0.0 111.143 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 77.34 8.23 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.79 -27.09 0.58 Allowed Glycine 0 C--N 1.298 -1.58 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.113 173.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.479 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -124.64 31.72 5.63 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.833 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -64.44 13.24 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 124.815 1.246 . . . . 0.0 112.963 176.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -109.77 -12.54 18.43 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -147.7 71.72 11.56 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 34.9 Cg_exo -49.3 163.33 0.39 Allowed 'Trans proline' 0 C--O 1.25 1.104 0 C-N-CA 124.291 3.327 . . . . 0.0 113.824 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 115' ' ' ASN . 28.8 t -97.5 102.23 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 t -81.1 128.74 34.07 Favored 'General case' 0 N--CA 1.427 -1.619 0 O-C-N 124.206 0.941 . . . . 0.0 109.981 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.04 158.01 45.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.47 -173.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -90.18 -3.25 57.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.432 0.634 . . . . 0.0 110.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' HA3' HD21 ' A' ' 43' ' ' LEU . . . 108.2 117.14 4.08 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -68.71 -33.05 73.28 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 65.73 13.61 9.06 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.509 1.147 . . . . 0.0 110.953 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 107' ' ' ASP . 5.7 t -143.3 155.14 44.39 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.43 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 46' ' ' LYS . 92.5 t -82.33 -39.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 124.958 1.303 . . . . 0.0 110.419 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -59.32 -44.75 92.56 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 121.937 0.875 . . . . 0.0 111.282 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 36.2 t70 -70.3 -25.76 63.47 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.956 -177.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.757 HD22 HD21 ' A' ' 29' ' ' LEU . 18.4 mt -77.89 -38.98 44.63 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.532 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 69.8 mt -59.06 -50.07 81.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.8 tptp -63.49 -24.9 68.02 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.102 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.602 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.5 t80 -68.77 -65.49 0.7 Allowed 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.631 HG21 HG21 ' A' ' 63' ' ' VAL . 3.4 mt -66.7 -14.33 17.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.49 1.138 . . . . 0.0 108.743 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . . . -91.18 -11.93 36.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.485 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 46.8 mt-10 -120.42 -41.45 2.61 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.202 1.001 . . . . 0.0 109.384 174.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.602 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.9 m-80 -86.07 -24.6 26.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.652 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.17 168.18 51.67 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.592 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 13.4 mmmm -100.2 -24.64 14.51 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.883 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.45 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.5 m-85 -84.39 -12.76 53.88 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.899 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 35.0 mmtp 52.82 59.68 4.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.304 1.002 . . . . 0.0 110.016 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 81.52 0.78 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.779 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.757 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.16 -41.08 63.62 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.519 2.146 . . . . 0.0 111.419 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.1 mt -114.02 93.21 4.26 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.47 17.99 2.06 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 p -81.95 167.94 18.39 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.014 -0.593 . . . . 0.0 111.076 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.79 97.38 2.21 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 122.014 0.911 . . . . 0.0 111.08 -174.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.83 66.2 0.01 OUTLIER Glycine 0 C--N 1.281 -2.527 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.936 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' CB ' ' HA ' ' A' ' 52' ' ' ALA . 13.9 Cg_endo -62.73 -48.31 7.33 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.931 1.754 . . . . 0.0 108.648 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.7 p -67.42 130.1 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.806 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 m -73.52 106.45 5.31 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.377 0.608 . . . . 0.0 111.015 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.58 111.02 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 16' ' ' ASN . 47.4 t -106.45 129.21 60.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 15' ' ' LYS . 15.5 m -79.94 172.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.63 -24.55 67.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.166 0.508 . . . . 0.0 110.419 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' HG23 ' A' ' 13' ' ' VAL . 16.5 tptp -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.808 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.735 ' HB2' HG13 ' A' ' 12' ' ' VAL . 30.8 m-20 -99.96 -14.21 18.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.9 -170.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -40.43 58.19 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.9 -11.09 59.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.269 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.5 pt-20 -106.45 -41.5 5.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.33 1.062 . . . . 0.0 111.198 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.446 HG12 ' HG3' ' A' ' 19' ' ' GLU . 31.7 mm -84.41 -57.33 4.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 CA-C-N 113.045 -1.888 . . . . 0.0 112.229 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.619 ' HA ' HG11 ' A' ' 28' ' ' VAL . 65.8 t -82.21 -32.77 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.442 0 CA-C-O 122.006 0.907 . . . . 0.0 111.578 -172.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 27.4 2.71 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -94.32 139.6 30.87 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.775 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -105.79 15.2 27.1 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.127 0.571 . . . . 0.0 111.483 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.6 p -81.19 -13.07 58.96 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.42 0.629 . . . . 0.0 109.439 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -160.55 161.85 32.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.936 0.894 . . . . 0.0 108.61 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.1 m-20 -82.43 128.8 34.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.5 t -119.38 123.06 70.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.692 0.758 . . . . 0.0 111.612 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' OH ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -94.36 114.08 26.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.589 HD12 HG21 ' A' ' 21' ' ' VAL . 10.8 tt -108.53 144.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.284 -1.366 . . . . 0.0 112.739 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 38.4 tt0 -120.66 121.28 37.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.786 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.418 ' HB2' ' H ' ' A' ' 84' ' ' THR . 97.5 m-85 -91.43 121.85 33.5 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -141.26 -173.47 3.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.786 0.803 . . . . 0.0 112.314 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -142.92 148.49 45.86 Favored Pre-proline 0 N--CA 1.429 -1.509 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -83.93 -12.62 8.34 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.004 1.802 . . . . 0.0 110.463 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -95.56 0.95 53.56 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.605 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 53.8 t -83.37 117.24 22.89 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.562 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.47 -29.54 74.9 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 65.1 m80 -67.33 -39.92 85.88 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.43 -32.92 74.8 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.201 0.524 . . . . 0.0 110.489 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 64.4 mmtt -65.83 -18.68 65.5 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.612 0.72 . . . . 0.0 111.396 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.85 -11.76 21.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.895 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.741 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 97.0 mt -97.02 -26.74 14.9 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.267 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.63 97.33 Favored Pre-proline 0 C--N 1.284 -2.271 0 C-N-CA 124.665 1.186 . . . . 0.0 113.641 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.33 0.96 8.42 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.574 1.516 . . . . 0.0 112.781 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 13.2 pttm -109.4 -32.3 7.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.47 -43.9 20.1 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.293 -171.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.56 -12.59 59.85 Favored 'General case' 0 N--CA 1.409 -2.515 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.564 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.97 -52.01 5.18 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HB2' HG13 ' A' ' 105' ' ' VAL . 3.3 tm? -73.92 -34.5 64.39 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.37 93.89 Favored Glycine 0 CA--C 1.479 -2.209 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.771 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.489 ' HA ' ' CB ' ' A' ' 8' ' ' PRO . . . -58.39 -53.31 59.73 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -54.53 -42.59 71.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.61 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -76.77 -45.99 26.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.99 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.74 17.7 3.84 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 9.1 tppt? -128.93 -36.11 1.81 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.661 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 21.8 t -100.76 -155.53 0.52 Allowed 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -57.21 -0.22 0.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -114.19 3.12 15.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 57' ' ' SER . 57.8 pttt -74.96 -6.33 48.69 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.892 0.853 . . . . 0.0 111.096 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.76 -2.34 17.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.371 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -117.78 -130.1 0.3 Allowed 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 112' ' ' ILE . 2.1 p -53.88 130.62 15.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.697 0.761 . . . . 0.0 112.071 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -114.78 128.47 71.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.001 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.9 mm -85.21 123.32 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -131.29 163.48 27.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 48.9 pttt -157.15 143.66 18.14 Favored 'General case' 0 CA--C 1.48 -1.73 0 O-C-N 121.87 -0.519 . . . . 0.0 112.303 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 10.9 p -121.69 144.3 31.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -84.67 113.55 21.37 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.72 -0.11 46.02 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.143 -171.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.7 t -127.3 -7.12 5.87 Favored 'General case' 0 N--CA 1.424 -1.757 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.767 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.74 -33.73 9.73 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -119.15 132.78 56.01 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.455 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.34 106.33 12.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -87.17 141.97 33.29 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.507 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -86.81 2.38 7.11 Favored 'Trans proline' 0 N--CA 1.477 0.549 0 C-N-CA 123.282 2.655 . . . . 0.0 110.598 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -79.33 -175.86 4.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.471 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -105.51 131.6 52.71 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 125.653 1.581 . . . . 0.0 109.012 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 81' ' ' GLY . 32.3 mm -109.28 124.28 65.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.34 28.24 6.58 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.395 1.093 . . . . 0.0 112.441 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.482 ' H ' HG22 ' A' ' 79' ' ' ILE . . . -179.6 -120.33 0.67 Allowed Glycine 0 C--N 1.296 -1.641 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 36.7 t80 -115.36 -52.55 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 165.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 6.3 Cg_exo -91.37 170.82 3.08 Favored 'Trans proline' 0 N--CA 1.423 -2.641 0 N-CA-C 109.42 -1.031 . . . . 0.0 109.42 165.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.418 ' H ' ' HB2' ' A' ' 32' ' ' PHE . 97.6 m -163.04 152.17 14.89 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.0 mt -121.91 137.3 55.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.473 ' O ' HG22 ' A' ' 30' ' ' ILE . 94.1 mttt -140.63 128.15 21.4 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.193 0.521 . . . . 0.0 110.73 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.469 HD13 ' HD3' ' A' ' 89' ' ' PRO . 3.4 tm? -98.53 117.02 32.01 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -100.55 96.31 5.21 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -66.52 160.39 46.08 Favored 'Trans proline' 0 CA--C 1.465 -2.936 0 C-N-CA 122.024 1.816 . . . . 0.0 111.67 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.31 77.12 8.22 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.0 -20.35 0.67 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.185 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -137.22 55.27 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.926 0.87 . . . . 0.0 111.462 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.45 -1.99 29.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.201 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.3 -16.2 35.68 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -138.47 63.88 35.88 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.508 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.33 160.36 0.94 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.749 3.633 . . . . 0.0 113.196 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 115' ' ' ASN . 38.3 t -96.51 97.93 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.3 t -74.52 132.91 42.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.46 168.53 19.56 Favored 'General case' 0 C--N 1.278 -2.51 0 C-N-CA 125.999 1.72 . . . . 0.0 108.975 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.3 m -115.56 -18.89 10.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.107 0.479 . . . . 0.0 110.567 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.77 115.13 1.82 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.915 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 p -83.67 -10.96 57.82 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 111.435 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 65.68 18.18 11.11 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.203 1.001 . . . . 0.0 113.011 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 107' ' ' ASP . 9.0 t -138.3 150.94 47.11 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.292 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 50' ' ' LEU . 94.2 t -73.48 -33.76 40.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 125.507 1.523 . . . . 0.0 109.632 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' A' ' 106' ' ' GLU . 28.7 mt-10 -58.25 -45.88 86.98 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 122.825 1.298 . . . . 0.0 109.957 -176.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 25.9 t70 -73.7 -27.84 61.42 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 112.115 -2.312 . . . . 0.0 109.696 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 112' ' ' ILE . 17.5 mt -69.67 -43.36 72.7 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.26 -53.45 39.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 110' ' ' LYS . 2.7 tmmm? -60.64 -32.78 71.94 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.908 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.605 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -59.97 -71.17 0.14 Allowed 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.713 -176.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.576 HG21 HG21 ' A' ' 63' ' ' VAL . 4.0 mp -70.9 -8.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.612 1.196 . . . . 0.0 109.34 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -86.83 -23.68 25.23 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.555 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 -37.7 4.51 Favored 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 122.122 0.963 . . . . 0.0 108.941 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.605 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 58.1 m-80 -87.22 -27.65 22.85 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 113.2 -1.818 . . . . 0.0 109.648 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.79 158.31 42.72 Favored Glycine 0 N--CA 1.408 -3.216 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.852 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.523 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 31.3 mmmt -87.76 -26.01 23.12 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.593 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.9 m-85 -80.59 -16.19 54.75 Favored 'General case' 0 N--CA 1.388 -3.544 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.92 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 58.2 57.85 3.78 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.44 86.15 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.023 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.51 -53.24 3.58 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.528 2.152 . . . . 0.0 111.587 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.8 tp -117.3 115.44 25.27 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.12 149.9 7.94 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.2 m -83.63 93.44 7.89 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.358 0.599 . . . . 0.0 109.918 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -97.4 145.48 26.12 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.09 116.71 4.86 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.426 ' CG ' ' HA ' ' A' ' 48' ' ' GLU . 47.4 Cg_endo -72.26 -36.1 5.94 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 121.798 1.666 . . . . 0.0 110.88 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.435 HG11 ' HB3' ' A' ' 47' ' ' TYR . 1.2 p -81.11 124.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.926 175.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 48.1 m -63.11 108.96 1.36 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.746 0.784 . . . . 0.0 111.39 -173.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.5 t -79.15 107.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 16' ' ' ASN . 46.3 t -103.71 129.01 56.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.669 HG23 ' HB3' ' A' ' 15' ' ' LYS . 17.1 m -78.77 170.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.308 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -26.29 66.66 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.669 ' HB3' HG23 ' A' ' 13' ' ' VAL . 32.0 tttm -55.72 -51.42 67.39 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.611 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -100.46 -3.89 29.98 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.355 -172.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -54.28 -38.69 66.17 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -81.07 -5.2 57.35 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.592 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 12.3 pt-20 -106.26 -44.68 4.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 122.574 1.178 . . . . 0.0 110.841 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.492 HG12 ' HG3' ' A' ' 19' ' ' GLU . 23.2 mm -81.43 -54.74 9.39 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.367 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.617 HG21 HD12 ' A' ' 30' ' ' ILE . 83.9 t -81.34 -30.99 11.31 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 CA-C-O 121.28 0.562 . . . . 0.0 111.643 -174.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.452 ' HG ' ' CE2' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -95.16 32.17 1.77 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -96.75 151.65 19.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.09 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' HB3' ' HD3' ' A' ' 93' ' ' LYS . 7.7 p-10 -115.45 17.88 16.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.712 0.291 . . . . 0.0 111.512 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.9 p -71.36 -37.27 71.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HA ' ' CE1' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -146.66 176.23 10.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 58.9 m-20 -82.02 141.35 33.3 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 21' ' ' VAL . 38.2 t -126.01 119.53 54.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.732 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HG ' HD23 ' A' ' 87' ' ' LEU . 9.2 mt -86.57 121.08 28.6 Favored 'General case' 0 CA--C 1.468 -2.211 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.617 HD12 HG21 ' A' ' 21' ' ' VAL . 9.6 tt -114.0 144.87 20.69 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 117.518 -1.673 . . . . 0.0 110.289 173.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -129.83 113.61 14.89 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.356 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' HD1' ' O ' ' A' ' 84' ' ' THR . 28.5 m-85 -78.91 134.2 36.9 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -145.02 -171.71 3.7 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.296 0.997 . . . . 0.0 110.435 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -141.98 155.94 65.42 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -84.4 -16.35 5.9 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.641 1.56 . . . . 0.0 110.261 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.8 p-90 -96.18 2.86 53.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.039 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.685 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.5 t -84.43 119.05 24.68 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.489 -173.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.17 -23.94 76.08 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.445 ' O ' HD13 ' A' ' 43' ' ' LEU . 35.8 m80 -76.0 -42.69 47.3 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 122.722 -0.281 . . . . 0.0 111.472 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 20.5 p -68.5 -25.14 64.81 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.587 0.708 . . . . 0.0 109.911 -178.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 53.5 mtmt -75.3 -5.24 43.66 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.504 0.668 . . . . 0.0 110.863 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB1' ' HD2' ' A' ' 103' ' ' ARG . . . -94.7 -16.04 23.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.561 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 11.2 mp -93.27 -10.96 33.72 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.228 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.29 -45.27 54.64 Favored Pre-proline 0 C--N 1.287 -2.131 0 C-N-CA 125.005 1.322 . . . . 0.0 113.219 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -67.82 -30.92 32.92 Favored 'Trans proline' 0 C--N 1.378 2.107 0 CA-C-N 120.136 1.084 . . . . 0.0 110.92 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 2.2 ptmm? -75.38 -33.18 61.01 Favored 'General case' 0 C--O 1.201 -1.494 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.435 ' HB3' HG11 ' A' ' 9' ' ' VAL . 13.9 m-85 -68.75 -50.97 46.16 Favored 'General case' 0 CA--C 1.465 -2.323 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.031 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.426 ' HA ' ' CG ' ' A' ' 8' ' ' PRO . 41.4 mt-10 -69.73 -36.47 75.89 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.219 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 17.1 mm-40 -85.28 -46.61 10.85 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.086 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.595 HD23 HG13 ' A' ' 105' ' ' VAL . 2.4 tm? -76.16 -39.52 54.74 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.71 -30.66 59.47 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 118.781 -1.676 . . . . 0.0 112.754 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.61 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -68.4 -47.12 68.15 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.363 173.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 89.5 mt -62.62 -41.11 98.81 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.253 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -80.47 -46.88 15.16 Favored 'General case' 0 N--CA 1.414 -2.236 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.926 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.76 12.71 12.2 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 45.6 mtmt -134.47 -19.37 1.89 Allowed 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 123.235 0.614 . . . . 0.0 112.556 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.709 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 50.6 m -100.53 -170.84 1.92 Allowed 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.24 9.87 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.75 -5.26 29.01 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.4 pttp -76.91 -11.1 59.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.236 1.017 . . . . 0.0 109.221 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.67 -16.91 26.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.51 -133.9 0.34 Allowed 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 3.1 p -58.6 133.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.74 0.781 . . . . 0.0 112.752 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.97 133.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.427 HD12 HD12 ' A' ' 29' ' ' LEU . 22.1 mm -95.18 113.2 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 175.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' THR . . . -118.47 156.97 28.12 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 123.529 0.518 . . . . 0.0 110.567 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -147.63 140.51 24.9 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 p -126.2 141.0 47.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -88.11 115.81 25.85 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.42 -12.62 59.98 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.93 0.892 . . . . 0.0 112.288 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 t -112.85 -18.73 12.2 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.281 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.04 -26.23 18.43 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -133.0 95.62 3.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.331 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.08 133.61 49.25 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.795 0.807 . . . . 0.0 111.657 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.69 152.05 42.64 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.251 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.07 -1.63 9.4 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 123.506 2.804 . . . . 0.0 112.11 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -83.42 144.13 29.81 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.432 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.75 133.6 35.14 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.408 0.623 . . . . 0.0 109.47 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.617 HG23 ' OG1' ' A' ' 84' ' ' THR . 31.2 mt -111.03 128.13 67.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.706 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.546 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 1.7 mp0 -68.24 -36.36 79.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.22 -126.35 3.76 Favored Glycine 0 C--N 1.295 -1.704 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.474 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 11.8 t80 -112.91 -49.04 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 6.1 Cg_exo -88.62 168.19 5.95 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.436 1.424 . . . . 0.0 110.226 168.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.617 ' OG1' HG23 ' A' ' 79' ' ' ILE . 22.9 m -161.6 138.04 8.21 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 19.8 mt -106.75 139.74 27.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 50.6 mtmt -143.5 121.87 12.35 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 121.061 0.458 . . . . 0.0 110.136 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.529 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tm? -98.25 112.87 24.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.555 ' CE2' ' HG3' ' A' ' 96' ' ' PRO . 27.5 m-85 -97.22 97.76 4.1 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 19.3 Cg_endo -70.0 161.94 44.07 Favored 'Trans proline' 0 CA--C 1.468 -2.791 0 C-N-CA 121.557 1.505 . . . . 0.0 111.719 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.84 77.64 7.7 Favored 'General case' 0 N--CA 1.399 -2.975 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.01 -19.92 0.75 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.237 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.444 ' H ' ' HG2' ' A' ' 89' ' ' PRO . . . -135.06 39.61 2.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.897 0.856 . . . . 0.0 110.529 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HD3' ' HB3' ' A' ' 24' ' ' ASP . 42.1 pttt -67.45 -5.67 15.92 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.638 1.175 . . . . 0.0 110.872 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.96 -20.58 49.53 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -141.05 67.68 27.22 Favored Pre-proline 0 N--CA 1.433 -1.288 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.555 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 22.9 Cg_exo -49.26 164.71 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 124.298 3.332 . . . . 0.0 113.056 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 115' ' ' ASN . 18.6 t -92.78 89.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -73.14 126.11 29.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.176 -1.375 . . . . 0.0 111.782 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.67 176.0 9.25 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.658 -174.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -108.82 -53.23 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.59 136.87 2.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.728 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.6 p -108.37 -7.95 15.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 20.5 ttp85 65.81 8.37 5.24 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 123.911 0.885 . . . . 0.0 112.234 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 107' ' ' ASP . 4.7 t -123.56 146.88 47.79 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.653 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.595 HG13 HD23 ' A' ' 50' ' ' LEU . 78.2 t -77.78 -35.35 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 125.687 1.595 . . . . 0.0 110.078 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.413 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.1 mt-10 -62.92 -43.83 97.73 Favored 'General case' 0 CA--C 1.488 -1.425 0 CA-C-O 122.198 0.999 . . . . 0.0 110.45 -173.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.7 t70 -69.25 -28.76 66.61 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 113.261 -1.79 . . . . 0.0 109.988 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.516 HD22 HD13 ' A' ' 29' ' ' LEU . 32.3 mt -68.98 -46.12 68.88 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 106' ' ' GLU . 64.0 mt -55.15 -53.86 30.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 22.2 tptp -62.64 -25.16 67.97 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.74 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.3 t80 -69.11 -62.35 1.42 Allowed 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.455 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.4 mt -71.63 -9.82 13.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.554 1.169 . . . . 0.0 108.544 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -90.92 -19.71 23.01 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.534 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 42.8 mt-10 -110.42 -43.27 3.92 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 122.461 1.124 . . . . 0.0 108.361 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 60.8 m-80 -85.27 -29.74 24.36 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.017 -1.902 . . . . 0.0 109.909 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.9 149.29 28.09 Favored Glycine 0 N--CA 1.397 -3.965 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.617 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -89.78 -20.24 23.76 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.186 0.993 . . . . 0.0 108.774 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 26' ' ' LYS . 21.3 m-85 -85.24 -5.46 59.32 Favored 'General case' 0 N--CA 1.393 -3.295 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.602 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 34.4 mmtp 48.76 52.43 14.06 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.545 1.153 . . . . 0.0 110.871 173.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.03 93.15 3.24 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.269 2.089 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.828 0 CA-C-O 119.238 -0.757 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -73.53 43.25 0.75 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 124.45 3.433 . . . . 0.0 113.486 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.0 tp -85.06 1.76 46.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.523 1.154 . . . . 0.0 107.983 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.71 -144.68 4.68 Favored Glycine 0 N--CA 1.416 -2.693 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -91.61 12.31 21.45 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.823 0.82 . . . . 0.0 110.825 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -90.7 151.24 21.32 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.668 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.77 -178.25 30.01 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.17 -48.21 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.312 2.008 . . . . 0.0 110.515 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 65' ' ' ILE . 2.3 p -69.64 129.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.554 -1.203 . . . . 0.0 107.922 175.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -76.18 110.65 10.85 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.872 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.5 105.83 6.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.631 HG13 ' HB2' ' A' ' 16' ' ' ASN . 47.6 t -108.59 114.15 45.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.643 HG23 ' HB3' ' A' ' 15' ' ' LYS . 31.3 m -68.91 168.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -23.18 65.49 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.258 0.552 . . . . 0.0 110.918 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.643 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -60.95 -46.01 92.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.189 174.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.631 ' HB2' HG13 ' A' ' 12' ' ' VAL . 13.8 m-20 -99.96 -13.51 19.08 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.936 -171.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.02 -33.44 25.15 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -74.47 -13.2 60.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.045 0.45 . . . . 0.0 111.624 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.6 pt-20 -105.96 -52.47 2.8 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.642 0.734 . . . . 0.0 110.92 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.494 HG12 ' HG3' ' A' ' 19' ' ' GLU . 20.6 mm -74.35 -57.83 5.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.889 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.665 HG21 HD12 ' A' ' 30' ' ' ILE . 91.6 t -74.93 -33.27 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.23 1.014 . . . . 0.0 110.777 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.0 tp -96.06 23.72 6.22 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.548 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.452 ' OD1' HG22 ' A' ' 25' ' ' THR . 7.6 t70 -75.02 167.69 21.43 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.522 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -115.94 -3.71 12.12 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.202 -0.936 . . . . 0.0 112.679 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.452 HG22 ' OD1' ' A' ' 23' ' ' ASP . 14.8 t -111.74 3.16 17.58 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.204 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 25' ' ' THR . 66.1 mmtt -135.64 138.75 43.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.603 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 71.0 m-20 -76.47 116.9 17.59 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 171.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 21' ' ' VAL . 39.9 t -112.92 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.714 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.451 ' HG ' HD23 ' A' ' 87' ' ' LEU . 8.0 mt -84.12 124.63 31.34 Favored 'General case' 0 CA--C 1.464 -2.361 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.665 HD12 HG21 ' A' ' 21' ' ' VAL . 13.3 tt -116.1 143.76 25.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.229 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 29.2 tt0 -115.78 117.18 29.5 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -84.44 121.11 27.11 Favored 'General case' 0 CA--C 1.462 -2.416 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -141.47 -171.53 3.33 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.865 0.841 . . . . 0.0 112.705 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -151.79 154.17 32.64 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 11.2 Cg_endo -80.7 -20.51 7.84 Favored 'Trans proline' 0 CA--C 1.505 -0.932 0 C-N-CA 121.675 1.583 . . . . 0.0 109.947 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.414 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 64.7 p-90 -91.82 4.69 52.28 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.125 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 42.7 t -82.78 117.19 22.5 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.829 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.3 -35.75 92.07 Favored Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.545 ' O ' HD13 ' A' ' 43' ' ' LEU . 79.6 t60 -65.32 -45.36 84.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.806 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.89 -41.52 91.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.273 0.559 . . . . 0.0 110.692 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -70.94 -2.93 16.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' O ' ' HE2' ' A' ' 46' ' ' LYS . . . -102.23 -22.17 14.22 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.664 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 10.8 mp -92.44 -16.26 26.11 Favored 'General case' 0 C--O 1.195 -1.805 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.005 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.59 92.6 Favored Pre-proline 0 C--N 1.275 -2.639 0 C-N-CA 124.702 1.201 . . . . 0.0 112.967 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.8 Cg_exo -63.75 -35.21 58.64 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.14 1.226 . . . . 0.0 111.632 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -81.75 -30.97 32.19 Favored 'General case' 0 C--O 1.177 -2.754 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.905 -175.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.664 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -77.53 -29.6 52.41 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.065 -174.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -83.43 -29.55 27.99 Favored 'General case' 0 C--O 1.191 -1.982 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.964 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.572 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 52.6 mt-10 -79.95 -45.06 19.18 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.909 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.99 -39.1 63.9 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.39 -37.06 90.09 Favored Glycine 0 CA--C 1.479 -2.169 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.027 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -64.88 -50.79 65.17 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 96.0 mt -57.49 -40.11 77.91 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.583 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -76.99 -46.75 22.83 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.655 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -86.63 19.44 2.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -137.15 -27.49 0.97 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.885 -0.509 . . . . 0.0 110.358 176.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.684 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 27.5 t -94.38 -157.07 0.53 Allowed 'General case' 0 C--O 1.208 -1.127 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.79 1.56 0.86 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -109.15 2.61 21.15 Favored 'General case' 0 CA--C 1.481 -1.709 0 O-C-N 121.336 -0.853 . . . . 0.0 109.118 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 57' ' ' SER . 23.0 pttp -75.21 -9.34 58.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 122.204 1.002 . . . . 0.0 109.546 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -104.53 -0.58 27.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.041 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.75 -132.33 0.24 Allowed 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.638 HG21 HG21 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -43.3 128.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.49 1.516 . . . . 0.0 112.798 176.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.4 t -107.61 131.54 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mm -95.3 118.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 172.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -133.13 161.26 34.89 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.029 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 31' ' ' GLU 0.256 61.4 pttt -156.41 146.95 21.64 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.17 140.37 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.893 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.11 115.65 22.49 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.27 -4.97 55.4 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.986 0.914 . . . . 0.0 112.26 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -118.34 -15.43 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.288 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.91 -33.03 12.34 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -118.57 118.02 30.55 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.27 114.6 12.82 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.955 0.884 . . . . 0.0 109.43 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.11 143.06 25.47 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.48 -3.15 6.71 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 123.016 2.477 . . . . 0.0 110.417 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.24 174.67 4.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.739 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -103.87 118.87 37.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.528 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.04 139.87 19.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 123.95 0.9 . . . . 0.0 109.083 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.34 -16.35 24.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.33 -94.39 0.17 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 51.9 t80 -128.15 -51.42 0.03 OUTLIER Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.7 Cg_endo -94.5 168.82 1.76 Allowed 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 120.93 1.087 . . . . 0.0 109.661 166.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.3 m -163.35 143.32 8.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 31.6 mt -107.38 134.93 47.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -136.38 132.5 35.62 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.451 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -101.88 115.07 29.74 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.403 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 46.6 m-85 -99.58 96.18 4.32 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.427 ' HG2' ' C ' ' A' ' 92' ' ' ALA . 11.8 Cg_endo -64.69 160.07 42.12 Favored 'Trans proline' 0 CA--C 1.46 -3.183 0 C-N-CA 122.066 1.844 . . . . 0.0 112.157 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.42 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -79.16 78.23 5.63 Favored 'General case' 0 N--CA 1.397 -3.08 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.263 173.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.71 -33.06 0.82 Allowed Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.697 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.427 ' C ' ' HG2' ' A' ' 89' ' ' PRO . . . -121.78 37.16 4.43 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.625 0.726 . . . . 0.0 111.349 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -69.0 16.69 0.05 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.27 1.028 . . . . 0.0 112.708 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.1 -2.46 18.37 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.459 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 13.6 pt20 -135.1 45.32 1.39 Allowed Pre-proline 0 CA--C 1.579 2.091 0 CA-C-N 115.215 -0.493 . . . . 0.0 109.987 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 69.6 Cg_exo -44.56 155.95 0.25 Allowed 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 124.549 3.5 . . . . 0.0 115.577 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 115' ' ' ASN . 44.5 t -91.56 97.52 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 t -75.6 127.58 33.39 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.282 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 149.11 45.13 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.287 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.5 m -84.2 -30.35 25.85 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.33 0.586 . . . . 0.0 109.55 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.11 104.74 2.75 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.7 m -70.45 -5.78 31.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.718 0.807 . . . . 0.0 113.17 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 27.3 ttp180 64.22 29.2 13.93 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-O 122.233 1.016 . . . . 0.0 110.509 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.498 ' OG1' ' HB3' ' A' ' 107' ' ' ASP . 7.3 p -123.68 159.33 29.59 Favored 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.689 -0.632 . . . . 0.0 111.881 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 46' ' ' LYS . 59.6 t -95.73 -40.48 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.569 0.748 . . . . 0.0 109.137 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.521 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.7 mt-10 -65.44 -38.56 90.25 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 122.657 1.218 . . . . 0.0 110.03 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.9 t70 -76.5 -22.35 54.6 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.317 -177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.34 -44.98 64.02 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.096 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' A' ' 106' ' ' GLU . 70.8 mt -53.47 -53.46 24.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 48.4 mmtt -70.02 -13.98 62.48 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.638 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -71.3 -63.77 1.05 Allowed 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.638 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -69.52 -12.82 16.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 122.615 1.198 . . . . 0.0 108.503 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -88.26 -27.93 21.43 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.331 -175.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -113.76 -27.61 7.73 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.712 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.638 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.4 m-80 -92.57 -27.69 17.2 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.583 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.25 160.21 47.67 Favored Glycine 0 N--CA 1.406 -3.327 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.824 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 90' ' ' ALA . 48.7 mtpt -93.68 -23.71 18.14 Favored 'General case' 0 CA--C 1.474 -1.957 0 CA-C-N 118.392 1.096 . . . . 0.0 109.537 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.603 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 4.7 m-85 -77.99 -15.84 58.61 Favored 'General case' 0 N--CA 1.405 -2.682 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.989 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 56.52 59.26 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.78 78.69 0.45 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -173.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.688 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.543 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.09 -45.04 43.72 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.975 2.45 . . . . 0.0 112.056 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -150.6 151.4 32.5 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.01 -81.1 0.36 Allowed Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 m -129.18 100.07 5.48 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.907 0.384 . . . . 0.0 110.238 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -90.7 115.89 28.14 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.166 0.508 . . . . 0.0 109.844 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.81 92.16 0.76 Allowed Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.58 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.6 Cg_endo -69.19 -35.66 13.89 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 122.325 2.017 . . . . 0.0 111.79 -173.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 65' ' ' ILE . 1.8 p -83.25 129.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.99 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.734 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 m -69.15 105.93 2.65 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.995 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -78.21 109.88 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 16' ' ' ASN . 43.2 t -113.63 115.36 49.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.629 HG23 ' HB3' ' A' ' 15' ' ' LYS . 18.4 m -72.34 170.17 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.42 -3.12 13.06 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.528 0.68 . . . . 0.0 111.546 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB3' HG23 ' A' ' 13' ' ' VAL . 3.2 tppp? -78.27 -35.65 47.79 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.125 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.592 ' HB2' HG13 ' A' ' 12' ' ' VAL . 11.6 m-20 -112.02 -8.87 14.03 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.817 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.45 -27.84 27.01 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 9.9 p30 -83.71 -9.92 58.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 108.834 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -46.5 4.1 Favored 'General case' 0 N--CA 1.397 -3.084 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.574 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.14 -49.87 13.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.317 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.728 HG21 HD12 ' A' ' 30' ' ' ILE . 88.5 t -79.59 -26.91 12.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-O 121.53 0.681 . . . . 0.0 111.447 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -99.49 26.79 5.77 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-O 122.514 1.15 . . . . 0.0 108.552 -175.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.21 149.41 44.63 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.689 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.19 9.63 14.69 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.524 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -115.38 6.55 14.86 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.861 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.413 ' HD2' HG23 ' A' ' 64' ' ' VAL . 16.3 pttm -160.1 158.73 30.84 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.564 0.746 . . . . 0.0 108.994 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.8 m-20 -86.9 123.4 31.99 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 21' ' ' VAL . 47.4 t -114.65 117.11 54.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.626 -0.671 . . . . 0.0 112.506 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HG ' HD23 ' A' ' 87' ' ' LEU . 6.6 mt -89.12 111.02 21.69 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.728 HD12 HG21 ' A' ' 21' ' ' VAL . 10.6 tt -103.6 143.6 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.33 -1.348 . . . . 0.0 112.208 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -117.66 113.16 21.49 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.148 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.432 ' CD1' HD11 ' A' ' 79' ' ' ILE . 96.6 m-85 -77.69 124.08 27.49 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 169.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.559 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 17.6 p90 -139.7 -176.96 4.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.304 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -147.31 148.07 30.49 Favored Pre-proline 0 N--CA 1.418 -2.071 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.68 -20.78 9.02 Favored 'Trans proline' 0 CA--C 1.51 -0.688 0 C-N-CA 121.365 1.377 . . . . 0.0 110.361 -173.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -97.53 8.01 45.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.247 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 27.7 t -81.76 124.04 29.29 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.971 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.85 99.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.347 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -68.28 -35.91 78.58 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.014 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 47.2 t -65.91 -37.1 85.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.34 0.59 . . . . 0.0 110.163 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.9 mtmt -71.38 -10.0 59.06 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.405 0.621 . . . . 0.0 111.116 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -95.77 -21.76 17.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.215 1.007 . . . . 0.0 109.061 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.678 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 95.7 mt -87.56 -23.42 24.35 Favored 'General case' 0 C--O 1.177 -2.761 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.51 -52.67 57.74 Favored Pre-proline 0 C--N 1.267 -3.021 0 C-N-CA 125.13 1.372 . . . . 0.0 114.151 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.51 -27.12 23.27 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 121.31 1.34 . . . . 0.0 112.353 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HE2' ' O ' ' A' ' 102' ' ' SER . 3.8 ptpp? -85.67 -32.46 21.96 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.678 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -76.44 -33.48 58.76 Favored 'General case' 0 N--CA 1.402 -2.858 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.314 -171.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -83.11 -20.88 34.0 Favored 'General case' 0 C--O 1.187 -2.197 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.65 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.2 tt0 -86.14 -49.24 7.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.86 -36.79 64.88 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.86 -36.42 81.88 Favored Glycine 0 CA--C 1.476 -2.352 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.044 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -61.3 -55.05 36.22 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 88.4 mt -61.94 -39.66 92.86 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.617 -176.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 3.3 m-85 -84.16 -20.18 32.89 Favored 'General case' 0 C--O 1.186 -2.237 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.13 22.23 13.09 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 60' ' ' LYS . 4.9 tppt? -142.5 -42.05 0.33 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.39 0.614 . . . . 0.0 110.036 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 44.7 m -88.53 -156.25 0.37 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.18 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.35 17.04 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . 14.8 m-85 -126.31 -1.97 6.93 Favored 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 121.477 -0.765 . . . . 0.0 109.874 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 23.2 pttm -70.45 -7.65 44.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.311 1.053 . . . . 0.0 110.059 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.55 -6.43 20.58 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.682 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -115.13 -48.14 2.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.147 0.975 . . . . 0.0 110.854 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 120' ' ' ALA . 47.5 t -128.52 155.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.036 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 53.3 t -135.96 127.83 44.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 172.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.442 ' C ' HG23 ' A' ' 9' ' ' VAL . 32.1 mm -93.82 126.67 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.2 165.66 20.89 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.565 0.346 . . . . 0.0 111.556 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -144.39 148.74 35.07 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' A' ' 30' ' ' ILE . 9.0 p -131.68 135.39 59.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.402 ' HB3' HD22 ' A' ' 73' ' ' ASN . 10.5 t0 -82.63 106.85 14.82 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 -11.97 59.92 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 123.845 0.858 . . . . 0.0 112.023 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -105.43 -15.03 15.13 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.495 0.664 . . . . 0.0 111.01 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.16 -28.78 11.26 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.402 HD22 ' HB3' ' A' ' 69' ' ' ASP . 11.4 m-80 -126.57 111.97 14.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.915 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.94 127.73 33.24 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.58 148.55 37.95 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.347 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -84.84 -6.78 9.59 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.859 2.373 . . . . 0.0 111.189 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.51 137.69 38.05 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.294 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -82.76 140.37 33.06 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.309 0.576 . . . . 0.0 110.306 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.527 HG23 ' OG1' ' A' ' 84' ' ' THR . 55.4 mt -126.9 132.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 124.225 1.01 . . . . 0.0 108.803 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -73.94 -29.32 61.96 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.54 0.685 . . . . 0.0 110.647 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.62 -114.37 1.9 Allowed Glycine 0 C--N 1.299 -1.503 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.5 t80 -123.84 -53.4 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.52 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.826 171.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -89.99 155.47 4.88 Favored 'Trans proline' 0 N--CA 1.419 -2.855 0 CA-C-N 120.154 1.091 . . . . 0.0 109.936 169.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.527 ' OG1' HG23 ' A' ' 79' ' ' ILE . 6.9 m -163.85 140.44 6.78 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.538 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 30.2 mt -107.89 134.65 49.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 86.8 mttt -135.86 129.46 32.39 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.524 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -100.46 115.97 31.32 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -99.27 97.84 5.87 Favored Pre-proline 0 C--N 1.292 -1.894 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.3 Cg_endo -70.04 161.83 44.49 Favored 'Trans proline' 0 CA--C 1.465 -2.962 0 C-N-CA 121.986 1.791 . . . . 0.0 111.076 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.05 77.22 6.76 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-O 123.004 1.383 . . . . 0.0 109.107 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.15 -34.84 0.72 Allowed Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.779 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -112.8 33.19 5.15 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.912 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' H ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -65.79 0.92 1.5 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.286 1.434 . . . . 0.0 112.787 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.76 -12.15 28.83 Favored Glycine 0 C--O 1.239 0.461 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.421 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 4.0 pt20 -134.63 51.07 5.58 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 122.87 0.468 . . . . 0.0 110.982 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 17.2 Cg_exo -45.28 157.08 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 124.512 3.475 . . . . 0.0 114.818 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 22.0 t -90.27 97.08 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.906 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.447 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 8.8 t -75.9 128.55 35.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.086 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.27 166.13 25.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.692 -172.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.5 t -98.85 -33.91 10.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 143.24 172.52 14.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.517 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.496 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.9 m -128.55 150.17 50.3 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -98.88 34.28 2.13 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.83 0.824 . . . . 0.0 109.692 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -146.11 149.13 33.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.209 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 46' ' ' LYS . 66.2 t -80.4 -29.63 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.291 0.567 . . . . 0.0 109.513 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.14 -45.38 93.24 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 122.236 1.017 . . . . 0.0 110.126 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 26.3 t70 -71.97 -24.27 61.56 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.63 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 108' ' ' LEU . 21.5 mt -71.92 -44.56 63.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.857 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.22 -51.49 62.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 16.2 tppt? -68.06 -20.32 64.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.798 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.7 OUTLIER -69.06 -64.48 0.86 Allowed 'General case' 0 C--O 1.183 -2.416 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.421 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.0 mt -67.3 -15.28 19.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 122.758 1.266 . . . . 0.0 108.286 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -84.81 -21.22 29.98 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.816 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -117.87 -40.1 3.04 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 122.051 0.929 . . . . 0.0 109.818 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.5 m-80 -80.28 -26.08 39.1 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.916 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.41 164.58 45.68 Favored Glycine 0 N--CA 1.404 -3.448 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.238 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.539 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 8.9 mmmm -94.23 -26.26 16.72 Favored 'General case' 0 CA--C 1.458 -2.572 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.421 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.8 m-85 -83.63 -11.64 57.02 Favored 'General case' 0 N--CA 1.379 -3.992 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.39 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 53.86 60.46 3.63 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.458 1.099 . . . . 0.0 108.772 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 63' ' ' VAL . . . -47.82 24.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.274 -2.683 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.732 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -74.55 -2.81 12.92 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.936 2.424 . . . . 0.0 113.489 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 71.9 14.41 5.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.033 1.333 . . . . 0.0 111.286 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.68 154.6 25.65 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -75.75 -57.3 3.96 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 117.408 0.604 . . . . 0.0 110.278 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.66 93.19 4.11 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.699 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.408 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 93.84 104.86 1.78 Allowed Glycine 0 N--CA 1.421 -2.319 0 CA-C-N 115.338 -0.846 . . . . 0.0 114.669 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -65.93 -40.9 15.05 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.29 1.993 . . . . 0.0 107.191 168.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 65' ' ' ILE . 1.5 p -68.2 133.58 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.725 171.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 m -66.05 102.75 0.84 Allowed 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 121.448 0.642 . . . . 0.0 110.153 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -75.55 102.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 16' ' ' ASN . 55.2 t -98.72 126.52 51.86 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.884 0 C-N-CA 125.915 1.686 . . . . 0.0 107.443 -174.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 15' ' ' LYS . 27.7 m -79.03 173.87 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.21 -17.53 64.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.885 0.374 . . . . 0.0 110.916 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB3' HG23 ' A' ' 13' ' ' VAL . 33.5 tttm -65.67 -45.14 84.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.401 0.62 . . . . 0.0 110.546 171.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.789 ' HB2' HG13 ' A' ' 12' ' ' VAL . 61.2 m-20 -93.79 -10.14 35.16 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.775 -165.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -58.9 -37.28 76.27 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.83 -7.22 58.56 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.867 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 10.9 pt-20 -105.75 -51.39 3.0 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 122.019 0.914 . . . . 0.0 110.882 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.516 HG12 ' HG3' ' A' ' 19' ' ' GLU . 35.4 mm -80.02 -52.96 13.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.409 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 30' ' ' ILE . 60.7 t -82.95 -21.24 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 CA-C-O 122.025 0.917 . . . . 0.0 111.002 -173.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.72 29.0 4.75 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.64 133.11 34.84 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -105.5 21.18 17.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -105.3 -8.25 18.37 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.291 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.513 ' HD2' HG23 ' A' ' 64' ' ' VAL . 20.3 pttm -154.81 159.55 40.66 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.835 0.854 . . . . 0.0 108.78 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 79.0 m-20 -80.93 120.31 24.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 21' ' ' VAL . 22.3 t -111.65 119.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.045 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HG ' HD23 ' A' ' 87' ' ' LEU . 10.5 mt -88.07 123.21 32.53 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 172.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.657 HD12 HG21 ' A' ' 21' ' ' VAL . 9.3 tt -113.66 149.25 16.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 117.806 -1.557 . . . . 0.0 110.447 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' A' ' 43' ' ' LEU . 35.2 tt0 -130.66 113.17 13.85 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.371 0.605 . . . . 0.0 109.844 175.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 84' ' ' THR . 95.7 m-85 -75.33 131.68 40.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 173.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.517 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.8 p90 -147.67 -173.25 4.23 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.709 0.766 . . . . 0.0 111.652 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -150.52 148.1 23.06 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.91 -16.87 8.56 Favored 'Trans proline' 0 CA--C 1.499 -1.269 0 C-N-CA 122.13 1.887 . . . . 0.0 110.299 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -91.19 -1.12 57.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.705 -1.588 . . . . 0.0 111.267 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 45.2 t -86.31 117.85 25.38 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.127 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.74 -28.82 73.47 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.644 ' O ' HD13 ' A' ' 43' ' ' LEU . 20.1 t60 -63.14 -46.25 88.1 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 30.9 t -60.93 -33.06 72.57 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.252 0.548 . . . . 0.0 111.368 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 37' ' ' CYS . 41.8 mmtt -63.68 -12.12 31.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.42 16.83 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.928 1.347 . . . . 0.0 108.862 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.2 mp -99.0 -22.86 15.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.604 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.452 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -68.79 -44.28 30.49 Favored Pre-proline 0 C--N 1.283 -2.312 0 C-N-CA 124.637 1.175 . . . . 0.0 113.296 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 51.2 Cg_endo -64.5 -16.56 55.83 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.569 1.513 . . . . 0.0 113.116 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -101.08 -28.47 12.69 Favored 'General case' 0 CA--C 1.473 -2.015 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.647 177.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -73.87 -39.41 63.96 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.12 -174.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 2.1 mp0 -80.17 -20.85 43.86 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 119.703 -0.799 . . . . 0.0 113.112 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.3 tt0 -85.44 -46.45 10.89 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -73.2 -40.89 64.38 Favored 'General case' 0 CA--C 1.467 -2.231 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.21 94.6 Favored Glycine 0 CA--C 1.461 -3.296 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.133 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.49 -56.09 25.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.4 mt -59.75 -43.01 94.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.194 -175.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.64 -42.72 33.81 Favored 'General case' 0 C--O 1.188 -2.153 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.55 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.1 16.54 8.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.0 tppt? -130.87 -33.01 1.61 Allowed 'General case' 0 C--N 1.316 -0.848 0 O-C-N 122.049 -0.407 . . . . 0.0 110.538 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.581 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 14.3 t -96.08 -160.82 0.82 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.222 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.16 15.19 0.07 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.541 1.136 . . . . 0.0 113.434 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -118.05 -3.16 11.14 Favored 'General case' 0 C--O 1.194 -1.868 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 57' ' ' SER . 60.8 pttt -71.75 -4.18 26.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.835 0.826 . . . . 0.0 112.848 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -110.35 -9.59 14.63 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -98.0 -49.96 4.57 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.239 1.019 . . . . 0.0 109.352 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.2 t -137.26 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.058 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.513 HG23 ' HD2' ' A' ' 26' ' ' LYS . 53.7 t -124.75 130.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.523 ' C ' HG23 ' A' ' 9' ' ' VAL . 34.9 mm -94.68 122.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -132.51 158.61 41.67 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 122.578 0.351 . . . . 0.0 110.703 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -151.93 139.36 19.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.654 -0.654 . . . . 0.0 109.955 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 11.1 p -116.44 139.87 41.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -85.58 110.28 19.13 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.84 -9.73 59.56 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 124.077 0.861 . . . . 0.0 112.331 -172.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -109.93 -18.17 13.45 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.436 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.28 -32.91 11.66 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -123.28 101.62 7.47 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -62.82 116.11 4.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.301 0.572 . . . . 0.0 110.6 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 32' ' ' PHE . 33.2 m -91.96 144.97 30.05 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.502 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -90.24 0.11 5.41 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.168 2.579 . . . . 0.0 112.246 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -78.53 -179.02 6.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.071 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.66 106.37 14.43 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.017 0.913 . . . . 0.0 109.974 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.54 HG23 ' OG1' ' A' ' 84' ' ' THR . 43.9 mt -96.56 136.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.103 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.438 HE21 ' C ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -88.3 -9.17 53.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.16 -116.46 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.577 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 78.3 t80 -118.16 -58.84 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.77 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.5 Cg_exo -87.85 156.67 7.38 Favored 'Trans proline' 0 N--CA 1.425 -2.519 0 CA-C-N 120.385 1.173 . . . . 0.0 109.414 167.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.54 ' OG1' HG23 ' A' ' 79' ' ' ILE . 17.6 m -159.25 136.93 10.1 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.843 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 42.8 mt -101.64 137.43 29.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.53 121.96 19.43 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.0 tm? -99.14 112.92 24.94 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.57 100.43 7.1 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.421 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 12.7 Cg_endo -65.97 159.36 49.53 Favored 'Trans proline' 0 CA--C 1.463 -3.045 0 C-N-CA 121.812 1.674 . . . . 0.0 109.92 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.6 77.23 8.47 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.892 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.18 -39.24 0.45 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 113.0 -1.909 . . . . 0.0 110.269 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.421 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -109.46 58.18 0.61 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.242 1.02 . . . . 0.0 110.493 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 8.13 3.36 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.167 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.53 -1.85 9.05 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.614 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 47.8 mt-30 -133.12 46.74 2.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.42 0.688 . . . . 0.0 110.803 176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 85.6 Cg_exo -54.1 156.25 13.46 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 123.561 2.841 . . . . 0.0 113.245 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 115' ' ' ASN . 15.0 t -95.37 95.68 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.133 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -72.19 128.45 35.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.434 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.31 170.85 14.95 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 125.289 1.436 . . . . 0.0 109.502 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.5 t -108.13 -31.13 8.05 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.162 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.65 110.79 0.61 Allowed Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.591 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.1 m -62.69 -26.43 68.66 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 123.751 0.821 . . . . 0.0 111.838 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.41 ' HG2' HD12 ' A' ' 43' ' ' LEU . 70.2 mtm180 64.61 17.72 11.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.987 0.915 . . . . 0.0 112.254 -175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -152.04 153.41 33.93 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.258 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 46' ' ' LYS . 60.2 t -77.2 -39.19 28.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 124.676 1.19 . . . . 0.0 109.739 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -55.75 -47.69 76.55 Favored 'General case' 0 C--O 1.251 1.184 0 C-N-CA 124.926 1.29 . . . . 0.0 110.936 -172.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 32.5 t70 -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.758 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 23.0 mt -70.7 -39.97 73.13 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.571 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.42 -52.62 54.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 45.2 tptt -70.07 -15.77 63.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.3 t80 -71.51 -62.74 1.3 Allowed 'General case' 0 C--O 1.191 -1.983 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.494 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 3.2 mt -65.94 -13.72 16.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.871 1.319 . . . . 0.0 108.015 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -82.81 -33.5 27.2 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.681 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -109.06 -35.21 6.38 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.929 0.871 . . . . 0.0 109.39 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.7 m-80 -86.07 -30.0 22.96 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 113.579 -1.646 . . . . 0.0 108.267 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.91 163.92 51.3 Favored Glycine 0 N--CA 1.406 -3.331 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.873 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -98.9 -23.33 15.38 Favored 'General case' 0 CA--C 1.452 -2.799 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.629 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.464 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 12.9 m-85 -80.04 -14.09 58.81 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.516 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 55.78 56.1 6.43 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 124.184 0.927 . . . . 0.0 110.011 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.37 38.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.298 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.37 -21.4 61.11 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 123.303 2.669 . . . . 0.0 112.88 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.7 mt -102.07 93.37 5.21 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.91 164.34 26.46 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.0 m -149.66 142.92 25.14 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.46 14.19 32.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.727 0.775 . . . . 0.0 110.035 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.52 171.57 25.81 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.9 -32.53 54.89 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 123.45 2.767 . . . . 0.0 110.79 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.571 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.3 p -73.0 133.12 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.927 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 18.9 m -74.9 107.96 7.32 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 121.735 0.778 . . . . 0.0 111.129 -173.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.73 108.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.613 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.8 t -109.82 110.49 32.33 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.643 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 15' ' ' LYS . 16.3 m -69.81 166.97 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.954 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.66 -23.53 63.14 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.152 0.501 . . . . 0.0 110.698 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.639 ' HB3' HG23 ' A' ' 13' ' ' VAL . 44.2 tttp -59.97 -42.4 94.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.396 173.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HB2' HG13 ' A' ' 12' ' ' VAL . 20.0 m-20 -105.75 -9.88 17.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.491 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -54.07 -27.52 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -86.46 -8.15 57.84 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.303 1.049 . . . . 0.0 108.939 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -105.86 -43.19 4.94 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.693 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mm -94.06 -54.7 6.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.717 HG21 HD12 ' A' ' 30' ' ' ILE . 78.3 t -72.98 -25.51 22.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 CA-C-O 121.885 0.85 . . . . 0.0 112.077 -174.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 22' ' ' LEU . 1.7 tm? -99.8 16.32 24.04 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 122.502 1.144 . . . . 0.0 108.974 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.47 150.7 23.59 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.122 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.509 ' HB3' ' CE ' ' A' ' 93' ' ' LYS . 6.3 p-10 -115.29 17.09 16.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -90.85 -14.23 32.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.677 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.625 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.06 161.15 42.92 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.156 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 m-20 -78.47 126.21 30.44 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 21' ' ' VAL . 33.5 t -115.37 115.29 48.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.46 ' HG ' HD23 ' A' ' 87' ' ' LEU . 8.8 mt -85.72 128.51 34.81 Favored 'General case' 0 CA--C 1.467 -2.243 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 21' ' ' VAL . 12.7 tt -115.9 144.76 22.8 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 C-N-CA 118.026 -1.469 . . . . 0.0 110.564 171.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 39.8 tt0 -125.41 112.25 16.07 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -78.14 126.91 31.5 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.58 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 28.7 p90 -144.03 -175.79 4.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.111 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -146.1 144.23 21.18 Favored Pre-proline 0 N--CA 1.42 -1.954 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -80.1 -17.81 10.37 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 121.627 1.551 . . . . 0.0 110.249 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -89.65 1.16 56.39 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.638 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 42.0 t -83.68 118.89 24.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.346 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.11 -38.29 94.14 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.561 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 35.8 m80 -68.11 -36.99 80.65 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.857 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 34.8 t -64.91 -34.83 79.34 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.797 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -69.07 -15.27 63.41 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.542 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.54 -10.31 32.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.075 0.94 . . . . 0.0 109.438 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 78.7 mt -97.77 -13.51 21.34 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.858 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.77 90.81 Favored Pre-proline 0 C--N 1.255 -3.543 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.531 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.44 -12.58 20.68 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.355 1.37 . . . . 0.0 113.059 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 43' ' ' LEU . 9.8 ptmm? -92.27 -32.24 15.1 Favored 'General case' 0 CA--C 1.466 -2.268 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.571 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -82.95 -41.48 18.77 Favored 'General case' 1 N--CA 1.378 -4.075 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.078 -171.876 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -73.69 -42.39 61.32 Favored 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.682 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 tt0 -74.79 -38.4 62.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.791 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 108' ' ' LEU . 24.3 tp -72.79 -40.18 66.1 Favored 'General case' 0 CA--C 1.472 -2.027 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.61 -40.66 96.69 Favored Glycine 0 CA--C 1.473 -2.573 0 CA-C-N 113.559 -1.655 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.78 -53.53 49.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 94.0 mt -52.35 -39.1 60.29 Favored 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 124.169 0.918 . . . . 0.0 110.968 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.281 4.1 m-30 -77.79 -49.86 13.49 Favored 'General case' 0 C--O 1.187 -2.213 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.071 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.525 ' C ' ' HE2' ' A' ' 56' ' ' LYS . . . -76.1 6.91 4.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -120.39 -43.97 2.49 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 124.369 1.068 . . . . 0.0 109.304 -177.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -91.68 -169.59 2.34 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -76.86 28.93 0.13 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -122.51 4.18 9.62 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -65.42 -16.65 63.84 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -119.35 5.09 11.18 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.735 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -95.33 -45.57 7.08 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.532 1.158 . . . . 0.0 109.245 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -135.0 142.99 38.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.866 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.391 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 26' ' ' LYS . 51.4 t -119.21 119.54 61.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mm -86.6 116.14 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.737 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -127.24 160.71 30.45 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.174 0.511 . . . . 0.0 111.32 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -153.78 145.18 23.09 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 122.015 -0.428 . . . . 0.0 110.24 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.38 140.79 47.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.63 109.18 17.79 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.33 60.43 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.292 1.037 . . . . 0.0 112.681 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 t -111.36 -18.1 12.98 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.571 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.58 -30.37 13.33 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -131.53 83.29 2.09 Favored 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 131.52 46.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.849 0.833 . . . . 0.0 110.102 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.13 156.86 36.58 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.531 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.43 -7.69 11.72 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.768 2.312 . . . . 0.0 110.469 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -67.42 153.25 44.12 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.114 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.89 126.88 39.35 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -124.51 128.8 73.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.794 0.331 . . . . 0.0 110.479 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -81.03 -27.71 35.68 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.121 0.568 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.13 -120.22 3.83 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.597 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.3 t80 -133.22 -58.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.1 Cg_endo -87.67 149.33 7.37 Favored 'Trans proline' 0 N--CA 1.424 -2.613 0 CA-C-N 120.252 1.126 . . . . 0.0 109.188 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.7 m -162.45 149.99 13.9 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -173.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.6 mt -110.37 138.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 91.3 mttt -137.21 128.42 27.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.46 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.4 tm? -101.34 115.07 29.67 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -98.67 97.51 4.93 Favored Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 19.5 Cg_endo -66.65 158.1 57.62 Favored 'Trans proline' 0 CA--C 1.464 -3.01 0 C-N-CA 121.993 1.796 . . . . 0.0 111.14 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.94 77.91 8.71 Favored 'General case' 0 N--CA 1.394 -3.258 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.69 -23.17 0.34 Allowed Glycine 0 N--CA 1.422 -2.246 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.231 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.413 ' H ' ' HG2' ' A' ' 89' ' ' PRO . . . -138.34 61.11 1.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.539 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 24' ' ' ASP . 19.7 ptpt -77.81 5.28 9.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.283 0.633 . . . . 0.0 110.536 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.65 -11.83 25.94 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.41 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.0 pt20 -130.71 48.23 3.55 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 122.789 0.436 . . . . 0.0 110.831 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 28.8 Cg_exo -46.51 150.4 2.34 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.285 2.656 . . . . 0.0 113.365 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 18.7 t -93.82 98.92 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.542 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.446 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 11.1 t -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.447 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.48 160.0 40.65 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.938 -169.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 p -87.37 -58.71 2.48 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.531 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.16 121.77 4.77 Favored Glycine 0 N--CA 1.432 -1.62 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -80.54 22.3 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 59.41 22.12 10.55 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 t -137.73 159.13 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 122.282 -0.261 . . . . 0.0 110.343 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG13 HD13 ' A' ' 50' ' ' LEU . 96.0 t -77.18 -29.42 17.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 124.045 0.938 . . . . 0.0 110.257 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 27.0 mt-10 -59.24 -45.71 90.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 123.331 1.538 . . . . 0.0 108.869 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -62.1 -35.97 80.32 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 111.302 -2.681 . . . . 0.0 109.305 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.2 mt -75.16 -43.53 51.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.49 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.6 mt -55.14 -52.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -66.01 -22.87 66.47 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.382 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.607 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.5 OUTLIER -67.34 -63.73 1.0 Allowed 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.548 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.5 mt -71.81 -8.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.494 1.14 . . . . 0.0 108.953 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.8 -28.98 15.59 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.313 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.17 -43.92 6.46 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 61.4 m-80 -85.84 -29.93 23.35 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.166 -1.833 . . . . 0.0 109.833 -174.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -74.15 155.77 49.47 Favored Glycine 1 N--CA 1.392 -4.243 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.915 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -94.82 -23.11 17.63 Favored 'General case' 0 CA--C 1.468 -2.175 0 CA-C-O 121.753 0.787 . . . . 0.0 109.195 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.51 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 17.2 m-85 -82.21 -9.73 59.4 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 51.81 51.88 15.68 Favored 'General case' 0 C--N 1.365 1.242 0 C-N-CA 124.325 1.05 . . . . 0.0 110.376 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -75.1 90.42 2.51 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.185 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.459 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.86 112.63 2.51 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.693 2.262 . . . . 0.0 110.538 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.0 mt -85.46 129.57 34.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.667 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.21 -115.18 2.23 Favored Glycine 0 N--CA 1.419 -2.486 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m 62.67 103.71 0.03 OUTLIER 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.935 0.894 . . . . 0.0 109.887 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 6' ' ' GLU 0.268 0.1 OUTLIER -70.34 77.52 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -171.768 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.0 51.66 0.28 Allowed Glycine 0 N--CA 1.422 -2.294 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.522 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.56 -44.91 0.45 Allowed 'Trans proline' 0 C--N 1.376 2.026 0 CA-C-N 119.709 1.755 . . . . 0.0 109.536 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 65' ' ' ILE . 1.5 p -69.91 125.56 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 12' ' ' VAL . 20.2 m -72.96 106.72 4.97 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.0 -171.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.6 114.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.772 HG13 ' HB2' ' A' ' 16' ' ' ASN . 83.5 t -116.62 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 15' ' ' LYS . 16.2 m -71.88 173.51 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.638 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.582 ' H ' ' HB3' ' A' ' 73' ' ' ASN . . . -60.02 -26.95 66.5 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.471 0.708 . . . . 0.0 110.852 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.502 ' HB3' HG23 ' A' ' 13' ' ' VAL . 30.4 tttm -62.08 -50.99 69.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.772 ' HB2' HG13 ' A' ' 12' ' ' VAL . 54.0 m-20 -86.85 -14.49 41.92 Favored 'General case' 0 CA--C 1.464 -2.356 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.196 -168.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -57.79 -32.14 67.25 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -78.87 -17.93 54.78 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.545 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 11.9 pt-20 -104.49 -45.16 4.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.415 1.102 . . . . 0.0 111.213 -173.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.513 HG12 ' HG3' ' A' ' 19' ' ' GLU . 33.7 mm -83.91 -54.35 9.17 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.486 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.638 HG21 HD12 ' A' ' 30' ' ' ILE . 61.1 t -81.62 -37.15 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 121.474 0.654 . . . . 0.0 111.278 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.8 35.07 1.16 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.519 ' OD2' ' HD3' ' A' ' 26' ' ' LYS . 17.6 t70 -86.87 151.79 23.02 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.143 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.74 14.35 16.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 p -101.67 -23.12 14.29 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.319 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HD3' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -142.33 164.85 29.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 74.4 m-20 -81.63 120.02 24.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.9 t -115.1 121.02 66.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.728 0.775 . . . . 0.0 111.227 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.584 HD21 HD22 ' A' ' 108' ' ' LEU . 18.4 tp -93.33 124.94 37.67 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.638 HD12 HG21 ' A' ' 21' ' ' VAL . 12.4 tt -115.1 147.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 C-N-CA 117.596 -1.642 . . . . 0.0 112.953 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 27.3 tt0 -117.15 114.37 23.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.417 ' HD2' ' O ' ' A' ' 84' ' ' THR . 97.4 m-85 -83.84 124.15 30.65 Favored 'General case' 0 CA--C 1.464 -2.344 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 170.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -142.41 -172.5 3.63 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.311 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.99 150.7 39.55 Favored Pre-proline 0 N--CA 1.419 -2.006 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -78.65 -20.12 10.87 Favored 'Trans proline' 0 CA--C 1.5 -1.223 0 C-N-CA 121.391 1.394 . . . . 0.0 110.152 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -89.28 -2.78 58.6 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.489 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 47.0 t -77.11 118.52 19.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.467 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.73 -37.23 93.92 Favored Glycine 0 C--O 1.236 0.225 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -64.84 -42.13 95.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.918 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.7 t -62.55 -43.14 99.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.079 0.466 . . . . 0.0 110.704 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 49.5 mtmt -66.65 -18.44 65.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.601 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 -18.96 25.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.596 0.712 . . . . 0.0 109.424 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 72.6 mt -88.47 -26.86 21.86 Favored 'General case' 0 C--O 1.196 -1.752 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.372 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.11 -51.57 61.08 Favored Pre-proline 0 C--N 1.286 -2.171 0 C-N-CA 125.813 1.645 . . . . 0.0 114.299 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -66.01 -30.81 47.47 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.066 1.178 . . . . 0.0 111.319 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.484 ' CB ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -87.45 -28.9 21.81 Favored 'General case' 0 CA--C 1.43 -3.65 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.243 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -73.83 -36.33 64.91 Favored 'General case' 0 N--CA 1.386 -3.651 0 O-C-N 123.78 0.675 . . . . 0.0 109.61 -174.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.93 -49.48 61.55 Favored 'General case' 0 C--O 1.193 -1.912 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.595 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.62 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 40.8 mt-10 -75.15 -33.26 61.5 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -173.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 108' ' ' LEU . 13.0 tp -73.15 -41.69 63.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.81 -43.07 99.65 Favored Glycine 0 CA--C 1.475 -2.437 0 CA-C-N 112.922 -1.945 . . . . 0.0 112.271 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -62.8 -52.05 64.71 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 84.2 mt -60.35 -36.68 78.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.746 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . 0.251 2.0 m-85 -76.42 -50.95 12.82 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 116.932 -1.907 . . . . 0.0 110.873 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -83.6 22.76 1.03 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -151.07 -31.26 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 176.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 m -87.06 -85.78 0.16 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.36 -5.33 9.87 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -126.41 23.48 6.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 19.3 pttp -69.89 -15.42 63.07 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.351 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -116.26 15.9 15.86 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.652 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -131.97 -110.46 0.24 Allowed 'General case' 0 N--CA 1.4 -2.962 0 C-N-CA 119.909 -0.717 . . . . 0.0 110.984 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 112' ' ' ILE . 92.9 t -55.51 129.45 16.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 123.499 0.72 . . . . 0.0 111.853 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 26' ' ' LYS . 96.0 t -114.48 123.99 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.022 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.5 mm -89.33 118.55 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -126.14 165.9 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -155.83 144.72 20.49 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 122.077 -0.389 . . . . 0.0 110.744 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.405 HG12 HD11 ' A' ' 30' ' ' ILE . 11.7 p -127.05 145.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.78 111.89 22.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.11 -14.7 61.02 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.409 ' HB ' ' CZ ' ' A' ' 82' ' ' PHE . 9.9 t -107.98 -6.27 16.68 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.258 0.551 . . . . 0.0 111.492 -175.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.05 -48.26 2.99 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.582 ' HB3' ' H ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -100.56 101.1 11.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.09 117.12 8.68 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.091 0.472 . . . . 0.0 110.886 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.24 150.0 36.32 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.626 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -89.94 -4.41 5.32 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.029 2.486 . . . . 0.0 112.273 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.43 144.87 53.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.856 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.48 113.29 22.3 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.641 0.734 . . . . 0.0 109.455 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.522 HG23 ' OG1' ' A' ' 84' ' ' THR . 55.3 mt -106.32 144.93 14.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.373 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -80.78 -17.24 51.56 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.885 0.85 . . . . 0.0 111.318 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.489 ' H ' HG22 ' A' ' 79' ' ' ILE . . . -144.38 -112.19 0.81 Allowed Glycine 0 C--N 1.278 -2.673 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.541 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 48.2 t80 -123.21 -54.68 0.03 OUTLIER Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.28 171.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.9 Cg_endo -89.36 155.06 5.48 Favored 'Trans proline' 0 N--CA 1.429 -2.284 0 CA-C-N 120.307 1.145 . . . . 0.0 110.324 170.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.522 ' OG1' HG23 ' A' ' 79' ' ' ILE . 15.9 m -165.84 143.3 5.56 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.7 mt -105.86 133.57 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 94.4 mttt -135.95 124.02 22.92 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.193 0.52 . . . . 0.0 110.392 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -98.47 115.33 28.3 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -95.92 98.16 3.67 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.55 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -68.54 158.32 58.16 Favored 'Trans proline' 0 CA--C 1.461 -3.145 0 C-N-CA 121.586 1.524 . . . . 0.0 110.302 178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.91 77.47 8.73 Favored 'General case' 0 N--CA 1.402 -2.834 0 C-N-CA 118.632 -1.227 . . . . 0.0 107.974 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.95 -34.1 0.44 Allowed Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.915 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -120.65 35.98 4.71 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.109 0.957 . . . . 0.0 109.963 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.12 2.73 1.4 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 125.523 1.529 . . . . 0.0 112.126 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.15 25.94 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.406 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 4.0 pt20 -137.34 54.52 8.34 Favored Pre-proline 0 CA--C 1.578 2.034 0 C-N-CA 123.724 0.809 . . . . 0.0 110.808 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 12.9 Cg_exo -45.06 160.61 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 125.014 3.809 . . . . 0.0 115.137 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 115' ' ' ASN . 24.8 t -94.4 98.6 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.329 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.472 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 14.2 t -73.52 132.49 42.93 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.651 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.71 164.41 30.29 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.184 -174.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -87.35 -68.55 0.74 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.74 129.17 1.26 Allowed Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -71.63 -37.19 70.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 117.195 0.498 . . . . 0.0 110.821 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 65.96 17.43 10.8 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.284 1.033 . . . . 0.0 111.375 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -150.18 161.7 41.89 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 46' ' ' LYS . 61.8 t -86.2 -43.23 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.04 0.447 . . . . 0.0 109.955 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -54.4 -39.36 67.18 Favored 'General case' 0 N--CA 1.396 -3.165 0 C-N-CA 126.188 1.795 . . . . 0.0 112.665 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.6 t70 -80.75 -23.38 39.45 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.511 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.584 HD22 HD21 ' A' ' 29' ' ' LEU . 17.3 mt -74.7 -41.6 59.91 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.713 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.6 mt -58.62 -51.52 70.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 45.5 tptt -65.8 -21.34 66.48 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.029 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.606 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -68.22 -65.51 0.69 Allowed 'General case' 0 C--O 1.186 -2.27 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.569 HG21 HG11 ' A' ' 63' ' ' VAL . 3.1 mt -67.72 -12.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.517 1.151 . . . . 0.0 108.806 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -87.77 -22.2 24.69 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.05 -176.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -114.78 -35.39 4.84 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 122.261 1.029 . . . . 0.0 109.166 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.606 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 57.6 m-80 -88.97 -21.93 23.29 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 113.342 -1.754 . . . . 0.0 109.478 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -83.16 163.9 41.79 Favored Glycine 0 N--CA 1.404 -3.452 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.749 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.55 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 12.0 mmmm -93.68 -24.71 17.76 Favored 'General case' 0 CA--C 1.457 -2.61 0 CA-C-N 118.228 1.014 . . . . 0.0 108.406 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.51 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 20.6 m-85 -81.41 -14.0 57.64 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.549 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 54.68 55.91 7.37 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 123.989 0.806 . . . . 0.0 109.101 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.65 82.18 0.43 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.265 1.892 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.626 176.698 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.993 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -82.55 115.99 2.56 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.145 1.896 . . . . 0.0 111.572 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.5 -35.72 58.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.79 144.01 3.93 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.571 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.9 m 68.43 9.16 7.1 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.104 0.962 . . . . 0.0 112.464 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -97.36 96.02 8.08 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.044 0.925 . . . . 0.0 108.867 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.56 77.91 0.9 Allowed Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -170.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 17.8 Cg_endo -57.64 -42.03 64.58 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 123.599 2.866 . . . . 0.0 111.481 -175.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.6 p -70.44 118.61 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.904 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.926 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 m -63.23 107.11 0.99 Allowed 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.571 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.404 HG22 ' HE3' ' A' ' 67' ' ' LYS . 44.7 t -79.99 109.82 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 16' ' ' ASN . 21.0 t -109.23 128.77 64.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.744 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.568 HG23 ' HB3' ' A' ' 15' ' ' LYS . 18.9 m -75.27 166.94 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 73' ' ' ASN . . . -60.99 -21.72 63.82 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 110.587 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' HG23 ' A' ' 13' ' ' VAL . 46.0 tptt -62.44 -52.87 61.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.34 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -95.56 -3.33 46.69 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.524 -174.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -24.05 43.05 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -87.96 -8.89 55.04 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 10.8 mt-10 -104.53 -51.74 3.03 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.363 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.63 -51.12 14.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.361 -175.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.591 ' HA ' HG11 ' A' ' 28' ' ' VAL . 60.3 t -83.31 -28.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.88 0.848 . . . . 0.0 110.709 -172.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.56 26.35 6.22 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.212 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.72 141.32 28.6 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.574 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 8.7 p-10 -109.0 21.64 16.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.4 p -93.07 -17.41 23.86 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.679 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.09 166.05 30.94 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 73.8 m-20 -80.52 130.42 35.13 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' ' 21' ' ' VAL . 24.8 t -119.69 118.4 57.06 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.334 -0.854 . . . . 0.0 112.005 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 108' ' ' LEU . 9.4 mt -87.8 116.34 25.88 Favored 'General case' 0 CA--C 1.473 -1.983 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 21' ' ' VAL . 12.6 tt -106.07 145.23 14.23 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 118.089 -1.445 . . . . 0.0 110.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 67' ' ' LYS . 37.1 tt0 -127.94 109.59 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 84' ' ' THR . 95.9 m-85 -73.01 128.38 35.29 Favored 'General case' 0 CA--C 1.465 -2.305 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.528 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 27.3 p90 -142.76 -170.95 3.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 124.014 0.821 . . . . 0.0 111.242 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -148.34 144.61 18.88 Favored Pre-proline 0 C--N 1.289 -2.06 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.56 -22.52 12.1 Favored 'Trans proline' 0 CA--C 1.503 -1.041 0 C-N-CA 121.629 1.553 . . . . 0.0 110.419 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -97.36 3.58 51.02 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 113.129 -1.85 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.579 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 36.7 t -77.76 129.31 35.33 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.62 99.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.554 ' O ' HD13 ' A' ' 43' ' ' LEU . 8.5 m-70 -65.42 -44.34 87.69 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.092 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 35.4 t -56.48 -41.15 76.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.201 0.524 . . . . 0.0 110.519 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 55.8 mtmt -73.17 -2.75 22.88 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.013 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -107.37 -18.65 13.81 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.857 1.313 . . . . 0.0 108.411 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.6 mp -96.93 -11.02 25.18 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.504 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -46.89 47.55 Favored Pre-proline 0 C--N 1.278 -2.518 0 C-N-CA 125.754 1.621 . . . . 0.0 113.935 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -60.51 -29.54 88.83 Favored 'Trans proline' 0 C--N 1.381 2.253 0 CA-C-N 120.983 1.387 . . . . 0.0 111.926 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 2.6 pttm -84.56 -31.48 24.35 Favored 'General case' 0 C--O 1.188 -2.167 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.742 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -79.3 -33.37 43.33 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.003 -174.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 35.3 mm-40 -70.04 -48.19 58.94 Favored 'General case' 0 C--O 1.185 -2.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.7 tt0 -71.41 -47.41 56.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.211 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.58 -39.3 73.97 Favored 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.55 95.27 Favored Glycine 0 CA--C 1.467 -2.945 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.86 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.24 -55.73 22.47 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 95.9 mt -56.7 -43.62 80.71 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.665 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -78.89 -41.88 28.63 Favored 'General case' 0 C--O 1.194 -1.825 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.6 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.67 16.58 6.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 6.3 tppt? -128.46 -36.87 1.85 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.127 -0.358 . . . . 0.0 110.523 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 10.5 m -87.42 -168.4 2.22 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -174.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -74.78 22.97 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.404 0.621 . . . . 0.0 112.567 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -120.96 2.1 10.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 57' ' ' SER . 58.8 pttt -74.75 -0.27 17.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.017 0.913 . . . . 0.0 112.242 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -120.21 4.53 10.81 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.672 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 76.6 ttt180 -99.15 -48.89 4.68 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.757 1.265 . . . . 0.0 107.734 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.533 HG21 HG21 ' A' ' 112' ' ' ILE . 2.5 p -147.57 138.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.175 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' A' ' 26' ' ' LYS . 78.2 t -117.07 131.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.435 ' C ' HG23 ' A' ' 9' ' ' VAL . 37.9 mm -93.41 119.11 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.94 165.76 18.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.358 0.599 . . . . 0.0 111.907 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 31' ' ' GLU . 56.1 mtmt -143.96 160.61 40.53 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.405 ' CG1' HD11 ' A' ' 30' ' ' ILE . 9.4 p -144.68 144.62 21.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 172.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -88.18 118.41 27.75 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.18 54.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.025 0.53 . . . . 0.0 111.907 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -119.63 -23.63 6.49 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.602 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.49 -24.3 14.82 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -118.77 97.49 5.74 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.73 111.88 1.14 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.151 0.501 . . . . 0.0 111.258 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 14' ' ' ALA . 35.8 m -99.32 143.22 26.01 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.932 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -94.09 2.18 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.326 2.684 . . . . 0.0 109.981 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -80.14 165.58 22.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.32 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -88.65 123.38 33.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.422 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.8 mm -105.43 140.43 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.627 1.171 . . . . 0.0 108.125 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.9 -29.21 16.03 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.36 0.6 . . . . 0.0 110.479 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.01 -108.5 1.15 Allowed Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 t80 -117.82 -53.16 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 166.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 3.2 Cg_exo -90.45 162.2 4.45 Favored 'Trans proline' 0 N--CA 1.43 -2.245 0 C-N-CA 121.151 1.234 . . . . 0.0 109.244 164.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.427 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 97.8 m -161.32 141.13 10.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 33.9 mt -106.36 128.97 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 30' ' ' ILE . 41.2 mtmt -135.34 129.18 33.02 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 121.292 0.568 . . . . 0.0 109.645 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.4 tm? -100.38 117.7 35.11 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -98.98 97.55 5.21 Favored Pre-proline 0 C--N 1.291 -1.978 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.604 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 14.3 Cg_endo -68.03 160.68 47.56 Favored 'Trans proline' 0 CA--C 1.464 -2.989 0 C-N-CA 121.973 1.782 . . . . 0.0 111.746 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.54 77.43 8.4 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 122.638 1.208 . . . . 0.0 108.564 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.02 -39.25 0.56 Allowed Glycine 0 C--N 1.285 -2.287 0 CA-C-N 113.107 -1.861 . . . . 0.0 109.915 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 94' ' ' GLY . . . -113.66 31.23 6.66 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.492 0.663 . . . . 0.0 110.864 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -64.72 13.61 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.658 1.183 . . . . 0.0 113.677 177.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -108.03 -13.08 20.72 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -140.03 70.27 35.24 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 123.981 0.912 . . . . 0.0 108.558 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.4 Cg_exo -49.31 160.24 0.96 Allowed 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 123.926 3.084 . . . . 0.0 113.428 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.461 HG11 ' OD1' ' A' ' 115' ' ' ASN . 54.1 t -100.53 104.16 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.43 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.451 ' HA ' ' HG2' ' A' ' 86' ' ' LYS . 8.7 t -75.23 132.19 40.91 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.632 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 146.53 39.66 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.714 -175.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.2 p -73.69 -59.31 2.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.491 0.662 . . . . 0.0 110.49 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.55 125.69 0.85 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 15.2 m -71.06 -41.54 70.6 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 60.99 26.09 16.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 122.371 1.081 . . . . 0.0 108.93 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.7 t -161.51 157.37 24.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.908 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 46' ' ' LYS . 58.1 t -83.9 -37.12 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 124.18 0.992 . . . . 0.0 110.005 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -57.78 -45.16 86.37 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.277 1.036 . . . . 0.0 110.918 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 33.9 t70 -68.32 -31.0 70.11 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.794 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 29' ' ' LEU . 27.8 mt -72.16 -42.75 65.58 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.311 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.61 -51.05 70.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -66.19 -21.5 66.32 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.88 -178.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.4 OUTLIER -69.98 -61.33 1.82 Allowed 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -69.48 -9.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.579 1.181 . . . . 0.0 108.281 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -91.04 -24.4 20.06 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.869 -177.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -104.4 -39.7 6.35 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-O 123.225 1.488 . . . . 0.0 108.71 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 59.3 m-80 -95.6 -26.14 15.88 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.432 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.36 157.63 40.75 Favored Glycine 0 N--CA 1.403 -3.525 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.922 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.604 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 4.3 mmmp? -88.39 -27.28 21.7 Favored 'General case' 0 CA--C 1.466 -2.251 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.474 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 26.0 m-85 -79.98 -11.2 59.81 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.242 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 55.32 45.9 24.6 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 124.244 0.965 . . . . 0.0 109.396 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . . . -67.05 86.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.005 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.11 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.546 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.1 -46.69 30.95 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.996 3.13 . . . . 0.0 114.543 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.9 -17.83 45.85 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.658 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.96 16.12 61.75 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.953 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 m -82.32 69.65 9.1 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.676 0.751 . . . . 0.0 109.865 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -73.95 -32.59 63.56 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.24 101.74 2.29 Favored Glycine 0 N--CA 1.404 -3.445 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 43.5 Cg_endo -70.78 -35.44 9.63 Favored 'Trans proline' 0 CA--C 1.503 -1.048 0 C-N-CA 122.384 2.056 . . . . 0.0 110.572 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.4 p -83.65 137.66 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.1 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.929 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 m -75.01 93.92 2.79 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 122.248 1.023 . . . . 0.0 110.378 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.23 104.52 3.59 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.386 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 13' ' ' VAL . 23.4 t -102.21 141.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.599 HG23 ' HB3' ' A' ' 15' ' ' LYS . 20.6 m -85.24 170.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.93 -31.22 69.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.073 0.463 . . . . 0.0 110.294 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.599 ' HB3' HG23 ' A' ' 13' ' ' VAL . 29.4 tttm -53.93 -39.79 66.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.152 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -110.45 -2.54 16.51 Favored 'General case' 0 C--O 1.208 -1.109 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.744 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -58.6 -30.93 67.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -77.93 -13.19 59.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 12.3 pt-20 -106.57 -44.75 4.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.404 1.097 . . . . 0.0 111.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.441 HG12 ' HG3' ' A' ' 19' ' ' GLU . 19.0 mm -79.16 -54.88 10.81 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.917 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.677 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.634 HG21 HD13 ' A' ' 30' ' ' ILE . 60.1 t -84.72 -29.66 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 121.62 0.724 . . . . 0.0 111.304 -173.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.94 32.37 2.41 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.703 ' OD2' HG22 ' A' ' 25' ' ' THR . 30.6 t70 -96.57 150.01 21.13 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.162 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -116.86 20.33 13.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.703 HG22 ' OD2' ' A' ' 23' ' ' ASP . 13.9 t -98.64 -3.67 35.58 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.475 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -150.9 161.99 41.64 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 77.1 m-20 -81.46 128.13 33.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.606 HG11 ' HA ' ' A' ' 21' ' ' VAL . 21.2 t -118.04 121.62 67.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.148 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HG ' HD23 ' A' ' 87' ' ' LEU . 9.9 mt -90.31 116.79 28.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.634 HD13 HG21 ' A' ' 21' ' ' VAL . 1.5 tp -104.45 145.28 13.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.615 ' N ' HG13 ' A' ' 30' ' ' ILE . 41.2 tt0 -126.39 104.34 8.12 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 124.151 0.907 . . . . 0.0 108.589 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 84' ' ' THR . 98.3 m-85 -76.34 128.03 34.04 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -142.47 -175.39 4.44 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.949 0.881 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -138.36 153.25 72.68 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 174.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 59.8 Cg_endo -84.16 -14.78 7.0 Favored 'Trans proline' 0 C--N 1.326 -0.607 0 CA-C-N 121.8 1.678 . . . . 0.0 110.665 -173.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.42 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 56.3 p-90 -96.64 4.58 51.83 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.624 -1.626 . . . . 0.0 111.772 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 39' ' ' HIS . 46.4 t -80.63 121.57 26.0 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.628 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.83 92.85 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 46.5 m80 -60.72 -45.26 94.95 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 15.0 p -70.74 -25.7 63.04 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.952 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 56.3 mtmt -74.48 -20.59 59.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.6 0.714 . . . . 0.0 110.228 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.36 -9.83 37.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.672 1.225 . . . . 0.0 108.248 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.589 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 81.0 mt -97.83 -11.92 22.75 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.036 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.45 -50.5 73.15 Favored Pre-proline 0 C--N 1.255 -3.509 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.546 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.13 -16.5 31.9 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 121.453 1.435 . . . . 0.0 113.052 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 43' ' ' LEU . 8.8 ptmm? -86.58 -38.49 17.09 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -82.11 -26.51 33.51 Favored 'General case' 0 N--CA 1.396 -3.13 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.117 -171.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 42.4 mt-10 -77.58 -33.08 54.01 Favored 'General case' 0 C--O 1.18 -2.583 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.241 175.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -83.45 -47.86 10.94 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.523 HD22 HD13 ' A' ' 108' ' ' LEU . 7.0 tp -64.64 -46.25 83.33 Favored 'General case' 0 CA--C 1.469 -2.147 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -77.75 -20.54 73.63 Favored Glycine 0 CA--C 1.474 -2.505 0 CA-C-N 114.172 -1.376 . . . . 0.0 114.987 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -71.7 -50.41 30.62 Favored 'General case' 0 CA--C 1.477 -1.856 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.59 -45.13 69.33 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.165 -173.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 42.2 m-85 -74.91 -27.67 60.31 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' GLY . . . -107.88 16.1 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -136.86 -33.05 0.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.441 -0.162 . . . . 0.0 111.163 176.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 22.2 m -84.62 -164.31 0.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -77.81 28.06 0.17 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.9 3.52 5.97 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 22.6 pttp -72.56 -12.56 61.11 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.805 0.812 . . . . 0.0 111.048 -174.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -109.85 5.65 22.73 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -106.22 -49.77 3.29 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.372 1.082 . . . . 0.0 109.1 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG21 HG21 ' A' ' 112' ' ' ILE . 2.5 p -138.82 135.58 43.0 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.172 -1.831 . . . . 0.0 109.309 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 26' ' ' LYS . 75.6 t -112.58 127.28 69.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 9' ' ' VAL . 31.8 mm -90.56 121.19 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.656 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -130.06 161.37 31.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.282 0.563 . . . . 0.0 111.701 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' ' HD2' ' A' ' 47' ' ' TYR . 14.5 ptmt -152.03 145.29 24.69 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.414 HG12 HD11 ' A' ' 30' ' ' ILE . 7.6 p -129.83 139.69 50.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 109.71 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -82.18 101.48 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.39 -9.08 58.38 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.389 1.075 . . . . 0.0 112.412 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 t -105.84 -19.72 13.66 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.726 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.36 -42.76 9.12 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -113.11 102.77 10.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.012 -1.449 . . . . 0.0 107.529 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -67.71 135.1 52.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.91 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 32' ' ' PHE . 29.7 m -113.53 143.23 28.99 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.26 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.05 -8.57 16.59 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 123.303 2.669 . . . . 0.0 113.759 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.45 174.2 10.84 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -100.91 139.91 35.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.399 0.619 . . . . 0.0 109.626 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.596 HG23 ' OG1' ' A' ' 84' ' ' THR . 59.5 mt -123.39 117.06 50.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -74.85 -9.41 58.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.56 -140.11 4.9 Favored Glycine 0 C--N 1.3 -1.433 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.559 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 4.9 t80 -100.54 -50.44 0.19 Allowed Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -92.58 171.12 2.41 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 121.097 1.198 . . . . 0.0 110.291 167.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.596 ' OG1' HG23 ' A' ' 79' ' ' ILE . 3.1 m -169.17 146.8 3.67 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 49.7 mt -110.63 140.5 29.48 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.324 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' HG22 ' A' ' 30' ' ' ILE . 65.7 mttm -140.26 127.6 21.26 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.481 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.1 tm? -102.07 111.95 24.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -94.75 101.9 7.89 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HB2' ' HG3' ' A' ' 117' ' ' LYS . 11.8 Cg_endo -65.65 161.03 40.5 Favored 'Trans proline' 0 CA--C 1.464 -2.986 0 C-N-CA 121.658 1.572 . . . . 0.0 110.051 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 117' ' ' LYS . . . -81.5 77.5 8.36 Favored 'General case' 0 N--CA 1.395 -3.207 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.887 173.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.38 -45.31 0.41 Allowed Glycine 0 N--CA 1.415 -2.711 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.909 171.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -104.62 58.47 0.7 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.856 0.836 . . . . 0.0 111.166 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -69.78 -2.89 13.29 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.878 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' C ' ' HD3' ' A' ' 96' ' ' PRO . . . -116.85 1.5 19.79 Favored Glycine 0 CA--C 1.497 -1.093 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.652 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 14.8 mt-30 -135.58 45.79 1.49 Allowed Pre-proline 0 CA--C 1.552 1.019 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 72.7 Cg_exo -60.11 159.28 26.66 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.773 2.315 . . . . 0.0 112.296 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 115' ' ' ASN . 13.5 t -97.15 91.14 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t -72.89 130.3 40.08 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.03 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.36 171.9 13.5 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 125.192 1.397 . . . . 0.0 108.798 -170.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.2 m -107.28 -62.28 1.44 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.207 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.45 127.77 1.35 Allowed Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.901 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.8 m -98.22 -27.62 14.07 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.756 0.313 . . . . 0.0 111.21 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 61.93 12.63 4.98 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.841 1.256 . . . . 0.0 112.095 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -138.15 158.13 44.93 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 121.776 -0.578 . . . . 0.0 110.971 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.97 -34.38 6.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 124.277 1.031 . . . . 0.0 109.597 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -57.19 -47.9 80.11 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.105 1.362 . . . . 0.0 110.136 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 22.6 t70 -70.15 -29.11 65.93 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.642 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 50' ' ' LEU . 22.2 mt -74.41 -39.66 62.49 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.3 mt -56.31 -54.11 31.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.5 tptp -64.61 -21.91 66.83 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.546 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 2.2 t80 -69.62 -64.83 0.8 Allowed 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.517 HG21 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -65.58 -16.68 20.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.758 1.266 . . . . 0.0 108.272 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.43 -19.16 31.74 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.459 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 31.7 mt-10 -115.3 -44.86 2.96 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.963 0.887 . . . . 0.0 109.694 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 52.0 m-80 -79.33 -26.81 42.12 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.563 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.64 162.48 41.46 Favored Glycine 0 N--CA 1.404 -3.439 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 43.1 mtpt -96.99 -21.79 17.21 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.184 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.517 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.7 m-85 -77.56 -17.45 57.87 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.309 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 57.76 47.33 15.71 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 124.001 0.813 . . . . 0.0 109.504 175.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.23 96.28 1.38 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.11 -173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.21 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.682 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.84 107.68 1.35 Allowed 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.711 2.274 . . . . 0.0 112.003 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.1 tp -88.65 122.59 32.25 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.602 0.715 . . . . 0.0 109.994 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.58 178.31 32.48 Favored Glycine 0 N--CA 1.421 -2.334 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 m -84.69 -52.61 5.95 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 118.397 1.098 . . . . 0.0 109.868 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.52 -22.04 15.66 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.797 0.808 . . . . 0.0 109.857 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.35 178.24 15.23 Favored Glycine 0 C--N 1.294 -1.776 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.352 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 24.6 Cg_endo -66.57 -41.39 11.55 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.885 2.39 . . . . 0.0 110.787 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.6 p -71.37 131.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.339 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 13.7 m -69.58 102.89 1.94 Allowed 'General case' 0 N--CA 1.415 -2.225 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.958 -175.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.55 113.79 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 16' ' ' ASN . 57.7 t -113.28 119.13 59.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 15' ' ' LYS . 28.7 m -71.45 170.45 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -26.19 67.58 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 110.79 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB3' HG23 ' A' ' 13' ' ' VAL . 2.8 tppp? -60.74 -53.04 62.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.759 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.662 ' HB2' HG13 ' A' ' 12' ' ' VAL . 39.7 m-20 -86.43 -15.52 40.02 Favored 'General case' 0 CA--C 1.478 -1.794 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.257 -169.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -53.55 -32.23 49.85 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 4.2 p30 -75.05 -18.46 60.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 13.0 pt-20 -105.81 -45.64 4.33 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.161 0.981 . . . . 0.0 111.311 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.474 HG12 ' HG3' ' A' ' 19' ' ' GLU . 26.3 mm -78.25 -55.8 9.15 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.108 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.93 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.649 ' HA ' HG11 ' A' ' 28' ' ' VAL . 63.4 t -80.0 -35.91 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 111.495 -174.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -96.39 37.52 1.26 Allowed 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.42 155.57 29.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.709 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -115.67 5.27 14.24 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 t -124.5 14.22 8.82 Favored 'General case' 0 C--O 1.249 1.078 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.875 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -153.18 148.19 26.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 118' ' ' TYR . 79.4 m-20 -80.63 119.32 23.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.649 HG11 ' HA ' ' A' ' 21' ' ' VAL . 17.4 t -115.91 121.64 67.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.757 HD21 HD22 ' A' ' 108' ' ' LEU . 19.1 tp -94.36 117.89 30.8 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 21' ' ' VAL . 11.6 tt -112.26 145.79 17.89 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 C-N-CA 117.571 -1.652 . . . . 0.0 111.346 176.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' OE2' HD23 ' A' ' 43' ' ' LEU . 34.5 tt0 -127.55 108.21 10.6 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HD1' ' O ' ' A' ' 84' ' ' THR . 91.5 m-85 -69.31 130.08 41.59 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.662 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 34.2 p90 -144.28 -172.57 3.81 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.608 0.718 . . . . 0.0 111.454 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -153.33 150.43 23.63 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -78.16 -24.85 7.75 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 121.607 1.538 . . . . 0.0 109.184 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -93.6 15.02 17.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 112.984 -1.916 . . . . 0.0 111.757 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 43.2 t -95.3 120.2 35.13 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.112 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.11 -35.01 82.63 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.643 ' O ' HD13 ' A' ' 43' ' ' LEU . 10.1 t60 -60.47 -53.21 60.24 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 33' ' ' TYR . 11.8 t -54.65 -40.42 68.99 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -67.72 -12.27 60.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.93 -10.4 24.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.762 1.267 . . . . 0.0 108.708 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 39' ' ' HIS . 10.8 mp -101.52 -17.62 16.32 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.722 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.95 -41.86 48.46 Favored Pre-proline 0 C--N 1.283 -2.316 0 C-N-CA 124.435 1.094 . . . . 0.0 113.225 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 35.7 Cg_endo -63.99 -20.26 67.59 Favored 'Trans proline' 0 C--N 1.385 2.454 0 CA-C-N 120.739 1.3 . . . . 0.0 112.383 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 47' ' ' TYR . 1.6 pttm -91.03 -32.73 15.79 Favored 'General case' 0 C--O 1.173 -2.963 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -73.32 -37.02 66.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.363 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.31 -17.34 46.15 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -87.84 -45.25 10.45 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 8.3 tp -69.59 -46.44 66.31 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.84 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.13 -31.01 71.77 Favored Glycine 0 CA--C 1.465 -3.034 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.996 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -62.56 -52.47 63.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 1.6 pp -64.21 -42.27 96.69 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.727 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.532 ' OH ' ' HA ' ' A' ' 109' ' ' ILE . 19.3 m-85 -66.97 -43.93 81.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.171 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . . . -93.55 16.12 14.44 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 3.3 tppt? -131.95 -26.07 1.99 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.681 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 29.1 t -85.53 -170.61 3.2 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.742 0.306 . . . . 0.0 110.181 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -72.42 12.21 0.5 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.872 1.269 . . . . 0.0 113.552 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.432 ' CE2' ' HA ' ' A' ' 54' ' ' TYR . 11.5 p90 -132.04 11.17 4.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 57' ' ' SER . 21.9 pttp -67.36 -13.31 61.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.016 0.912 . . . . 0.0 111.463 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.54 17.5 19.17 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.075 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HE ' ' HB3' ' A' ' 118' ' ' TYR . 16.4 ttp180 -125.7 -45.14 1.78 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 122.546 1.165 . . . . 0.0 108.963 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.631 HG21 HG21 ' A' ' 112' ' ' ILE . 1.7 p -131.88 143.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 C-N-CA 126.556 1.942 . . . . 0.0 108.142 173.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.51 130.6 70.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 9' ' ' VAL . 46.2 mm -89.37 117.17 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 30' ' ' ILE . . . -123.62 161.16 25.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.34 143.12 22.92 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 30' ' ' ILE . 7.8 p -123.33 139.31 50.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.403 ' HB3' ' ND2' ' A' ' 73' ' ' ASN . 10.0 t0 -83.09 109.48 17.19 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.29 -11.73 59.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.193 0.933 . . . . 0.0 112.413 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 t -106.59 -27.09 11.07 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.656 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.29 -34.27 17.74 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 69' ' ' ASP . 8.1 m-80 -119.08 104.09 10.14 Favored 'General case' 0 N--CA 1.403 -2.784 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.74 118.8 13.06 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.302 0.572 . . . . 0.0 110.588 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.23 145.62 31.89 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.702 -174.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.1 -8.73 12.99 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.1 2.533 . . . . 0.0 111.282 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.82 -172.72 4.13 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.088 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.74 129.96 56.23 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.186 0.517 . . . . 0.0 110.67 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -84.14 129.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.71 -22.81 22.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.397 0.618 . . . . 0.0 110.837 -174.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.99 -105.42 0.62 Allowed Glycine 0 C--N 1.31 -0.899 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.64 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 47.6 t80 -117.82 -57.34 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 4.3 Cg_exo -91.5 164.41 3.53 Favored 'Trans proline' 0 N--CA 1.418 -2.963 0 N-CA-C 108.54 -1.369 . . . . 0.0 108.54 162.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.484 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 98.9 m -153.64 135.27 14.4 Favored 'General case' 0 C--N 1.27 -2.848 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.933 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 34.1 mt -98.9 136.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 30' ' ' ILE . 45.7 mtpt -139.19 117.38 11.86 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 3.3 tm? -96.89 114.41 26.03 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -97.64 96.72 3.42 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.592 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . 12.1 Cg_endo -68.78 158.98 55.64 Favored 'Trans proline' 0 CA--C 1.461 -3.173 0 C-N-CA 121.841 1.694 . . . . 0.0 111.143 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 77.34 8.23 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.79 -27.09 0.58 Allowed Glycine 0 C--N 1.298 -1.58 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.113 173.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.479 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -124.64 31.72 5.63 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.833 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -64.44 13.24 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 124.815 1.246 . . . . 0.0 112.963 176.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 92' ' ' ALA . . . -109.77 -12.54 18.43 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -147.7 71.72 11.56 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 34.9 Cg_exo -49.3 163.33 0.39 Allowed 'Trans proline' 0 C--O 1.25 1.104 0 C-N-CA 124.291 3.327 . . . . 0.0 113.824 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 115' ' ' ASN . 28.8 t -97.5 102.23 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 t -81.1 128.74 34.07 Favored 'General case' 0 N--CA 1.427 -1.619 0 O-C-N 124.206 0.941 . . . . 0.0 109.981 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.04 158.01 45.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.47 -173.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -90.18 -3.25 57.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.432 0.634 . . . . 0.0 110.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' HA3' HD21 ' A' ' 43' ' ' LEU . . . 108.2 117.14 4.08 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -68.71 -33.05 73.28 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 65.73 13.61 9.06 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.509 1.147 . . . . 0.0 110.953 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 107' ' ' ASP . 5.7 t -143.3 155.14 44.39 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.43 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 46' ' ' LYS . 92.5 t -82.33 -39.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 124.958 1.303 . . . . 0.0 110.419 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -59.32 -44.75 92.56 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 121.937 0.875 . . . . 0.0 111.282 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 36.2 t70 -70.3 -25.76 63.47 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.956 -177.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.757 HD22 HD21 ' A' ' 29' ' ' LEU . 18.4 mt -77.89 -38.98 44.63 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.532 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 69.8 mt -59.06 -50.07 81.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 20.8 tptp -63.49 -24.9 68.02 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.102 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.602 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.5 t80 -68.77 -65.49 0.7 Allowed 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.631 HG21 HG21 ' A' ' 63' ' ' VAL . 3.4 mt -66.7 -14.33 17.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.49 1.138 . . . . 0.0 108.743 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . . . -91.18 -11.93 36.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.485 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 110' ' ' LYS . 46.8 mt-10 -120.42 -41.45 2.61 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.202 1.001 . . . . 0.0 109.384 174.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.602 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 55.9 m-80 -86.07 -24.6 26.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.652 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.17 168.18 51.67 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.592 ' HG2' ' HB2' ' A' ' 89' ' ' PRO . 13.4 mmmm -100.2 -24.64 14.51 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.883 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.45 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 13.5 m-85 -84.39 -12.76 53.88 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.899 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 35.0 mmtp 52.82 59.68 4.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 124.304 1.002 . . . . 0.0 110.016 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.42 81.52 0.78 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.779 . . . . . . . . 0 0 . 1 stop_ save_